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SYNTHETIC EFFORTS TOWARD IRCINIASTATIN ANALOGUES AND NAHUOIC 
ACIDS; DEVELOPMENT OF ANION RELAY CHEMISTRY TACTIC  
Qi Liu 
Amos B. Smith, III 
 
Polyketides constitute a group of highly structurally diverse and biologically active 
natural products. Synthetic efforts toward two families of polyketides, namely irciniastatins 
and nahuoic acids, are represented in this thesis, in conjunction with the development of 
Anion Relay Chemistry (ARC) tactic as a useful tool for polyketide construction.  
Chapter one describes the design and synthesis of seven novel irciniastatin 
analogues, achieved by structural simplification of the tetrahydropyran core as well as by 
functional group variation of the C(11) substituent of irciniastatin A. These analogues are 
in turn evaluated against several cancer cell lines; all possess antiproliferative activity in 
nanomolar range. 
Chapter two describes the extension of the ARC tactic to achieve effective [1,5]-
vinyl Brook rearrange via incorporation of conformational constraints. Three types of 
restrained linchpins are designed, synthesized and validated for both alkylation and cross 
coupling reactions. Density Functional Theory (DFT) calculation also provides insight into 




Chapter three presents the first total synthesis of a member of the nahuoic acid 
family, namely Ci(Bii), in a longest linear sequence of 16 steps. Nahuoic acids are highly 
hydroxylated and cis-decalin-scaffold-containing polyketides. These acids are the first 
series of natural products isolated to date that exhibit S-adenosylemethionine (SAM) 
competitive inhibition activity against SETD8 enzyme. Our synthesis highlights a 
titanium-catalyzed asymmetric Diels–Alder reaction to generate the cis-decalin skeleton, 
Type II ARC tactic to construct the polyol chain, and a late-stage strategic large fragment 
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CHAPTER 1 DESIGN, SYNTHESIS AND EVALUATION OF 
IRCINIASTATIN ANALOGUES: SIMPLIFICATION OF THE 
TETRAHYDROPYRAN CORE AND THE C(11) SUBSTITUENTS 
Adapated with permission from Liu, Q.; An, C.; TenDyke, K.; Cheng, H.; Shen, Y. 
Y.; Hoye, A. T.; Smith, A. B., III. “Design, Synthesis and Evaluation of Irciniastatin 
Analogues: Simplification of the Tetrahydropyran Core and the C(11) 
Substituents”Journal of Organic Chemistry. 2016, 81, 1930-1942. Open access article 
published under an ACS AuthorChoice License. Author Attributions: Q.L. designed and 
performed experiments and analyzed experimental data toward the synthesis of the (8)-
desmethoxy-C(11)-deoxy-C(12)-di-desmethyl-irciniastatin analogue. C.A. designed and 
performed experiments and analyzed experimental data toward the synthesis of C(11) 
substituted irciniastatin A analogues. K.T., H.C and Y.Y.S. designed and performed the 
biological evaluations of the irciniastatin analogues. A.T.H and A.B.S. contributed to the 
design of the irciniastatin analogues and discussions of experiments. A.B.S directed the 
investigations. All authors contributed to the preparation of the manuscript. 
1.1 Introduction 
The irciniastatins (Figure 1.1), potent architecturally intriguing marine cytotoxins, 
have attracted considerable interest due to their highly selective profiles toward numerous 
cancer cell lines. Irciniastatin A and irciniastatin B [(+)-1.1 and (–)-1.2] were initially 
isolated by Pettit,1 followed within months by psymberin independently isolated by Crews; 
  2 
2 the later was confirmed to be (+)-irciniastatin A (1.1). We have retained the family name 
irciniastatin, given the initial isolation and naming by Pettit.   
Structurally related to the irciniastatins are congeners from the pederin family (e.g. 
1.3).3,4 Common features of the pederin family are the acid-labile N,O-aminal group, in 
conjunction with the highly substituted 2,6-trans-tetrahydropyran core. The 
dihydroisocoumarin motif however was only found in the irciniastatins.4 Despite the 
structural similarities, (+)-irciniastatin A (1.1) was initially reported to display significant 
differential activities (>10,000-fold) against a wide range of cancer cell lines, which was 
not observed for other members of the pederin family.2 Taken together, the initial structural 
and biological studies suggest that the observed differential cytotoxicity of the irciniastatins 
might arise via a novel mode of action. 
 
Figure 1.1 Structures of the Irciniastatins and Pederin 
Although (+)-irciniastatin A (1.1) and (–)-irciniastatin B (1.2) possess almost 
identical chemical structures, (–)-irciniastatin B (1.2) is reported to be 10 times more 
cytotoxic compared to (+)-irciniastatin A (1.1) against three cell lines: human pancreas 
(BXPC-3), breast (MCF-7), and glioblastoma (SF268).1 The disparity in biological activity 
between 1 and 2, given only a single oxidation state difference at C(11), is further enhanced 













































  3 
that the C(11)-deoxy congener (1.4) was 3-10 times more cytotoxic than (+)-irciniastatin 
A (1.1). This observation suggests that the hydroxyl group at C(11) is not required for high 
potency (Figure 2).5 Of equal interest, from the perspective of design, Floreancig and 
coworkers reported that C(8)-desmethoxy irciniastatin A (1.5) also retained high levels of 
cytotoxicity similar to (+)-irciniastatin A (1.1), which in turn implies that the presence of 
the C(8)-N,O-aminal is also not a requirement to preserve biological activity (Figure 1.2).6  
 
Figure 1.2 Previously Synthesized Irciniastatin Analogues 
Further biological evaluation of irciniastatin A (1.1) led Usui and co-workers to 
report that treatment of human leukemia Jurkat cells initiates apoptosis by triggering stress-
activated protein kinases such as JNK and p38.7 Subsequently in 2012 the De Brabander 
and Roth groups performed a forward genetic screen in C. Elegans identifying the main 
molecular target of (+)-irciniastatin A (1.1) to be the ribosome, which is also targeted by 
the pederins. These studies further revealed that the cross-resistance of an irciniastatin-
resistant mutant strain did not occur with mycalamide A, a member of the pederin family, 
thereby suggesting two distinct binding modes.8 Adding to the intrigue of these 
compounds, De Brabander and Roth reported that “totally synthetic” (+)-irciniastatin A 
(1.1) did not display the differential cytotoxicity that had been reported earlier by the Crews 
group.2,8 We also note that Kataoka and coworkers reported that (+)-irciniastatin A (1.1) 
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acetoxycycloheximide, cytotrienin A, and deoxyinvalenol.9,10 Finally and very recently,  
Usui and coworkers suggested that the irciniastatins are similar to mycalamide B, another 
member of the pederin family, that binds to the E-site of the ribosome to inhibit protein 
translation.11  
Given the interesting biological profiles, the unusual structural features, and the 
limited abundance of the irciniastatins, the synthetic community has invested considerable 
effort directed at the total synthesis of these natural products and related congeners. Indeed, 
since their initial isolation in 2004, seven syntheses of (+)-irciniastatin A (1.1) have been 
reported.6,12-17 These efforts include the seminal total synthesis and structural confirmation 
by DeBrabander and coworkers,12 the late-stage, three-component union by the Floreancig 
group leading to the shortest synthesis to date (14-step longest linear sequence),6 and our 
2008 synthesis of (+)-irciniastatin A (1.1).14 The total synthesis of the more active of the 
two irciniastatin congeners, (−)-irciniastatin B (1.2), was subsequently completed in our 
laboratory in 201218 via augmentation of our earlier synthesis of (+)-irciniastatin A (1.1)14 
and then recently by Iwabuchi and coworkers (2015) 11. In view of the continuing synthetic 
and biological interest in the irciniastatins, we undertook the design, synthesis, and 
biological evaluation of a structurally diminutive congener of the irciniastatins (1.6, Figure 
3), as well as several C(11)-irciniastatin analogs (1.7-1.11, Figure 1.3), available from late-
stage intermediates in our total synthesis campaigns.  
Our design strategy for the proposed diminutive form of (+)-irciniastatin A (1.1) 
began with retaining the 2,6-trans-tetrahydropyran core, which is conserved across all 
active members of the pederin families. However, in planning a synthetic route that would 
permit the rapid construction of diverse analogues, the dense functionality of the pyran ring 
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posed a considerable challenge. Our initial strategy therefore was to remove the C(12)-
gem-dimethyl unit in the tetrahydropyran core. The consequence on biological activity of 
removing the dimethyl group had not until our work (vide infra) been determined, although 
Floreancig and coworkers did propose that this structure unit minimizes the activation 
energy required to adopt a favorable active-site binding conformation.6 We also chose to 
remove the C(8)-methoxy group of the N,O-aminal as well as the C(11)-hydroxy group, 
given that the removal of both groups in other congeners had not led to significant loss of 
biological activity.5,6 Removal of the C(8)-methoxy group of the N,O-aminal unit would 
also permit a more facile synthesis. Taken together, these structural modifications held the 
promise for more ready access to potentially highly active irciniastatin analogues. We thus 
identified C(8)-desmethoxy-C(11)-deoxy-C(12)-di-desmethyl-irciniastatin 1.6 as our 
initial target. In addition, to probe the SAR at C(11) of the native irciniastatin structure, we 
also undertook manipulation of several late-stage intermediates reported earlier in our total 
synthesis of (–)-irciniastatin B (1.2) (Figure 3).18 We envision that such analogues would 
add further insights to the SAR of the tetrahydropyran core, and in turn provide direction 
for the future design of accessible, potentially potent irciniastatin analogues.  
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1.2 Results and Discussion 
1.2.1 Synthesis of C(8)-Desmethoxy-C(11)-deoxy-C(12)-di-desmethyl-irciniastatin 
(1.6) 
From the synthetic perspective, we envisioned that analogue 1.6 would arise via the 
union of side chain 1.12, featuring a TBS protecting group instead of the earlier utilized 
SEM ether14,18 with primary amine 1.13. The latter was prepared via a stereoselective syn-
aldol union between aldehyde 1.14,18 possessing robust 3,4-dimethoxybenzyl groups that 
had proven effective in our synthesis of (–)-irciniastatin B (1.2)18 and  pyran 1.15 (Scheme 
1.1). Pyran 1.15 in turn would be constructed via a 6-exo-tet cyclization of epoxide 1.16 
available in 6 steps from commercially available material.  
Scheme 1.1 Retrosynthetic Analysis for C(8)-Desmethoxy-C(11)-deoxy-C(12)-di-
desmethyl-irciniastatin (1.6) 
 
We began the synthesis of acid (–)-1.12 by protection of alcohol (+)-1.17,19 
prepared previously in our synthesis of irciniastatins as the TBS ether, followed by 
reductive removal of the pivalate group to furnish (+)-1.18 (Scheme 1.2). A two-step 












































  7 
Scheme 1.2 Synthesis of Acid Side Chain (–)-1.12 
 
Construction of the tetrahydropyran core of the union partner 1.15 was envisioned 
via a cyclization tactic, similar to what was developed in our syntheses of (+)-irciniastatin 
A (1.1) and (–)-irciniastatin B (1.2), namely a 6-exo-tet cyclization involving epoxide 1.22 
(Scheme 3). To access epoxide 1.22, we first constructed (+)-1.20 from the commercially 
available unsaturated alcohol 1.19, protected as a TBS ether, followed by a Jacobsen 
hydrolytic kinetic resolution (HKR).20-22 The TBS ether was then removed and the resulting 
alcohol subjected to modified Ley oxidation conditions23 to furnish aldehyde (+)-1.21. We 
next set out to unite 2-butanone with aldehyde (+)-1.21 via a base-mediated aldol reaction 
to arrive at alcohol 1.22. Not surprisingly, a 1:1 mixture of diastereomers was observed, 
which proved separable via chromatography at a later step (vide infra).  
For the proposed cyclization step, alcohol 1.22 was treated with a catalytic amount 
of camphorsulfonic acid (CSA), which furnished exclusively the tetrahydropyran ring via 
what we envision to be a 6-exo-tet pathway. Although both 6-exo-tet and 7-endo-tet 
pathways are feasible,24,25 the 6-exo-tet pathway dominates we reason due to a combination 
of a favored 6-membered ring transition state and the enhanced stabilization of partial 
positive charge on the internal carbon over the terminal carbon of the epoxide. Protection 
of the resulting primary alcohol then permitted chromatographic separation of the trans 
and cis isomers of 1.15, each available in 36% yield for the two steps. Stereochemical 
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2. NaH2PO4•2H2O, NaClO2
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70% yield over two steps (–)-1.12
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(Scheme 1.3). We note that although construction of alcohol 1.22 was not stereoselective, 
we have identified a rapid and economical route to (+)-trans-1.15 and (–)-cis-1.15, thereby 
holding the potential for a variety of future diastereomeric irciniastatin analogues. 
Scheme 1.3 Synthesis and Stereochemical Assignments of Tetrahydropyran 1.15 
 
We turned next to the union of aldehyde 1.1418 with 2,6-trans-tetrahydropyran (+)-
1.15 (Scheme 1.4). Preliminary experiments demonstrated that the Lewis acid Cl2BPh, 
previously employed in our irciniastatin A and B syntheses14,26 led to the undesirable loss 
of the TBS groups. More importantly, given the absence of the gem-dimethyl unit present 
in our previous irciniastatin syntheses, the substrate-controlled reaction proceeded with 
poor diastereoselectivity due to potential conformational changes in the transition state of 
the aldol union. However, upon screening several Lewis acids, we discovered that  the 
Paterson boron reagent,27 (–)-Ipc2BOTf, furnished the desired aldol product (+)-1.23 in 
64% isolated yield, with both excellent diastereoselectivity (dr>20:1) and 
enantioselectivity (vide infra) under the reagent-controlled conditions. It is noteworthy that 
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to provide all four stereoisomers at C(16) and C(17) of (+)-1.23, from which more 
irciniastatin congeners could be prepared for future SAR studies.  
Scheme 1.4 Fragment Union and Stereochemical Assignment 
 
Reduction28 of (+)-1.23 under chelation controlled conditions with concomitant 
lactonization upon treatment with aqueous sodium hydroxide solution (2N) led to lactone 
(+)-1.24 in 91% yield with excellent dr (>20:1). To confirm the stereochemistry of (+)-
1.24, we performed a Mosher ester analysis29 on (+)-1.24, as well as with extensive NMR 
experiments on the derived acetonide (–)-1.27 (1H, 13C, HSQC, COSY,  ROESY), thereby 
establishing both the desired syn 1,3-diol configuration based on the diagnostic method 
pioneered by Evans30 and Rychnovsky,31 as well as the requisite absolute configuration. 
The absolute stereochemical configuration of (+)-1.24 was further supported by matching 
(–)-Ipc2BOTf, i-Pr2NEt
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the CD spectrum of (+)-1.24 with late-stage intermediates employed in our earlier synthesis 
of (–)-irciniastatin B (1.2) (See Experimental Section and Computational Data, Figure 
E1.1). Alcohol (+)-1.24 was then protected as the TBS ether followed by selective removal 
of the primary TBS group by treatment with TBAF buffered with acetic acid to furnish 
primary alcohol (+)-1.25.  
With advanced alcohol (+)-1.25 in hand, introduction of the primary amine was 
now required to permit union with acid 1.12 (Scheme 1.5). Initial attempts employing 
either reductive amination or Mitsunobu conditions32 however failed to provide the desired 
amine 1.13. After considerable optimization, amination of (+)-1.25 was eventually 
achieved by triflation of the primary alcohol followed by treatment with liquid ammonia, 
the product of which was carried forward to the amide coupling step without further 
purification. We note that in previous total syntheses of (+)-irciniastatin A (1) and (–)-
irciniastatin B (1.2), significant experimentation was required to effect the difficult amide 
union, given the sterically hindered Teoc-protected N,O-aminal moiety.14-16,18 As 
anticipated, amide formation employing primary amine 1.13 now proceeded in a more 
straightforward manner; reaction of 1.13 and acid chloride 1.28, the latter derived in situ 
from acid (–)-1.12 via treatment with SOCl2, led to (+)-1.29 in a combined yield of 59%. 
A two-stage deprotection sequence, employing DDQ, followed by treatment with TASF 
completed the synthesis of (+)-C(8)-desmethoxy-C(11)-deoxy-C(12)-di-desmethyl-
irciniastatin (1.6).  
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Scheme 1.5 Amide Coupling and Completion of (+)-C(8)-Desmethoxy-C(11)-deoxy-
C(12)-di-desmethyl-irciniastatin (1.6) 
 
 In summary, this convergent strategy now permits access to irciniastatin analogue 
(6), absent three structural features compared to the natural products. The advantages of 
this synthetic venture include facile union of advanced intermediates and the potential to 
access multiple diastereomeric intermediates that hold the promise for future 
stereochemically diverse irciniastatin analogues. 
1.2.2 Synthesis of C(11)-Irciniastatin Analogues 1.7-1.11 
Epi-C(11)-irciniastatin A (1.7), as described in our recent report on total synthesis 
of (–)-irciniastatin B (1.2),19 was readily available via the direct reduction of (–)-
irciniastatin B (1.2). Construction of other C(11)-irciniastatin analogues (1.8-1.11) could 
be accessed by manipulating late-stage synthetic irciniastatin A and B intermediates. 
Critical to the success of the latter venture was the availability of alcohol (–)-1.30 (Scheme 
1.6), which could be readily oxidized chemoselectively to ketone (–)-1.31 and then 
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worth noting that selective modification at the C(11) position of 1.30 and 1.31 is hampered 
by the presence of the neighboring gem-dimethyl group, as well as the overall instabilities 
of the molecules owing to the presence of the N,O-aminal, which limited the number of 
possible functional group manipulations that could be employed to generate analogues.  
Scheme 1.6 Synthetic Strategy to C(11)-Irciniastatin Analogues 1.8-1.11 
 
We reasoned that the biological activity of analogues lacking the hydroxyl 
functionality at C(11) would be affected by lowering the polarity (i.e., the hydrogen-bond 
donating ability) of the substituents. Alcohol (–)-1.30 (Scheme 1.7) was therefore treated 
with acetyl chloride to furnish the corresponding acetate in 87% yield. Subsequent global 
deprotection resulted in (–)-C(11)-OAc-irciniastatin A (1.8) in 75% yield for the two steps. 
The larger derivative possessing a benzyl group at C(11) was synthesized in a similar 
fashion to provide (+)-C(11)-OBz-irciniastatin A (1.9) to probe the spacial requirements 
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Scheme 1.7 Construction of C(11)-Irciniastatin Analogues 1.8-1.11 
 
Next, we constructed the C(11)-irciniastatin B methylene and O-methyloxime 
congeners (1.10 and 1.11) via chemical manipulation of ketone (–)-1.31. We reasoned that 
an exomethylene moiety at C(11) would not only provide a structural, though not 
electronic, isostere of the native ketone, but also would increase the hydrophobicity of the 
molecule. To this end, Wittig methenylation33 of ketone (–)-1.31 followed by global 
deprotection provided (+)-C(11)-exomethylene-irciniastatin B (1.10) (Scheme 1.7). We 
also envisioned that an O-methyloxime moiety at C(11) might be a suitable, extended 
isostere of the ketone.34 In this case, although the electronic properties at C(11) might be 
similar to the ketone, the (+)-C(11)-O-methyloxime analogue (1.11) would now possess 
two potential hydrogen bond acceptor sites. Construction of (1.11) was readily achieved 
via reaction of O-methylhydroxylamine hydrochloride with ketone (–)-1.31, followed by 
global deprotection.  
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1.2.3 Biological Evaluation of the Irciniastatin Analogues  
Biological evaluation of the synthetic analogues was achieved by cell viability 
assays35 against proliferative cells lines including A2058 (melanoma), H522-T1 (non-small 
cell lung cancer), and/or HCT-116 (colon cancer) (Tables 1.1 and 1.2). In addition, we 
compared the resultant IC50 value with the cytotoxicity data of analogues against quiescent 
IMR-90 immortalized human fibroblasts to measure selectivity, defined by the ratio of IC50 
between IMR-90 and different tumor cell line. Analogues with high selectivity values 
would be viewed to have greater potential as a therapeutic drug lead.  
We discovered that even without the substituents found in the native pyran core of 
the irciniastatins, analogue 1.6 remarkably retained significant antiproliferative properties 
at the nanomolar level (IC50 = 160 nM), albeit with an about 800-fold decrease in activity 
compared to (+)-irciniastatin A (1.1) in the same experiment (Table 1.1). Previous studies 
had revealed that removing C(8)-N,O-aminal decreased the cytotoxicity by around 10-fold 
compared to 1.1.5,6 Also of interest, Floreancig and coworkers have suggested that the gem-
dimethyl group plays a key role in permitting the molecule to adopt an appropriate 
conformation for protein target binding, although an appropriate analogue to test this 
hypothesis had not been synthesized and evaluated.6 Pleasingly, our findings suggest that 
the combined removal of the C(12) gem-dimethyl group, the hydroxyl at C(11), and the 
methoxy group at C(8) leads to the diminutive analogue 1.6 that retains tumor cell growth 
inhibitor in the nanomolar range suggesting that although the gem-dimethyl group may 
well influence the activity of the irciniastatins, its presence is not necessary to achieve 
tumor cell growth inhibition. Based on these initial results, the simple tetrahydropyran 
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scaffold is an attractive structural motif to provide facile synthetic access to active 
irciniastatin analogues for future SAR studies.  
Table 1.1 Antiproliferative IC50 (nM) Values for (+)-Irciniastatin A (1.1) and (+)-
C(8)-Desmethoxy-C(11)-deoxy-C(12)-di-desmethyl-Irciniastatin (1.6)  
  IC50 (nM) 
Entry Compound HCT-116 




Biological evaluation of irciniastatin analogues 1.7-1.11 further reveals that the 
C(11) position is highly tolerant of a variety of nonpolar functional groups with either the 
(R) or (S) configuration (Table 1.2). For example, epi-C(11)-irciniastatin A (1.7) displays 
a similar activity profile as irciniastatin A (1.1). Functionalization of the C(11)-hydroxyl 
group to a acetyl or benzoyl group led to retention of cytotoxicity at the subnanomolar 
level, with benzoate 1.9 displaying about a 5-fold decrease in activity compared to both the 
acetate 1.8 and (+)-irciniastatin A (1.1). Interestingly, the C(11)-irciniastatin B analogues 
1.10 and 1.11 with similar geometries (i.e., exomethylene) and electronic properties (i.e., 
O-methyl oxime) at C(11) as in the natural product revealed significant cell growth 
inhibition properties. Although increasing the hydrophobicity of C(11), vis-à-vis the C(11) 
methylene congener, did not lead to an improvement in the cytotoxicity, the excellent 
functional group tolerance at C(11) holds the promise for ready conjugation at this site with 
biological probes to explore the mode of action of the irciniastatins.  
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Table 1.2 Proliferative Cell Growth Inhibition Assay and IMR-90 Cytotoxicity 
Assay IC50 Values (nM) for (+)-Irciniastatin A (1.1), (–)-Irciniastatin B (1.2), and 
C(11)-Irciniastatin Analogues 1.7-1.11 









1 (+)-irciniastatin A (1.1) 0.4 (68) 1 (27) 4 (7) 27 
2 (–)-irciniastatin B (1.2) 0.5 (114) 0.8 (71) 3 (19) 57 
3 epi-C(11)-irciniastatin A (1.7) 0.4 (85) 0.9 (38) 3 (11) 34 
4 (+)-C(11)-OAc-irciniastatin A (1.8) 0.4 (68) 0.7 (39) 2 (14) 27 
5 (–)-C(11)-OBz-irciniastatin A (1.9) 2.7 (30) 5.4 (15) NA 81 
6 (+)-C(11)-exomethylene 
irciniastatin B (1.10) 
0.7 (68) 1.6 (31) 1 (49) 49 
7 (+)-C(11)-O-methyloxime-
irciniastatin B (1.11) 
0.5 (92) 0.8 (58) NA 46 
It is important to note that in the assay data reported in Table 2, a change in the 
automation protocol for cell preparation and sample handling occurred from the earlier 
assay (Table 1). In particular, the control compound (+)-irciniastatin A (1.1) was less potent 
against the HCT-116 cell line (IC50 4 nM vs. IC50 0.2 nM). We are however confident that 
the relative potencies in each assay (Table 1 and Table 2) are reliable.  
Finally, from the selectivity panel screen in Table 2, we note that (–)-irciniastatin 
B (1.2) appears to be more selective than (+)-irciniastatin A (1.1) across the three tested 
cell lines. Consistent with this result, the irciniastatin B C(11)-methylene and O-
methyloxime analogues (1.10 and 1.11) possessed higher selectivities for inhibiting A2085 
(melanoma) cell growth over non-proliferating IMR-90, compared both to (+)-irciniastatin 
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A (1.1) and the two related acetate and benzoate congeners (1.8 and 1.9). The higher 
selectivity values suggest that the irciniastatin B scaffold, wherein the C(11) position 
resides in an oxidized state, holds greater potential as a therapeutic lead compared to (+)-
irciniastatin A (1) and the corresponding C(11) analogues.  
1.1 Summary 
In summary, we have exploited our earlier developed convergent synthetic strategy 
to the irciniastatins to access a series of novel, active totally synthetic analogues of these 
intriguing natural products, including the identification of a simplified central scaffold that 
permits retention of biological activity. As a further enrichment of the synthetic strategies 
toward the irciniastatins and their analogues, the synthesis of C(11)-deoxy-C(12)-di-
desmethyl-irciniastatin 1.6 features: (A) rapid and economic access to both the trans- and 
cis-tetrahydropyran cores via a 6-exo-tet epoxide cyclization, (B) application of a 
diastereoselective aldol reaction mediated by a chiral boron Lewis acid to provide 
potentially all four stereoisomers, and (C) direct access to primary amine (1.13) via 
triflation and ammonia substitution to permit installation of various side chains. Pleasingly, 
in cell viability assays, analogue 1.6 retained antiproliferative activity in the nanomolar 
range, demonstrating that the C(8)-N,O-aminal, C(11)-hydroxyl, and C(12)-gem-dimethyl 
groups are not essential for biologic activity. In addition, manipulation of the C(11) 
position, employing late-stage intermediates derived from our total synthesis of the 
irciniastatins, permitted access to a series of C(11)-irciniastatin analogues 1.7-1.11. The 
derived congeners display significant biological profiles, demonstrating high functional 
group tolerance at C(11). Of importance, the higher selectivity level was consistently 
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observed with irciniastatin B derivatives oxidized at C(11), indicating that the C(11) 
oxidized tetrahydropran core may serve as a better scaffold for lead development.  
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CHAPTER 2 TYPE II ANION RELAY CHEMISTRY: 
CONFORMATIONAL CONSTRAINTS TO ACHIEVE 
EFFECTIVE [1,5]-VINYL BROOK REARRANGEMENTS 
Adapted with permission from Liu, Q.; Chen, Y.; Zhang, X.; Houk, K. N.; Liang, 
Y.; Smith, A. B., III. "Type II Anion Relay Chemistry: Conformational Constraints to 
Achieve Effective [1,5]-Vinyl Brook Rearrangements" Journal of American Chemical 
Society, 2016, 139, 8710–8717. Copyright 2017 American Chemical Society. Author 
Attributions: Q.L. designed and performed experiments and analyzed experimental data. 
Y.C., X.Z., K.N.H. and Y.L. designed and performed the computational studies. A.B.S 
directed the investigations. All authors contributed to the preparation of the manuscript. 
2.1 Introduction 
In 2005, we defined a new platform for the construction of molecular complexity 
termed Anion Relay Chemistry (ARC; Scheme 2.1).1 Critical to the success of this tactic 
is the ability to migrate charge in a controlled manner from an oxygen to a carbon atom, 
bearing an Anion Stabilizing Group (ASG), during a reversible Brook rearrangement.2 
The dithiane group, introduced by Corey and Seebach3 for umpolung reactions and 
subsequently exploited by the Schaumann4 and Tietze5 groups for what we now view as 
early versions of the ARC tactic, has proven to be an excellent ASG for both Type I and 
Type II ARC transformations involving [1,4]-Brook rearrangements.6 Indeed, by 
employing a series of diverse dithiane ARC linchpins, a number of architecturally complex 
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targets have been achieved, as demonstrated in synthetic ventures toward spirastrellolide 
E,7 (−)-secu’amamine A,8 rhizopodin,9  enigmazole A10 and most recently mandelalide A.11 
Scheme 2.1 Anion Relay Chemistry: Type I and Type II 
 
Following the success of the ARC tactic exploiting the dithiane as an sp3 carbon 
ASG, several linchpins were subsequently designed, synthesized and validated to exploit 
sp2-hybridized carbons in [1,4]-Brook rearrangements. Anions derived from furans,12 
arenes and olefins were employed.13 During this study, the stability of the sp2 carbanion 
derived from arenes and olefins during the reversible O to C(sp2) Brook rearrangement, 
not surprisingly, proved less favorable compared to the C(sp3) dithiane stabilized 
carbanions.  To augment the sp2 based ARC tactic, we introduced a stabilization factor, via 
the formation of an organo-cuprate.13,14 The latter permitted the successful validation of 
vinyl silanes bearing b or g electrophilic carbonyl sites for Type II ARC transformations 
based on [1,4]-Brook rearrangements.13 During these earlier studies, we recognized 
however that the Brook rearrangement was quite sensitive to the specific location of the 
silyl group on the double bond. The conditions that proved effective for linchpin 2.10 (1.2 
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linchpin 2.12. In this case, two equivalents of both n-BuLi and CuI were required to 
complete the 1,4-silyl C(sp2) to O migration over the course of a 2 h period at room 
temperature (Scheme 2).13 At the time, it was not clear why a second equivalent of n-BuLi 
and CuI significantly improved the [1,4]-vinyl Brook rearrangement of 2.12. 
Scheme 2.2 Type II ARC with [1,4]-Brook Rearrangement 
 
Recognizing that [1,5]-Brook rearrangements with vinyl linchpins, and in particular 
linchpins with terminal olefins held considerable promise for the construction of molecular 
complexity, we began to investigate an ARC tactic based on [1,5] silyl C(sp2) to O 
migrations (Figure 2.1).15 We reasoned that by anchoring the requisite ARC functionality 
on a phenyl or cyclohexyl ring in a 1,2 fashion would limit bond rotation and thereby 
potentially enhance the [1,5]-Brook rearrangement. 
 
Figure 2.1 Previous and Present Work: Union Reaction Exploiting [1,5]-Brook 
Rearrangements 
2.2 Results and Discussion 
O TMS
1a n-BuLi (1.2 eq.), Et2O, −78 ºC
1b CuI (1.2 eq.), HMPA:THF (1:1)
     rt, 30 min
1c Electrophile, rt





1a n-BuLi (2.0 eq.), Et2O, −78 ºC
1b CuI (2.0 eq.), HMPA:THF (1:1)
     rt, 2 h
1c Electrophile, rt
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2.2.1 Experimental Studies of Type II ARC Exploiting [1,5]-Vinyl Brook 
Rearrangements 
To initiate this study, we prepared phenyl linchpin 2.14 via Negishi cross coupling 
of (1-trimethylsilyl)-vinyl zinc with 2-bromo-benzaldehyde (See Experimental Section and 
Computational Date, E2). Our initial conditions for the [1,5]-Brook rearrangement were 
derived from our previous work involving [1,4] silyl C(sp2) to O migration,13 as well as 
from earlier observations of the Takeda16 and Song groups.17 Specifically, after addition of 
two equivalent of n-BuLi to aldehyde 2.14, the resulting lithium alkoxide was added into 
a suspension of CuBr·DMS in HMPA and THF (1:1) via cannula to trigger the Brook 
rearrangement presumably permitting the formation of a vinyl-cuprate. Importantly, we 
subsequently discovered that in place of adding two equiv. of the required nucleophile, an 
additive (i.e., 1 equiv. of a tert-butoxide salt) could be employed to achieve similar results, 
thus eliminating the need for two equivalents of the potentially valuable nucleophile. The 
vinyl-cuprate was then subjected to alkylation with a variety of electrophiles, to furnish 
three-component adducts in modest to good yields (Table 2.1).  
The organo-cuprate generated from the [1,5]-Brook rearrangement was next 
evaluated for cross coupling with various electrophilic partners, employing Pd(PPh3)4 as 
the catalyst (Table 2.2). Both electron-deficient and –rich aryl iodides proved viable 
substrates under the ARC/CCR protocol. Vinyl bromide could also be employed as the 
cross-coupling partner to provide diene 2.16e. In addition to n-BuLi, methyl, phenyl, 2-
propenyl, 2-furanyl and 2-methyl-1,3-dithianyl lithiums were examined as the initiating 
nucleophile for the ARC process; all worked, leading to the desired three-component 
adducts 2.16f-2.16j.   
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Conditions 1 or 2 Table 2.1 
Conditions 1: (a) 2.0 equiv. n-BuLi, 
Et2O, -78 °C; (b) 2.0 equiv. 
CuBr·DMS, HMPA/THF (1:1), rt; 
and then (c) and (d). Conditions 2: 
(a) 1.1 equiv. n-BuLi, THF, -78 °C; 
(b) 2.0 equiv. CuBr·DMS, 1.0 equiv. 
t-BuOK, HMPA, rt; and then (c) and 

















































O Li I CN CN 2.16i (57%)b,c
S S
Me Li




Conditions 1 or 2
(c) Electrophile, 5 mol% Pd(PPh3)4
    THF, rt;
(d) 1 N HCl, rt
Table 2.2 
Conditions 1: (a) 2.0 equiv. 
nucleophile, Et2O, -78 °C; (b) 2.0 
equiv. CuBr·DMS, HMPA/THF 
(1:1), rt; and then (c) and (d). 
Conditions 2: (a) 1.1 equiv. 
nucleophile, THF, -78 °C; (b) 2.0 
equiv. CuBr·DMS, 1.0 equiv. t-
BuOK, HMPA, rt; and then (c) and 
(d).  a Conditions 1. b Conditions 2. 
c For conditions 2(b), 60 °C. d for 
conditions 2(a), rt. 
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Encouraged by the viability of the ARC alkylation and cross coupling protocols 
exploiting a [1,5]-Brook rearrangement with phenyl linchpin 2.14, we turned to evaluate 
cyclohexyl-based linchpins, constructed via conjugate addition18,19 of the vinyl-cuprate 
derived from 2.1720 to aldehyde 2.18 (Scheme 2.3); a 1:1 mixture of cis- and trans-
linchpins (2.19 and 2.20), separable via flash chromatography with the stereochemistry 
assigned by NMR and subsequent chemical conversion (vide infra) resulted in a combined 
yield of 63%.  Importantly, cis-linchpin 2.19 could be readily converted to the trans-
congener (2.20) by treatment with DBU in MeOH. 
Scheme 2.3 Preparation of Cyclohexyl Incorporated Linchpins 2.19 and 2.20 
 
With both cyclohexyl-linchpins (2.19 and 2.20) in hand, we first conducted an 
optimization study with cis-cyclohexyl linchpin 2.19 exploiting the conditions outlined in 
Table 2.3. Compared to the phenyl linchpin (2.14), an increase in reaction temperature was 
required to effectively trigger the [1,5]-Brook rearrangement. Again, t-BuOK could be 
employed to promote Brook rearrangement thus saving 1 equivalent of the nucleophile, 
although a longer reaction time was required to complete the Brook process.  In the case 
of the TMS linchpin, the longer reaction time unfortunately resulted in several side 
reactions (i.e., loss of TMS group and/or decomposition of the vinyl-cuprate). To shorten 
the required reaction time and thus side product formation, we increased the solvent 
polarity to further promote the Brook rearrangement efficiency (entry 7). 
TMS Br
1a Mg, THF, reflux
1b CuBr•DMS, HMPA
      THF/DMS, –50 ºC













63% dr = 1:12.17 2.182.19 2.20
DBU, MeOH
near quant.
  28 








HMPA:THF T(h) ratioa 
(2.21:2.22:2.23) 
1b 1.1   1:1 0.5 1 : 0 : 0 
2 1.1 1.2  1:1 6 1 : 0 : 0 
3 1.1 2.0  1:1 6 1 : 0.2 : 0.1 
4 1.5 2.0  1:1 3 0.1 : 1 : 0.7 
5 2.0 2.0  1:1 0.75 0 : 1 : 0 
6 1.1 2.0 1.0c 1:1 1.5 0.1 : 1 : 0.7 
7d 1.1 2.0 1.0c 1:0 0.75 0 : 1 : 0 
 
a Ratio of major products (2.21:2.22:2.23) by NMR analysis of the reaction mixture: values 
are reported as 0 if less than 0.05. b Isolated yield for product 2.21: 86%. c t-BuOK. d 
Isolated yield for product 2.22: 73%. 
Continuing with the envisioned vinyl-cuprate intermediate derived via the [1,5]-
Brook rearrangement, we introduced an electrophile to complete the tri-component ARC 
tactic.  As with phenyl linchpin 2.14, the vinyl-cuprate was evaluated for both alkylation 
(Table 2.4) and cross coupling (Table 2.5); both reactions proceeded leading to the three-

























1a n-BuLi, THF, −78 ºC
1b CuBr•DMS, additive
    HMPA/THF, 60 ºC, T
1c H2O
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Table 2.4 Three-component coupling of linchpin 2.19 via ARC/Alkylation 
 
                            
 
 




 Conditions 1: (a) 2.0 equiv. n-
BuLi, THF, -78 °C; (b) 2.0 equiv. 
CuBr×DMS, HMPA/THF (1:1), 
60 °C; and then (c) and (d). 
Conditions 2: (a) 1.1 equiv. n-
BuLi, THF, -78 °C; (b) 2.0 equiv. 
CuBr×DMS, 1.0 equiv. t-BuOK, 
HMPA, 60 °C; and then (c) and 
(d). a Conditions 1. b Conditions 2. 
 
Table 2.5 
Conditions 1: (a) 2.0 equiv. 
nucleophile, THF, -78 °C; (b) 
2.0 equiv. CuBr·DMS, 
HMPA/THF (1:1), 60 °C; and 
then (c) and (d). Conditions 2: 
(a) 1.1 equiv. nucleophile, THF, 
-78 °C; (b) 2.0 equiv. 
CuBr·DMS, 1.0 equiv. t-BuOK, 
HMPA, 60 °C; and then (c) and 













Conditions 1 or 2
(c) Electrophile, 5 mol% Pd(PPh3)4 
    THF, rt
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Conditions 1 or 2
(c) Electrophile, rt
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Notably nucleophile additions to cis-linchpin 2.19 proved highly diastereoselective 
(>20:1), yielding the Felkin-Anh product,21 which was confirmed in the case of three-
component adduct 2.25h by X-ray analysis of the derived 4-nitrobenzoic ester (2.26) 
(Figure 2.2). 
                           
Figure 2.2 Elucidation of relative configuration via x-ray analysis 
We next extended the [1,5] ARC tactic to trans-linchpin 2.20. High Felkin-Anh 
selectivity upon addition of the nucleophile to the aldehyde was achieved. The 
stereochemistry of the isolated product was again confirmed by X-ray analysis of the p-
nitrobenzoic ester derivative 2.27 (Figure 2.2).   
The [1,5]-Brook rearrangement of trans-linchpin 2.20 however proved more 
challenging than the cis-linchpin. In particular, difficulties were encountered in retaining 
the TMS silyl group during the [1,5]-Brook protocol.  As a result, multiple alkylation 
byproducts were observed due to competing O-alkylation when an electrophile was 
introduced. To resolve this issue, we turned to the more robust TBS counterpart 2.31 which 
was prepared in similar fashion as the TMS linchpin (Scheme 2.4).  As expected, loss of 















    −78 ºC, 85%
2. 4-Nitrobenzoyl chloride
    Pyridine, 80 ºC
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trigger Brook rearrangement, presumably due to the increase steric hindrance of TBS 
group. As mentioned earlier during the optimization of cis-linchpin, longer reaction times 
resulted in multiple side reactions.  In this case, decomposition of a significant amount of 
the vinyl-cuprate occurred.  To decrease the reaction time, we employed a 5 min. pulse of 
microwave irradiation (Biotage: high setting) at 100 °C . The derived vinyl-cuprate was 
then employed for three-component unions, as demonstrated by alkylation with benzyl 
bromide and CCR with 4-iodobenzonitrile (Scheme 2.4). 
Scheme 2.4 Synthesis and Evaluation of trans Linchpin 2.31 
 
2.2.2 Computational Studies of Type II ARC Exploiting [1,5]-Vinyl Brook 
Rearrangements 
To understand the mechanism and reactivity trends of the [1,4]- and [1,5]-vinyl 
Brook rearrangements, we conducted computational studies using DFT (M06 with 
solvation) calculations,22,23 in which MeLi was used as a computational model for the 
experimentally employed n-BuLi. First, three [1,4]-vinyl Brook rearrangements were 
compared to reveal the effect on the energetics of the position of C=C double bond and the 
copper reagent employed. The results are summarized in Scheme 2.5, with the key 
structures illustrated in Figure 2.3.   
TBS Br
2a Mg, THF, reflux
2b CuBr•DMS, HMPA
      THF/DMS, −78 ºC
2c 2.18, TMSCl, THF






















1a n-BuLi, Et2O, −78 ºC
1b CuBr•DMS, t-BuOK 












1a n-BuLi, Et2O, −78 ºC
1b CuBr•DMS, t-BuOK
     HMPA, mw, 100 ºC
1c 4-Iodobenzonitrile
     5 mol% Pd(PPh3)4 
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Figure 2.3 DFT-optimized structures of intermediates and transition states for [1,4]-
vinyl Brook rearrangements; carbon: gray, hydrogen: white, oxygen: red, lithium: 
blue, copper: green, and iodine: purple. 
 
Scheme 2.5 Comparisons of [1,4]-Vinyl Brook Rearrangements Involving Different 
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For the [1,4]-Brook rearrangement of substrate A having an internal C=C double 
bond (Scheme 2.5a), coordination of the CuI to both C=C bond and oxygen atom of A 
generates an intermediate Ac; this step is exergonic by 28.5 kcal/mol in THF.  
Subsequently, the oxygen atom attacks the trimethylsilyl group via transition state TSA 
(Figure 2.3), in which the forming O-Si bond distance is 1.85 Å and the breaking C-Si bond 
is 2.37 Å, while the C-Cu distance is decreased to 1.96 Å. The free energy barrier for this 
process is 16.0 kcal/mol (from Ac to TSA). Importantly the resultant [1,4]-Brook 
rearrangement product Ap is more stable than Ac by 6.3 kcal/mol.  
As reported above, our experimental results demonstrate that the [1,4]-Brook 
rearrangement is sensitive to the position of C=C double bond (Scheme 2.2). The computed 
reaction pathway of the [1,4]-Brook rearrangement of B having a terminal C=C double 
bond with 1 equivalent of CuI is illustrated in Scheme 2.5b.  In this case, the formation of 
intermediate Bc via coordination of CuI to both C=C bond and oxygen atom of B is 
exergonic by 35.5 kcal/mol, which is 7 kcal/mol more favorable than that of Ac (-35.5 
versus -28.5 kcal/mol). Subsequent [1,4]-Brook rearrangement via transition state TSB 
requires an activation free energy of 29.8 kcal/mol. This barrier is 13.8 kcal/mol higher 
than that for Ac with an internal C=C double bond (29.8 versus 16.0 kcal/mol). As shown 
in Figure 3, the coordination of the internal C=C double bond forms a strained C-Cu-O-C 
four membered ring in Ac, with C-Cu and O-Cu distances of 2.10 and 2.22 Å. However, 
in the Brook rearrangement transition state TSA, the corresponding distances are 
significantly increased to 2.75 and 2.70 Å, respectively. This indicates there is remarkable 
strain-release in transition state TSA, leading to a low barrier.24 However, when the 
position of C=C double bond is changed from internal to terminal, the strained C-Cu-O-C 
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MeLi + Li++ CuX2−MeCu2 CuX +
X = I ΔGsol = -54.6 kcal/mol
ΔGsol = -58.0 kcal/molX = Br
four membered ring in Ac evolves to an unstrained C-Cu-O-C-C-C six membered ring in 
Bc. As a result, there is no strain-release in transition state TSB, making the barrier much 
higher, and in the product (Bp), which is even 0.2 kcal/mol less stable than Bc (-35.3 versus 
-35.5 kcal/mol). This result explains why the [1,4]-Brook rearrangement of B having a 
terminal C=C double bond does not occur using 1 equivalent of CuI. 
To achieve efficiency with the [1,4]-Brook rearrangement of B, experiments 
demonstrate that 2 equivalents of a Cu(I) salt and a second equivalent of lithium reagent 
are required (Scheme 2.2). However, it was not clear what copper reagent is involved. Our 
calculations reveal that the most favorable reaction between 1 equivalent of MeLi with 2 
equivalents of CuX (X = I or Br) is to form MeCu (Eq. 2.1), which is exergonic by more 
than 50 kcal/mol. This suggests that under these reaction conditions, MeCu instead of CuX 
will trigger Brook rearrangement. 
                                          
                                                                   (Eq. 2.1) 
In Scheme 5c, we outline the computed reaction pathway of [1,4]-Brook 
rearrangement of B with 1 equivalent of MeCu. Here the MeCu is also coordinated by both 
the C=C bond and the oxygen atom of B to form intermediate Cc. However, this process 
is much less exergonic than that using CuI (-20.4 versus -35.5 kcal/mol). The subsequent 
[1,4]-Brook rearrangement via transition state TSC thus requires an activation free energy 
of 25.8 kcal/mol. This barrier is 4 kcal/mol lower than that using CuI (25.8 versus 29.8 
kcal/mol).  According to the frontier molecular orbital (FMO) analysis, the LUMO energies 
of CuI and MeCu are -15.3 and 1.3 kcal/mol, respectively. This indicates that CuI is a much 
better electron acceptor than MeCu, leading to a much stronger coordination or bonding 
interaction. As shown in Figure 2.3, the geometries of intermediates Bc and Cc, and 
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transition states TSB and TSC are very similar. In the Brook rearrangement transition state 
TSB or TSC, one C-Cu bond (TSB: 1.96 Å; TSC: 1.97 Å) is forming, and one O…Cu and 
the other C…Cu coordinations (shown as green lines in the right structures of Figure 3) 
disappear. When MeCu is employed instead of CuI, two weaker O…Cu and C…Cu 
interactions are needed to overcome in the transition state although one weaker C-Cu bond 
is forming. Overall, this decreases the barrier for the Brook rearrangement. Therefore, the 
alkyl cuprate is more active than the Cu(I) salt to trigger Brook rearrangement, in 
agreement with the experimental results. 
Four [1,5]-vinyl Brook rearrangements were next compared to reveal the role of the 
conformational constraints of substrates. The results are summarized in Scheme 2.6, with 
the key structures illustrated in Figure 2.4. 
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Figure 2.4 DFT-optimized structures of intermediates and transition states for [1,5]-
vinyl Brook rearrangements; carbon: gray, hydrogen: white, oxygen: red, lithium: 
blue, and copper: green. 
For the MeCu mediated [1,5]-Brook rearrangement of substrate D having a terminal 
C=C double bond (Scheme 2.6a), the reaction free energy for the coordination step is -20.1 
kcal/mol, which is very close to that of [1,4]-Brook rearrangement substrate C (-20.4 
kcal/mol, Scheme 2.5c). However, the barrier for [1,5]-Brook rearrangement is 3.7 
kcal/mol higher than that for the [1,4] reaction (29.5 versus 25.8 kcal/mol).  As shown in 
Figures 3 and 4, the forming and breaking bond distances in transition states TSC and TSD 
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are almost identical; the main difference is the conformational change of the tether. In 
intermediate Dc, the dihedral angle along the (CH2)2 tether is -73.2o, but this angle becomes 
-57.9o in transition state TSD. This means a 15.3o conformational change, requiring 
additional energy as compared to [1,4]-Brook rearrangement from Cc to TSC, in which 
the tether is CH2 without the dihedral angle change. This explains why efficient [1,5]-
Brook rearrangements are more challenging.  
In Scheme 2.6b-d, we illustrate the computed reaction pathways of the three 
experimentally studied [1,5]-vinyl Brook rearrangements involving phenyl, cis-
cyclohexyl, and trans-cyclohexyl linchpins. The activation free energies for these 
rearrangements are 23.3 (from Ec to TSE), 25.6 (from Fc to TSF), and 29.7 (from Gc to 
TSG) kcal/mol, respectively. This reactivity trend is in accordance with the increase in 
reaction temperature for Brook rearrangement observed experimentally. More importantly, 
the calculations demonstrate that there is a good correlation between the conformational 
change of the tether and the barrier for [1,5]-Brook rearrangement.  As illustrated in Figure 
4, when the tether is switched from phenyl, to cis-cyclohexyl, and to trans-cyclohexyl, the 
corresponding conformational change is increased from 4.8o (from -1.4o to -6.2o), to 6.1o 
(from -41.4o to -47.5o), and to 13.5o (from 39.8o to 53.3o). Consequently, the barrier is 
increased from 23.3, to 25.6, and 29.7 kcal/mol (Scheme 2.6b-d). These results indicate 
that using the tether with conformational constraints can efficiently lower the [1,5]-Brook 
rearrangement barrier. 
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2.3 Conclusions 
In summary, we have achieved extension of the ARC tactic exploiting more 
challenging [1,5]-Brook rearrangements with a series of conformationally anchored 
bifunctional vinyl linchpins. Phenyl, cis-cyclohexyl, and trans-cyclohexyl linchpins were 
systematically evaluated via both experimental and computational approaches. Of 
importance, we demonstrated that introduction of an additional amount of organolithium 
or t-BuOK as additive lowers the energy barrier to facilitate the requisite Brook 
rearrangement.  As such, this ARC protocol now holds considerable synthetic promise for 
the rapid elaboration of advanced intermediates for complex molecule synthesis. 
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CHAPTER 3 TOTAL SYNTHESIS OF (–)-NAHUOIC ACID 
CI(BII) 
3.1  Introduction 
3.1.1 Isolation 
The nahuoic acids constitute a family of highly hydroxylated and cis-decalin-
scaffold-containing polyketides. In 2013 Anderson and coworkers isolated the first 
member of this group, nahuoic acid A (3.1, Figure 3.1).1 This acid was produced from 
cultures of a Stremptomyces sp. obtained from a tropical marine sediment collected near 
the passage Padana Nahua in Papua New Guinea. Subsequently in 2016, the same group 
reported the isolation of an additional four nahuoic acids (B-E).2  
 
Figure 3.1 Structure of Nahuoic Acids 
In the same year, Qi and coworkers independently reported the isolation of four 
compounds, also named nahuoic acids B-E, but from the cultures obtained from the South 
China Sea gorgonian coral Melitodes squamata.3 In this thesis, I will label the nahuoic 
acids B-E isolated by Anderson as Bi-Ei (3.2, 3.3, 3.5, and 3.6) given his initial isolation of 













Nahuoic Acid A: R1=OH, R2=H       (3.1)   
                      Bi: R1=H, R2=OH       (3.2) 
                      Ci (Bii): R1=R2=OH    (3.3)











Nahuoic Acid Di (Eii): R1=OH, R2=H  (3.5)
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Bii-Eii. (3.3, 3.4, 3.7 and 3.6). Two of the members are common (Ci with Bii and Dii with 
Ei) among the seven distinct analogs documented collectively so far by the two groups. 
3.1.2 Structure Elucidation 
The nahuoic acids contain a highly functionalized and substituted cis-decalin ring 
system. For example, the decalin scaffold of nahuoic acid Ci(Bii) (3.3) possesses eight 
continuous stereogenetic center [C(4)-C(10) and C(14)] including a quaternary carbon 
center C(10). Those acids also have a skipped polyol side chains and three tri-substituted 
olefins. 
 To elucidate their structure, the molecular compositions were first established by 
high resolution ESI-MS analysis. Their relative configurations were then determined based 
on extensive NMR studies as well as derivatization of the polyol motifs as acetonides. 
These compounds displayed unique 13C resonance signal patterns. Multiple carbon signals, 
even primary carbons, were barely observed by 13C NMR experiments, likely due to the 
unique conformational exchanges of the cis-decalin backbones. Nuclear magnetic 
resonance experiments including heteronuclear single quantum correlation (HSQC) and 
heteronuclear multiple bond correlation (HMBC) were thus used to identify those carbon 
signals. The absolute configurations were assigned by a modified Mosher ester analysis in 
conjunction with comparisons of the experimental and the calculated electronic circular 
dichroism (ECD) spectra.1–3  
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3.1.3 Plausible Biosynthetic Pathways  
With the structures of seven nahuoic acids available, we postulate here a plausible 
biogenesis of nahuoic acids, prior to initiating our synthetic studies. To the best of our 
knowledge, no one has proposed a biosynthetic pathway. To this end, we propose the 
assembly of nahiuoic acid A to be initiated from the side chain terminal [C(23) terminal, 
Scheme 3.1] with isobutyryl-coenzyme A (CoA) (3.8) as the starter unit. During its chain 
elongation process, incorporation of four malonyl (3.9) and six methylmalonyl (3.10) 
extender units (Pathway A; Scheme 3.1) would complete the synthesis of a 23-carbon 
linear intermediate (3.11). Alternatively, condensation of ten malonyl extender units (3.9) 
in conjunction with the six methyl groups from six S-adenosyl methionines (SAM) 
(Pathway B; Scheme 3.1) would be required to give rise to the polyketide chain. 
































































































  45 
This complete polyketide chain could be further folded to construct the cis-decalin 
system via an intramolecular Diels–Alder reaction (IMDA) to provide nahuoic acid A 
through an exo-transition state (exo-TS; Scheme 3.1) between the dienophilic olefin C(4)-
C(5) and diene C(10)-C(13). However, it is not clear to us whether such exo-mode of DA 
reaction would be favored under spontaneous, non-enzymatic conditions given the 
diastereomeric endo-reactivity. Alternatively, an exo-selective IMDA could be mediated 
by a Diels-Aldrase (DAase), notwithstanding that very few DAases have been identified 
and characterized so far.4  
Besides nahuoic acid A (3.1), six other congeners (3.2-3.7) were identified. Those 
acids differ at the C(7) and C(8) oxidation states, presumably adjusted by additional 
enzymes. The other structural difference is the presence of an additional unit of CH2CHOH 
on the side chain of nahuoic acid Di(Eii), Ei and Dii (3.5-3.7), the biosynthesis of which 
could be attributed to the incorporation of an additional extender unit [i.e., malonyl CoA 
(3.9)]. 
3.1.4  Biological Activities 
As a sole mammalian protein methyltransferase (PMTs), the SET [Su(var), E(z), 
and Trithorax] domain-containing protein 8 (SETD8, also known as SET8, PR-SET7, and 
KMT5A) is responsible for the transfer of one methyl group from S-adenosylemethionine 
(SAM, 3.13) to histone H4 Lys20 residue (H4K20, 3.14, Scheme 3.2). Histone H4 lysine 
20 monomethylation (H4K20me1) is associated with transcriptional activation and cell 
cycle regulation. Abnormal levels of this process are linked to cancer and mental disorder. 
Besides H4K20, SETD8 also monomethylates lysine residue 382 of p53 to inhibit 
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apoptosis, and lysine residue 248 of proliferating cell nuclear antigen (PCNA) that is 
known to suppress cancer cell growth.5–8 
Scheme 3.2 Monomethylation of Histone Lysine by SETD8 
 
Given the essential role of SETD8 in regulating biological processes, identification 
of inhibitors is crucial for the investigation of SEDT8’s cellular effects. Such inhibitors can 
also serve as lead structures for potential anticancer therapeutics.  Indeed, significant effort 
has been invested in discovering SETD8 inhibitors (e.g., 3.17,9 3.18,10 and 3.1911 in Figure 
3.2). Compounds identified in this regard were mainly found through high throughput 
screening (HTS) (for compounds 3.17 and 3.18) or structure-based drug design efforts (to 
derive 3.19 from a substrate peptide).  
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In contrast to above compounds (3.17-3.19) as substrate (3.14) inhibitors, the 
nahuoic acids achieve inhibitory effect as competitive inhibitors of the SAM cofactor 
(3.13). Of special note, nahuoic acid A (3.1), with an IC50 around 8 µM in vitro, is the first 
natural product possessing selective SETD8 inhibitory activity.1 Anderson et al.2 also 
evaluated the SETD8 inhibition activities of nahuoic acids Bi-Ei following their isolation 
in 2016. All five compounds exhibited moderate inhibitory effect against SETD8 (Table 
3.1). However, the SETD8 inhibition activities of nahuoic Cii (3.4) and Dii (3.7), 
exclusively isolated by Qi and coworkers,3 remain untested. 
Table 3.1 In Vitro Inhibition of SETD8 by Nahuoic Acids A−Ei (3.1-3.3, 3.5 and 3.6) 
Compounds 3.1 3.2 3.3 3.5 3.6 
IC50 (µM) 8 27 41 76 13 
Hill slope 1.4 1.7 1.5 1.7 1.7 
In addition to the in vitro inhibition effect on the SETD8 enzyme, nahuoic acids 
also display moderate cell cytotoxicity in human cancer cells. For example, exposure of 
osteo sarcoma U2OS cells to nahuoic acid A resulted in cell proliferation inhibition with 
an apparent IC50 value of 65±2 µM. In an attempt to improve cell permeability, Anderson 
et al. prepared and tested nahuoic acid A pentaacetate (3.20) and the methyl ester (3.21) as 
prodrug versions against a series of cell lines (Table 3.2).2 The pentacetate version (3.20) 
displayed similar activity as nahuoic acid A, while the methyl ester (3.21) revealed a weak 
effect on cell proliferation, indicating a potential effect of the acid functionality for cell 
cytotoxicity. However, further structure activity relationships (SAR) clearly remain to be 
explored. 
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Figure 3.3 Structure of Prodrug Versions of Nahuoic Acid A (3.20 and 3.21) 
 
Table 3.2  Cell Growth Inhibition (IC50, µM) of Nahuoic Acid A (3.1) and 
Pentaacetate Derivative 3.20 against different cell lines 
 USO2 SUM159 MDA-MB-436 
Nahuoic Acid A (3.1) 65   



























Methyl nahuoic acid A pentaacetate (3.21)
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3.2 Total Synthesis of (–)-Nahuoic Acid Ci(Bii) 
3.2.1 Strategic Disconnection of Nahuoic Acids 
Given the unique biological profiles of the nahuoic acids as selective inhibitor of 
SETD8 enzyme and the unusual structure features as cis-decaling containing polyketides, 
we launched an investigation toward the total synthesis of the nahuoic acids. 
Retrosynthetically, we envisioned that a disconnection between C(13) and C(14) would 
permit a convergent approach to the nahuoic acids and their synthetic analogues (Scheme 
3.3). This disconnection would lead to two major fragments, cis-decalin (generically 
depicted as 3.22) and acetylene (3.23-a for nahuoic acids 3.1-3.4; and 3.23-b for nahuoic 
acids 3.5-3.7), which would be united from the sterically encumbered concave face 
employing an allylic alkoxide directed alkyne-alkene coupling tactic developed by 
Micalizio and coworkers in 2010.12,13 
Scheme 3.3 Strategic Disconnection of Nahuoic Acids 
 
3.2.2 Introduction to Micalizio’s Alkoxide-Directed Alkyne-Alkene Coupling 
The Micalizio reaction is an alkoxide-directed alkyne-alkene coupling tactic with 
net allylic transposition (Scheme 3.4). An alkyne (generically depicted as 3.25) is treated 
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this stage, the Ti(IV) is reduced to Ti(II) (3.24), followed by ligand exchange between the 
low-valent titanium alkoxide 3.24 and the alkyne 3.25 to generate a titanium-alkyne 
complex 3.26.14 The required allylic alkoxide (3.27), the second component of this union 
tactic, is then introduced. The resulting titanium ate complex 3.28 then undergoes an 
intramolecular carbometallation to effect the key C-C bond formation in 3.29, followed by 
a syn-elimination and subsequent protonation of a carbon-Titanium bond during the work-
up to furnish a 1,4-diene 3.31.12,15  
Scheme 3.4 Micalizio’s Alkoxide Directed Alkyne-Alkene Coupling 
 
From the above mechanistic perspective, this carbon-carbon bond construction 
method results in the cis-relationship between R1 and R2 on the tri-substituted olefin [C(1)-
C(2)] in a geometrically controlled fashion. Regioselectivity with respect to the placement 
of C(1) and C(2) could also be achieved with structurally elaborated substrates, as 
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products (Scheme 3.5 and 3.6). For example, the union between late stage allylic alcohol 
3.32 and phenyl-2-butyne (3.33) gave rise to lehualide B (3.34) in 50% yield.16 However, 
the regiochemical control between C(15) and C(16) was poor, resulting in the formation of 
a 1.3:1 ratio of isomers, probably due to the insufficient steric bias between the methyl and 
benzyl groups in the internal alkyne 3.33. Employing the more sterically differentiated 
ethynyltrimethylsilane (3.35) solved this regioselectivity problem; the resulting (E)-vinyl 
silane was then carried forward to complete the total synthesis. 
Scheme 3.5 Synthesis of Lehualide B Employing Alkyne-Alkene Coupling Tactic 
 
This union strategy has also been employed by Micalizio and Diez for the total 
synthesis of (-)-vittatalactone (3.40) in a complementary sense, in which a complex alkyne 
substrate 3.37 was employed (Scheme 3.6).15 In this case, the regioselectivity was dictated 
by the substantial steric bulk at C(4) methine over the much smaller C(7) methyl group of 
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Scheme 3.6 Synthesis of (–)-Vittatalactone Employing Alkyne-Alkene Coupling 
Tactic 
 
Encouraged by Micalizio’s successful application of this titanium-mediated 
reductive coupling method in such complex settings, we launched an investigation toward 
the total synthesis of the nahuoic acids using the Micalizio union tactic as a strategic 
transformation. However, challenges still existed: (1) The allylic hydroxyl group was on 
the concave face of the cis-decalin and also adjacent to a neopentyl center. This increase 
in steric hindrance would very likely compromise the directing effect of the alkoxyl group 
in the decalin coupling partner. (2) Regioselectivity of the alkyne partner could also be 
problematic, in light of the lack of significant selectivity when the alkyne 3.33 was used in 
the synthesis of lehualide B. In spite of this unfavorable precedent, we reasoned that the 
bulk of the proximal acetonide unit in 3.23-a and 3.23-b would provide some level of 
selectivity. 
3.2.3 Synthesis of Alkyne Side Chain: A Showcase for the Multicomponent ARC Union 
Tactic  
Anion Relay Chemistry (ARC) was first introduced by Schaumann17 and Tietze18 
groups and subsequently developed and validated by the Smith group.19,20 This tactic 
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negative charge through bond and/or space. With this technique, we can rapidly arrive at a 
plethora of multicomponent adducts by modifying individual coupling components. 
Compared to the traditional methods in polyketide synthesis (e.g., aldol reaction), the ARC 
strategy possesses the advantage of rapid access to structural diversity as well as 
convergence. (Refer to part 2 of this thesis for additional utility of the ARC tactic) 
Most recently (2015), the Smith group developed and preliminarily evaluated a new 
bifunctional linchpin 3.45 (Scheme 3.7) in the synthetic studies toward rhizopodin.21 To 
evaluate further the synthetic utility of 3.45 in complex molecule synthesis, we first 
targeted the synthesis of the 1,3,5-triol fragment 3.23-a to showcase the synthetic value of 
3.45 in our ARC chemistry. 
3.2.3.1 First-generation synthesis of 3.23-a 
In our first-generation retrosynthetic analysis, the alkyne functionality in 3.23-a 
was envisioned to arise from the aldehyde 3.41 via a Corey-Fuchs reaction (Scheme 3.7). 
This aldehyde could be derived through functional group manipulation from the dithiane-
containing intermiediate 3.42, which in turn would be accessed via a four-component ARC 
process with the linchpin 3.45 as the centerpiece. The linchpin 3.45 can be prepared in six 
steps from commercially available (R)-Roche ester.21 
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To our delight, the one-pot synthetic sequence involving epoxide (+)-3.43 and 
chloromethylmethyl chloride (MOMCl, 3.44), linchpin (+)-3.45, and isopropenyllithium 
(3.46) gave rise to the four-component adduct (–)-3.42 in 84% yield with excellent 
diastereoselectivity (Scheme 3.8). In this event, Felkin-Anh controlled diastereoslective 
attack of the linchpin aldehyde with isopropenyllithium generated alkoxide 3.47. In the 
same flask, addition of HMPA triggered a [1,4]-Brook rearrangement22 to form a 
carbanion, which readily underwent a ring-opening addition reaction with the epoxide (+)-
3.43 to form an alkoxide 3.48. This alkoxide was then alkylated with MOMCl to furnish 
the desired intermediate (–)-3.42. 
Scheme 3.8 First-Generation ARC Four-Component Union 
 
The dithiane moiety in (–)-3.42 was then removed under oxidative condition with 
concomitant cleavage of the labile TMS ether (Scheme 3.9).23 The resulting hydroxyl 
ketone (+)-3.49 then underwent a chelation-controlled Prasad reduction24 to furnish syn-
diol (+)-3.50, which in turn was protected as the acetonide (+)-3.51.25 After reduction of 
terminal alkene with Wilkinson catalyst26 to (+)-3.52, the PMB group was removed with 
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fragment [(+)-3.23-a], we attempted a one-pot hydrogenation both to hydrogenate the 
olefin and to remove the protecting group with the benzyl ether counterpart of (+)-3.50, 
instead of employing a PMB group. However, we were not successful to remove the benzyl 
ether under catalytic hydrogenolysis conditions [Pd/C, Pd(OH)2/C and Wilkinson catalyst]. 
Notwithstanding this minor setback, the revealed alcohol in (–)-3.53 was next oxidized to 
the aldehyde (–)-3.41, which was then subjected to the two-step Corey-Fuchs protocol to 
complete the desired alkyne coupling partner (+)-3.23-a.28 In total, this alkyne fragment 
was prepared in a total of 9 flasks in 13% overall yield.  
Scheme 3.9 First-Generation Synthesis of Alkyne Fragment 
 
3.2.3.2 Second-Generation Synthesis of (+)-3.23-a 
The versatility of the ARC chemistry enabled a more efficient second-generation 
synthesis of (+)-3.23-a, in which we envisioned the homopropargylic moiety in (+)-3.23-
a to arise from the ring opening of the epoxide 3.55 with propynyllithium. The epoxy 
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could in turn be conveniently installed if epichlorohydrin (3.58) were used in place of the 
epoxide 3.43 (cf. Scheme 3.7) in a now three-component ARC coupling protocol (Scheme 
3.10). 
Scheme 3.10 Second-Generation Retrosynthetic Analysis of Acetylene Side Chain 
 
Indeed, an analogous one-flask reaction between the linchpin (+)-3.45, 
isopropyllithium (3.57), and (R)-epichlorohydrin (–)-3.52 furnished the three-component 
product (+)-3.56 in 76% yield with excellent diastereoselectivity (>20:1) on a five-gram 
scale (Scheme 3.11).  
















































-50 oC to rt
76% d.r. > 20:1 





















(+)-3.56-50 oC to rt
(–)-3.58
  57 
Following an analogous route (Scheme 3.12, cf. Scheme 3.9), the adduct (+)-3.56 
was then subjected to dithiane removal and simultaneous deprotection of TMS group to 
provide the hydroxyl ketone (+)-3.62.29 A chelation controlled reduction of (+)-3.62 
afforded the syn-diol (+)-3.63,24, which was protected as the acetonide (+)-3.55. An 
BF3·THF30 promoted ring opening of the epoxide (+)-3.55 from the terminal position with 
propynyllithium and protection of the resulting homopropargylic alcohol (+)-3.64 as the 
methoxymethyl (MOM) ether31 then completed construction of (+)-3.23-a in a total of 6 
flasks in 30% overall yield. 
Scheme 3.12 Second-Generation Synthesis of Alkyne Fragment 
 
 
3.2.4 Synthesis of Decalin: Exploitation of A Diels–Alder Reaction 
3.2.4.1 First-Generation Synthesis of the Decalin Fragment 
Having achieved an efficient synthesis of the alkyne fragment, we turned our 
attention next to the construction of cis-decalin component of nahuoic acid Ci(Bii) (3.3). 
As showed in Scheme 3.13, we aimed at decalin 3.22-a for the synthesis of nahuoic acid 
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turn could be constructed via two intermolecular Diels–Alder reactions as the key carbon-
carbon bond forming events. The cis-decalin skeleton in an intermediate like 3.65 would 
be forged between the cyclohexenone 3.66 and the diene 3.67 via a diastereoselective endo-
Diels–Alder reaction. Elaborated cylohexenone 3.66 in turn would then be prepared by an 
enantioselective Diels–Alder reaction between the diene 3.68 and acrolein (3.69).32,33 
Scheme 3.13 First-Generation Retrosynthetic Analysis of Decalin 
 
The requisite known Danishefsky diene 3.68 was available in three steps from 3-
pentanone (3.70, Scheme 3.14).34,35 In order to probe the feasibility of our envisioned 
synthetic sequence, we first performed the cycloaddition under thermal conditions to give 
rise to the racemic cycloadduct 3.71.36 Reduction of aldehyde 3.71 followed by an HF-
mediated elimination afforded a 4.2 :1 mixture of isomers.37 The major isomer, derived 
from the endo product of the Diels–Alder reaction, was isolated and determined to be the 
desired cis-enone 3.72, whose relative configuration of the stereogenic centers was 
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Alcohol 3.72 was then protected as the TBDPS-ether 3.66 to serve as the new dienophile 
for the second Diels–Alder reaction. 
Scheme 3.14 Synthesis and Stereochemical Assignment of Enone 3.60 
    
The required known diene 3.67 for the second Diels-Alder reaction was prepared 
in a straightforward fashion. To this end, addition of di-lithiated propargyl alcohol to 
acetaldehyde followed by trapping of the di-alkoxide with MOMCl furnish the bis-MOM 
protected alkyne 3.76.38 Cis-hydrogenation of the alkyne and a subsequent kinetic 
elimination provided (E, E)-diene 3.66 in 50% yield with excellent stereoselectivity.39 
Scheme 3.15 Synthesis of Diene 3.67 
 
Unfortunately, we were not able to promote the projected Diels–Alder reaction 
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decaline skeleton.42–45 Use of strong Lewis acids such as BF3•Et2O or AlCl3 led to 
immediate decomposition of the diene (3.67) even at –78 ºC, while milder Lewis acids like 
SnCl4, EtAlCl2, Me2AlCl, (i-PrO)2TiCl2 and ZnCl2 only attenuated such propensity toward 
decomposition (slow decomposition at room temperature). Lastly, very week Lewis acid 
like Yb(FOD)2 had no effect over the reactants (no reaction at 100 ºC). We next screened 
a series of dienes, including the TBS and benzyl protected counterparts of 3.67 as well as 
the more reactive Danishefsky diene. Unfortunately, we still could not achieve the second 
Diels–Alder reaction. Therefore, we decided that it was necessary to enhance the reactivity 
of the dienophile by virtue of structural modification. 
Scheme 3.16 Diels–Alder Reaction Between Enone 3.66 and Diene 3.67 
 
3.2.4.2 Second-Generation Synthesis of the Decalin Fragment of Nahuoic Acid CiB(ii) 
Since cyclohexenone 3.66 proved to be an unreactive dienophile, we reasoned that 
benzoquinone 3.80 would be a more suitable substrate for the Diels–Alder reaction due to 
the presence of an additional carbonyl group (Scheme 3.17). That is, more electron-
deficient dienophile could facilitate the cycloaddition reaction with an electron-rich diene. 
Furthermore, the planar geometry of 3.80 should also benefit the reaction due to reduced 
steric hindrance. The vinyl group in 3.22-b in turn would be installed via a copper-mediated 
conjugate addition to enone 3.78, which would be derived from the initial cycloadduct 3.79 
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Scheme 3.17 Second-Generation Retrosynthetic Analysis of Decalin 
 
Toward this end, we prepared the benzoquinone derivative 3.80 in two steps from 
the o-methoxyvanillin (3.81).46,47 We were pleased to find that the cycloaddition reaction 
of this dienophile with diene 3.67 occurred smoothly under thermal conditions at 120 °C 
to afford the desired endo-product with high chemo- and regio-selectivity (Table 3.3, entry 
1). We further identified the use of the 1-naphathyl-substitued Ti-TADDOL complex (–)-
C348,49 among the five catalysts (C1-C5) we screened to achieve promising level of 
enantioselectivity (ca. 73% ee) for this transformation, although the Ti-TADDOL (–)-C3 
had to be used in one full equivalent.50–52 Of interest, when the 2-naphthyl substituted 
TADDOL-Ti (C4)53–55 catalyst was employed, the Diels–Alder reaction favored the 
opposite enantiomer (+)-3.79 (–40% ee, entry 8). Importantly, addition of 4 Å molecular 
sieves was found to enable substoichiometric use of the titanium reagent (entry 6). Further 
optimization of the temperature and solvent (entry 7) led to the formation of the desired 
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be easily recovered via chromatography and recycled to regenerate the titanium-catalyst (–
)-C5 following the literature protocol.56,57 Importantly, the enantiomeric excess of (–)-3.79 
could be further enriched to greater than 99% (determined by chiral SFC) by 
crystallization. The absolute configuration (–)-3.79 was established via single crystal X-
ray analysis.  












1   Toluene/CH2Cl2 120 48 71  
2 C1 (0.5)  CH2Cl2 0 12 20 3 
3 C2 (1)  Toluene/CH2Cl2 –78 1 43 20 
4 C3 (1)  CH2Cl2 –40 24 71 73 
5 C3 (0.2)  CH2Cl2 0 to rt 24 25 55 
6 C3 (0.2) 4 Å MS CH2Cl2 –60 12 80 71 
7 C3 (0.2) 4 Å MS toluene –40 48 95 85 
8 C4 (0.2) 4 Å MS CH2Cl2 –60 48 88 (–)-44 
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With the highly enantio-enriched intermediate (-)-3.79 in hand, we proceeded to 
complete construction of cis-decalin 3.22-b (Scheme 3.18). To this end, vinylogous ester 
(–)-3.79 was subjected to exhaustive hydride reduction, followed by acid-mediated 
hydrolysis-elimination cascade58 to provide a-hydroxycyclohexenone (–)-3.83, which was 
protected as the TBS ether (–)-3.78. Selective dihydroxylation59 of C(2,3) to form the 
corresponding diol of the acetonide (–)-3.87 proved difficult. To circumvent this problem, 
the cyclohexanone moiety had to be first masked. This operation was achieved using the 
Lindlar catalyst. Diastereoselective dihydroxylation of (+)-3.84 then gave rise to diol (+)-
3.85, which was converted to acetonide (+)-3.86.25 The enone functionality was thereafter 
re-introduced by virtue of the Saegusa-Ito oxidation60 in 85% yield. The resulting enone (–
)-3.87 finally underwent a diastereoselective CuBr·DMS-mediated conjugate addition61,62 
to arrive at ketone (+)-3.88. The overall yield for this eight-step sequence was 21%. 
Scheme 3.18 Synthesis of Intermediate (+)-3.88 
 
Kinetic enolization of (+)-3.88 and the subsequent trapping by Tf2O gave vinyl 
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Comin’s reagent63 or phenyl triflimide resulted in the silyl-migrated isomer (+)-3.90. 
Interestingly, silyl migration was not observed when the nascent lithium enolate was 
treated with D2O, which suggests that the silyl migration event occurred during the 
triflation stage. Kumada cross coupling with methylmagnesium bromide was then 
employed to furnish (+)-3.91,64,65 which upon deprotection of TBS ether completed 
construction of the cis-decalin fragment (+)-3.22-b, whose structure and absolute 
configuration was confirmed by X-ray analysis.  
Scheme 3.19 Optimization of Enolization-Triflation Cascade and Completion of 



















































































3.89:3.90 = 1 : 0.9 (THF, - 40 oC)
3.89:3.90 =  1: 0.6 (THF)
3:89:3.90 =  1 : 1.4 (Et2O)
3.89:3.90 = 1 : 2.9 (THF)
(+)-3.89 (+)-3.90 (< 5%)(+)-3.88
NMR ratio of 3.89 to 3.90 
with each triflation reagent
(under various conditions)
Comin's Reagent Phenyl Triflimide
Total Steps = 12
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3.3 Micalizio Coupling and Late-Stage Elaboration 
3.3.1.1 Micalizio Coupling 
Having procured the requisite decalin (+)-3.22-b and alkyne side chain (+)-3.23-a, 
we proceeded with our investigation into their union by virtue of the Micalizio reaction 
(Table 3.4).12,15,66 This union process proved challenging due to the involvement of a 
myriad of reagents and multiple operative experimental events. We examined this process 
in two major stages: generation of the reactive titanium-alkyne complex 3.92 and the 
carbon-carbon bond formation stage. 
 We first evaluated various titanium sources including Ti(Oi-Pr)4, TiCl(Oi-Pr)3 and 
TiCl2(Oi-Pr)2, as well as the reducing agents such as c-C5H9MgCl and n-BuLi. When the 
reaction was performed at –45 ºC in toluene, and was subsequently quenched with H2O or 
D2O, we observed an alkene that would have derived from protonation of 3.92. Among all 
possible combination of the titanium species and the organometallic reagents, use of Ti(Oi-
Pr)4 and c-C5H9MgCl turned out to be the most efficient, followed by that of TiCl(Oi-Pr)3 
and c-C5H9MgCl, although minor byproducts were detected under both conditions.  
Next, in a separate flask, decalin (+)-3.22-b was treated with n-BuLi in toluene and 
then transferred into pre-formed 3.92. Although we indeed observed the desired product, 
conversion of the decalin was problematic under a number of conditions (Table3.4, entry 
2-6). To circumvent this issue, we increased the stoichiometry of the alkyne (+)-3.23-a as 
well as the titanium and the Grignard reagents. When two equivalents of alkyne and 
TiCl(Oi-Pr)3 were employed, we achieved a 66% conversion of decalin (+)-3.22-b (entry 
8), while with Ti(Oi-Pr)4 a 50% conversion was observed (entry 6). This difference in 
reactivity can be rationalized by the coordination competition between the substrate-
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derived alkoxide and the additional equivalent of isopropoxide from the Ti(Oi-Pr)4.67 In an 
attempt to alleviate further such competition, we also tested TiCl2(Oi-Pr)2. However, the 
generation of the titanium-alkyne complex in the first stage turned out to be problematic, 
thus resulting in even lower conversion of the decalin (entry 7). 




















1c  1 Ti(Oi-Pr)
4
 [1.1]  2.2    
2 1 1.1 Ti(Oi-Pr)
4
 [1.2] 2.4 1.2 2:1 64% 26% 
3 1 1.5 Ti(Oi-Pr)
4
 [1.6] 3.2 1.2 2:1   
4 1.5 1 Ti(Oi-Pr)
4
 [1.5] 3.0 1.8 3:1   
5 1 2 Ti(Oi-Pr)
4
 [2.4] 4.8 1.2 1:1 41% 35% 
6 1 1.1 TiCl(Oi-Pr)
3
[1.2] 2.4 1.2 1:1   




[2.2] 4.4 1.2 3.4:1   
8 1 2 TiCl(Oi-Pr)
3
[2.2] 4.4 1.2 1:2 30% 61% 
aRatio is determined by NMR analysis of the crude reaction mixture; bisolated yield and recovered 
percentage of decalin 3.22-b; cWhen n-BuLi was employed as the reducing reagent, complex mixture was 
observed during the generation stage of intermediate 3.92, thus decalin was not added; dTiCl2(Oi-Pr)2 was 
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With the best conditions being TiCl(Oi-Pr)3 and 2 equiv. of alkyne fragment (+)-
3.23-a, we were able to achieve the union adduct (–)-3.94 in 61% isolated yield (87% based 
on recovered decalin). Such union protocols had been performed on various scales either 
as small as 15 mg or as large as 200 mg, consistently resulting in over 50% yield. In total, 
we had obtained more than half gram of the coupling product (–)-3.94. Importantly, the 
alkoxide on the concave face directed the approach of complex 3.92, leading to the desired 
stereochemistry at C(12) in (–)-3.94 as suggested by the NOE correlation between C(4) 
hydrogen and C(12) hydrogen in (–)-3.94. Importantly, the triplet splitting pattern for C(14) 
hydrogen suggested that the desired regioselectivity was also achieved to furnish the tri-
substituted E-alkene C(13,14) with methyl group proximal to the decalin C(12), 
presumably due to minimization of the steric hindrance between the methyl group with the 
decalin vis-á-vis the methylene group.  
3.3.2 Late-Stage Elaboration to Nahuoic Acid Ci(Bii) 
The endgame to complete the total synthesis of nahuoic acid Ci(Bii) (3.3) now only 
required the attachment of the unsaturated carboxylic acid moiety onto the terminal olefin 
of the cis-decalin of (–)-3.94 and global deprotection.  
To access rapidly the tri-substituted unsaturated carboxylic acid moiety, we 
attempted an olefin metathesis68 between (–)-3.94 and methacrylic acid, which 
unfortunately resulted in the decomposition of (–)-3.94 due to the presence of the acid-
labile acetals. We therefore probed the viability of metathesis reactions with methacrylates 
and others terminal olefins that would furnish the corresponding esters or allylic alcohol 
derivatives. In order to be prudent with the use of the precious intermediate (–)-3.94, we 
carried out a model study between an earlier decalin-based intermediate, (+)-3.22-b, and 
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various metathesis partners (A1-A3 in Scheme 3.20) to develop initial metathesis 
conditions. Although the silyl ether A2 was resistant to metathesis and the use of the PMB 
ether A3 led to a complex mixture, we were pleased to find that the desired product (+)-
3.95 was formed in 67% yield when neat methyl methacrylate (A1) was used in the 
presence of 20 mol% Hovedya-Grubbs II catalyst. To the best of our knowledge, this is the 
first successful cross metathesis to prepare a tri-substituted olefins from a 3-
vinylcyclohexane-containing substrates.69 
Scheme 3.20 Model Studies of Olefin Metathesis 
 
Encouraged by the result of the model study, we next turned to examine the real 
substrate (–)-3.94. Unfortunately, the same condition used for model substrate failed to 
give any product, presumably due to the additional steric hindrance imposed by the long 
side chain in (–)-3.94 compared to (+)-3.22-b. Olefin metathesis in the presence of high 
levels of steric hindrance, especially cross metathesis, have been a longstanding 
challenge.70,71 In those cases, higher loading of catalysts are usually needed to promote 
reactions.72  
To overcome the challenging metathesis of (–)-3.94, we increased the loading of 
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for the first time gave rise to the desired product (–)-3.96 in 30 % yield. During the reaction, 
a significant competing side reaction was polymerization of the methyl acrylate. Addition 
of solvents [i.e., CH2Cl2, hexafluorobenzene, toluene, xylenes, ionic liquid (1-Butyl-3-
methylimidazolium tetrafluoroborate)] and radical inhibitors [i.e., butylated 
hydroxytoluene (BHT), hydroquinone (HQ)] did slow down the polymerization process, 
but solvents and additives also substantially retarded the desired olefin metathesis, and 
ultimately led to the decomposition of substrate (–)-3.94 at such elevated temperature. 
Among the other unsaturated carbonyl compounds (i.e., A4-A7, table 3.5), we have 
attempted, only ethyl methacrylate A4 gave a similar result to that of methyl methacrylate 
A1. Heating with microwave also did not improve the outcome of the reactions. 
Table 3.5 Olefins and Catalysts Screened for Olefin Metathesis 
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We next screened a series of metathesis catalysts (C6-C12, Table 3.5) in an attempt 
to improve the yield and decrease the catalyst loading. Unfortunately, only HG-II (C6) 
gave the desired product, whereas the use of all other catalysts proved unfruitful. With the 
Schrocks catalyst (C12), the methacrylate A1 polymerized at room temperature, leaving 
the substrate (–)-3.94 untouched. We do note that Hoveyda-Grubbs II catalyst could be 
lowered to 50 mol% by adding the catalyst in several portions, which afforded the desired 
product (–)-3.96 in 29% yield (57% BRSM) (Scheme 3.21).  
Alternatively, we attempted a two-step protocol to arrive at ester (–)-3.96, namely 
a Lemieux–Johnson oxidation and a subsequent Horner–Wadsworth–Emmons (HWE) 
reaction (Scheme 3.21). Unfortunately, chemoselective oxidation of the terminal olefin 
under standard or modified Lemieux-Johnson conditions was problematic, resulting in the 
isolation of the (–)-3.97 desired aldehyde in only 25% yield, as the best result. Further 
derivatization to the ester under HWE reaction conditions turned out to be more 
challenging. As such, we maintained the olefin metathesis to construct the tri-substituted 
olefin. 
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The fully protected intermediate (–)-3.96 was next subjected to various conditions 
to remove the two MOM and two acetonide protection groups. Use of BrØnsted acids such 
as HCl or TFA led to the decomposition of (–)-3.96, while Lewis acids such as TMSBr, 
Cl2SiMe2/Bu3NBr and ZnBr2/nBuSH were either ineffective or led to complex mixtures. 
A major challenge proved to be removal of the MOM ether protecting groups while 
minimizing the formation of methylene acetals, which in turn proved highly resistant to 
hydrolysis. Eventually, we discovered that treatment of the fully protected intermediate (–
)-3.96 with LiBF473,74 at 75-90 ºC achieved the successful hydrolysis of both the acetonides 
and MOM ethers, leading to the desired polyol (–)-3.98 in 49% yield. Finally, 
saponification of (–)-3.98 with LiOH completed the total synthesis of nahuoic acid Ci(Bii) 
[(–)-3.3]. 
Scheme 3.22 Removal of Protection Groups toward the Completion of (–)-Nahuoic 
Acid Ci(Bii) 
 
The spectral data for (–)-nahuoic acid Ci(Bii) has been independently reported by 
both Anderson and Qi.2,3 A major difference was observed in their 1H NMR spectrum 
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500 MHz 1H NMR spectrum of our synthetic material was pleasingly in excellent 
agreement with that reported by Qi and coworker. Upon addition of trace amount of 
deuterated TFA,2 the six exchangeable proton resonances in our 1H NMR spectrum became 
indistinguishable, which now prove identical to the 1H and 13C NMR data published by 
Anderson et al. (Table 3.6). Two other spectroscopic properties (i.e., HRMS parent ion 
identification and chiroptic properties) of synthetic nahuoic Ci(Bii) [(–)-3.3] were also in 
total agreement with that of the isolated samples: HRESIMS [M+Na]+ (calcd for 
C30H50NaO8, 561.3403), observed: 561.3408 (synthetic sample), 561.3398 (natural sample 
isolated by Anderson), 561.3393 (natural sample isolated by Qi); [a]20D    – 6.1 (c 0.17, 
MeOH; synthetic sample), −6.6 (c 1.4, MeOH; natural sample isolated by Anderson), −5.4 
(c 0.82, MeOH; natural sample isolated by Qi). 
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Table 3.6 Comparisons of NMR Spectral Data Between the Synthetic Nahuoic 
Acid Ci(Bii) (with trace TFA-d)a and the Natural product reported by Andersonb 
1H NMR Chemical Shift (d ppm), multiplicity (J Hz) 13C NMR Chemical Shift (d, ppm) 
 Natural Synthetic Dd Natural Synthetic Dd 
1    169.2 169.1 -0.1 
2    124.4 124.4 0.0 
3 6.41, bd (10.3) 6.41, bd (10.9) 0.00 149.0 148.9 -0.1 
4c 3.40 3.41 0.01 36.2 36.2 0.0 
5c 1.47 1.47 0.00 50.6 50.6 0.0 
6 2.34 m 2.34 m 0.00 30.6 30.7 0.1 
7 3.52, dd (11.7, 2.1) 3.52, dd (11.6, 3.0)  0.00 68.4 68.4 0.0 
8 3.74, bs 3.74, bt (2.8) 0.00 74.7 74.7 0.0 
9 3.40, bs 3.41, bs 0.01 75.7 75.7 0.0 
10    40.5 40.5 0.0 
11 5.13, bs 5.13, bs 0.00 133.1 133.0 -0.1 
12    131.6 131.5 -0.1 
13 2.22, bd (9.4) 2.22, bd (9.4) 0.00 56.5 56.5 0.0 
14    134.9 135.0 0.1 
15 4.98, m 4.98, m 0.00 125.4 125.5 0.1 
16a 1.91, m 1.91, m 0.00 37.0 37.0 0.0 
16b 2.03, m 2.03, m 0.00    
17 3.57, m 3.57, m 0.00 67.1 67.1 0.0 
18ac 1.17 1.18 0.01 41.7 41.7 0.0 
18bc 1.42 1.42 0.00    
19 3.77, dm (9.5) 3.77, dt (9.6, 3.0) 0.00 70.0 70.0 0.0 
20c 1.39 1.39 0.00 39.7 39.7d 0.0 
21 3.12, dd (7.1, 4.0) 3.12, dd (7.3, 4.0) 0.00 78.6 78.7 0.1 
22 1.63, m 1.63, m 0.00 30.3 30.3 0.0 
23 0.76, d (6.6) 0.75, d (3.0) 
-
0.01 19.5 19.5 0.0 
24 1.58, bs 1.58, d (1.0) 0.00 13.0 13.0 0.0 
25 0.85, d (7.4) 0.85, d (8.1) 0.00 17.9 17.9 0.0 
26 1.14, s 1.14, s 0.00 27.7 27.7 0.0 
27 1.45, bs 1.46, bs 0.01 21.7 21.6 -0.1 
28 1.39, bs 1.40, bs 0.01 12.1 12.1 0.0 
29 0.76, d (6.7) 0.77, d (3.0) 0.01 7.2 7.1 -0.1 
30 0.83, d (6.8) 0.83 (6.9) 0.00 18.5 18.5 0.0 
a. DMSO-d6, 500 MHz 1H NMR, 125 MHz 13C NMR. b. DMSO-d6, 600 MHz 1H NMR, 150 MHz 
13C NMR. c.For 1H NMR: Multiplicity not determined due to overlapping signals; chemical shifts 
determined from 2D data. d.For 13C NMR: chemical shifts determined from 2D data.  
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3.3.3 Summary of the First Total Synthesis Nahuoic Acid Ci(Bii) 
In summary, we have achieved the first total synthesis of a member of the nahuoic 
acid family of cis-decalin-containing polyketides, namely Ci(Bii) [(–)-3.3], in a longest 
linear sequence of 16 steps. Highlights of the synthesis include a titanium-catalyzed 
asymmetric Diels–Alder reaction to generate the cis-decalin skeleton, Type II Anion Relay 
Chemistry (ARC) to construct the polyol chain, and a late-stage strategic large fragment 
union via a Micalizio alkoxyl-directed alkyne-alkene coupling (Scheme 3.23). 
Scheme 3.23 Summary of the Total Synthesis nahuoic acid Ci(Bii) 
 
 
3.4 Future Direction: Synthetic Studies toward Nahuoic Acid Congeners and 
Potential Analogues 
Having achieved the total synthesis of nahuoic acid Ci(Bii), we next aimed at other 
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the synthetic route toward nanhuoic acid Ci(Bii), for which we proposed a diversity-
oriented retrosynthetic analysis as presented in Scheme 3.24. 
Scheme 3.24 Diversity-Oriented Retrosynthetic Analysis of Nahuoic Acids 
 
The strategic Micalizio reaction, which permitted a highly convergent synthesis of 
nahuoic Ci(Bii), should enable individual structural modifications on both the decalin like 
3.22 and the alkyne (3.23-a or 3.23-b) fragments. As shown in Scheme 3.24, (+)-3.23-a 
could also be used to arrive at the nahuoic acids 3.1, 3.2 and 3.4, if one were to use a decalin 
derivative with different oxidation states and C(7) and/or C(8). Conversely, for nahuoic 
acids 3.5, 3.6, and 3.7, the requisite side chain fragment 3.23-b and its precursor 3.99 would 



























































































      3.58
Type II ARC
  76 
3.100, linchpin 3.101, and epoxide epi-3.55, the latter constructed in an analogous manner 
as (+)-3.55 if (S)-epichlorohydrin [(+)-(S)-58] were used. 
Intermediate (–)-3.78 toward the total synthesis of nahuoic acid Ci (3.3) can also 
serve as a common precursor to access nahuoic acids 3.1,3.2 and 3.4-3.7 (Scheme 3.25). 
Selective epoxidation of the C(7)-C(8) olefin and subsequent ring opening of 3.102 could 
ultimately furnish nahuoic acids 3.1, 3.2, 3.5 and 3.6. On the other hand, indiscriminated 
hydrogenation of both olefins would lead to nahuoic acids 3.4 and 3.7, which have not been 
evaluated against the SETD8 enzyme. 
Scheme 3.25 Derivatization of the Common Intermediate (–)-3.78 
 
In summary, our total synthesis of (–)-nahuoic acids Ci(Bii) has paved the way for 
the construction of other nahuoic acid congeners and potential analogues. Given nahuoic 
acids’ unique biological activity as selective SETD8 inhibitors but with moderate potency, 
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congeners as well as the synthesis of therapeutic lead compounds via structure-activity 
relationship studies of synthetic intermediates or analogues.  
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E 1 EXPERIMENTAL SECTION CORRESPONDING TO 
CHAPTER 1 
E1.1 Materials and Methods 
 Reactions were performed either in flame or oven-dried glassware under a nitrogen 
atmosphere unless noted otherwise. Anhydrous diethyl ether (Et2O), tetrahydrofuran 
(THF), dichloromethane (CH2Cl2) and toluene were obtained from a solvent purification 
system. Triethylamine, diisopropylethylamine and pyridine were freshly distilled from 
calcium hydride under a nitrogen atmosphere. All chemicals were purchased from 
commercial vendors, unless otherwise referenced. Reactions were magnetically stirred 
unless stated otherwise and monitored by thin layer chromatography (TLC) with 0.25 mm 
pre-coated silica gel plates. Silica gel chromatography was performed utilizing ACS grade 
solvents and silica gel. Preparatory TLC was performed using 500 µm pre-coated silica gel 
plates and ACS grade solvents. Medium pressure liquid chromatography was conducted 
by using a medium pressure pump equipped with a high pressure glass column (350 mm ´ 
35 mm or 350 mm × 10 mm) packed with silica gel (Standard Grade, porosity 60 Å, particle 
size 32-63 µm).   
Infrared spectra were obtained using a FT/IR plus spectrometer. Optical rotations 
were obtained using a polarimeter at 589 nm. CD spectra were obtained using a circular 
dichroism spectrometer in a 1 mm quartz cell. 1H NMR spectra (500 MHz field strength) 
and 13C NMR spectra (125 MHz field strength) were obtained on a 500 MHz spectrometer 
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or a cryomagnet (500MHz/52mm) with a 5 mm dual cryoprobe. Chemical shifts are 
reported relative to chloroform (δ 7.26), benzene (δ 7.16) or methanol (δ 3.31) for 1H NMR 
spectra and chloroform (δ 77.16), benzene (δ 128.06) or methanol (δ 49.15) for 13C spectra. 
The following abbreviations are used to describe multiplicities in 1H NMR spectra: s 
(singlet), brs (broad singlet), d (doublet), dd (doublet of doublets), ddd (doublet of doublet 
of doublets), dt (doublet of triplets), dq (doublet of quartets), t (triplet), td (triplet of 
doublets), m (multiplet) and q (quartet), app (apparent). High-resolution mass spectra 
(HRMS) were measured on  a LC-TOF mass spectrometer. 
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E1.2 Experimental Procedures 
 
(2R,3S)-2-((tert-butyldimethylsilyl)oxy)-3-methoxy-5-methylhex-5-en-1-ol 
(+)-1.18. To a solution of (2R,3S)-2-hydroxy-3-methoxy-5-methylhex-5-en-1-yl pivalate 
(+)-1.1719 (840 mg, 3.44 mmol) dissolved in CH2Cl2 (10 mL) at 0 ºC was added 2,6-lutidine 
(0.78 mL, 6.71 mmol, 1.95 equiv) and TBSOTf (0.84 mL, 3.65 mmol, 1.06 equiv). After 
the reaction was stirred for 1.5 h at room temperature, the reaction was quenched with a 
saturated aqueous solution of NaHCO3 (10 mL) and extracted with EtOAc (3 ´ 15 mL). 
The combined organic layers were washed with brine (20 mL), dried over MgSO4, and 
concentrated in vacuo to yield crude (2R,3S)-2-((tert-butyldimethylsilyl)oxy)-3-methoxy-
5-methylhex-5-en-1-yl pivalate (+)-1.S1 (1.18 g) as faint yellow oil: [a]20D   +11.8 (c 3.5, 
CHCl3); IR (neat) 3076, 2957, 2930, 2857, 1733, 1480, 1472, 1462, 1283, 1255, 1159, 
1115, 836, 777 cm–1; 1H NMR (500 MHz, CDCl3) δ 4.82 (brs, 1H), 4.79 (brs, 1H), 4.18 
(dd, J = 11.5, 4.5 Hz, 1H), 4.05 (dd, J = 11.5, 5.3 Hz, 1H), 3.90 (ddd, J = 5.3, 4.5, 3.6 Hz, 
1H), 3.40 (s, 3H), 3.43-3.35 (m, 1H), 2.30-2.16 (m, 2H), 1.78 (S, 3H), 1.22 (s, 9H), 0.90 
(s, 9H), 0.09 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 178.5, 143.1, 112.6, 81.4, 72.2, 65.7, 
58.7, 39.3, 38.9, 27.4, 26.6, 25.9, 22.9, 18.1, –4.6; HRMS (ES+) m/z 381.2442 [(M+Na)+; 







     –78 ºC
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To a solution of (+)-1.S1 (1.18 g, azeotroped with benzene three times) in CH2Cl2 
(30 mL) at –78 ºC was added DIBAL-H (10.3 mL, 1 M in toluene, 3.13 equiv). The reaction 
was stirred for 30 min at –78 ºC then quenched by addition of MeOH (5 mL). After 
warming to room temperature, a saturated aqueous solution of Rochelle’s salt (20 mL) was 
added. The biphasic mixture was stirred for 1 h at room temperature to allow the organic 
layer to clear. The layers were separated and the aqueous layer was extracted with EtOAc 
(3 ´ 20 mL). The combined organic layers were washed with brine (30 mL), dried over 
MgSO4, and concentrated in vacuo. The crude mixture was purified by column 
chromatography on SiO2 (15% EtOAc/hexanes) to provide (+)-1.18 (860 mg, 3.13 mmol 
91% yield over two steps) as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 4.81 (brs, 1H), 
4.79 (brs, 1H) 3.74-3.60 (m, 3H), 3.43 (s, 3H), 3.41 (dd, J = 8.6, 4.6 Hz, 1H), 2.27 (dd, J 
= 14.3, 4.5 Hz, 1H), 2.22-2.14 (m, 2H), 1.78 (s, 3H), 0.9 (s, 9H), 0.09 (s, 6H); 13C NMR 
(125 MHz, CDCl3) δ 143.0, 112.9, 81.9, 74.4, 64.0, 59.2, 40.3, 26.0, 22.9, 18.2, –4.4, –4.5. 
Extra analytical data is available in previously reported literature.1 
 
(2S,3S)-2-((tert-butyldimethylsilyl)oxy)-3-methoxy-5-methylhex-5-enoic acid 
(–)-1.12. To a solution of (+)-1.18 (220 mg, 0.80 mmol) in CH2Cl2 (70 mL) was added 
NaHCO3 (150 mg, 1.79 mmol, 2.23 equiv) and Dess-Martin periodinane (374 mg, 0.88 
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saturated aqueous solution of NaHCO3 (30 mL). The layers were separated and the aqueous 
layer was extracted with CH2Cl2 (3 ´ 30 mL). The combined organic layers were washed 
successively with a saturated aqueous solution of Na2S2O3 (30 mL), a saturated aqueous 
solution of NaHCO3 (30 mL), and brine (40 mL). The organic layer was then dried over 
MgSO4 and concentrated in vacuo to afford crude (2S,3S)-2-((tert-butyldimethylsilyl)oxy)-
3-methoxy-5-methylhex-5-enal (–)-1.S2 (220 mg) as a colorless oil: [a]20D   –22.0 (c 0.2, 
CHCl3); IR (neat) 2954, 2929, 2857, 1733, 1472, 1463, 1253, 1145, 1108, 898, 838, 779 
cm–1;  1H NMR (500 MHz, CDCl3) δ 9.59 (d, J = 1.1 Hz, 1H) 4.83 (brs, 2H), 4.14 (dd, J = 
2.4, 1.1 Hz, 1H), 3.61 (dt, J = 7.0, 2.4 Hz, 1H), 3.40 (s, 3H), 2.31 (dd, J = 3.8, 7.2 Hz, 1H)-
2.25 (dd, J = 13.7, 7.1 HZ, 1H), 1.68 (s, 3H), 0.94 (s, 9H), 0.10 (s, 3H), 0.08 (s, 3H); 13C 
NMR (125 MHz, CDCl3) δ 203.7, 141.7, 114.5, 83.0, 78.6, 58.1, 38.6, 25.9, 22.7, 18.3, –
4.7, –4.8. HRMS (ES+) m/z 295.1702 [(M+Na)+; calcd for C14H28O3SiNa: 295.1705]. 
The crude material (–)-1.S2 (220 mg) was dissolved in t-BuOH/H2O (3:1, 20 mL) 
and cooled to 0 °C. To the reaction mixture was added NaH2PO4×2H2O (235 mg, 1.51 
mmol, 1.89 equiv), 2-methyl-2-butene (4.60 mL, 43.3 mmol, 54.1 equiv), and NaClO2 (235 
mg, 80 wt%, 2.08 mmol, 2.60 equiv). The reaction mixture was stirred for 10 min then 
poured into H2O (20 mL), diluted with EtOAc (40 mL) and acidified with 10% citric acid 
to pH=4. The layers were separated and the aqueous layer was extracted with EtOAc (3 ´ 
30 mL). The combined organic layers were washed with brine (30 mL), dried over Na2SO4, 
and concentrated in vacuo. The crude mixture was purified by column chromatography on 
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SiO2 (25% EtOAc/hexanes) to provide acid (–)-1.12 (160 mg, 0.555 mmol, 70% over two 
steps) as a colorless oil: [a]20D   –4.8 (c 0.6, CHCl3); IR (neat) 2929, 2852, 1727, 1465, 1357, 
1253, 1154, 838, 777 cm–1; 1H NMR (500 MHz, CDCl3) δ 4.86 (brs, 1H), 4.82 (brs, 1H), 
4.44 (d, J = 2.1 Hz, 1H), 3.66 (ddd, J = 7.9, 5.6, 2.1 Hz, 1H), 3.44 (s, 3H), 2.33 (dd, J = 
14.3, 8.1 Hz, 1H), 2.19 (dd, J = 14.3, 5.5 Hz, 1H), 1.77 (S, 3H), 0.96 (s, 9H), 0.19 (s, 3H), 
0.15 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 171.9, 141.7, 113.7, 81.9, 73.8, 58.5, 38.0, 
25.9, 22.8, 18.3, –4.5, –5.4. HRMS (ES+) m/z 311.1643 [(M+Na)+; calcd for 
C14H28O4SiNa: 311.1655]. 
 
Tert-butyldimethyl(4-(oxiran-2-yl)butoxy)silane (±)-1.20. To a solution of 5-
hexenol 1.19 (21.0 g, 0.210 mol) in THF (350 mL) was added imidazole (15.9 g, 0.233 
mol, 1.11 equiv) and TBSCl (33.4 g, 0.222 mol, 1.06 equiv) and The reaction was allowed 
to stir at room temperature for 3 h. The reaction was quenched with H2O (80 mL) and 
extracted with EtOAc (3 ´ 150 mL). The combined organic layers were dried over MgSO4 
and concentrated in vacuo to afford the crude tert-butyl(hex-5-en-1-yloxy)dimethylsilane 
(45.0 g).  
The crude material (45.0 g) was then dissolved in CH2Cl2 (500 mL), cooled to 0 °C 
and treated with m-CPBA (77% purity, 54.9 g, 0.245 mol, 1.17 equiv) in three equal 




41% yield over three steps, >96% ee
1. TBSCl, imidazole, THF
2. m-CPBA, CH2Cl2, 0 ºC to rt
1.19
(+)-1.20
3. (R,R)-salen-Co(II), AcOH, H2O, THF
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temperature and was stirred overnight. The reaction vessel was cooled to 0 °C and filtered 
through a pad of Celite®. The filtrate was poured into a mixture of a saturated aqueous 
solution of NaHCO3 (200 mL) and a saturated aqueous solution of Na2S2O3 (200 mL). The 
organic layer was separated and the aqueous layer was extracted with EtOAc (3 ´  200 mL). 
The combined organic layers were dried over MgSO4 and concentrated in vacuo to afford 
(±)-1.20 (45.0 g) as colorless oil.  
(R)-tert-butyldimethyl(4-(oxiran-2-yl)butoxy)silane (+)-1.20. (R,R)-(−)-N,N’-
Bis(3,5-di-tert-butylsalicylidene)-1,2- cyclohexanediaminocobalt(II) (1.20 g, 1.99 mmol, 
0.01 equiv) was activated by stirring with AcOH ( 0.47 mL, 8.21 mmol, 0.04 equiv) in an 
open flask for 30 min. The crude epoxide (±)-1.20 (45.0 g) and THF (2.6 mL) was added 
to the catalyst mixture. Then reaction mixture was cooled to 0 ºC and H2O (1.96 mL, 109 
mmol, 0.56 equiv) was introduced. The reaction mixture was allowed to warm to room 
temperature. After 8 h, the crude mixture was purified via distillation (65 ºC, 0.025 torr) to 
provide (+)-1.20 as colorless oil (20.0 g, 87.0 mmol, 41% yield over three steps). 
Enantiomeric excess (ee) >96% was determined by 19F NMR of the corresponding both R 
and S Mosher ester on secondary alcohol/azide derived from reacting (+)-1.20 with sodium 
azide.20 All spectroscopic analysis matched the reported literature except for optical 
rotation, while the optical rotation of s-enantiomer was reported to be –4.4 (c 1.00, 
CHCl3).22  [a]20D   +4.8 (c 3.2, CHCl3); IR (neat) 2929, 2857, 1472, 1255, 1100, 836, 775 cm
–
1; 1H NMR (500 MHz, CDCl3) δ 3.62 (t, J = 6.1 Hz, 2H), 2.90 (m, 1H), 2.74 (dd, J = 5.0, 
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4.0 Hz, 1H), 2.46 (dd, J = 5.1, 2.7 Hz, 1H), 1.63-1.43 (m, 6H), 0.89 (s, 9H), 0.04 (s, 6H); 
13C NMR (125 MHz, CDCl3) δ 63.1, 52.4, 47.2, 32.7, 32.4, 26.1, 22.5, 18.5, –5.2; HRMS 
(ES+) m/z 231.1747, [(M+H)+; calcd for C16H23O: 231.1749]. 
 
(R)-4-(oxiran-2-yl)butan-1-ol (+)-1.S3. To a solution of (+)-1.20 (3.0 g, 13.0 
mmol) in THF (60 mL) was added TBAF (20 mL 1 M in THF, 20.0 mmol, 1.54 equiv) at 
0 ºC. The reaction was allowed to warm to room temperature and stirred for 3 h before 
quenching with a saturated aqueous solution of NaHCO3 (20 mL). The mixture was 
extracted with EtOAc (3 x 30 mL) and the combined organic layers were washed with brine 
(30 mL), dried over MgSO4, and concentrated in vacuo. The crude mixture was purified 
by column chromatography on SiO2 (75% to 100% diethyl ether/hexanes) to provide (+)-
1.S3 (1.4 g, 12.0 mmol, 92% yield) as a colorless oil: [a]20D   +13.0 (c 4.7, CHCl3); IR (neat) 
3399 (br), 2937, 2864, 1411, 1057,880 cm–1; 1H NMR (500 MHz, CDCl3) δ 3.65 (m, 2H), 
2.91 (m, 1H), 2.74 (dd, J = 5.0, 4.0 Hz, 1H), 2.47 (dd, J = 5.0, 2.7 Hz, 1H), 1.69-1.46 (m, 
6H), 0.09 (t, J = 5.1 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 62.8, 52.4, 47.2, 32.5, 32.3, 
22.4; HRMS (ES+) m/z 117.0923 [(M+H)+; calcd for C6H13O2: 117.0916]. 
 
(R)-4-(oxiran-2-yl)butanal (+)-1.21. A suspension of NMO/TPAP in CH2Cl2 was 













    4 Å molecular sieves
    CH2Cl2,  57%
TPAP, NMO
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TPAP (39 mg, 0.11 mmol, 0.05 equiv) in CH2Cl2 (4 mL). A solution of (+)-1.S3 (250 mg, 
2.15 mmol) in CH2Cl2 (1 mL) was added to the NMO/TPAP suspension over 20 min via 
syringe pump. After addition was complete, the reaction mixture was stirred for 2 h and 
the mixture was diluted with pentanes (4 mL). Without concentration, the entire reaction 
mixture was directly purified via flash chromatography (50% diethyl ether/pentanes) to 
provide (+)-1.21 as a colorless liquid (140 mg, 1.23 mmol, 57% yield). Aldehyde (+)-1.21 
was found to be volatile and unstable, and was used into next step as soon as possible: [a]20D   
+11.5 (c 2.5, CHCl3); IR (neat) 3421 (br), 2925, 2854, 2726, 1723, 1456, 1260, 1102, 664 
cm–1; 1H NMR (500 MHz, CDCl3) δ 9.78 (m, 1H), 2.91 (m, 1H), 2.75 (dd, J = 4.9, 4.0 Hz, 
1H), 2.60-2.48 (m, 2H), 2.47 (dd, J = 5.0, 2.7 Hz, 1H), 1.89-1.72 (m, 2H), 1.74-1.61 (m, 
1H), 1.54-1.46 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 202.1, 52.0, 47.0, 43.5, 31.8, 18.7; 
HRMS (ES+) m/z 115.0739 [(M+H)+; calcd for C6H11O2: 115.0759]. 
 
5-hydroxy-8-((R)-oxiran-2-yl)octan-3-one 1.22. To a solution of 2-butanone 
(1.34 mL, 15 mmol, 1.70 equiv) in THF (8 mL) was added dropwise a freshly prepared 
solution of LDA (15 mmol, 1.70 equiv) in THF (72 mL) at –78 ºC. The reaction mixture 
was stirred for 30 min at –78 ºC. A solution of aldehyde (+)-1.21 (1.0 g, 8.8 mmol) in THF 
(10 mL) was then added dropwise at –78 ºC. The reaction mixture was stirred for another 
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extracted with EtOAc (3 ´ 70 mL) and the combined organic layers were washed with 
brine (40 mL), dried over MgSO4, and concentrated in vacuo. The crude mixture was 
purified by column chromatography on SiO2 (25% to 50% EtOAc/hexanes) to provide 1.22 




2-one 1.15. To a solution of 1.22 (dr = 1:1) (1.34 g, 7.2 mmol) in CH2Cl2 (134 mL) was 
added CSA (332 mg, 1.43 mmol, 0.2 equiv). The reaction mixture was stirred at room 
temperature for 2 h and was quenched by addition of a saturated aqueous solution of 
NaHCO3 (40 mL) and extracted with EtOAc (3 ´ 40 mL). The combined organic layers 
were washed with brine (40 mL), dried over MgSO4, and concentrated in vacuo to afford 
mixture of trans- and cis-pyran isomers. To a solution of the crude pyran mixture in CH2Cl2 
(70 mL) was added 2,6-lutidine (3.25 mL, 28.2 mmol, 3.9 equiv) and TBSOTf (2.0 mL, 
8.7 mmol, 1.2 equiv) at 0 °C. The reaction mixture was stirred for 30 min and quenched 
with a saturated aqueous solution of NaHCO3 (50 mL) and extracted with CH2Cl2 (3 ´ 40 
mL). The combined organic layers were washed with brine (50 mL), dried over MgSO4, 
and concentrated in vacuo. The two diastereomers were separated by MPLC on SiO2 (8% 














    CH2Cl2
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and (–)-cis-1.15 (780 mg, 2.6 mmol, 36% yield over two steps) as colorless oils.  
Stereochemical configuration was determined by NOE NMR analysis on each isomer. 
Pyran (+)-trans-1.15: [a]20D   +26.8 (c 4.5, CHCl3); IR (neat) 2932, 2856, 1715, 1256, 1102, 
836, 776 cm–1; 1H NMR (500 MHz, CDCl3) 4.25 (m, 1H), 3.73 (m, 1H), 3.66 (dd, J = 10.1, 
5.5 Hz, 1H), 3.60 (dd, J = 10.1, 6.6 Hz, 1H), 2.66 (dd, J = 15.5, 8.0 Hz, 1H), 2.49 (dq, J = 
7.3, 1.7 Hz, 2H), 2.42 (dd, J = 15.1, 5.6 Hz, 1H), 1.74-1.59 (m, 4H), 1.50-1.40 (m, 1H) 
1.40-1.31 (m, 1H), 1.04 (t, J = 7.3 Hz, 3H), 0.89 (s, 9H), 0.049 (s, 3H), 0.046 (s, 3H); 13C 
NMR (125 MHz, CDCl3) δ 210.1, 72.2, 68.99, 64.7, 46.6, 36.8, 30.1, 26.5, 26.1, 18.5, 18.4, 
7.7, –5.2, –5.3; HRMS (ES+) m/z 323.2018 [(M+Na)+;  calcd for C16H32O3NaSi:323.2018]. 
Pyran (–)-cis-1.15: [a]20D   –16.9 (c 3.8, CHCl3); IR (neat) 2930, 2857, 1716, 1254, 1078, 
836, 777 cm–1; 1H NMR (500 MHz, CDCl3) δ 3.78 (m, 1H) 3.60 (dd, J = 10.3, 5.5 Hz, 1H), 
3.45 (dd, J = 10.3, 5.5 Hz, 1H), 3.40 (m, 1H), 2.65 (dd, J = 15.3, 7.7 Hz, 1H), 2.53 – 2.43 
(m, 1H), 2.39 (dd, J = 15.3, 5.1 Hz, 1H), 1.88-1.81 (m, 1H), 1.67-1.46 (m, 4H), 1.28-1.08 
(m, 2H), 1.03 (t, J = 7.3 Hz, 3H), 0.88 (s, 9H), 0.04 (s, 3H), 0.03 (s, 3H); 13C NMR (125 
MHz, CDCl3) δ 210.3, 78.6, 74.4, 66.9, 49.4, 37.1, 31.8, 27.9, 26.1, 23.2, 18.5, 7.7, –5.1, 
–5.2; HRMS (ES+) m/z 301.2198 [(M+H)+;  calcd for C16H33O3Si:301.2199]. 
 
(–)-Ipc2BOTf, i-Pr2NEt
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Ketone (+)-1.23. Freshly prepared (–)-Ipc2BOTf27 (0.57 mL, ca. 0.88 M in 
hexanes, 1.2 equiv) was diluted with CH2Cl2 (0.8 mL). To the resulting solution was added 
i-Pr2NEt (0.15 mL, 0.858 mmol, 2.0 equiv) at –78 ºC. The reaction mixture was stirred for 
15 min and then a solution of (+)-trans-1.15 (130 mg, 0.433 mmol) in CH2Cl2 (0.8 mL) 
was added. The reaction mixture was stirred at –78 ºC for 1 h then warmed to –20 ºC and 
stirred for an additional 2 h. The boron-enolate solution was then cooled to –78 ºC and a 
solution of aldehyde 1.14 (295 mg, 0.562 mmol, 1.3 equiv) in CH2Cl2 (0.8 mL) was added. 
The reaction mixture was stirred for 2 h at –78 ºC before warming to –20 ºC and stirred for 
an additional 16 h. The reaction was quenched with pH 7 phosphate buffer (3 mL), warmed 
to room temperature and diluted with diethyl ether (3 mL). The layers were separated and 
the aqueous layer was extracted with diethyl ether (3 ´  3 mL). The combined organic layers 
were concentrated to remove the majority of the solvent in vacuo. The crude boronic ester 
was dissolved in MeOH/THF (5 mL, 1:1), and to the mixture was added pH 7 phosphate 
buffer (2 mL) and cold H2O2 (50% w/v, 2 mL) dropwise at 0 ºC. The reaction mixture was 
allowed to warm to room temperature and was stirred for 90 min. The reaction mixture was 
extracted by EtOAc (3 ´ 10 mL) and the combined organic layers were washed with a 
saturated aqueous solution of NaHCO3 (20 mL) and brine (30 mL), dried over MgSO4, and 
concentrated in vacuo. The crude mixture was purified by column chromatography on SiO2 
(40% EtOAc/hexanes) to provide (+)-1.23 (230 mg, 0.279 mmol, 64%, dr > 20:1) as a 
white amorphous solid: [a]20D   +23.8 (c 3.5, CHCl3); IR (neat) 3437 (br), 2957, 3000, 2934, 
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2856, 1707, 1592, 1517, 1463, 1265, 1159, 1099, 1028, 837, 762 cm–1; 1H NMR (500 MHz, 
CDCl3) δ 6.93 (m, 3H), 6.91-6.80 (m, 3H), 6.49 (s, 1H), 5.00 (dA,B, J = 16.7 Hz, 1 H), 4.99 
(dA,B, J = 16.7 Hz, 1 H), 4.95 (s, 2H), 4.30-4.22 (m, 1H), 4.09-4.00 (m, 1H), 3.90 (s, 3H), 
3.89 (s, 3H), 3.88 (s, 3H), 3.87 (s, 3H), 3.85 (s, 3H), 3.75-3.69 (m, 1H), 3.68-3.57 (m, 3H), 
2.92 (dd, J = 16.1, 7.1 Hz, 1H), 2.86 (dd, J = 14.2, 3.2 Hz, 1H), 2.65-2.55 (m, 2H), 2.18 (s, 
3H), 1.75-1.62 (m, 4H), 1.49-1.40 (m, 1H), 1.40-1.34 (m, 1H), 1.20 (d, J = 7.0 Hz, 3H), 
0.87 (s, 9H), 0.04 (s, 3H), 0.03 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 212.3, 170.7, 158.9, 
155.0, 149.2, 149.1, 148.9, 148.8, 136.8, 129.33, 129.26, 119.8, 119.6, 119.0, 117.60, 
111.1, 111.0, 110.6, 110.5, 97.4, 72.2, 71.7, 71.0, 70.4, 68.5, 64.5, 55.97, 55.94, 55.92, 
55.90, 52.9, 52.6, 46.5, 35.6, 30.0, 26.4, 26.0, 18.4, 18.3, 11.6, 11.4, –5.2, –5.3; HRMS 
(ES+) m/z 847.4068 [(M+Na)+;  calcd for C45H64O12NaSi:847.4065]. 
 
Diol (+)-1.S4. To a solution of ketone (+)-1.23 (26 mg, 0.032 mmol) in THF/MeOH 
(0.53 mL, 3:1) at –78 ºC was added Et2BOMe (0.12 mL, 1 M in THF, 3.8 equiv). The 
reaction mixture was stirred for 30 min followed by the addition of NaBH4 (10 mg, 0.26 
mmol, 8.1 equiv). The reaction mixture was stirred for 2 h at –78 ºC, then warmed to 0 ºC 
and stirred for an additional 2 h. The reaction mixture was then quenched by slow addition 























     –78 ºC to 0 ºC, 72%
NaBH4, Et2BOMe
    THF/MeOH
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solution). The reaction mixture was warmed to room temperature and stirred for 1 h. The 
reaction mixture was diluted with EtOAc and the layers were separated. The aqueous layer 
was extracted with EtOAc (3 ´ 4 mL) and the combined organic layers were washed with 
brine (10 mL), dried over MgSO4, and concentrated in vacuo. The crude mixture was 
purified by column chromatography on SiO2 (50% EtOAc/hexanes) to provide the diol (+)-
1.S4 (19 mg, 23.0 µmol, 72% yield) as off-white foam, which dried to be a white 
amorphous solid: [a]20D   +20.3 (c 0.7, CHCl3); IR (neat) 3462 (br), 2930, 1724,1591, 1516, 
1463, 1264, 1159, 1028, 837, 763 cm–1; 1H NMR (500 MHz, C6D6) δ 7.02-6.99 (m, 1H), 
6.86-6.81 (m, 3H), 6.58 (dd, J = 8.0, 5.3 Hz, 2H), 6.48 (s, 1H), 4.90 (dA,B, J = 11.9 Hz, 
1H), 4.87 (dA,B, J = 11.9 Hz, 1H), 4.76 (brs, 2H), 4.54-4.49(m, 1H), 4.38 (s, 1H), 4.08 (d, 
J = 2.4 Hz, 1H), 4.02 (d, J = 10.0 Hz, 1H), 3.77-3.67 (m, 1H), 3.68 (s, 3H), 3.62-3.57 (m, 
1H), 3.55 (dd, J = 10.2, 8.0 Hz, 1H), 3.52 (s, 3H), 3.44 (s, 3H), 3.41 (s, 3H), 3.40 (s, 3H), 
3.35-3.27 (m, 2H),  3.17 (dd, J = 13.6, 6.1 Hz, 1H), 2.55 (s, 3H), 2.03 (dt, J = 14.3, 10.5 
Hz, 1H), 1.72-1.66 (m, 1H), 1.40-1.20 (m, 10H), 1.31 (d, J = 6.9 Hz, 3H), 1.09-0.97 (m, 
2H), 0.95 (s, 9H), 0.85-0.78 (m, 1H), 0.04 (s 3H), 0.03 (s, 3H); 13C NMR (125 MHz, C6D6) 
δ 170.5, 159.3, 155.7, 150.8, 150.7, 150.3, 150.2, 139.0, 130.4, 130.2, 120.4, 120.1, 120.0, 
119.7, 112.4, 112.3, 112.0, 111.8, 97.8, 78.0, 77.0, 74.1, 71.8, 71.4, 71.0, 65.3, 56.0, 55.89, 
55.87, 52.3, 43.1, 37.2, 37.1, 30.7, 30.6, 26.7, 26.4, 19.2, 18.8, 12.6, 7.0, –4.96, –5.01; 
HRMS (ES+) m/z 849.4199 [(M+Na)+;  calcd for C49H62O11NaSi:849.4221]. 
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Acetal (-)-1.27. To a solution of diol (+)-1.S4 (8.0 mg, 9.7 µmol) in CH2Cl2 (150 
uL) was added 2,2-dimethoxypropane (150 uL) and a catalytic amount of PPTS. The 
reaction mixture was stirred for 1 h at room temperature and quenched with a saturated 
aqueous solution of NaHCO3 (3 mL) and extracted with CH2Cl2 (3 ´ 3 mL). The combined 
organic layers were washed with brine (5 mL), dried over MgSO4, and concentrated in 
vacuo. The crude mixture was purified by column chromatography on SiO2 (25% 
EtOAc/hexanes) to provide (–)-1.27 (6.0 mg, 6.9 µmol, 71% yield) as a white foam: [a]20D   
–2.3 (c 0.5, CHCl3); IR (neat) 2932, 1724, 1592, 1517, 1462, 1264, 1159, 1029, 837 cm–1; 
1H NMR (500 MHz, C6D6) δ 7.03 (d, J = 2.0 Hz, 1H), 6.89 -6.82 (m, 3H), 6.59 (t, J = 8.0 
Hz, 2H), 6.49 (s, 1H), 4.90 (s, 2H), 4.75 (s, 2H), 4.40 (dt, J = 8.1, 3.0 Hz, 1H), 4.12 (ddd, 
J = 7.8, 6.4, 2.1 Hz, 1H), 3.99-3.92 (m, 1H), 3.80-3.76 (m, 1H), 3.73 (s, 3H), 3.75-3.71 (m, 
1H), 3.65 (dd, J = 9.9, 6.6 Hz, 1H), 3.54 (s, 3H), 3.44 (s, 3H), 3.41 (s, 3H), 3.40 (s, 3H), 
3.31 (dd, J = 14.2, 8.2 Hz, 1H), 2.85 (dd, J = 14.3, 3.4 Hz, 1H), 2.50 (s, 3H), 2.16 (m, 1H), 
1.62-1.49 (m, 3H), 1.48 (s, 3H), 1.42 (m, 4H), 1.28 (s, 3H), 1.21-1.11 (m, 1H), 1.09 (d, J 
= 6.7 Hz, 3H), 0.98 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H); 13C NMR (125 MHz, C6D6) δ 169.7, 
159.0, 155.6, 150.8, 150.7, 150.4, 150.2, 139.1, 130.4, 130.1, 120.6, 120.1, 119.9, 119.6, 
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55.89, 55.87, 52.1, 36.4, 36.1, 35.3, 30.62, 30.57, 30.0, 27.7, 26.5, 19.9, 19.0, 18.9, 12.7, 
6.0, –4.76, –4.83; HRMS (ES+) m/z 889.4567 [(M+Na)+;  calcd for 
C48H70O12NaSi:889.4534]. 
 
Lactone (+)-1.24. To a solution of alcohol (+)-23 (330 mg, 0.400 mmol) in THF 
(6.3 mL) and MeOH (2.1 mL) cooled to –78 ºC was added Et2BOMe (1.35 mL, 1 M in 
THF, 3.4 equiv). The reaction mixture was stirred for 30 min and NaBH4 (126 mg, 3.33 
mmol, 8.3 equiv) was added. The reaction mixture was stirred for 2 h at –78 ºC, then 
warmed to 0 ºC and stirred for an additional 2 h. The reaction was then quenched with a 2 
N aqueous solution of NaOH (13.5 mL). The reaction was allowed to stir at room 
temperature for 1 h and then extracted with EtOAc (3 ´ 4 mL). The combined organic 
layers were washed with brine (10 mL), dried over MgSO4 and concentrated in vacuo. The 
crude mixture was purified via flash chromatography on SiO2 (50% EtOAc/hexanes) to 
provide (+)-24 (288 mg, 0.362 mmol, 91% yield) as a white amorphous solid: [a]20D   +28.8 
(c 3.0, CHCl3); IR (neat) 3490 (br), 3006, 2934, 2856, 1710, 1593, 1517, 1463, 1265, 1160, 
1139, 1087, 1029, 837, 754, 665 cm–1; 1H NMR (500 MHz, CDCl3) δ 7.34 (d, J = 1.9 Hz, 
1H), 6.97-6.91 (m, 3H), 6.88 (d, J = 8.0 Hz, 1H), 6.83 (d, J = 8.3 Hz, 1H), 6.53 (s, 1H), 
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12.0, 5.3, 2.6 Hz, 1H), 4.17-4.12 (m, 1H), 4.05-4.01 (m, 1H), 3.97 (s, 1H), 3.90 (s, 3H), 
3.89 (s, 3H), 3.88 (s, 3H), 3.87 (s, 3H), 3.85 (m, 1H), 3.70 (dd, J = 10.4, 7.9 Hz, 1H), 3.56 
(dd, J = 10.4, 4.7 Hz, 1H), 3.00 (dd, J = 16.5, 2.7 Hz, 1H), 2.88 (dd, J = 16.5, 12.0 Hz, 1H), 
2.11 (s, 3H), 2.09-1.99 (m, 1H), 1.92-1.83 (m, 1H), 1.73-1.54 (m, 4H), 1.47-1.20 (m, 3H), 
1.12 (d, J = 6.9 Hz, 3H), 0.87 (s, 9H), 0.04 (brs, 6H); 13C NMR (125 MHz, CDCl3) δ 163.8, 
161.1, 160.2, 149.4, 149.3, 149.1, 148.6, 142.1, 129.5, 128.8, 120.1, 119.0, 116.0, 111.1, 
110.9, 110.7, 110.5, 107.8, 97.8, 78.6, 73.9, 72.3, 71.9, 71.0, 70.4, 64.4, 56.1, 56.03, 56.00, 
55.99, 42.6, 36.8, 30.7, 29.5, 26.0, 18.7, 18.4, 11.2, 10.0, –5.25, –5.34; HRMS (ES+) m/z 
817.3958 [(M+Na)+; calcd for C44H62O11NaSi: 817.3959]. 
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Figure E1.1 CD Spectrum of Intermediates en Route to (+)-C(8)-desmethoxy-C(11)-
deoxy-C(12)-di-desmethyl-irciniastatin A (6) and Irciniastatin  A (1) (in ethanol) 
 
 
MTPA-esters (R)-1.26 and (S)-1.26: (R)-1.26. To a solution of (+)-1.24 (5.4 mg, 
6.8 µmol) in CH2Cl2 (150 uL) was added stock solutions of R-(+)-MTPA-OH (60 uL, 
0.1g/mL in CH2Cl2, 3.8 equiv), DCC (50 uL, 0.1g/mL in CH2Cl2, 3.6 equiv), and DMAP 
(30 uL, 0.1 g/mL in CH2Cl2, 3.6 equiv). The reaction was allowed to stir for 8 h. The 
reaction mixture was directly loaded on preparatory TLC (500 µm, 60% EtOAc/hexanes) 
for purification to provide R-MTPA-methyl ester 20 (3.4 mg, 3.4 µmol, 50%) as a white 
amorphous powder: [a]20D   +66.6 (c 0.3, CHCl3); IR (neat) 2929, 2854, 1742, 1718, 1593, 
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7.43 (d, J = 7.7 Hz, 2H), 7.32 (d, J = 1.9 Hz, 1H), 7.24-7.11 (m, 3H), 6.98-6.90 (m, 3H), 
6.88 (d, J = 7.8 Hz, 1H), 6.84 (d, J = 8.3 Hz, 1H), 5.48-5.39 (m, 1H), 5.17 (dA, B, J = 11.9 
Hz, 1H), 5.11 (dA, B, J = 11.9 Hz, 1 H), 5.04(s, 2H), 3.92 (s ,3H), 3.90 (s, 3H), 3.89 (s, 3H), 
3.88 (s, 3H), 3.87-3.82 (m, 1H), 3.79-3.71 (m, 2H), 3.66 (dd, J = 10.1, 5.2 Hz, 1H), 3.60 
(dd, J = 10.1, 6.9 Hz, 1H), 3.53 (s, 3H), 2.93 (dd, J = 16.3, 2.4 Hz, 1H), 2.56 (dd, J = 16.2, 
12.1 Hz, 1H), 2.09 -2.11 (m, 2H), 2.11 (s, 3H), 1.78-1.70 (m, 1H), 1.70-1.53 (m, 4H), 1.51-
1.46 (m,1H), 1.38-1.30 (m, 1H), 1.08 (d, J = 6.8 Hz, 3H), 0.87 (s, 9H), 0.04 (s, 3H), 0.03 
(s, 3H); 13C NMR (125 MHz, CDCl3) δ 165.9, 162.9, 161.1, 160.1, 149.3, 149.2, 149.0, 
148.5, 140.9, 132.1, 129.4, 129.2, 128.6, 128.3, 126.8, 119.9, 118.9, 115.9, 111.0, 110.7, 
110.5, 110.4, 107.4, 97.7, 77.4, 77.2, 74.5, 71.8, 70.8, 70.3, 68.3, 64.1, 56.0, 55.90, 55.88, 
55.85, 55.5, 39.4, 34.7, 30.1, 29.7, 29.6, 26.1, 25.9, 18.3, 18.2, 11.0, 9.9, –5.3, –5.4; HRMS 
(ES+) m/z 1033.4341 [(M+Na)+; calcd for C54H69O13NaSiF3:1033.4346]. (S)-1.26: In an 
entirely analogous fashion, (S)-(–)-MTPA-OH was used to produce the S-MTPA-methyl 
ester 20 (4.6 mg, 4.6 µmol, 67%) as a white amorphous solid:[a]20D   +24.4 (c 0.4, CHCl3); 
IR (neat) 2929, 2855, 1741, 1716, 1593, 1517, 1463, 1266, 1244, 1161, 1080, 1027, 837, 
738 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.48-7.42 (m, 2H), 7.33 (d, J = 1.9 Hz, 1H), 7.29-
7.21 (m, 3H), 6.95 (m, 3H), 6.88 (d, J = 7.9 Hz, 1H), 6.84 (d, J = 7.9 Hz, 1H),  6.56 (s, 
1H), 5.46-5.38 (m, 1H), 5.18 (dA,B, J = 11.9 Hz, 1 H), 5.11 (dA,B, J = 11.9 Hz, 1 H), 5.06-
5.00 (m, 2H), 4.10 (ddd, J = 12.1, 6.4, 2.3 Hz, 1H), 3.92 (s, 3H), 3.90 (s, 3H), 3.89 (s, 3H), 
3.88 (s, 3H), 3.75-3.70 (m, 1H), 3.69-3.60 (m, 2H), 3.53 (dd, J = 10.2, 6.5 Hz, 1H), 3.46 
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(s, 3H), 2.92 (dd, J = 16.3, 2.5 Hz, 1H), 2.65 (dd, J = 16.3, 12.2 Hz, 1H), 2.29-2.20 (m, 
1H), 2.12-2.05 (m, 1H), 2.06 (s, 3H), 1.70-1.68 (m, 1H), 1.63-1.53 (m, 4H), 1.48-1.40 (m, 
1H), 1.34-1.27 (m, 1H), 1.12 (d, J = 6.8 Hz, 3H), 0.87 (s, 9H), 0.03 (s, 3H), 0.02 (s, 3H); 
13C NMR (125 MHz, CDCl3) δ 166.6, 163.6, 161.7, 160.7, 149.9, 149.8, 149.6, 149.1, 
141.5, 132.3, 130.1, 129.8, 129.2, 129.0, 128.0, 120.5, 119.4, 116.54, 111.6, 111.3, 111.1, 
111.0, 108.0, 98.3, 78.2, 77.8, 75.7, 72.5, 71.4, 70.9, 68.2, 64.6, 56.6, 56.51, 56.48, 56.5, 
55.9, 39.6, 34.8, 30.7, 30.3, 30.3, 26.7, 26.5, 19.0, 18.9, 11.6, 10.7, –4.7, –4.8; HRMS 
(ES+) m/z 1033.4371 [(M+Na)+;  calcd for C54H69O13NaSiF3:1033.4357]. 
 
Bis-TBS ether (+)-1.S5. To a solution of (+)-1.24 (170 mg, 0.214 mmol) in CH2Cl2 
(5 mL) at 0 °C was added 2,6-lutidine (127 µL, 1.10 mmol, 5.1 equiv) and TBSOTf (120 
uL, 0.52 mmol, 2.5 equiv). After 3 h, the reaction was quenched with a saturated aqueous 
solution of NaHCO3 (10 mL) and extracted with CH2Cl2 (3 ´ 10 mL). The combined 
organic layers were washed successively with an aqueous solution of HCl (10 mL, 1 N), a 
saturated aqueous solution of NaHCO3 (20 mL), and brine (20 mL). The organic layer was 
dried over MgSO4 and concentrated in vacuo. The crude mixture was purified via flash 
chromatography on SiO2 (35% EtOAc/hexanes) to provide (+)-1.S5 (187 mg, 0.206 mmol, 
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1712, 1593, 1517, 1463, 1264, 1160, 1139, 1080, 1030, 836, 774, 754 cm-1; 1H NMR (500 
MHz, CDCl3) δ 7.33 (d, J = 1.9 Hz, 1H), 6.99-6.91 (m, 3H), 6.91-6.81 (m, 2H), 6.53 (s, 
1H), 5.18 (dA,B, J = 11.9 Hz, 1 H), 5.11 (dA,B, J = 11.9 Hz, 1 H), 5.01 (dA,B, J = 11.3 Hz, 1 
H), 4.99 (dA, B, J = 11.3 Hz, 1 H), 4.32 (ddd, J = 12.1, 7.0, 2.4 Hz, 1H), 4.02-3.94 (m, 
1H), 3.93 (s, 3H), 3.91 (s, 3H), 3.90 (s, 3H), 3.88 (s, 3H), 3.87-3.82(m, 1H), 3.70-3.62 (m, 
2H), 3.60-3.52 (m, 1H), 3.05 (dd, J = 16.4, 2.5 Hz, 1H), 2.68 (dd, J = 16.4, 12.1 Hz, 1H), 
2.10 (s, 3H), 1.87 (ddd, J = 14.0, 8.3, 5.4 Hz, 1H), 1.70-1.59 (m, 5H), 1.42 (m, 1H), 1.32 
(m, 1H), 1.10 (d, J = 6.8 Hz, 3H), 0.88 (s, 9H), 0.84 (s, 9H), 0.07 (s, 3H), 0.04 (s, 3H), 0.03 
(s, 3H), 0,02 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 163.7, 161.1, 160.2, 149.4, 149.3, 
149.1, 148.6, 141.7, 129.5, 128.9, 120.1, 119.0, 115.8, 111.2, 111.0, 110.8, 110.6, 108.0, 
97.8, 78.6, 72.0, 71.0, 70.4, 70.3, 68.3, 64.6, 56.2, 56.1, 56.04, 56.02, 41.4, 37.5, 30.5, 30.4, 
26.8, 26.1, 26.0, 18.6, 18.5, 18.1, 11.3, 10.6, –3.8, –4.4, –5.1, –5.2; HRMS (ES+) m/z 
931.4810 [(M+Na)+;  calcd for C50H76O11NaSi2:931.4824]. 
 
Alcohol (+)-1.25. To a solution of (+)-1.S5 (250 mg, 0.275 mmol) in THF (4.15 
mL) at 0 ºC was added a stock solution of TBAF and acetic acid in THF (4.15 mL; recipe 
for stock solution: 1.4 mL TBAF (1 M in THF), 64 µL AcOH, and 2.74 mL THF). The 
reaction mixture was allowed to warm to room temperature and stirred for 10 h. The 
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reaction mixture was quenched with a saturated aqueous solution of NaHCO3 (10 mL) and 
extracted EtOAc (3 ´ 10 mL). The combined organic layers were washed with brine (20 
mL), dried over MgSO4, and concentrated in vacuo. The crude mixture was purified via 
flash chromatography on SiO2 (30% to 80% EtOAc/hexanes) to provide recovered (+)-S3 
(115 mg, 0.126 mmol, 46%) alcohol (+)-1.25 (105 mg, 0.132 mmol, 48%) as a white 
amorphous solid: [a]20D   +23.6 (c 2.0, CHCl3); IR (neat) 3487 (br), 2932, 2856, 1710, 1593, 
1517, 1463, 1264, 1159, 1083, 1029, 836, 810, 754 cm–1; 1H NMR (500 MHz, CDCl3) δ 
7.32 (d, J = 1.9 Hz, 1H), 6.99-6.90 (m, 4H), 6.87 (d, J = 8.1 Hz, 1H), 6.83 (d, J = 8.6 Hz, 
1H), 6.53 (s, 1H), 5.18 (dA, B, J = 11.9 Hz, 1 H), 5.11 (dA,B, J = 11.9 Hz, 1 H), 5.02 (dA,B, J 
= 11.3 Hz, 1 H), 5.00 (dA,B, J = 11.3 Hz, 1 H), 4.33 (ddd, J = 11.9, 6.7, 2.4 Hz, 1H), 4.07- 
3.99 (m, 1H), 3.92 (s, 3H), 3.90 (s, 3H), 3.89 (s, 3H), 3.88 (s, 3H), 3.94-3.87 (m, 1H), 3.79 
– 3.72 (m, 1H), 3.70 – 3.62 (m, 1H), 3.49 – 3.41 (m, 1H), 3.03 (dd, J = 16.4, 2.5 Hz, 1H), 
2.71 (dd, J = 16.4, 12.0 Hz, 1H), 2.10 (s, 3H), 2.09-2.04 (m, 1H), 2.00 (dd, J = 8.2, 3.7 Hz, 
1H), 1.94 (ddd, J = 14.2, 9.0, 5.3 Hz, 1H), 1.70-1.56 (m, 4H), 1.40-1.30 (m, 2H), 1.10 (d, 
J = 6.8 Hz, 3H), 0.85 (s, 9H), 0.09 (s, 3H), 0.04 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 
163.5, 161.2, 160.2, 149.4, 149.3, 149.1, 148.6, 141.5, 129.5, 128.8, 120.1, 119.1, 115.9, 
111.2, 110.9, 110.8, 110.6, 107.9, 97.9, 78.5, 71.4, 71.0, 70.4, 69.9, 68.2, 64.1, 56.2, 56.06, 
56.04, 56.03, 41.3, 36.6, 30.2, 29.8, 26.4, 25.9, 18.6, 18.2, 11.2, 10.3, –3.7, –4.4; HRMS 
(ES+) m/z 817.3950 [(M+Na)+; calcd for C44H62O11NaSi:817.3959]. 
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Amine 1.13. To a solution of (+)-1.25 (23 mg, 0.029 mmol) in CH2Cl2 (2 mL) at –
78 ºC was added Et3N (23 uL, 0.164 mmol, 5.6 equiv) and Tf2O (184 uL, 50 uL/mL in 
CH2Cl2, 0.055 mmol, 1.9 equiv). The reaction mixture was stirred for 1 h and diluted with 
CH2Cl2 (2 mL). The resulting mixture was treated with condensed anhydrous ammonia (4 
mL) at –20 ºC and was stirred for 3 h. The system was warmed to 0 ºC to ensure residual 
ammonia is evaporated then diluted with EtOAc (4 mL) and an aqueous solution of NaOH 
(1 N, 10 mL). The layers were separated and the aqueous layer was extracted with EtOAc 
(3 ´ 10 mL). The combined organic layers were washed with brine (15 mL), dried over 
MgSO4, and concentrated in vacuo to provide amine 1.13 (23 mg) as a brown foam. Crude 
amine 1.13 was carried forward without further purification. 
 
Acid Chloride 1.28. To a solution of acid (–)-1.12 (35 mg, 0.12 mmol) in CH2Cl2 
(0.72 mL) was added pyridine (50 uL, 0.62 mmol, 5.2 equiv) and thionyl chloride (35 uL, 
0.48 mmol, 4.0 equiv) at 0 °C. After addition, the reaction mixture was stirred at room 
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(ca. 0.02 mmHg). After removal of CH2Cl2, the residue was suspended in toluene (1 mL). 
The upper layer clear solution was transferred to another flask and dried in vacuo for next 
step immediately. 
Amide (+)-1.29. The crude acid chloride 1.28 was dissolved in CH2Cl2 (0.5 mL), 
followed by addition of i-Pr2NEt (52 uL, 0.30 mmol, 10 equiv) and a solution of crude 
amine 13 (23 mg) in CH2Cl2 (0.5 mL) at 0 ºC. The reaction mixture was stirred at the same 
temperature for 2 h before warming to room temperature for another 2 hours. The reaction 
mixture was quenched with a saturated aqueous solution of NaHCO3 (3 mL) and extracted 
with EtOAc (3 ´ 5 mL). The combined organic layers were washed with brine (10 mL), 
dried over MgSO4, and concentrated in vacuo. The crude mixture was purified via flash 
chromatography on SiO2 (66% EtOAc/hexanes) to provide amide (+)-1.29 (18 mg, 0.017  
mmol, 59% over two steps) as a white amorphous solid: [a]20D   +1.8  (c 0.7, CHCl3); IR 
(neat) 3429, 1714, 2856, 1714, 1675, 1593, 1517, 1463, 1262, 1160, 1139, 1083, 1029, 
836, 776, 731 cm–1; 1H NMR (500 MHz, CDCl3) δ 7.32 (d, J = 2.0 Hz, 1H), 7.01-6.90 (m, 
4H), 6.87 (dd, J = 7.9 Hz, 1H), 6.83 (dd, J = 8.3 Hz, 1H),  6.54 (s, 1H), 5.17 (dA, B, J = 11.6 
Hz, 1 H), 5.11 (dA, B, J = 11.6 Hz, 1 H), 5.02 (dA, B, J = 11.3 Hz, 1 H), 4.98 (dA, B, J = 11.3 
Hz, 1 H), 4.74 (brs, 1H), 4.70 (brs, 1H), 4.38 (d, J = 1.8 Hz, 1H), 4.30 (ddd, J = 12.2, 6.9, 
2.4 Hz, 1H), 3.96 (m, 1H), 3.92 (s, 3H), 3.90 (s, 3H), 3.89 (s, 3H), 3.88 (s, 3H), 3.87-3.84 
(m, 1H), 3.74-3.63 (m, 2H), 3.48 (ddd, J = 12.1, 7.3, 4.6 Hz, 1H), 3.37 (s, 3H), 3.17 (dt, J 
= 13.5, 4.6 Hz, 1H), 3.04 (dd, J = 16.4, 2.5 Hz, 1H), 2.71 (dd, J = 16.4, 12.2 Hz, 1H), 2.24 
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(dd, J = 14.7, 9.1 Hz, 1H), 2.10 (s, 3H), 2.05-1.94 (m, 2H), 1.88-1.72 (m, 2H), 1.69 (s, 3H), 
1.66-1.51 (m, 5H), 1.42-1.32 (m, 2H), 1.11 (d, J = 6.8 Hz, 3H), 0.92 (s, 9H), 0.85 (s, 9H), 
0.13 (s, 3H), 0.09 (s, 3H), 0.06 (s, 3H), 0.03 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 171.8, 
163.5, 161.3, 160.3, 149.5, 149.4, 149.2, 148.7, 142.7, 141.6, 129.5, 128.8, 120.2, 119.1, 
115.8, 112.6, 111.2, 111.0, 110.8, 110.6, 107.9, 97.8, 81.9, 78.1, 77.4, 74.0, 71.0, 70.9, 
70.5, 69.3, 69.1, 57.9, 56.2, 56.14, 56.11, 56.10, 42.5, 42.4, 37.5, 35.5, 30.9, 28.3, 27.8, 
26.1, 26.0, 22.8, 18.4, 18.3, 18.2, 11.4, 11.0, –3.9, –4.1, –4.3, –5.3; HRMS (ES+) m/z 
1064.5953 [(M+H)+; calcd for C58H90NO13Si2:1064.5951]. 
 
(+)-C(8)-desmethoxy-C(11)-deoxy-C(12)-di-desmethyl-Irciniastatin A (1.6). 
To a solution of amide (+)-1.29 (3.9 mg, 3.7 µmol) in CH2Cl2 (330 µL) was added H2O 
(40 µL) and a suspension of of 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (73 uL, 0.1 
g/mL in CH2Cl2, 8.7 equiv). The reaction mixture was stirred for 8 h and reaction progress 
was monitored by LC-MS. After removal of the two DMB-ethers, the reaction was 
quenched with a saturated aqueous solution of NaHCO3 (1 mL) and the biphasic mixture 
was stirred vigorously for an additional 30 min. The reaction mixture was diluted with 
























1. DDQ, CH2Cl2, H2O
2. TASF, DMF, 50 ºC
68% over two steps
(+)-1.29 (+)-C(8)-Desmethoxy-C(11)-deoxy-C(12)-
di-desmethyl-irciniastatin A (1.6)
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saturated aqueous solution of NaHCO3 (3 ´ 2 mL), brine (5 mL), dried over Na2SO4 and 
concentrated in vacuo to provide crude bis-phenol as a faint yellow oil. The bis-phenol was 
dissolved in DMF (0.8 mL) in a plastic vial, followed by addition of TAS-F (22 mg, 22 
equiv). The reaction mixture was warmed to 50 ºC and stirred for 24 h. The reaction 
mixture was quenched with a saturated aqueous solution of NH4Cl (1 mL) and extracted 
with EtOAc (5 ´ 2 mL). The combined organic layers were washed with brine (5 mL), 
dried over Na2SO4, and concentrated in vacuo. The crude mixture was purified by 
preparatory TLC (500 µm, 95% EtOAc/hexanes) to provide irciniastatin analogue (+)-1.6 
(1.35 mg, 2.5 µmol, 68% over two steps) as a white amorphous solid:  [a]20D   +7.6  (c 0.2, 
CHCl3); IR (neat)  3361 (br), 2926, 2855, 1655, 1618, 1542, 1462, 1378, 1252, 1171, 1105 
cm–1; 1H NMR (500 MHz, CD3OD) δ 6.25 (s, 1H), 4.74 (brs, 1H), 4.71 (brs, 1H), 4.52 
(ddd, J = 12.0, 5.9, 3.2 Hz, 1H), 4.32 (d, J = 2.9 Hz, 1H), 4.03-3.94 (m, 2H), 3.93-3.86 (m, 
1H), 3.67 (dt, J = 9.4, 3.3 Hz, 1H), 3.57 (dd, J = 13.7, 8.8 Hz, 1H), 3.34 (s, 3H), 3.23 (dd, 
J = 13.8, 4.5 Hz, 1H), 3.09 (dd, J = 16.6, 3.2 Hz, 1H), 2.90 (dd, J = 16.6, 12.0 Hz, 1H), 
2.28 (ddd, J = 14.6, 9.3, 1.0 Hz, 1H), 2.07 (s, 3H), 2.06-2.02 (m, 1H),1.98-1.87 (m, 1H), 
1.86-1.78 (m, 1H), 1.74-1.65 (m, 8H), 1.48-1.32 (m, 2H), 1.12 (d, J = 6.9 Hz, 3H)；13C 
NMR (125 MHz, CD3OD) δ 174.8, 172.4, 164.5, 163.7, 144.0, 141.0, 115.2, 113.0, 101.4, 
101.3, 82.5, 82.0, 72.4, 71.9, 71.3, 70.8, 57.6, 43.3, 41.7, 39.3, 38.3, 31.1, 29.3, 28.4, 22.9, 
19.3, 10.7, 9.6; HRMS (ES+) m/z 558.2670 [(M+Na)+; calcd for C28H41NO9Na: 558.2679]. 
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Acetate (+)-1.S6. To a solution of alcohol (–)-1.30 (7.0 mg, 6 µmol) in pyridine 
(0.42 mL) was added acetic anhydride (0.18 mL) dropwise. The reaction mixture was 
stirred for 7.5 h at room temperature. The reaction mixture was quenched with a saturated 
aqueous solution of NaHCO3 and extracted with EtOAc (3 ´ 0.5 mL). The combined 
organic layers were dried over MgSO4, filtered, and concentrated in vacuo. The crude 
mixture was purified via flash chromatography on SiO2 (40% to 45% EtOAc/hexanes) to 
furnish acetate (+)-1.S6 (6.3 mg, 5.1 µmol, 87%) as a colorless oil:  	+5.3 (c 0.5, 
CHCl3); IR (neat) 3391, 2925, 2858, 1716, 1687, 1592, 1516, 1462, 1371, 1249, 1150 cm–
1; 1H NMR (500 MHz, CDCl3) δ 7.31 (ap s, 1H), 7.23 (d, J = 9.7 Hz, 1H), 6.98 -6.92 (m, 
3 H), 6.87 (d, J = 8.7 Hz, 1H), 6.83 (d, J = 8.0 Hz, 1H), 6.54 (s, 1H), 5.16 (dA,B, J = 11.5 
Hz, 1H), 5.10 (dA,B, J = 12.3 Hz, 1H), 5.07 (d, J = 10.6 Hz, 1H), 4.98 (s, 2H), 4.87 (app t, 
J = 3.9 Hz, 1H), 4.82 (d, J = 6.8 Hz, 1H), 4.78 (s, 1H), 4.77 (s, 1H), 4.71 (app t, J = 7.6 
Hz, 2H), 4.63 (d, J = 7.2 Hz, 1H), 4.38 (app s, 1H), 4.31 (m, 1H), 4.00 (dd, J = 9.6, 2.9 Hz, 
2H), 3.92 (s, 3H), 3.90 (s, 3H), 3.88 (s, 3H), 3.87 (s, 3H), 3.76 -3.71 (m, 2H), 3.58 (dd, J = 
10.0, 6.9 Hz, 1H), 3.56-3.49 (m, 2H), 3.49-3.44 (m, 1H), 3.37 (s, 3H), 3.31 (s, 3H), 3.23 
(d, J = 15.4 Hz, 1H), 2.67 (dd, J = 16.4, 12.8 Hz, 1H), 2.36 (dd, J = 14.6, 8.8 Hz, 2H), 2.20 
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(s, 3H), 1.57 (ddd, J = 18.2, 7.9, 4.1 Hz, 1H), 1.16 (d, J = 6.8 Hz, 3H), 1.05 (s, 3H), 0.95-
0.90 (m 1H), 0.88 (s, 3H), 0.86-0.84 (m, 1H), 0.86-0.79 (ddd, J = 17.5, 11.5, 5.9 Hz, 1H), 
0.74-0.69 (ddd, J = 17.7, 11.7, 5.9 Hz, 1H), 0.01 (s, 9H), –0.11 (s, 9H); 13C NMR (125 
MHz, CDCl3) δ 171.2, 170.3, 163.7, 161.3, 160.4, 149.6, 149.4, 149.3, 148.8, 142.4, 
142.1, 129.6, 128.9, 120.2, 119.2, 116.2, 113.0, 111.3, 111.1, 111.0, 110.8, 108.1, 97.9, 
94.8, 94.4, 81.7, 81.5, 79.3, 75.6, 74.5, 71.2, 70.5, 66.2, 65.7, 58.0, 56.4, 56.2, 56.08, 56.07, 
56.0, 39.3, 38.4, 36.4, 30.2, 30.0, 29.9, 29.6, 27.9, 26.1, 22.9, 21.4, 20.2, 18.13, 18.10, 11.4, 
9.7, –1.2, –1.4; HRMS (ES+) m/z 1212.6318 [(M+H)+; calcd for C63H98NO18Si2: 
1212.6322]. 
 
C(11)-OAc-Irciniastatin A (+)-1.8. To a solution of fully protected acetate (+)-
1.S6 (5.1 mg, 4.2 µmol) in CH2Cl2 (50 µL) and H2O (15 µL) was added a suspension of 
2,3-dichloro-5,6-dicyano-1,4-benzoquinone (0.1 mL, 0.33 M in CH2Cl2, 8 equiv). After 10 
h, the reaction mixture was quenched with a saturated aqueous solution of NaHCO3 and 
extracted with EtOAc (5 ´ 0.5 mL). The combined organic layers were dried over MgSO4, 
filtered, and concentrated in vacuo. The crude mixture was purified via flash 
chromatography on SiO2 (50% EtOAc/hexanes) to afford a 1:2 mixture of the desired bis-
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solution of MgBr2/n-BuSH/MeNO2 in Et2O (0.155 mL; 25 equiv MgBr2 and 25 equiv n-
BuSH; stock solution:57.4 mg MgBr2, 33 µL n-BuSH, 62 µL MeNO2, and 0.62 mL Et2O). 
After 9 h, the reaction mixture was diluted with EtOAc, and quenched with a saturated 
aqueous solution of NaHCO3 and extracted with EtOAc (5 x 0.5 mL). The combined 
organic layers were dried over MgSO4, filtered and concentrated in vacuo. The crude 
mixture was purified via flash chromatography on SiO2 40% to 80% EtOAc/hexanes with 
5% v/v triethylamine,) to afford (+)-C(11)-OAc-irciniastatin A (+)-1.8 (1.9 mg, 3.1 µmol, 
75% over two steps) as a white amorphous solid:  +3.9 (c 0.15, CHCl3); IR (neat) 
3372, 2923, 2850, 1737, 1661, 1617, 1515, 1461, 1373, 1251, 1172, 1108, 1071 cm–1; 1H 
NMR (500 MHz, CDCl3) δ 11.15 (s, 1H), 7.17 (d, J = 9.7 Hz, 1H), 6.59 (bs, 1H), 6.30 (s, 
1H), 5.43 (dd, J = 10.3, 1.6 Hz, 1H), 4.89 (dd, J = 9.3, 4.4 Hz, 1H), 4.81 (s, 1H), 4.80 (s, 
1H), 4.59 (ddd, J = 11.8, 8.3, 3.8 Hz, 1H), 4.43 (app bs, 1H), 4.24 (brs, 1H), 3.97-3.90 (m, 
2H), 3.77-3.74 (m, 2H), 3.65 (d, J = 10.5 Hz, 1H), 3.44-3.35 (m, 1H), 3.40 (s, 3H), 3.39 (s, 
3H), 2.91-2.80 (m, 2H), 2.37 (dd, J = 14.6, 8.8 Hz, 1H), 2.18 (dd, J = 14.8, 3.9 Hz, 1H), 
2.10 (s, 3H), 2.03 (s, 3H), 1.91 (m, 2H), 1.83-1.78 (m, 1H), 1.76 (s, 3H), 1.63 (d, J = 15.0 
Hz, 1H), 1.11 (d, J = 7.1 Hz, 3H), 0.97 (s, 3H), 0.96 (s, 3H); 13C NMR (125 MHz, CDCl3) 
δ 173.3, 170.7, 162.5, 161.1, 142.2, 140.0, 113.3, 113.2, 101.9, 101.5, 82.6, 80.6, 79.4, 
79.0, 74.0, 73.4, 72.8, 71.8, 58.0, 56.7, 56.1, 42.8, 37.6, 37.5, 31.9, 29.9, 28.7, 27.1, 24.1, 
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Benzoate (+)-1.S7. To a solution of alcohol (–)-1.30 (6.0 mg, 5 µmol) in pyridine 
(0.30 mL) was added benzoyl chloride (30 µL, 0.43 mmol, 85 equiv) dropwise. The 
reaction mixture was stirred for 1 h at room temperature. Additional benzoyl chloride (50 
µL) was added and the reaction mixture was stirred for an additional 30 min. The reaction 
mixture was quenched with a saturated aqueous solution of NaHCO3 and extracted with 
EtOAc (3 ´ 0.5 mL). The combined organic layers were dried over MgSO4, filtered, and 
concentrated in vacuo. The crude mixture was purified via flash chromatography on SiO2 
(30% to 40% EtOAc/hexanes) to furnish benzoate (+)-1.S7(3.6 mg, 0.003 mmol, 55%) as 
a white amorphous solid:  +12.8 (c 0.3, CH2Cl2); IR (neat) 3454, 3351, 2954, 2926, 
2855, 1729, 1438, 1251, 1157, 1101, 1066, 1011, 1066, 833, 772 cm–1; 1H NMR (500 MHz, 
CD3OD) δ 8.17-8.00 (m, 3H), 7.59 (t, J = 8.3 Hz, 1H), 7.49 (t, J = 7.7 Hz, 2H), 7.26 (s, 1 
H), 7.08 (s, 1 H), 6.97 (d, J = 8.3 Hz, 1 H), 6.94 (s, 2 H), 6.89 (d, J = 8.4 Hz, 1 H), 6.74 (s, 
1 H), 5.22 (dd, J = 5.7, 5.2 Hz, 1 H), 5.20 (dA,B, J = 12.7 Hz, 1 H), 5.16-5.14 (m, 1 H), 5.14 
(dA,B, J = 12.7 Hz, 1 H), 5.09 (app s, 2 H), 4.76-4.68 (m, 6 H), 4.42 (ddd, J = 10.9, 5.4, 1.7 
Hz, 1 H), 4.28 (d, J = 3.2 Hz, 1 H), 4.04 (m, 1 H), 3.93 (m, 1 H), 3.84 (s, 3 H), 3.82 (s, 3 
H), 3.82 (bs, 6 H), 3.70 (ddd, J = 10.0, 10.0, 6.5 Hz, 1 H), 3.63 (m, 2H), 3.62-3.60 (m, 3 







































  115 
Hz, 1 H), 2.20 (d, J = 3.4 Hz, 1 H), 2.17 (s, 3 H), 2.14 (dd, J = 8.3, 4.5 Hz, 1 H), 2.11 (dd, 
J = 6.5,  2.9Hz, 1 H), 1.99 (m, 1 H), 1.90-1.85 (m, 1 H), 1.69 (s, 3 H), 1.15 (d, J = 6.8 Hz, 
3 H), 1.11 (s, 3 H), 1.05 (s, 3 H), 0.88-0.78 (m, 3 H), 0.68 (ddd, J = 13.4, 11.4, 5.6 Hz, 1 
H), –0.04 (s, 9 H), –0.13 (s, 9 H); 13C NMR (125 MHz, CD3OD) δ 173.9, 173.8, 167.5, 
166.4, 163.3, 162.1, 150.8, 150.8, 150.7, 150.2, 143.8, 143.4, 136.1, 134.6, 133.9, 131.7, 
131.6, 131.2, 130.8, 130.7, 130.4, 129.6, 121.6, 120.9, 117.2, 113.5, 113.0, 112.8, 112.7, 
112.4, 107.8, 99.1, 96.0, 95.5, 83.0, 82.9, 82.7, 80.7, 78.51, 78.46, 78.3, 76.7, 71.7, 71.5, 
67.1, 66.8, 58.5, 57.0, 56.63, 56.60, 40.7, 39.7, 38.4, 32.4, 31.3, 28.2, 25.6, 23.2, 19.11, 
19.05, 11.8, 9.4, –1.1, –1.3; high resolution mass spectrum (ES+) m/z 1296.6295 [(M+Na)+; 
calcd for C68H99NO18Si2Na: 1296.6298]. 
 
(–)-C(11)-OBz-Irciniastatin A (–)-1.9. To a solution of fully protected benzoate 
(+)-1.S7 (3.6 mg, 2.8 umol) in CH2Cl2 (100 µL) and H2O (18 µL) was added a suspension 
of 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (80 µL, 0.29 M in CH2Cl2, 8 equiv). After 
10 h, the reaction mixture was quenched with a saturated aqueous solution of NaHCO3 and 
extracted with EtOAc (5 ´ 0.5 mL). The combined organic layers were dried over MgSO4, 
filtered and concentrated in vacuo. The crude mixture was purified via flash 
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phenol and 3,4-dimethoxybenzalehyde, respectively. The mixture was treated with a stock 
solution of MgBr2/n-BuSH/MeNO2 in Et2O (0.140 mL; 25 equiv MgBr2 and 25 equiv n-
BuSH; stock solution:89.9 mg MgBr2, 36 µL n-BuSH, 100 µL MeNO2, and 0.98 mL Et2O). 
After 9.5 h, the reaction mixture was diluted with EtOAc, and quenched with a saturated 
aqueous solution of NaHCO3 and extracted with EtOAc (5 ´ 0.5 mL). The combined 
organic layers were dried over MgSO4, filtered and concentrated in vacuo. The crude 
mixture was purified via flash chromatography on SiO2 (40% to 50% EtOAc/hexanes) to 
afford (+)-C(11)-OBz-irciniastatin A (–)-1.9 (1.0 mg, 1.4 umol, 50% over two steps) as a 
white amorphous solid:  –13.7 (c 0.08, CHCl3); IR (neat) 3372, 2943, 1726, 1663, 
1599, 1446, 1377, 1253, 1114 cm–1; 1H NMR (500 MHz, C6D6) δ 11.93 (bs, 1H), 8.17 (d, 
J = 7.5 Hz, 3H), 7.10 (t, J = 7.5 Hz, 2H), 6.31 (s, 1H), 5.67 (t, J = 8.3 Hz, 1H), 5.27 (dd, J 
= 9.9, 4.4 Hz, 1H), 5.04 (s, 1H), 4.92 (s, 1H), 4.61 (bs, 1H), 4.33 (m, 3H), 4.17 (d, J = 9.7 
Hz, 1H), 3.91 (ddd, J = 4.0, 3.5, 3.5 Hz, 1H), 3.73 (d, J = 10.4 Hz, 1H), 3.59 (bs, 1H), 3.32 
(s, 3H), 3.25 (s, 3H), 2.63 (d, J = 16.3 Hz, 1H), 2.65-2.51 (ddd, J = 12.4, 12.4, 8.7 Hz, 1H), 
2.46 (dd, J = 14.0, 4.6 Hz, 2H), 2.26 (m, 1H), 2.02 (s, 3H), 1.93 (m, 1H), 1.79 (s, 3H), 1.58 
(bs, 1H), 1.46 (d, J = 13.9 Hz, 1H), 1.06 (d, J = 6.6 Hz, 3H), 0.96 (s, 3H), 0.79 (s, 3H); 13C 
NMR (125 MHz, C6D6) δ 173.7, 170.9, 165.7, 163.2, 161.8, 142.6, 140.1, 133.2, 130.9, 
129.9, 128.8, 127.5, 113.6, 113.5, 102.0, 101.6, 82.2, 81.5, 80.1, 78.9, 74.3, 73.8, 73.5, 
57.8, 56.3, 43.1, 38.1, 37.8, 33.0, 32.4, 30.2, 30.1, 28.4, 27.2, 23.1, 14.4, 10.6, 9.2; HRMS 
(ES+) m/z 736.3286 [(M+Na)+; calcd for C38H51NO12Na: 736.3309]. 
€ 
[α]D20
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Olefin (–)-1.S8. To a solution of PPh3MeBr (75.4 mg, 0.211 mmol) in THF (0.46 
mL) was added KOt-Bu (0.20 mL, 0.20 mmol) to provide a yellow solution, which was 
stirred for 5 min. The solution (40 µL, 0.32 M in THF, 2.5 equiv) was added to a separate 
vial containing a solution of ketone (–)-1.31 (6.0 mg, 5.1 umol) in THF (0.26 mL) and the 
yellow reaction mixture was allowed to stir for 1 h at room temperature. The reaction 
mixture was quenched with water and extracted with EtOAc (4 ´ 0.5 mL). The combined 
organic layers were dried over MgSO4, filtered and concentrated in vacuo. The crude 
mixture was purified via flash chromatography on SiO2 (40% EtOAc/ hexanes) to furnish 
olefin (–)-1.S8 (5.0 mg, 4.3 µmol, 84%) as a white amorphous oil:  –3.4 (c 0.4, 
CHCl3); IR (neat) 3422, 2951, 1715, 1686, 1592, 1515, 1463, 1417, 1378, 1246, 1157, 
1083, 1027 cm–1; 1H NMR (500 MHz, CDCl3) δ 7.41 (d, J = 9.7 Hz, 1 H), 7.31 (app s, 1 
H), 6.97-6.93 (m, 3 H), 6.87 (d, J = 8.5 Hz, 1 H), 6.88 (d, J = 8.3 Hz, 1 H), 6.54 (s, 1 H), 
5.17 (dA,B, J = 11.7 Hz, 1 H), 5.10 (dA,B, J = 11.7 Hz, 1 H), 5.03 (d, J = 19.9 Hz, 1 H), 4.98 
(s, 2 H), 4.87 (d, J = 5.5 Hz, 1 H), 4.86 (s, 1 H), 4.78 (app s, 2 H), 4.70 (d, J = 13.6 Hz, 1 
H), 4.64 (dA,B, J = 7.0 Hz, 1 H), 4.60 (dA,B, J = 6.8 Hz, 1 H), 4.42 (app s, 1 H), 4.22 (ap t, 
J = 10.8 Hz, 1 H), 3.96 (m, 2 H), 3.92 (s, 3 H), 3.90 (s, 3 H), 3.88 (s, 3 H), 3.87 (s, 3 H), 
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11.0, 5.3 Hz, 1 H), 3.40 (s, 3 H), 3.30 (s, 3 H), 3.23 (d, J = 16.1 Hz, 1 H), 2.64 (dd, J = 
16.2, 12.3 Hz, 1 H), 2.38 (dd, J = 14.9, 9.0 Hz, 1 H), 2.30-2.22 (m, 2 H), 2.13 (s, 3 H), 
2.06-1.97 (m, 2 H), 1.72 (s, 3 H), 1.66-1.63 (m, 1 H), 1.19 (s, 3 H), 1.16 (d, J = 6.7 Hz, 3 
H), 0.99 (s, 3 H), 0.95-0.86 (m, 2 H), 0.84-0.78 (ddd, J = 14.0, 12.0, 5.6 Hz, 1 H), 0.75-
0.67 (ddd, J = 13.8, 12.2, 6.1 Hz, 1 H), 0.01 (s, 9 H), –0.10 (s, 9 H); 13C NMR (125 MHz, 
CDCl3) δ171.5, 163.8, 161.3, 160.4, 149.6, 149.4, 149.3, 148.8, 148.3, 142.4, 142.1, 129.6, 
128.9, 120.2, 119.2, 116.1, 113.0, 111.3, 111.1, 111.0, 110.8, 109.7, 108.2, 97.9, 94.9, 94.7, 
81.6, 81.5, 79.7, 79.4, 74.6, 72.2, 71.2, 70.5, 66.1, 65.5, 58.1, 56.3, 56.2, 40.2, 39.5, 38.4, 
33.8, 29.9, 28.7, 27.5, 23.2, 23.0, 18.2, 11.4, 9.6, –1.2, –1.4; HRMS (ES+) m/z 1188.6088 
[(M+Na)+; calcd for C62H95NO16Si2Na: 1188.6087]. 
 
C(11)-Exomethylene-Irciniastatin B (+)-1.10. To a solution of olefin (–)-1.S8 
(5.0 mg, 4.3 umol) in CH2Cl2 (0.05 mL) and H2O (15 µL) was added a suspension of 2,3-
dichloro-5,6-dicyano-1,4-benzoquinone (0.1 mL, 0.34 M in CH2Cl2, 8.0 equiv). After 11.5 
h, the reaction mixture was quenched with a saturated aqueous solution of NaHCO3 and 
extracted with EtOAc (5 ´ 0.5 mL). The combined organic layers were dried over MgSO4, 
filtered and concentrated in vacuo. The crude mixture was purified via flash 
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3,4-dimethoxybenzalehyde, respectively. The mixture was treated with a stock solution of 
MgBr2/n-BuSH/MeNO2 in Et2O (0.20 mL; 25 equiv MgBr2, 25 equiv n-BuSH; stock 
solution: 42.3 mg MgBr2, 18 µL n-BuSH, 46 µL MeNO2, and 0.46 mL Et2O). After 10 h, 
the reaction mixture was diluted with EtOAc, and quenched with a saturated aqueous 
solution of NaHCO3 and extracted with EtOAc (5 ´ 0.5 mL). The combined organic layers 
were dried over MgSO4, filtered, and concentrated in vacuo. The crude mixture was 
purified via flash chromatography on SiO2, 40% to 80% EtOAc/ hexanes with 5% v/v 
triethylamine) to afford (+)-C(11)-exomethylene-irciniastatin A (+)-1.10 (2.0 mg, 3.3 
µmol, 77% over two steps) as a white amorphous solid:  +12.7 (c 0.17, CHCl3); IR 
(neat) 3379, 2921, 1732, 1659, 1623, 1514, 1454, 1379, 1254, 1109 cm–1; 1H NMR (500 
MHz, CDCl3) δ 11.15 (s, 1 H), 7.28 (d, J = 10.3, 6.7 Hz, 1H), 6.68 (bs, 1H), 6.30 (s, 1 H), 
5.28 (dd, J = 10.3,  6.7Hz, 1H), 4.87 (s, 2H), 4.81 (s, 1H), 4.79 (s, 1H), 4.52 (ddd, J = 4.0, 
16.4, 8.0 Hz, 1H), 4.45 (d, J = 3.0 Hz, 1H), 4.01 (d, J = 10.1 Hz, 1H), 3.92-3.88 (m, 2H), 
3.77-3.74 (ddd, J = 12.7, 9.4, 3.8 Hz, 1H), 3.63 (d, J = 10.7 Hz, 1H), 3.40 ( s, 3H), 3.35 (s, 
3H), 3.34-3.31 (m, 1H), 2.93-2.80 (m, 2H), 2.52 (dd, J = 14.2, 5.4 Hz, 1H), 2.42-2.35 (m, 
2 H), 2.16 (dd, J = 3.9, 14.8 Hz, 1 H), 2.02 (s, 3 H), 1.88 (m, 1 H), 1.79 (dd, J = 10.6, 
2.8Hz, 1H), 1.75 (s, 3H), 1.55 (d, J = 14.5 Hz, 1H), 1.14 (s, 3H), 1.10 (d, J = 7.0 Hz, 3H), 
1.06 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 173.3, 170.7, 162.5, 161.2, 148.2, 142.2, 
140.0, 113.4, 113.2, 110.0, 101.7, 101.5, 83.4, 80.6, 80.2, 79.1, 73.9, 73.2, 72.7, 58.0, 56.5, 
€ 
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43.0, 39.9, 37.5, 33.0, 32.1, 28.5, 25.0, 22.9, 21.7, 10.7, 9.5; HRMS (ES–) m/z 606.3280 
[(M–H)–; calcd for C32H48NO10: 606.3278]. 
 
O-Methyloxime (+)-1.S9. To a solution of (–)-1.31 (6.0 mg, 5.1 µmol) in pyridine 
(0.3 mL) was added methoxyamine hydrochloride (8.8 mg, 0.105 mmol, 20.6 equiv) and 
the reaction mixture was warmed to 50 ºC. After 2 h, the reaction mixture was quenched 
with a saturated aqueous solution of NaHCO3 and extracted with EtOAc (3 ´ 0.5 mL). The 
combined organic layers were dried over MgSO4, filtered and concentrated in vacuo. The 
crude mixture was purified via flash chromatography on SiO2 (35% to 40% EtOAc/ 
hexanes) to furnish O-methyloxime (+)-1.S9 (4.9 mg, 4.1 µmol, 80%) as an odorless oil: 
 +11.3 (c 0.4, CH2Cl2); IR (neat) 3421, 2930, 1715, 1680, 1593, 1516, 1462, 1378, 
1247, 1157, 1029 cm–1; 1H NMR (500 MHz, CDCl3) δ 7.36 (d, J = 10.1 Hz, 1H), 7.31 (d, 
J = 1.9 Hz, 1H), 6.98-6.93 (m, 3H), 6.87 (d, J = 8.7 Hz, 1H), 6.83 (d, J = 8.3 Hz, 1H), 6.54 
(s, 1H), 5.17 (dA,B, J = 12.1 Hz, 1H), 5.10 (dA,B, J = 11.8 Hz, 1H), 5.05 (dd, J = 10.1, 1.2 
Hz, 1H), 4.98 (s, 2H), 4.84 (dA,B, J = 6.5 Hz, 1H), 4.79 (s, 1H), 4.77 (s, 1H), 4.69 (dA,B, J 
= 6.4 Hz, 1H), 4.65 (dA,B, J = 6.4 Hz, 1H), 4.60 (dA,B, J = 7.3 Hz, 1H), 4.40 (d, J = 2.3 Hz, 
1H), 4.22 (ddd, J = 11.5, 8.5, 2.2 Hz, 1H), 4.02 (dd, J = 3.5, 12.1 Hz, 1H), 3.97-3.93 (m, 
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3.60-3.54 (m, 2H), 3.53-3.48 (ddd, J = 11.7, 9.6, 5.6 Hz, 1H), 3.44-3.43 (ddd, J = 11.6, 9.9, 
5.8 Hz, 1H), 3.40 (s, 3H), 3.30 (s, 3H), 3.20 (dd, J = 16.6, 5.4 Hz, 1H), 3.07 (dd, J = 15.3, 
4.0 Hz, 1H), 2.67 (dd, J = 16.6, 12.3 Hz, 1H), 2.38 (dd, J = 14.7,  8.8 Hz, 1H), 2.23 (dd, J 
= 14.3, 4.5 Hz, 1H), 2.16-2.07 (m, 1H), 2.12 (s, 3H), 1.98-1.92 (m, 1H), 1.88 (dd, J = 15.0, 
12.3 Hz, 1H), 1.75 (ddd, J = 14.5, 10.3, 3.8 Hz, 1H), 1.72 (s, 3H), 1.24 (s, 3H), 1.16 (d, J 
= 6.7 Hz, 3H), 1.03 (s, 3H), 0.96-0.85 (m, 2H), 0.82-0.76 (ddd, J = 13.7, 11.4, 5.4 Hz, 1H), 
0.74-0.68 (ddd, J = 13.4, 11.7, 5.7 Hz, 1H), 0.00 (s, 9H), –0.10 (s, 9H); 13C NMR (125 
MHz, CDCl3) δ 171.5, 163.8, 161.3, 160.3, 158.2, 149.4, 149.3, 149.2, 148.7, 142.3, 141.9, 
129.5, 128.8, 120.2, 119.1, 115.9, 113.1, 111.1, 110.9, 110.8, 110.6, 107.9, 97.6, 95.0, 94.7, 
81.4, 81.3, 79.7, 79.5, 74.6, 71.0, 70.4, 70.4, 66.1, 65.6, 61.5, 58.0, 56.3, 56.2, 56.04, 56.00, 
55.99, 40.6, 39.5, 38.3, 29.9, 29.8, 29.2, 27.2, 23.4, 22.9, 21.5, 18.1, 18.0, 11.4, 9.6, –1.2, 
–1.4; high resolution mass spectrum (ES+) m/z 1219.6161 [(M+Na)+; calcd for 
C62H96N2O17Si2Na: 1219.6145]. 
 
C(11)-O-Methyloxime-Irciniastatin B (+)-1.11. To a solution of O-methyloxime 
(+)-1.S9 (4.9 mg, 4.1 µmol) in CH2Cl2 (0.160 mL) and H2O (26 µL) was added a suspension 
of 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (0.1 mL, 0.33 M in CH2Cl2, 8 equiv). After 
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extracted with EtOAc (3 ´ 0.5 mL). The combined organic layers were dried over MgSO4, 
filtered, and concentrated in vacuo to afford a 2:1 mixture of desired bis-phenol and 3,4-
dimethoxybenzalehyde, respectively. The crude mixture was carried forward without 
further purification. The mixture of bis-phenol and 3,4-dimethoxybenzaldehyde (1:2 
mixtures) was treated with a stock solution of MgBr2/n-BuSH/MeNO2 in Et2O (0.200 mL; 
25 equiv MgBr2, 25 equiv n-BuSH; stock solution: 47.4 mg MgBr2, 28 µL n-BuSH, 50 µL 
MeNO2, and 0.52 mL Et2O). After 10 h, the reaction mixture was diluted with EtOAc, and 
quenched with a saturated aqueous solution of NaHCO3 and extracted with EtOAc (5 ´ 0.5 
mL). The combined organic layers were dried over MgSO4, filtered and concentrated in 
vacuo. The crude mixture was purified via flash chromatography on water-washed SiO2 
(50 g of SiO2 washed with H2O (500 mL) then MeOH (500 mL) then EtOAc (500 mL) 
then hexanes (500 mL) and dried under vacuum overnight(30% to 50% to 70% 
EtOAc/hexanes with 5% v/v triethylamine) to afford (+)-C(11)-O-methyloxime-
irciniastatin B (+)-1.11 (1.6 mg, 2.5 µmol, 61% over two steps) as a white amorphous solid: 
 +24.8 (c 0.14, CH2Cl2); IR (neat) 3370, 2920, 2857, 1658, 1262, 1171, 1071 cm–1; 
1H NMR (500 MHz, CDCl3) δ 11.12 (s, 1H), 7.32 (d, J = 10.0 Hz, 1H), 6.30 (s, 1H), 5.49 
(brs, 1H), 5.13 (dd, J = 10.2, 6.8 Hz, 1H), 4.81 (s, 1H), 4.78 (s, 1H), 4.52 (ddd, J = 11.2, 
3.9, 3.9 Hz, 1 H), 4.45 (d, J = 2.7 Hz, 1H), 4.03 (d, J = 2.7 Hz, 1H), 3.97 (dt, J = 12.5, 6.2 
Hz, 1H), 3.86 (s, 3H), 3.78-3.76 (ddd, J = 9 3.5, 3.5 Hz, 1H), 3.73 (d, J = 11.3 Hz, 2H), 
3.39 (s, 3H), 3.36 (s, 3H), 2.91-2.80 (m, 3H), 2.70 (dd, J = 14.7, 5.3 Hz, 1H), 2.37 (dd, J = 
€ 
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14.7, 9.4 Hz, 1H), 2.14 (dd, J = 14.8, 3.7 Hz,  1H), 2.09 (s, 3H), 1.89 (m, 2H), 1.80 (dd, J 
= 15.0, 10.8 Hz, 1H), 1.75 (s, 3H), 1.59 (d, J = 15.0 Hz, 1H), 1.18 (s, 3H), 1.12 (app s, 3H), 
1.10 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 173.3, 170.8, 162.4, 161.4, 158.0, 142.1, 
139.9, 113.5, 113.3, 101.5, 83.5, 80.5, 80.4, 79.9, 73.1, 72.7, 72.4, 61.7, 57.9, 56.9, 42.8, 
40.7, 37.5, 32.4, 32.1, 29.9, 28.4, 23.7, 22.8, 20.9, 10.7, 9.2; HRMS (ES+) m/z 659.3156 
[(M+Na)+; calcd for C32H48N2O11Na: 659.3156]. 
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E1.3 References 
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E 2 EXPERIMENTAL SECTION AND COMPUTATIONAL DATA 
CORRESPONDING TO CHAPTER 2 
E2.1 Materials and methods  
Reactions were performed in either flame- or oven-dried glassware under a nitrogen 
atmosphere with anhydrous solvents, unless noted otherwise. Anhydrous diethyl ether 
(Et2O) and tetrahydrofuran (THF) were obtained from a solvent purification system. 
Hexamethylphosphoramide (HMPA) and trimethylsilyl chloride (TMSCl) was freshly 
purified prior to use by distillation over calcium hydride and stored in calcium hydride 
under nitrogen atmosphere. Commercial lithium reagents were titrated with 2,2-
diphenylacetic acid before use. All other commercially available reagents were used as 
received, unless otherwise noted. Reactions were magnetically stirred unless stated 
otherwise and monitored by thin-layer chromatography (TLC) with 0.25 mm precoated 
silica gel plates. Silica gel chromatography was performed utilizing ACS grade solvents 
and silica gel (particle size 40-63 µm). Medium pressure liquid chromatography was 
conducted by using a medium-pressure pump equipped with a high-pressure glass column 
(350 mm × 35 mm or 350 mm × 10 mm) packed with silica gel (standard grade, porosity 
60 Å, particle size 32−63 µm). 1H NMR spectra (500 MHz field strength) and 13C NMR 
spectra (125 MHz field strength) were recorded on a 500 MHz spectrometer. Chemical 
shifts are reported relative to chloroform (δ 7.26) and benzene (δ 7.16) for 1H NMR spectra 
and chloroform (δ 77.16) and benzene (δ 128.06) for 13C spectra. The following 
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abbreviations are used to describe multiplicities in 1H NMR spectra: s (singlet), d 
(doublet), dd (doublet of doublets), ddd (doublet of doublet of doublets), dt (doublet of 
triplets), dq (doublet of quartets), t (triplet), td (triplet of doublets), m (multiplet), q 
(quartet), and app (apparent). Infrared spectra were obtained using a FT/IR plus 
spectrometer. High-resolution mass spectra (HRMS) were measured on a LC-TOF mass 
spectrometer. Melting points were obtained on a Thomas-Hoover apparatus and are 
uncorrected. Single crystal X-ray structures were determined on a detector employing 
graphite-monochromated Mo-Ka radiation (l=0.71073Å) at a temperature of 143(1) K.  
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E2.2 Experimental procedures 
 
2-(1-(Trimethylsilyl)vinyl)benzaldehyde (2.14). To a solution of (1-
bromovinyl)trimethylsilane (2.17) (1.94 g, 10.8 mmol) in THF (20 mL) was added tert-
BuLi (16.5 mL, 21.6 mmol) dropwise at -78 °C. The resulting solution was stirred at -78 
°C for 30 min before the addition of a ZnCl2 solution (27.4 mL, freshly prepared from 
flame-dried ZnCl2 solid, 1 M in THF). The reaction mixture was then warmed to -20 °C 
and stirred for another 30 min. The cooling bath was removed and a solution of Pd(PPh3)4 
(416 mg, 0.36 mmol) and 2-bromobenzaldehyde (2.S1, 1.34 g, 7.2 mmol) in THF (20 mL) 
was added at room temperature. The resulting mixture was stirred vigorously for 12 hours 
at reflux temperature before it was cooled to room temperature. The reaction mixture was 
then quenched with a saturated aqueous solution of NH4Cl (20 mL), and extracted with 
Et2O (4 × 20 mL). The combined organic phases were washed with brine, dried over 
Na2SO4, filtered and concentrated. The crude material was purified by flash 
chromatography on silica gel (2:1 CH2Cl2/hexanes) to provide a pale-yellow oil (0.96 g, 
65%). IR (neat) 3057, 2956, 2843, 2747, 1694, 1597, 1475, 1389, 1250, 1194, 841, 773 
cm-1; 1H NMR (500 MHz, CDCl3) δ 10.11 (s, 1H), 7.93 (d, J = 7.4 Hz, 1H), 7.51 (dd, J = 
8.5, 7.5 Hz, 1H), 7.34 (dd, J = 8.5, 7.8 Hz, 1H), 7.07 (d, J = 7.8 Hz, 1H), 5.91 (d, J = 3.0 
Hz, 1H), 5.72 (d, J = 3.0 Hz, 1H), 0.12 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 192.6, 
1a  t-BuLi, THF, −78 ºC
1b ZnCl2, THF,  −78 ºC to rt
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151.4, 149.4, 133.5, 133.0, 130.7, 128.9, 127.7, 126.6, -1.6; HRMS (CI+) m/z 189.0737 
[(M-Me)+; calcd for C11H13OSi 189.0736]. 
 
1-(2-(Penta-1,4-dien-2-yl)phenyl)pentan-1-ol (2.15a).  
General procedures  
Condition 1: To a solution of linchpin 2.14 (50 mg, 0.245 mmol) in Et2O (0.5 mL) 
at -78 °C was added n-BuLi (200 µL, 2.4 M, 0.48 mmol). After 30 min, the resulting 
solution was transferred to a suspension of CuBr×DMS (98 mg, 0.48 mmol) in HMPA/THF 
(1 mL, 1:1) via cannula at room temperature. The resulting mixture was stirred for 2 h, 
followed by the addition of allyl bromide (41 uL, 0.48 mmol).  The resulting reaction 
mixture was stirred for another 2 h, followed by the addition of 1 N HCl (1 mL). After 10 
minutes, the reaction mixture was diluted with H2O (5 mL) and extracted with Et2O (3×5 
mL). The combined organic layers were washed with brine (15 mL), dried over anhydrous 
Na2SO4, filtered and concentrated. Flash chromatography (2:1 CH2Cl2/hexanes) afforded 
compound 2.15a (41 mg, 73%) as a colorless oil.  
Condition 2: To a solution of linchpin 2.14 (50 mg, 0.245 mmol) in THF (0.5 mL) 
at -78 °C was added n-BuLi (110 µL, 2.4 M, 0.26 mmol). After 30 min, the resulting 
solution was transferred to a suspension of CuBr×DMS (98 mg, 0.48 mmol) in HMPA (0.5 
mL) via cannula at room temperature, followed by the addition of t-BuOK (240 uL, 1 M 
OH
n-Bu
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in THF). The resulting mixture was stirred for 30 min, followed by the addition of allyl 
bromide (41 uL, 0.48 mmol). The resulting reaction mixture was stirred for 2 h, followed 
by the addition of 1 N HCl (1 mL). After 10 minutes, the reaction mixture was diluted with 
H2O (5 mL) and extracted with Et2O (3×5 mL). The combined organic layers were washed 
with brine (15 mL), dried over anhydrous Na2SO4, filtered and concentrated. Flash 
chromatography (2:1 CH2Cl2/hexanes) afforded compound 2.15a (42 mg, 74%) as a 
colorless oil. IR(neat) 3367 (br), 3077, 2956, 2931, 2859, 1638, 1430, 1045, 997, 910, 761 
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.52 (dd, J = 7.8, 1.4 Hz, 1H), 7.31 (ddd, J = 8.3, 7.6, 
1.5 Hz, 1H), 7.23 (ddd, J = 8.3, 7.5, 1.4 Hz, 1H), 7.08 (dd, J = 7.6, 1.4 Hz, 1H), 5.90-5.79 
(m, 1H), 5.24 (q, J = 1.6 Hz, 1H), 5.10 – 5.02 (m, 2H), 4.92-4.90 (m, 1H), 4.88 – 4.83 (m, 
1H), 3.11 – 2.99 (m, 2H), 1.85 – 1.76 (m, 1H), 1.73-1.65 (m, 2 H), 1.47 – 1.40 (m, 1H), 
1.37 – 1.25 (m, 3H), 0.89 (t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 147.6, 141.9, 
141.7, 135.5, 128.6, 127.7, 127.1, 125.8, 117.0, 115.5, 70.7, 43.5, 38.6, 28.6, 22.7, 14.2; 
HRMS (ES+) m/z 213.1637 [(M-OH)+; calcd for C16H21 213.1643]. 
 
1-(2-(4-Methylpenta-1,4-dien-2-yl)phenyl)pentan-1-ol (2.15b). Colorless oil 
(condition a: 41 mg, 68%; condition b: 43 mg, 73%). IR (neat) 3367 (br), 3077, 2956, 2931, 
2859, 1638, 1430, 1045, 997, 910, 761 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.51 (d, J = 
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Hz, 1H), 5.26 (s, 1H), 4.95 (s, 1H), 4.89 – 4.84 (m, 1H), 4.82 (s, 1H), 4.65 (s, 1H), 3.03 (s, 
2H), 1.86 – 1.78 (m, 1H), 1.77 (s, 3H), 1.73 – 1.64 (m, 2H), 1.49 – 1.40 (m, 1H), 1.39 – 
1.24 (m, 3H), 0.89 (t, J = 8.9 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 146.5, 142.6, 142.0, 
141.7, 128.6, 127.6, 127.1, 125.8, 116.4, 113.7, 70.6, 47.9, 38.5, 28.6, 22.8, 22.3, 14.2; 
HRMS (ES+) m/z 267.1722 [(M+Na)+; calcd for C17H24ONa 267.1725]. 
 
1-(2-(3-Phenylprop-1-en-2-yl)phenyl)pentan-1-ol (2.15c). Colorless oil 
(condition a: 48 mg, 70%; condition b: 50 mg, 73%). IR (neat) 3389 (br), 3062, 3027, 2955, 
2930, 2858, 1637, 1601, 1494, 1453, 1044, 905, 762, 731, 699 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 7.44 (d, J = 7.8 Hz, 1H), 7.31 – 7.28 (m, 1H), 7.26 – 7.17 (m, 4H), 7.11 – 7.05 
(m, 1H), 5.24 (s, 1H), 4.88 (s, 1H), 4.65 – 4. 59 (m, 1H), 3.67 (d, J = 14.6 Hz, 1H), 3.63 
(d, J = 14.6 Hz, 1H), 1.75 – 1.67 (m, 1H), 1.54 – 1.46 (m, 1H), 1.39 – 1.25 (m, 3H), 1.21 
– 1.12 (m, 1H), 1.06 (d, J = 3.3 Hz, 1H), 0.88 (t, J = 7.2 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) δ 148.3, 142.3, 140.9, 138.7, 129.5, 128.4, 128.3, 127.6, 127.0, 126.5, 125.9, 116.0, 
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1-(2-(Prop-1-en-2-yl)phenyl)pentan-1-ol (2.15d). Colorless oil (condition b: 38 
mg, 77%). IR (neat) 3359 (br), 3075, 2957, 2859, 1640, 1374, 1300, 1046, 1004, 900, 761 
cm-1;1H NMR (500 MHz, CDCl3) δ 7.52 (d, J = 7.8 Hz, 1H), 7.30 (dd, J = 8.2, 7.8 Hz, 
1H), 7.23 (dd, J = 8.2, 7.8 Hz, 1H), 7.11 (d, J = 7.8 Hz, 1H), 5.22 (s, 1H), 4.94 – 4.88 (m, 
1H), 4.84 (s, 1H), 2.07 (s, 3H), 1.85 – 1.74 (m, 2H), 1.73 – 1.66 (m, 1H), 1.49 – 1.40 (m, 
1H), 1.38 – 1.24 (m, 3H), 0.89 (t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 145.1, 
142.7, 141.6, 128.1, 127.5, 127.2, 125.8, 115.7, 70.7, 38.8, 28.5, 25.9, 22.7, 14.2; HRMS 
(ES+) m/z 227.1401 [(M+Na)+; calcd for C14H20ONa 227.1412]. 
 
1-(2-(1-(Phenylthio)vinyl)phenyl)pentan-1-ol (2.15e). Pale-yellow oil (condition 
a: 44 mg, 61%; condition b: 40 mg, 56%). IR (neat) 3073, 2959, 1766, 1716, 1466, 1285, 
1023, 743, 690 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.53 – 7.49 (m, 3H), 7.38 – 7.29 (m, 
4H), 7.26 – 7.20 (m, 2H), 5.15 – 5.11 (m, 1H), 5.11 (s, 1H), 5.05 (s, 1H), 1.86 – 1.79 (m, 
1H), 1.78 (d, J = 3.2 Hz, 1H), 1.75 – 1.71 (m, 1H), 1.50 – 1.42 (m, 1H), 1.38 – 1.28 (m, 
3H), 0.90 (t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 145.4, 143.0, 137.9, 135.1, 
131.9, 129.8, 129.5, 129.1, 128.9, 127.2, 126.0, 113.4, 70.4, 38.2, 28.6, 22.8, 14.2; HRMS 
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4-(1-(2-(1-Hydroxypentyl)phenyl)vinyl)benzonitrile (2.16a). 
General procedures  
Condition 1: To a solution of linchpin 2.14 (50 mg, 0.245 mmol) in Et2O (0.5 mL) 
at -78 °C was added n-BuLi (200 µL, 2.4 M, 0.48 mmol). After 30 min, the resulting 
solution was transferred to a suspension of CuBr×DMS (98 mg, 0.48 mmol) in HMPA/THF 
(1 mL, 1:1) via cannula at room temperature. The resulting mixture was stirred for 2 h, 
followed by the addition of a pre-mixed solution of 4-iodobenzonitrile (110 mg, 0.48 
mmol) and Pd(PPh3)4 (14 mg, 12 µmol) in THF (0.5 mL). The resulting reaction mixture 
was stirred overnight, followed by the addition of 1 N HCl (1 mL). After 10 minutes, the 
reaction mixture was diluted with H2O (5 mL) and extracted with Et2O (3×5 mL). The 
combined organic layers were washed with brine (15 mL), dried over anhydrous Na2SO4, 
filtered and concentrated. Flash chromatography (1:1:0.0125 CH2Cl2 /hexanes/MeOH) 
afforded compound 2.16a. 
Condition b: To a solution of linchpin 2.14 (50 mg, 0.245 mmol) in THF (0.5 mL) 
at -78 °C was added n-BuLi (110 µL, 2.4 M, 0.26 mmol). After 30 min, the resulting 
solution was transferred to a suspension of CuBr×DMS (98 mg, 0.48 mmol) in HMPA (0.5 
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in THF). The resulting mixture was stirred for 30 min, followed by the addition of a pre-
mixed solution of 4-iodobenzonitrile (110 mg, 0.48 mmol) and Pd(PPh3)4 (14 mg, 12 µmol) 
in THF (0.5 mL). The resulting reaction mixture was stirred overnight, followed by the 
addition of 1 N HCl (1 mL). After 10 minutes, the reaction mixture was diluted with H2O 
(5 mL) and extracted with Et2O (3×5 mL). The combined organic layers were washed with 
brine (15 mL), dried over anhydrous Na2SO4, filtered and concentrated. Flash 
chromatography (1:1:0.0125 CH2Cl2/hexanes /MeOH) afforded compound 2.16a. Pale-
yellow amorphous solid (condition a: 51 mg, 72%; condition b: 50 mg, 70%). IR (neat) 
3447 (br), 3061, 2955, 2845, 2228, 1604, 1504, 1403, 1016, 915, 850, 766 cm-1; 1H NMR 
(500 MHz,CDCl3) δ 7.59 (d, J = 8.4 Hz, 3H), 7.44 (dd, J = 7.6, 7.6  Hz, 1H), 7.37 (d, J = 
8.2 Hz, 2H), 7.33 (dd, J = 7.5, 7.5, 1H), 7.18 (d, J = 7.6, 1H), 5.92 (s, 1H), 5.39 (s, 1H), 
4.52 (dd, J = 8.3, 4.8 Hz, 1H), 1.67 – 1.58 (m, 1H), 1.57 – 1.45 (m, 2H), 1.24 – 1.10 (m, 
3H), 1.10 – 1.02 (m, 1H), 0.79 (t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 147.3, 
145.3, 142.9, 138.6, 132.5, 130.3, 128.9, 127.7, 127.1, 126.2, 118.9, 118.9, 111.5, 70.8, 
38.4, 28.3, 22.5, 14.1; HRMS (ES–) m/z 290.1550 [(M-H)– ; calcd for C20H20NO 290.1545]. 
 
1-(2-(1-Phenylvinyl)phenyl)pentan-1-ol (2.16b). Pale-yellow oil (condition a: 50 
mg, 77%; condition b: 46 mg, 71%). IR (neat) 3390 (br), 3058, 2955, 2858, 1615, 1494, 
OH
n-Bu
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1444, 1322, 1028, 903, 760, 710 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.55 (d, J = 7.8 Hz, 
1H), 7.39 (dd, J = 7.6, 7.6 Hz, 1H), 7.33 – 7.16 (m, 7H), 5.79 (d, J = 1.3 Hz, 1H), 5.20 (d, 
J = 1.4 Hz, 1H), 4.63 – 4.47 (m, 1H), 1.66 – 1.55 (m, 2H), 1.53 – 1.45 (m, 1H), 1.29 – 1.09 
(m, 3H), 1.09 – 0.99 (m, 1H), 0.79 (t, J = 7.2 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
148.7, 143.0, 141.0, 140.1, 130.3, 128.6, 128.3, 128.0, 127.4, 126.5, 125.9, 115.8, 70.7, 
38.1, 28.3, 22.5, 14.1; HRMS (CI+) m/z 266.1674 [(M)+; calcd for C19H22O 266.1671]. 
 
1-(2-(1-(P-tolyl)vinyl)phenyl)pentan-1-ol (2.16c). Pale-yellow oil (condition a: 
50 mg, 73%; condition b:54 mg, 78%). IR (neat) 3390 (br), 2929, 2858, 1510, 1447, 1040, 
900, 827, 759 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.57 (d, J = 7.8 Hz, 1H), 7.40 (dd, J = 
7.6, 7.6 Hz, 1H), 7.30 (ddd, J = 7.5, 7.5, 1.4 Hz, 1H), 7.22 (dd, J = 7.5, 1.5 Hz, 1H), 7.19 
– 7.15 (m, 2H), 7.10 (d, J = 8.1 Hz, 2H), 5.77 (d, J = 1.5 Hz, 1H), 5.16 (d, J = 1.5 Hz, 1H), 
4.63 (dd, J = 8.2, 4.9 Hz, 1H), 2.34 (s, 3H), 1.73 – 1.59 (m, 2H), 1.58 – 1.47 (m, 1H), 1.29 
– 1.23 (m, 1H), 1.23 – 1.21 (m, 2H), 1.11 – 1.03 (m, 1H), 0.80 (t, J = 7.2 Hz, 3H); 13C 
NMR (125 MHz, CDCl3) δ 148.5, 143.0, 140.3, 138.2, 137.9, 130.3, 129.3, 128.2, 127.3, 
126.4, 125.9, 114.9, 70.7, 38.0, 28.3, 22.5, 21.2, 14.0; HRMS (CI+) m/z 263.1794 [(M-
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1-(2-(1-(4-Methoxyphenyl)vinyl)phenyl)pentan-1-ol (2.16d). Pale-yellow oil 
(condition a: 52 mg, 72%; condition b: 55 mg; 76%). IR (neat) 3420 (br), 2954, 2931, 1607, 
1510, 1249, 1180, 1035, 837, 761 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.56 (d, J = 7.8 Hz, 
1H), 7.39 (dd, J = 7.6, 7.6 Hz, 1H), 7.30 (ddd, J = 7.4, 7.4, 1.4 Hz, 1H), 7.23 – 7.17 (m, 
3H), 6.86 – 6.76 (m, 2H), 5.71 (d, J = 1.4 Hz, 1H), 5.10 (d, J = 1.3 Hz, 1H), 4.63 (dt, J = 
8.4, 4.4 Hz, 1H), 3.79 (s, 3H), 1.68 – 1.61 (m, 1H), 1.55 – 1.49 (m, 2H), 1.29 – 1.13 (m, 
3H), 1.12 – 1.04 (m, 1H), 0.79 (t, J = 7.2 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 159.6, 
148.0, 143.0, 140.4, 133.7, 130.2, 128.2, 127.8, 127.4, 125.9, 113.93, 113.86, 70.7, 55.4, 
38.1, 28.3, 22.5, 14.1; HRMS (CI+) m/z 279.1736 [(M-OH)+; calcd for C20H23O 279.1749]. 
 
1-(2-(Buta-1,3-dien-2-yl)phenyl)pentan-1-ol (2.16e). Three equivalents of vinyl 
bromide were added for optimal yield. Pale-yellow oil (condition a: 40 mg, 75%; condition 
b: 42 mg; 78%); IR (neat) 3403 (br), 2955, 2930, 2870, 1749, 1466, 1379, 999, 761 cm-1; 
1H NMR (500 MHz, CDCl3) δ 7.55 (dd, J = 7.8, 1.4 Hz, 1H), 7.36 (ddd, J = 7.6, 7.6, 1.5 
Hz, 1H), 7.28-7.24 (m, 1H), 7.07 (dd, J = 7.5, 1.5 Hz, 1H), 6.67 (dd, J = 17.3, 10.4 Hz, 
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2H), 1.80 – 1.70 (m, 1H), 1.69 – 1.61 (m, 2H), 1.4-1.18 (m, 4H), 0.86 (t, J = 7.1 Hz, 3H); 
13C NMR (125 MHz, CDCl3) δ 147.6, 142.9, 140.0, 137.8, 129.8, 128.1, 127.2, 125.6, 
119.3, 117.6, 70.8, 38.3, 28.4, 22.7, 14.1; HRMS (ES+) m/z 199.1493 [(M-OH)+; calcd for 
C15H19 199.1487]. 
 
1-(2-(1-(P-tolyl)vinyl)phenyl)ethan-1-ol (2.16f). Pale-yellow oil (condition a: 41 
mg, 70%; condition b: 40 mg, 69%). IR (neat) 3367(br), 2971, 1616, 1510, 1446, 1118, 
1068, 1003, 900, 827, 761 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.62 (d, J = 7.8 Hz, 1H), 
7.41 (dd, J = 7.6, 7.6 Hz, 1H), 7.31 (dd, J = 7.4, 7.4 Hz, 1H), 7.21 (d, J = 7.7 Hz, 1H), 7.17 
(d, J = 7.7 Hz, 2H), 7.10 (d, J = 7.4 Hz, 2H), 5.79 (s, 1H), 5.17 (s, 1H), 4.85 (q, J = 6.5 Hz, 
1H), 2.34 (s, 3H), 1.77 – 1.55 (m, 1H), 1.30 (d, J = 6.4 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) δ 148.3, 143.8, 139.9, 138.01, 137.96, 130.2, 129.3, 128.3, 127.4, 126.4, 125.4, 
114.8, 66.8, 24.4, 21.3; HRMS (CI+) m/z 221.1326 [(M-OH)+; calcd for C17H17 221.1330]. 
 
Phenyl(2-(1-(p-tolyl)vinyl)phenyl)methanol (2.16g). Pale-yellow oil (condition 
a: 46 mg, 63%; condition b: 42 mg, 57%); IR (neat) 3414 (br), 3026, 1510, 1447, 1183, 
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Hz, 1H), 7.36 (ddd, J = 7.5, 7.5, 1.6 Hz, 1H), 7.31 (ddd, J = 7.4, 7.4, 1.5 Hz, 1H), 7.27 – 
7.17 (m, 8H), 7.11 (d, J = 8.0 Hz, 2H), 5.84 (d, J = 3.6 Hz, 1H), 5.79 (d, J = 1.3 Hz, 1H), 
5.13 (d, J = 1.3 Hz, 1H), 2.35 (s, 3H), 1.95 (d, J = 3.6 Hz, 1H); 13C NMR (125 MHz, 
CDCl3) δ 148.1, 143.7, 141.9, 140.9, 138.1, 138.0, 130.4, 129.4, 128.3, 128.2, 127.7, 127.6, 
127.2, 126.6, 115.4, 72.4, 21.3; HRMS (CI+) m/z 283.1487 [(M-OH)+; calcd for C22H19 
283.1487]. 
 
4-(1-(2-(1-Hydroxy-2-methylallyl)phenyl)vinyl)benzonitrile (2.16h). To a 
solution of 2-bromopropene (24 uL, 0.27 mmol) in THF (0.5 mL) was added dropwise t-
BuLi (370 uL, 1.48 M in hexanes, 0.55 mmol) at -78 oC. The reaction mixture was stirred 
for 30 minutes, followed by the addition of linchpin 14 (50 mg, 0.245 mmol) in THF (0.2 
mL). After 30 minutes, the reaction mixture was transferred to a suspension of CuBr×DMS 
(98 mg, 0.48 mmol) in HMPA (0.5 mL) via cannula at room temperature, followed by the 
addition of t-BuOK (240 uL,1 M in THF). The resulting suspension was stirred at room 
temperature for 30 minutes, followed by the addition of a pre-mixed solution of 4-
iodobenzonitrile (110 mg, 0.48 mmol) and Pd(PPh3)4 (14 mg, 12 µmol) in THF (0.5 mL). 
The resulting reaction mixture was stirred overnight, followed by the addition of 1 N HCl 




  138 
with Et2O (3×5 mL). The combined organic layers were washed with brine (15 mL), dried 
over anhydrous Na2SO4, filtered and concentrated. Flash chromatography (1:10 
EtOAc/toluene) afforded compound 2.16h (46 mg, 69%) as a pale-yellow oil: IR (neat) 
3446 (br), 3061, 2227, 1604, 1402, 1046, 906, 849,764 cm-1; 1H NMR (500 MHz, CDCl3) 
δ 7.58 (d, J = 7.6 Hz, 2H), 7.52 (d, J = 7.2 Hz, 1H), 7.45 – 7.37 (m, 3H), 7.34 (td, J = 7.5, 
1.4 Hz, 1H), 7.19 (d, J = 7.6 Hz, 1H), 5.95 (s, 1H), 5.42 (s, 1H), 5.06 (s, 1H), 5.00 (d, J = 
3.9 Hz, 1H), 4.90 (s, 1H), 1.65 (d, J = 4.1 Hz, 1H), 1.47 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δ 146.8, 146.3, 145.2, 139.9, 139.7, 132.4, 130.4, 128.8, 128.1, 127.3, 127.1, 119.1, 
118.9, 111.5, 111.3, 73.7, 19.4; HRMS (ES+) m/z 258.1293 [(M-OH)+; calcd for C19H16N 
258.1283]. 
 
4-(1-(2-(Furan-2-yl(hydroxy)methyl)phenyl)vinyl)benzonitrile (2.16i). To a 
solution of furan (20 uL, 0.27 mmol) in THF (0.5 mL) was added dropwise n-BuLi (110 
uL, 2.5 M in hexanes, 0.27 mmol) at -78 oC. After addition, the reaction mixture was 
warmed up to 0 oC and stirred for another hour. The resulting solution was then cooling 
down to -78 oC, followed by the addition of linchpin 14 (50 mg, 0.245 mmol) in THF (0.2 
mL). After 30 minutes, the reaction mixture was transferred to a suspension of CuBr×DMS 
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of t-BuOK (240 uL,1 M in THF), the resulting suspension was heated to 60 oC and stirred 
for another 45 minutes. The resulting mixture was then cooled down to room temperature, 
followed by the addition of a pre-mixed solution of 4-iodobenzonitrile (110 mg, 0.48 
mmol) and Pd(PPh3)4 (14 mg, 12 µmol) in THF (0.5 mL). The resulting reaction mixture 
was stirred overnight, followed by the addition of 1 N HCl (1 mL). After 10 minutes, the 
reaction mixture was diluted with H2O (5 mL) and extracted with Et2O (3×5 mL). The 
combined organic layers were washed with brine (15 mL), dried over anhydrous Na2SO4, 
filtered and concentrated. Flash chromatography (1:10 EtOAc/hexanes) afforded 
compound 2.16i (41 mg, 57%) as brown solid:  Note: The tri-component adduct 2.16i 
should be quickly isolated and purified due to its instablitiy: IR (neat) 3446 (br), 3074, 
2227, 1604, 1503, 1404, 1149, 1011, 924, 848, 740 cm-1; 1H NMR (500 MHz, CDCl3) δ 
7.75 (d, J = 7.9 Hz, 1H), 7.54 – 7.50 (m, 2H), 7.47 (dd, J = 7.8, 7.6 Hz, 1H), 7.38 (dd, J = 
8.7, 7.5 Hz, 1H), 7.31 (d, J = 8.6 Hz, 2H), 7.28 – 7.27 (m, 1H), 7.19 (dd, J = 7.6, 1.5 Hz, 
1H), 6.26 – 6.19 (m, 1H), 5.93 – 5.86 (m, 2H), 5.72 (d, J = 4.1 Hz, 1H), 5.32 (s, 1H), 2.15 
(d, J = 4.1 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 155.6, 146.4, 144.7, 142.4, 139.0, 
138.9, 132.3, 130.2, 128.7, 128.4, 127.5, 127.3, 119.2, 118.9, 111.4, 110.3, 108.0, 67.0; 
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4-(1-(2-(Hydroxy(2-methyl-1,3-dithian-2-yl)methyl)phenyl)vinyl)benzonitrile 
(2.16j). To a solution of 2-methyl-1,3-dithiane (33 uL, 0.27 mmol) in THF (0.5 mL) was 
added dropwise n-BuLi (110 uL, 2.5 M in hexanes, 0.27 mmol) at room temperature. The 
reaction mixture was stirred for another 10 minutes before cooling down to 0 oC, followed 
by the addition of linchpin 14 (50 mg, 0.245 mmol) in THF (0.2 mL). The resulting solution 
was then warmed up to room temperature and stirred for another 30 minutes before it was 
transferred to a suspension of CuBr×DMS (98 mg, 0.48 mmol) in HMPA (0.5 mL) via 
cannula at room temperature. t-BuOK (240 uL,1 M in THF) was then added. The resulting 
mixture was stirred for 30 min, followed by the addition of a pre-mixed solution of 4-
iodobenzonitrile (110 mg, 0.48 mmol) and Pd(PPh3)4 (14 mg, 12 µmol) in THF (0.5 mL). 
The resulting reaction mixture was stirred overnight, followed by the addition of 1 N HCl 
(2 mL). After 1 hour, the reaction mixture was diluted with H2O (5 mL) and extracted with 
Et2O (3×5 mL). The combined organic layers were washed with brine (15 mL), dried over 
anhydrous Na2SO4, filtered and concentrated. Flash chromatography (1:15 EtOAc/toluene) 
afforded compound 2.16j (48 mg, 53%) as a pale-yellow solid: IR (neat) 3467 (br), 3061, 
2923, 2226, 1603, 1374, 1027, 911, 849, 762 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.75 (d, 
J = 7.8 Hz, 1H), 7.60 (d, J = 8.1 Hz, 2H), 7.49 (d, J = 8.2 Hz, 2H), 7.42 – 7.31 (m, 2H), 
7.17 (d, J = 7.7 Hz, 1H), 6.04 (s, 1H), 5.56 (s, 1H), 4.95 (s, 1H), 2.97 (s, 1H), 2.89 (t, J = 
12.8 Hz, 1H), 2.71 (dd, J = 14.2, 13.1 Hz, 1H), 2.62 – 2.51 (m, 1H), 2.48 – 2.38 (m, 1H), 
2.03 – 1.94 (m, 1H), 1.88 – 1.74 (m, 1H), 1.45 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 
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147.5, 144.8, 141.2, 136.8, 132.4, 130.7, 129.1, 128.3, 127.6, 127.2, 119.6, 118.9, 
111.6,71.7, 54.7, 28.0, 26.1, 24.3, 23.8; HRMS (ES+) m/z 368.1155 [(M+H)+; calcd for 
C21H22NOS2 368.1143]. 
 
Synthesis of cyclohexyl linchpin 2.19 and 2.20. To a vigorously stirred suspension 
of magnesium turnings (2.11 g, 87.9 mmol) in THF (9 mL) was added a few drops of (1-
bromovinyl)trimethylsilane (8.74 g, 48.8 mmol) solution in THF (9 mL), followed by the 
addition of a few iodine crystals. After the reaction was initiated, another 9 mL THF was 
added, followed by the addition of the remaining (1-bromovinyl)trimethylsilane solution. 
The reaction mixture was stirred under reflux for another hour. After cooling to room 
temperature, the freshly prepared Grignard reagent was diluted with 9 mL THF and slowly 
cannulated into a suspension of CuBr×DMS (3.40 g, 16.5 mmol) in THF (20 mL) and 
dimethyl sulfide (20 mL) at -50 oC, followed by the addition of HMPA (17 mL, 97.7 
mmol). To this mixture was then added dropwise a THF (20 mL) solution of cyclohex-1-
ene-1-carbaldehyde (3.54 g, 32.1 mmol) and TMSCl (8.3 mL, 65.4 mmol). The resulting 
mixture was stirred for 1h before addition of 1 N HCl (40 mL).  After warming up to room 
temperature, the reaction mixture was extracted with Et2O (3×50 mL) and the combined 
organic layer was washed with brine, dried over anhydrous Na2SO4 and concentrated. The 
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to 100% CH2Cl2) to yield both cis-linchpin and trans-linchpin as colorless oils (cis:trans 
1:1, 4.25 g, 63%). Note: Both linchpins can be easily oxidized to the corresponding acids. 
Samples are stored under N2 atmosphere in a freezer (-20 oC) unless they are used 
immediately. Cis-2-(1-(trimethylsilyl)vinyl)cyclohexane-1-carbaldehyde (2.19). 
Colorless oil. IR (neat) 3054, 2934, 2857, 2740, 1718, 1449, 1249,927, 837, 758 cm-1; 1H 
NMR (500 MHz, CDCl3) δ 9.76 (d, J = 1.1 Hz, 1H), 5.64 (dd, J = 2.2, 1.7 Hz, 1H), 5.56 
(dd, J = 2.0, 1.1 Hz, 1H), 2.64 – 2.53 (m, 2H), 2.22 – 2.08 (m, 1H), 1.85 – 1.80 (m, 1H), 
1.75 – 1.70 (m, 1H), 1.64 – 1.57 (m, 1H), 1.56 – 1.51 (m, 1H), 1.51 – 1.45 (m, 1H), 1.40 – 
1.32 (m, 2H), 0.12 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 207.1, 153.6, 125.2, 49.1, 43.0, 
28.2, 27.0, 26.1, 22.6, -0.7; HRMS (CI+) m/z 195.1197 [(M-CH3)+; calcd for C11H19OSi 
195.1205]. Trans-2-(1-(trimethylsilyl)vinyl)cyclohexane-1-carbaldehyde (2.20). 
Colorless oil; IR (neat) 2931, 2855, 2707, 1726, 1447, 1249, 929, 838, 759, 690 cm-1; 1H 
NMR (500 MHz, CDCl3) δ 9.44 (d, J = 3.5 Hz, 1H), 5.70 – 5.63 (m, 1H), 5.46. (d, J = 1.9 
Hz, 1H), 2.59 – 2.43 (m, 1H), 2.30 (ddd, J = 12.6, 11.7, 3.3 Hz, 1 H), 1.89 – 1.73 (m, 4H), 
1.37 – 1.21 (m, 3H), 1.17 – 1.08 (m, 1H), 0.10 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 
205.4, 154.9, 125.4, 54.3, 43.7, 34.5, 26.9, 26.4, 25.0, -1.1; HRMS (ES+) m/z 195.1206 
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Intermediate 2.21. To a solution of linchpin 2.19 (50 mg, 0.24 mmol) in freshly 
degassed THF (0.5 mL, freeze-pump-thaw three cycles) at -78 °C was added n-BuLi (110 
µL, 2.4 M, 0.26 mmol). After stirring for 30 min, the reaction mixture was quenched with 
H2O (5 mL) and extracted with Et2O (3×5 mL). The combined organic layers were washed 
with brine (15 mL), dried over anhydrous Na2SO4, filtered and concentrated. The resulting 
crude residue was purified by flash chromatography (1:20 EtOAc/hexanes) to give 
intermediate 2.21. Colorless oil (55 mg, 86%). IR (neat) 3375 (br), 2929, 2856, 1450, 1408, 
1248, 925, 856, 836, 756, 687 cm-1; 1H NMR (500 MHz, CDCl3) δ 5.86 (s, 1H), 5.56 (d, J 
= 2.3 Hz, 1H), 3.73 – 3.66 (m, 1H), 2.63 – 2.47 (m, 1H), 1.89 – 1.79 (m, 1H), 1.79 – 1.69 
(m, 2H), 1.67 – 1.55 (m, 3H), 1.49 – 1.18 (m, 10H), 0.89 (t, J = 7.1 Hz, 3H), 0.09 (s, 9H); 
13C NMR (125 MHz, CDCl3) δ 155.9, 125.7, 73.7, 44.1, 42.2, 35.7, 29.6, 28.5, 25.4, 24.9, 
23.3, 22.9, 14.3, -0.9; HRMS (CI+) m/z 253.1988 [(M-CH3)+; calcd for C15H29OSi 
253.1988]. 
 
Intermediate 2.22. To a solution of linchpin 2.19 (50 mg, 0.24 mmol) in freshly 
degassed THF (0.5 mL, freeze-pump-thaw three cycles) at -78 °C was added n-BuLi (110 
µL, 2.4 M, 0.26 mmol). After stirring for 30 min, the resulting solution was transferred to 
a suspension of CuBr×DMS (98 mg, 0.48 mmol) in freshly distilled HMPA (0.5 mL) via 
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The resulting mixture was stirred at 60 oC for 45 min. The reaction mixture was then 
quenched with a saturated aqueous solution of NaHCO3 (5 mL) and extracted with Et2O 
(3×5 mL). The combined organic layers were washed with brine (15 mL), dried over 
anhydrous Na2SO4, filtered and concentrated. The resulting crude residue was purified by 
flash chromatography (hexanes to 1:33 EtOAc/hexanes, buffered with 5% Et3N) to give 
intermediate 2.22. Colorless oil (47 mg, 73%). IR (neat) 3073, 2927, 2860, 1450, 1250, 
1105, 1064, 953, 912, 839, 750, 684 cm-1; 1H NMR (500 MHz, CDCl3) δ 6.11 – 6.01 (m, 
1H), 5.03 (s, 1H), 5.02 – 4.98 (m, 1H), 3.39 – 3.32 (m, 1H), 2.44 – 2.35 (m, 1H), 1.81 (t, J 
= 14.6 Hz, 2H), 1.65 (d, J = 13.0 Hz, 1H), 1.49 – 1.37 (m, 5H), 1.33 – 1.17 (m, 6H), 1.16 
– 1.06 (m, 1H), 0.89 (t, J = 6.9 Hz, 3H), 0.09 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 138.8, 
115.5, 75.0, 45.2, 40.7, 34.0, 33.4, 26.6, 26.4, 24.9, 23.2, 21.3, 14.3, 0.8; HRMS (CI+) m/z 
268.2215 [(M)+; calcd for C16H32OSi 268.2222]. 
 
Byproduct 2.23. IR (neat) 3343 (br), 3072, 2925, 2859, 1450, 1129, 1041, 996, 
912 cm-1; 1H NMR (500 MHz, CDCl3) δ 6.21 (ddd, J = 16.7, 10.2, 9.9 Hz, 1H), 5.11 (dd, 
J = 17.2, 2.3 Hz, 1H), 5.05 (dd, J = 10.2, 2.3 Hz, 1H), 3.45 – 3.38 (m, 1H), 2.48 – 2.41 (m, 
1H), 1.84 (d, J = 12.6 Hz, 1H), 1.77 (d, J = 13.1 Hz, 1H), 1.65 (d, J = 13.2 Hz, 1H), 1.63 – 
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δ 139.7, 115.8, 74.9, 46.7, 42.8, 34.0, 33.6, 28.0, 26.6, 22.9, 22.7, 21.4, 14.3; HRMS (CI+) 
m/z 196.1819 [(M)+; calcd for C13H24O 196.1827]. 
 
Adduct 2.24a. 
General procedures.  
Condition 1: To a solution of linchpin 2.19 (50 mg, 0.24 mmol) in freshly degassed 
THF (0.5 mL, three freeze-pump-thaw cycles) at -78 °C was added n-BuLi (200 µL, 2.4 
M, 0.48 mmol). After stirring for 30 min, the resulting solution was transferred to a 
suspension of CuBr×DMS (98 mg, 0.48 mmol) in freshly distilled HMPA/THF (1 mL, 1:1) 
via cannula at room temperature.  The resulting mixture was stirred at 60 oC for 45 min, 
followed by the addition of allyl bromide (41 uL, 0.48 mmol).  The resulting mixture was 
stirred for 2 h before addition of 1 N HCl (1 mL). After 10 minutes, the reaction mixture 
was diluted with H2O (5 mL) and extracted with Et2O (3×5 mL). The combined organic 
layers were washed with brine (15 mL), dried over anhydrous Na2SO4, filtered and 
concentrated. The resulting crude residue was purified by flash chromatography (1:20 
EtOAc /hexanes) to give compound 2.24a. 
Condition 2: To a solution of linchpin 2.19 (50 mg, 0.24 mmol) in freshly degassed 
THF (0.5 mL, three freeze-pump-thaw cycles) at -78 °C was added n-BuLi (110 µL, 0.26 
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CuBr×DMS (98 mg, 0.48 mmol) in freshly distilled HMPA (0.5 mL) via cannula at room 
temperature, followed by the addition of t-BuOK (240 uL, 1 M in THF).  The resulting 
mixture was stirred at 60 oC for 45 min, followed by the addition of allyl bromide (41 uL, 
0.48 mmol).  The resulting mixture was stirred for 2 h before addition of 1 N HCl (1 mL). 
After 10 minutes, the reaction mixture was diluted with H2O (5 mL) and extracted with 
Et2O (3×5 mL). The combined organic layers were washed with brine (15 mL), dried over 
anhydrous Na2SO4, filtered and concentrated. The resulting crude residue was purified by 
flash chromatography (1:20 EtOAc /hexanes) to give compound 2.24a. Colorless oil 
(condition a: 35 mg, 63%; condition b: 35 mg, 63%). IR (neat) 3365 (br), 3078, 2926, 2853, 
1640, 1450, 1383, 996, 911, 894 cm-1; 1H NMR (500 MHz, CDCl3) δ 5.86 – 5.74 (m, 1H), 
5.06 (t, J = 1.3 Hz, 1H), 5.05 – 5.02 (m, 1H), 4.94 (s, 1H), 4.93 (s, 1H), 3.72 – 3.67 (m, 
1H), 2.77 (qd, J = 15.5, 7.0 Hz, 2H), 2.28 – 2.23 (m, 1H), 1.92 – 1.84 (m, 1H), 1.79 – 1.67 
(m, 4H), 1.57 – 1.51 (m, 2H), 1.45 – 1.24 (m, 9H), 0.89 (t, J = 7.0 Hz, 3H); 13C NMR (125 
MHz, CDCl3) δ 151.1, 136.7, 116.5, 111.6, 73.0, 43.8, 42.3, 41.9, 36.0, 28.6, 28.4, 25.7, 
24.6, 24.4, 22.9, 14.2; HRMS (ES+) m/z 237.2228 [(M+H)+; calcd for C16H29O 237.2218]. 
 
Adduct 2.24b. Colorless oil (condition a: 32 mg, 54%; condition b: 40 mg, 67%). 
IR (neat) 3365 (br), 3075, 2927, 2855, 16335, 1450, 1384, 1011, 892, 668 cm-1; 1H NMR 
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1H), 2.73 (s, 2H), 2.27 – 2.20 (m, 1H), 1.92 – 1.86 (m, 1H), 1.81 – 1.75 (m, 1H), 1.68 (s, 
3H), 1.56 – 1.46 (m, 5H), 1.45 – 1.37 (m, 5H), 1.34 – 1.24 (m, 4H), 0.90 (t, J = 7.1 Hz, 
3H); 13C NMR (125 MHz, CDCl3) δ 149.8, 143.8, 112.9, 112.4, 73.0, 46.5, 43.0, 42.0, 
36.1, 28.7, 28.5, 25.7, 24.58, 24.55, 22.9, 22.0, 14.3; HRMS (CI+) m/z 233.2261 [(M-OH)+; 
calcd for C17H29 233.2269]. 
 
Adduct 2.24c. Colorless oil (condition a: 45 mg, 66%; condition b: 48 mg, 71%). 
IR (neat) 3366 (br), 3027, 2927, 2855, 1639, 1494, 1451, 895, 746, 700 cm-1; 1H NMR 
(500 MHz, CDCl3) δ 7.27 (dd, J = 8.2, 7.3 Hz, 2H), 7.21 (dd, J = 8.2, 7.3 Hz, 1H), 7.16 (d, 
J = 7.3 Hz, 2H), 5.01 (s, 1H), 4.87 (s, 1H), 3.76 – 3.64 (m, 1H), 3.37 (d, J = 15.0 Hz, 1H), 
3.30 (d, J = 15.0 Hz, 1H), 2.24 – 2.19 (m, 1H), 1.90 – 1.83 (m, 1H), 1.81 – 1.74 (m, 1H), 
1.70 – 1.66 (m, 2H), 1.55 – 1.46 (m, 3H), 1.40 – 1.23 (m, 9H), 0.89 (t, J = 7.0 Hz, 3H); 13C 
NMR (125 MHz, CDCl3) δ 151.9, 139.8, 129.3, 128.4, 126.3, 112.9, 73.0, 44.2, 43.1, 42.5, 
36.0, 28.8, 28.5, 25.6, 24.6, 24.3, 22.8, 14.3; HRMS (ES+) m/z 287.2368 [(M+H)+; calcd 
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Adduct 2.24d. Colorless oil (condition b: 33 mg, 65%). IR(neat) 3371 (br), 2929, 
2856, 1643, 1451, 1375, 1248, 1047, 1009, 888 cm-1; 1H NMR (500 MHz, CDCl3) δ 4.86 
(s, 1H), 4.82 (s, 1H), 3.77 – 3.60 (m, 1H), 2.22 (dt, J = 8.4, 4.6 Hz, 1H), 1.91 – 1.80 (m, 
1H), 1.77 (s, 3H), 1.75 – 1.63 (m, 4H), 1.60 – 1.52 (m, 2H), 1.47 – 1.36 (m, 6H), 1.35 – 
1.24 (m, 3H), 0.89 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 149.0, 111.4, 73.1, 
45.5, 42.6, 35.9, 28.7, 28.5, 25.6, 24.7, 24.48, 24.47, 22.9, 14.3; HRMS (ES+) m/z 211.2065 
[(M+H)+; calcd for C14H27O 211.2062]. 
 
Adduct 2.24e. Three equivalents of diphenyl disulfide were added for optimal 
yield. Pale-yellow oil. (condition a: 32 mg, 45%; condition b: 38 mg, 53%). IR (neat) 3408 
(br), 2928, 2856, 1709, 1583, 1447, 1378, 1082, 1022, 908, 747, 691 cm-1; 1H NMR (500 
MHz, CDCl3) δ 7.44 (d, J = 7.2 Hz, 2H), 7.38 – 7.31 (m, 3H), 5.25 (s, 1H), 4.81 (s, 1H), 
3.85 – 3.78 (m, 1H), 2.49 – 2.44 (m, 1H), 2.00 – 1.93 (m, 1H), 1.90 – 1.81 (m, 2H), 1.77 – 
1.70 (m, 2H), 1.63 – 1.59 (m, 1H), 1.48 – 1.32 (m, 9H), 0.93 (t, J = 7.0 Hz, 3H); 13C NMR 
(125 MHz, CDCl3) δ 150.1, 134.3, 132.9, 129.4, 128.4, 111.6, 73.0, 45.2, 42.7, 36.2, 29.4, 











Condition 1: To a solution of linchpin 2.19 (50 mg, 0.24 mmol) in freshly degassed 
THF (0.5 mL, three freeze-pump-thaw cycles) at -78 °C was added n-BuLi (200 µL, 2.4 
M, 0.48 mmol). After stirring for 30 min, the resulting solution was transferred to a 
suspension of CuBr×DMS (98 mg, 0.48 mmol) in freshly distilled HMPA/THF (1 mL, 1:1) 
via cannula at room temperature.  The resulting mixture was stirred at 60 oC for 45 min 
before the addition of a pre-mixed solution of iodobenzene (98 mg, 0.48 mmol) and 
Pd(PPh3)4 (14 mg, 12 µmol) in THF (0.5 mL).  The resulting mixture was stirred overnight, 
followed by the addition of 1 N HCl (1 mL). After 10 minutes, the reaction mixture was 
diluted with H2O (5 mL) and extracted with Et2O (3×5 mL). The combined organic layers 
were washed with brine (15 mL), dried over anhydrous Na2SO4, filtered and concentrated. 
The resulting crude residue was purified by flash chromatography (1:20 EtOAc /hexanes) 
to give compound 2.25b.   
Condition 1: To a solution of linchpin 2.19 (50 mg, 0.24 mmol) in freshly degassed 
THF (0.5 mL, three freeze-pump-thaw cycles) at -78 °C was added n-BuLi (110 µL, 0.26 
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CuBr×DMS (98 mg, 0.48 mmol) in freshly distilled HMPA (0.5 mL) via cannula at room 
temperature, followed by the addition of t-BuOK (240 uL, 1 M in THF).  The resulting 
mixture was stirred at 60 oC for 45 min before the addition of a pre-mixed solution of 
iodobenzene (98 mg, 0.48 mmol) and Pd(PPh3)4 (14 mg, 12 µmol) in THF (0.5 mL).  The 
resulting mixture was stirred overnight before the addition of 1 N HCl (1 mL). After 10 
minutes, the reaction mixture was diluted with H2O (5 mL) and extracted with Et2O (3×5 
mL). The combined organic layers were washed with brine (15 mL), dried over anhydrous 
Na2SO4, filtered and concentrated. The resulting crude residue was purified by flash 
chromatography (1:20 EtOAc/hexanes) to give compound 2.25b. Pale-yellow oil 
(condition a: 40 mg, 61%; condition b: 38 mg, 57%). IR (neat) 3364 (br), 3078, 2928, 2856, 
1640, 1450, 1383, 996, 912, 894, 745 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.36 – 7.28 (m, 
4H), 7.26 – 7.21 (m, 1H), 5.30 (s, 1H), 5.18 (s, 1H), 3.77 – 3.72 (m, 1H), 2.93 – 2.83 (m, 
1H), 1.94 – 1.80 (m, 3H), 1.76 – 1.65 (m, 2H), 1.60 – 1.56 (m, 1H), 1.50 – 1.43 (m, 2H), 
1.35 – 1.28 (m, 2H), 1.25 – 1.14 (m, 4H), 1.11 – 1.04 (m, 1H), 0.80 (t, J = 6.9 Hz, 3H); 13C 
NMR (125 MHz, CDCl3) δ 152.5, 143.2, 128.4, 127.4, 126.8, 113.4, 72.7, 43.4, 41.2, 36.1, 
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Adduct 2.25a. Following the general procedure, the reaction mixture is treated with 
1N HCl to hydrolyze TMS silyl ether. Unfortunately, compound 2.25a has very close 
polarity to impurities. To simplify purification, before addition of 1N HCl, the reaction 
mixture was quenched with a saturated aqueous solution of NaHCO3 (5 mL), filtered 
through Celite, rinsed and extracted with hexanes (3×5 mL). The combined organic layers 
were washed with brine (15 mL), dried over anhydrous Na2SO4, filtered and concentrated. 
The resulting crude residue was purified by flash chromatography (hexanes to 1:40 EtOAc 
/hexanes, buffered with 1% Et3N) to give TMS protected product, which was submitted 
into 1N HCl/THF (2 mL, 1:1).  After 10 minutes, the reaction mixture was diluted with 
Et2O (5 mL) and extracted with Et2O (3×5 mL). The combined organic layers were washed 
with brine (15 mL), dried over anhydrous Na2SO4, filtered and concentrated to give the 
clean adduct 2.25 a. Pale-yellow oil (condition a: 35 mg, 49%; condition b: 38 mg, 53%). 
IR (neat) 3433 (br), 2928, 2857, 2228, 1604, 1502, 1451, 1402, 1014, 907, 847, 745 cm-1; 
1H NMR (500 MHz, CDCl3) δ 7.61 (d, J = 8.2 Hz, 2H), 7.43 (d, J = 8.0 Hz, 2H), 5.38 (s, 
1H), 5.31 (s, 1H), 3.74 – 3.62 (m, 1H), 2.94 – 2.83 (m, 1H), 1.92 – 1.80 (m, 3H), 1.74 – 
1.64 (m, 2H), 1.54 – 1.42 (m, 4H), 1.31 – 1.24 (m, 2H), 1.22 – 1.13 (m, 4H), 1.08 – 1.01 
(m, 1H), 0.80 (t, J = 6.8 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 151.0, 147.8, 132.3, 
127.5, 119.0, 116.0, 111.0, 72.5, 43.3, 41.0, 36.2, 28.2, 28.1, 26.0, 25.2, 24.0, 22.6, 14.1; 
HRMS (ES-) m/z 296.2017 [(M-H)-; calcd for C20H26NO 296.2014]. 
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Adduct 2.25c. Pale-yellow oil (37 mg, 54%; 40 mg, 59%). IR (neat) 3482 (br), 
2929, 2857, 1622, 1511, 1451, 1079, 1017, 895, 823, 730 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 7.23 (d, J = 7.9 Hz, 2H), 7.12 (d, J = 7.8 Hz, 2H), 5.27 (s, 1H), 5.13 (s, 1H), 3.78 
– 3.69 (m, 1H), 2.96 – 2.83 (m, 1H), 2.34 (s, 3H), 1.96 – 1.76 (m, 3H), 1.76 – 1.65 (m, 2H), 
1.61 – 1.42 (m, 4H), 1.36 – 1.26 (m, 2H), 1.20 (dd, J = 11.2, 5.2 Hz, 4H), 1.12 – 1.03 (m, 
1H), 0.80 (t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 152.4, 140.2, 137.1, 129.1, 
126.6, 112.7, 72.7, 43.4, 41.2, 36.1, 28.32, 28.28, 26.1, 25.3, 24.2, 22.7, 21.2, 14.2; HRMS 
(ES+) m/z 287.2371 [(M+H)+; calcd for C20H31O 287.2375]. 
 
 
Adduct 2.25d. Pale-yellow oil (condition a: 40 mg, 55%; condition b: 45 mg, 62%). 
Adduct 2.25e. Pale-yellow oil (condition b: 40 mg, 55%). 
IR (neat) 3421 (br), 2928, 2855, 1608, 1510, 1463, 1246, 1178, 1036,893, 835, 741 cm-1; 
1H NMR (500 MHz, CDCl3) δ 7.28 (d, J = 8.8 Hz, 2H), 6.85 (d, J = 8.8 Hz, 2H), 5.24 (s, 
1H), 5.10 (s, 1H), 3.81 (s, 3H), 3.74 – 3.68 (m, 1H), 2.89 – 2.83 (m, 1H), 1.94 – 1.89 (m, 
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1.24 – 1.05 (m, 5H), 0.81 (t, J = 6.9 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 159.1, 151.9, 
135.5, 127.8, 113.8, 112.1, 72.6, 55.4, 43.5, 41.1, 36.1, 28.3, 28.3, 26.1, 25.4, 24.2, 22.7, 
14.2; HRMS (ES+) m/z 303.2324[(M+H)+; calcd for C20H31O2 303.2324].  
 
Adduct 2.25f. Three equivalents of vinyl bromide were added for optimal yield. 
Pale-yellow oil (condition b: 36 mg, 68%). IR (neat) 3359 (br), 3087, 2929, 2856, 1804, 
1593, 1450, 990, 896 cm-1; 1H NMR (500 MHz, CDCl3) δ 6.29 (dd, J = 17.6, 10.9 Hz, 1H), 
5.24 (d, J = 17.6 Hz, 1H), 5.17 (s, 1H), 5.12 (s, 1H), 5.03 (d, J = 10.9 Hz, 1H), 3.69 – 3.55 
(m, 1H), 2.76 – 2.61 (m, 1H), 1.90 – 1.77 (m, 2H), 1.77 – 1.62 (m, 4H), 1.56 – 1.46 (m, 
1H), 1.44 – 1.21 (m, 9H), 0.87 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 149.0, 
140.1, 116.2, 112.9, 72.8, 42.4, 39.1, 36.1, 28.8, 28.2, 26.0, 24.6, 24.5, 22.8, 14.2; HRMS 
(CI+) m/z 222.1982 [M+; calcd for C15H26O 222.1984]. 
 
Adduct 2.25g. Pale-yellow oil (condition a: 32 mg, 55%; condition b: 30 mg, 51%). 
IR (neat) 3366 (br), 2926, 2853, 1622, 1511, 1449, 1384, 1089, 1065, 1040, 928, 895, 824 
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.24 (d, J = 7.9 Hz , 2H), 7.12 (d, J = 7.9 Hz, 2H), 
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1.88 (m, 1H), 1.85 - 1.77 (m, 2H), 1.77 – 1.65 (m, 2H), 1.61 – 1.53 (m, 3H), 1.50 - 1.39 
(m, 2H), 1.08 (d, J = 6.3 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 152.1, 140.3, 137.1, 
129.1, 126.6, 112.9, 68.7, 43.7, 43.0, 28.3, 26.1, 24.9, 24.1, 23.0, 21.2; HRMS (ES+) m/z 
245.1905[(M+H)+; calcd for C17H25O 245.1905]. 
 
Adduct 2.25h. Pale-yellow oil (condition a: 46 mg, 63%; condition b: 38 mg, 52%). 
IR (neat) 3432 (br), 3027, 2927, 2853, 1623, 1511, 1450, 1384, 1019, 897, 826, 762, 732, 
702 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.25 – 7.20 (m, 3H), 7.13 – 7.04 (m, 4H), 6.99 (d, 
J = 7.9 Hz, 2H), 5.30 (s, 1H), 5.25 (s, 1H), 4.99 – 4.94 (m, 1H), 2.74 – 2.67 (m, 1H), 2.33 
(s, 3H), 1.94 – 1.76 (m, 5H), 1.66 (d, J = 2.0 Hz, 1H), 1.63 - 1.56 (m, 2H), 1.47 – 1.39 (m, 
2H); 13C NMR (125 MHz, CDCl3) δ 151.8, 144.9, 140.5, 137.0, 129.0, 128.2, 127.1, 126.8, 
126.5, 113.4, 75.6, 44.0, 42.7, 28.5, 25.4, 24.7, 24.4, 21.2; HRMS (ES+) m/z 307.2066 
[(M+H)+; calcd for C22H27O 307.2062]. 
 
Derivative 2.26. To the three-component adduct 2.25h (33 mg, 0.11 mmol) in 
pyridine (0.4 mL) was added 4-nitrobenzoyl chloride (23 mg, 0.12 mmol). The reaction 
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The reaction mixture was extracted with hexanes (3×3 mL), washed with 1N HCl (2×3 
mL), and brine (6 mL). The organic layers were dried over anhydrous Na2SO4, filtered and 
concentrated. The resulting crude residue was purified by flash chromatography (1:20 
EtOAc/hexanes) to give compound 2.26. Colorless crystal (45 mg, 91%, m.p. 113-114 oC). 
IR (neat) 2925, 1726, 1528, 1345, 1272, 1100, 826, 719 cm-1; 1H NMR (500 MHz, CDCl3) 
δ 8.32 (d, J = 8.9 Hz, 2H), 8.25 (d, J = 8.9 Hz, 2H), 7.26 – 7.21 (m, 3H), 7.14 – 7.06 (m, 
4H), 7.00 (d, J = 7.8 Hz, 2H), 6.28 (d, J = 6.8 Hz, 1H), 5.30 (s, 1H), 5.14 (s, 1H), 2.80 – 
2.73 (m, 1H), 2.35 (s, 3H), 2.31 – 2.26 (m, 1H), 1.94 – 1.80 (m, 3H), 1.73 – 1.65 (m, 1H), 
1.64 – 1.56 (m, 3H), 1.51 – 1.45 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 164.0, 150.7, 
150.5, 140.1, 140.0, 137.2, 136.0, 130.8, 129.1, 128.5, 127.9, 126.8, 126.83, 123.81, 114.0, 
79.2, 42.7, 41.8, 28.1, 25.7, 24.4, 24.0, 21.2; HRMS (ES+) m/z 456.2178 [(M+H)+; calcd 
for C29H30NO4 456.2175]. 
 
Alcohol 2.S2. To a solution of trans-TMS linchpin 2.20 (30 mg, 0.14 mmol) in 
THF (0.4 mL) at – 78 oC was added PhLi (94 µL, 0.16 mmol, 1.7 M in dibutyl ether) 
dropwise. After 30 min, the reaction mixture was quenched with H2O (2 mL), diluted with 
Et2O (2 mL) and extract with Et2O (3×3 mL). The organic layers were dried over anhydrous 
Na2SO4, filtered and concentrated. The resulting crude residue was purified by flash 
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85%). IR (neat) 3417 (br), 2927, 2852, 1450, 1248, 1018, 924, 836, 758, 701 cm-1; 1H 
NMR (500 MHz, C6D6) δ 7.30 (d, J = 7.3 Hz, 2H), 7.24 – 7.20 (m, 2H), 7.14 – 7.08 (m, 
1H), 5.76 (d, J = 2.6 Hz, 1H), 5.59 (d, J = 2.6 Hz, 1H), 4.88 (d, J = 4.4 Hz, 1H), 2.48 (td, 
J = 11.3, 3.5 Hz, 1H), 1.84 – 1.76 (m, 1H), 1.76 – 1.66 (m, 1H), 1.64 – 1.57 (m, 2H), 1.52 
– 1.45 (m, 1H), 1.45 - 1.37 (m, 1H), 1.22 – 1.12 (m, 2H), 1.08 – 1.02 (m, 1H), 1.00 – 0.94 
(m, 1H), 0.19 (s, 9H); 13C NMR (125 MHz, C6D6) δ 156.9, 145.5, 128.2, 126.7, 125.9, 
124.3, 72.6, 48.7, 36.5, 27.2, 26.6, 23.5, -0.8; HRMS (ES+) m/z 311.1805 [(M+Na)+; calcd 
for C18H28OSiNa 311.1807]. 
 
Derivative 2.27. Following the procedure for 2.26, derivative 2.27 was prepared 
from S2 (19 mg, 0.066 mmol) and isolated as a white solid. Colorless crystal (29 mg, near 
quant., m.p. 93-94 oC). IR (neat) 2930, 2856, 1730, 1607, 1529, 1347, 1280, 1101, 840, 
720, 700 cm-1; 1H NMR (500 MHz, CDCl3) δ 8.34 (d, J = 8.8 Hz, 2H), 8.27 (d, J = 8.8 Hz, 
2H), 7.31 (t, J = 7.7 Hz, 2H), 7.23 (d, J = 8.0 Hz, 1H), 7.17 (d, J = 8.0 Hz, 2H), 6.13 (s, 
1H), 5.73 (s, 1H), 5.60 (s, 1H), 2.31 (td, J = 11.4, 3.4 Hz, 1H), 1.96 (t,  J = 11.2 Hz, 1H), 
1.86 – 1.71 (m, 4H), 1.56 – 1.47 (m, 1H), 1.36 – 1.24 (m, 1H), 1.22 - 1.09 (m, 2H), 0.05 
(s, 9H); 13C NMR (125 MHz, CDCl3) δ 163.8, 155.5, 150.7, 140.3, 136.1, 130.8, 128.4, 
127.3, 125.3, 123.9, 77.4, 46.9, 36.2, 26.9, 26.4, 24.9, -0.8; HRMS (ES+) m/z 460.1917 
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(1-Bromovinyl)(tert-butyl)dimethylsilane (2.29). To neat tert-
butyldimethyl(vinyl)silane (6.73 mL, 35 mmol) was added dropwise liquid Br2 (2.1 mL, 
41 mmol) at -78 °C. After addition, the mixture was warmed to room temperature and 
stirred for 2 h. The flask was then fitted with a water-cooled condenser, and Et2NH (19.9 
mL, 193 mmol) was cautiously added with continued stirring. After the addition was 
completed, the reaction mixture was heated at reflux for 12 hours, during which time a 
precipitate of diethylamine hydrochloride formed. The salts were separated from the cooled 
suspension by filtration and washed with Et2O (3×30 mL). The ether filtrate was carefully 
washed, first with 10 mL portions of 10% hydrochloric acid until the aqueous layer remains 
acidic (pH ca. 2), then with water (30 mL) and brine (30 mL). The ether solution was dried 
with anhydrous Na2SO4, concentrated, and purified by flash chromatography (hexanes) to 
give compound 2.29. Colorless oil (5.35g, 69%). IR (neat) 2930, 2858, 1469, 1252, 913, 
827, 776 cm-1; 1H NMR (500 MHz, CDCl3) δ 6.39 (d, J = 1.8 Hz, 1H), 6.21 (d, J = 1.8 Hz, 
1H), 0.96 (s, 9H), 0.18 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 136.1, 131.7, 26.9, 17.1, -
5.7; HRMS (CI+) m/z 220.0273 [(M)+; calcd for C8H17BrSi 220.0283]. 
 
Trans-TBS linchpin 2.31: To a vigorously stirred mixture of magnesium turnings 
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butyldimethylsilane (1.5 g, 6.8 mmol) in THF (1.3 mL). After the reaction initiation (iodine 
crystals were added), another 1.3 mL THF was added followed by the addition of the 
remaining (1-Bromovinyl)trimethylsilane solution. The reaction mixture was heated to 
reflux and kept for another hour. After cooling to room temperature, freshly prepared 
Grignard reagent was diluted with 1.3 mL THF and slowly cannulated into a suspension of 
CuBr×DMS (467 mg, 2.3 mmol) in THF (2.8 mL) and dimethyl sulfide (2.8 mL), followed 
by the addition of HMPA (2.4 mL, 13.8 mmol) at –78 oC. Then to this mixture was added 
dropwise a THF (3 mL) solution of cyclohex-1-ene-1-carbaldehyde (485 mg, 4.4 mmol) 
and TMSCl (1.1 mL, 8.7 mmol) via syringe pump over 30 minutes. After another hour, the 
reaction mixture was warmed up to room temperature and quenched with 1 N HCl (10 mL) 
and extracted with Et2O (3×20 mL).  The combined organic layer was washed with brine, 
dried over anhydrous Na2SO4 and concentrated. The crude residue was then dissolved in 
MeOH (30 mL) and 1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU) (1 mL, 6.7 mmol) was 
added. After stirring for 1 hour, the reaction mixture was directly concentrated and purified 
by column chromatography with silica gel (hexanes to 2:1 CH2Cl2/hexanes) to afford 
compound 2.31 as colorless oil (800 mg, 72 %) over two steps. IR (neat) 2929, 2856, 2705, 
1725, 1250, 824, 768 cm-1; 1H NMR (500 MHz, CDCl3) δ 9.51 (d, J = 3.5 Hz, 1H), 5.80 
(dd, J = 1.8, 0.9 Hz, 1H), 5.51 (d, J = 1.7 Hz, 1H), 2.50 (tt, J = 11.4, 3.4 Hz, 1H), 2.26 (td, 
J = 11.4, 3.2 Hz,  1H), 1.94 – 1.72 (m, 4H), 1.48 – 1.20 (m, 3H), 1.14 – 0.98 (m, 1H), 0.87 
(s, 9H), 0.07 (s, 3H), 0.05 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 205.3, 152.6, 127.3, 
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55.1, 43.4, 34.8, 27.1, 26.9, 26.5, 25.0, 17.3, -5.4, -5.5; HRMS (ES+) m/z 253.1983 
[(M+H)+; calcd for C15H29OSi 253.1988]. 
 
Adduct 2.32. To a solution of linchpin 2.31 (50 mg, 0.20 mmol) in freshly degassed 
Et2O (0.5 mL, degassed by three freeze-pump-thaw cycles) at -78 °C was added n-BuLi 
(86 µL, 0.22 mmol, 2.5 M in hexanes). After stirring for 30 min, the resulting solution was 
transferred to a suspension of CuBr×DMS (82 mg, 0.40 mmol) and t-BuOK (23 mg, 0.20 
mmol) in freshly distilled HMPA (1 mL) in a microwave vial (2 - 5 mL) via cannula at 
room temperature. The reaction mixture was purged under a positive pressure of N2 and 
then on high vacuum to remove Et2O. After the vial was refilled with N2, the resulting 
mixture was microwaved (Biotage: “high” level of absorption setting) at 100 oC for 5 min, 
followed by the addition of benzyl bromide (48 uL, 0.40 mmol). The resulting reaction 
mixture was stirred for 2 h at room temperature.  then quenched with a saturated aqueous 
solution of NH4Cl (3 mL) and extracted with Et2O (3×5 mL).  The combined organic layers 
were washed with brine (15 mL), dried over anhydrous Na2SO4, filtered and concentrated. 
The resulting crude residue was purified by flash chromatography (hexanes) to give 
compound 2.32 as a colorless oil 38 mg in 48% yield. IR (neat) 3074, 2929, 2855, 1462, 
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7.22 – 7.18 (m, 1H), 7.16 (d, J = 7.3 Hz, 2H), 4.85 (s, 1H), 4.42 (s, 1H), 3.79 (dd, J = 9.4, 
5.0 Hz, 1H), 3.30 (d, J = 16.4 Hz, 1H),  3.22 (d, J = 16.4 Hz, 1H), 2.20 (t, J = 11.4 Hz, 1H), 
1.78 – 1.72 (m, 1H), 1.70 – 1.64 (m, 3H), 1.52 – 1.40 (m, 3H), 1.34 – 1.26 (m, 4H), 1.22 – 
1.11 (m, 4H), 0.93 - 0.97 (m, 3H), 0.90 (s,  9H), 0.04 (s, 6H); 13C NMR (125 MHz, CDCl3) 
δ 153.4, 140.1, 129.8, 128.3, 126.0, 112.3, 72.3, 47.7, 42.9, 40.2, 35.3, 34.4, 28.5, 26.8, 
26.5, 26.3, 23.8, 23.2, 18.5, 14.3, -3.0, -4.2; HRMS (CI+) m/z 401.3252 [(M+H)+; calcd for 
C26H45OSi 401.3240]. 
 
Adduct 2.33. To a solution of linchpin 2.27 (50 mg, 0.20 mmol) in freshly degassed 
Et2O (0.5 mL, degassed by three freeze-pump-thaw cycles) at -78 °C was added n-BuLi 
(86 µL, 0.22 mmol, 2.5 M in hexanes). After stirring for 30 min, the resulting solution was 
transferred to a suspension of CuBr×DMS (82 mg, 0.40 mmol) and t-BuOK (23 mg, 0.20 
mmol) in freshly distilled HMPA (1 mL) in a microwave vial (2 - 5 mL) via cannula at 
room temperature. The reaction mixture was purged under a positive pressure of N2 and 
then on high vacuum to remove Et2O.  After the vial was refilled with N2, the resulting 
mixture was microwaved (Biotage: “high” level of absorption setting) at 100 oC for 5 min.  
A pre-mixed solution of Pd(PPh3)4 (12 mg, 10 µmol) and 4-iodobenzonitrile (92 mg, 0.40 
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temperature overnight before addition of a saturated aqueous solution of NH4Cl (3 mL).  
The mixture was extracted with Et2O (3×5 mL) and the combined organic layers were 
washed with brine (15 mL), dried over anhydrous Na2SO4, filtered and concentrated. The 
resulting crude residue was purified by flash chromatography (1:25 EtOAc/hexanes) to 
give compound 2.33 as a colorless oil 50 mg in 61% yield. IR (neat) 2930, 2855, 2228, 
1605, 1462, 1252, 1085, 856, 773 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.59 (d, J = 8.2 Hz, 
2H), 7.47 (d, J = 8.6 Hz, 2H), 5.41 (s, 1H), 5.16 (s, 1H), 3.73 (dd, J = 9.6, 4.7 Hz, 1H), 
2.56 – 2.44 (m, 1H), 1.99 (d, J = 11.3 Hz, 1H), 1.85 - 1.77 (m, 1H), 1.76 - 1.65 (m, 2H), 
1.56 – 1.46 (m, 2H), 1.37 – 1.31 (m, 1H), 1.30 - 1.19 (m, 5H), 1.18 – 1.08 (m, 1H), 1.07- 
0.96 (m, 1H), 0.89 – 0.85 (m, 4H), 0.77 (s, 9H), -0.09 (s, 3H), -0.37 (s, 3H); 13C NMR (125 
MHz, CDCl3) δ 152.8, 148.3, 132.2, 127.3, 119.2, 115.2, 110.7, 72.0, 44.8, 44.4, 37.1, 35.0, 
28.2, 26.9, 26.3, 26.1, 23.9, 23.0, 18.3, 14.2, -3.1, -4.8; HRMS (ES+) m/z 
412.3025[(M+H)+; calcd for C26H42NOSi 412.3036]. 
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E2.3 Data for Single Crystal X-ray Structures 
E2.3.1 X-ray Structure Determination of Compound 2.26  
                                                                      
 Compound 2.26, C29H29NO4, crystallizes in the triclinic space group P1
_
 with a=9.4816(6)Å, 
b=10.0759(6)Å, c=13.0176(8)Å, α=83.550(3)°, β=89.861(3)°, γ=84.338(3)°, V=1229.70(13)Å3, 
Z=2, and dcalc=1.230 g/cm3 . X-ray intensity data were collected on a Bruker APEXII [1] CCD area 
detector employing graphite-monochromated Mo-Kα radiation (λ=0.71073Å) at a temperature of 
100K. Preliminary indexing was performed from a series of thirty-six 0.5° rotation frames with 
exposures of 10 seconds. A total of 3702 frames were collected with a crystal to detector distance 
of 37.6 mm, rotation widths of 0.5° and exposures of 15 seconds: 
scan type 2θ ω φ χ Frames 
f -15.50 258.48 -351.72 19.46 739 
w -15.50 -82.24 18.69 41.79 142 
f -23.00 -25.79 -280.64 73.66 658 
f -23.00 315.83 -339.66 28.88 720 
f 19.50 59.55 -5.19 -26.26 721 
f -18.00 -6.31 -48.02 -86.54 722 
 
Rotation frames were integrated using SAINT [2], producing a listing of unaveraged F2 and σ(F2) 
values. A total of 40564 reflections were measured over the ranges 3.148 ≤ 2θ ≤ 51.002°, -11 ≤ h 
≤ 11, -12 ≤ k ≤ 12, -15 ≤ l ≤ 15 yielding 4518 unique reflections (Rint = 0.0561). The intensity data 
were corrected for Lorentz and polarization effects and for absorption using SADABS [3] (minimum 
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SHELXS-97 [4]. Refinement was by full-matrix least squares based on F2 using SHELXL-2014 [5]. 
All reflections were used during refinement. The weighting scheme used was w=1/[σ2(Fo2 )+ 
(0.0341P)2 + 1.7278P] where P = (Fo2 + 2Fc2)/3. Non-hydrogen atoms were refined anisotropically 
and hydrogen atoms were refined using a riding model. Refinement converged to R1=0.0581 and 
wR2=0.1409 for 3648 observed reflections for which F > 4σ(F) and R1=0.0711 and wR2=0.1474 
and GOF =1.135 for all 4518 unique, non-zero reflections and 308 variables. The maximum Δ/σ in 
the final cycle of least squares was 0.000 and the two most prominent peaks in the final difference 
Fourier were +0.59 and -0.30 e/Å3.  
 Table E2.1 lists cell information, data collection parameters, and refinement data. Final 
positional and equivalent isotropic thermal parameters are given in Tables E2.2 and E2.3 
Anisotropic thermal parameters are in Table E2.4 Tables E2.5 and E2.6 list bond distances and 
bond angles. Figure E2.1 is an ORTEP representation of the molecule with 50% probability thermal 
ellipsoids displayed.  
 
Figure E2.1 ORTEP Drawing of Compound 2.26 with 50% Thermal Ellipsoids 
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Table E2.1 Summary of Structure Determination of Compound 2.26 
Empirical formula  C29H29NO4  
Formula weight  455.53  
Temperature/K  100  
Crystal system  triclinic  
Space group  P1
_
  
a  9.4816(6)Å  
b  10.0759(6)Å  
c  13.0176(8)Å  
α  83.550(3)°  
β  89.861(3)°  
γ  84.338(3)°  
Volume  1229.70(13)Å3  
Z  2  
dcalc  1.230 g/cm3  
μ  0.082 mm-1  
F(000)  484.0  
Crystal size, mm  0.28 × 0.26 × 0.03  
2θ range for data collection      3.148 - 51.002°  
Index ranges  -11 ≤ h ≤ 11, -12 ≤ k ≤ 12, -15 ≤ l ≤ 15  
Reflections collected  40564  
Independent reflections  4518[R(int) = 0.0561]  
Data/restraints/parameters  4518/0/308  
Goodness-of-fit on F2  1.135  
Final R indexes [I>=2σ (I)]  R1 = 0.0581, wR2 = 0.1409  
Final R indexes [all data]  R1 = 0.0711, wR2 = 0.1474  
Largest diff. peak/hole  0.59/-0.30 eÅ-3  
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Table E2.2 Refined Positional Parameters for Compound 2.26 
Atom x y z U(eq) 
O1 0.82864(18) 0.74078(16) 0.18570(13) 0.0260(4) 
O2 1.0591(2) 0.76740(19) 0.15338(15) 0.0357(5) 
O3 1.2406(2) 0.2347(2) 0.52528(16) 0.0448(5) 
O4 1.0256(3) 0.1805(2) 0.52527(18) 0.0526(6) 
N1 1.1176(3) 0.2509(2) 0.49450(19) 0.0371(6) 
C1 0.6365(3) 0.8297(2) 0.0638(2) 0.0264(6) 
C2 0.6255(3) 0.6992(2) 0.0110(2) 0.0268(6) 
C3 0.6175(3) 0.5760(2) 0.0904(2) 0.0287(6) 
C4 0.4945(3) 0.5970(3) 0.1644(2) 0.0342(6) 
C5 0.5058(3) 0.7218(3) 0.2206(2) 0.0317(6) 
C6 0.5179(3) 0.8465(3) 0.1429(2) 0.0299(6) 
C7 0.7862(3) 0.8462(2) 0.1017(2) 0.0258(5) 
C8 0.7959(3) 0.9836(2) 0.1358(2) 0.0257(5) 
C9 0.7923(3) 1.0081(3) 0.2390(2) 0.0282(6) 
C10 0.7944(3) 1.1387(3) 0.2645(2) 0.0311(6) 
C11 0.7971(3) 1.2444(3) 0.1878(2) 0.0316(6) 
C12 0.8023(3) 1.2214(2) 0.0847(2) 0.0307(6) 
C13 0.8034(3) 1.0913(3) 0.0589(2) 0.0282(6) 
C14 0.9699(3) 0.7102(2) 0.1998(2) 0.0267(6) 
C15 1.0025(3) 0.5903(2) 0.2790(2) 0.0264(6) 
C16 1.1445(3) 0.5434(3) 0.2946(2) 0.0321(6) 
C17 1.1832(3) 0.4306(3) 0.3643(2) 0.0338(6) 
C18 1.0773(3) 0.3677(3) 0.4169(2) 0.0313(6) 
C19 0.9349(3) 0.4118(3) 0.4027(2) 0.0317(6) 
C20 0.8987(3) 0.5243(3) 0.3329(2) 0.0288(6) 
C21 0.7383(3) 0.6860(2) -0.0707(2) 0.0266(6) 
C22 0.8513(3) 0.5963(3) -0.0598(2) 0.0310(6) 
C23 0.7210(3) 0.7865(3) -0.1645(2) 0.0268(6) 
C24 0.8295(3) 0.8649(3) -0.1973(2) 0.0324(6) 
C25 0.8141(3) 0.9565(3) -0.2852(2) 0.0358(6) 
C26 0.6909(3) 0.9721(3) -0.3442(2) 0.0319(6) 
C27 0.5831(3) 0.8942(3) -0.3118(2) 0.0316(6) 
C28 0.5963(3) 0.8033(3) -0.2235(2) 0.0291(6) 
C29 0.6736(3) 1.0714(3) -0.4405(2) 0.0404(7) 
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Table E2.3 Positional Parameters for Hydrogens in Compound 2.26 
Atom x y z U(eq) 
H1 0.615 0.9037 0.0089 0.035 
H2 0.5345 0.7123 -0.0262 0.036 
H3a 0.6057 0.4983 0.0547 0.038 
H3b 0.7056 0.5585 0.1295 0.038 
H4a 0.4941 0.5186 0.2149 0.045 
H4b 0.4058 0.6072 0.126 0.045 
H5a 0.4226 0.7364 0.263 0.042 
H5b 0.5884 0.7072 0.2657 0.042 
H6a 0.4284 0.869 0.106 0.04 
H6b 0.5341 0.9213 0.1807 0.04 
H7 0.8518 0.8356 0.0442 0.034 
H9 0.7884 0.9373 0.291 0.038 
H10 0.794 1.1545 0.3335 0.041 
H11 0.7955 1.3316 0.2052 0.042 
H12 0.805 1.2928 0.0331 0.041 
H13 0.8091 1.0756 -0.0101 0.038 
H16 1.214 0.5877 0.2583 0.043 
H17 1.2779 0.3984 0.3751 0.045 
H19 0.8656 0.3672 0.4389 0.042 
H20 0.8037 0.5559 0.3221 0.038 
H22a 0.9202 0.5959 -0.1107 0.041 
H22b 0.8614 0.5341 -0.0012 0.041 
H24 0.9137 0.8556 -0.1595 0.043 
H25 0.8876 1.0082 -0.305 0.048 
H27 0.4996 0.9032 -0.3505 0.042 
H28 0.5216 0.7531 -0.2032 0.039 
H29a 0.6941 1.0254 -0.5003 0.061 
H29b 0.7378 1.1389 -0.4372 0.061 
H29c 0.578 1.1131 -0.445 0.061 
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Table E2.4 Refined Thermal Parameters (U's) for Compound 2.26 
Atom U11 U22 U33 U23 U13 U12 
O1 0.0279(9) 0.0171(8) 0.0321(10) -0.0001(7) -0.0080(7) -0.0005(7) 
O2 0.030(1) 0.0333(11) 0.0421(11) 0.0055(9) -0.0040(9) -0.0045(9) 
O3 0.0491(13) 0.0368(12) 0.0446(12) -0.0022(9) -0.0166(10) 0.0131(10) 
O4 0.0600(15) 0.0364(12) 0.0570(15) 0.0131(11) -0.0091(12) -0.0032(11) 
N1 0.0478(16) 0.0246(12) 0.0372(14) -0.0036(10) -0.0074(12) 0.0045(11) 
C1 0.0315(14) 0.0152(12) 0.0316(14) -0.0008(10) -0.0074(11) -0.0004(10) 
C2 0.0286(13) 0.0182(12) 0.0333(14) -0.0033(10) -0.0109(11) -0.0012(10) 
C3 0.0313(14) 0.0175(12) 0.0377(15) -0.0051(11) -0.0092(11) -0.0024(10) 
C4 0.0356(15) 0.0258(14) 0.0413(16) -0.0012(12) -0.0069(12) -0.0068(12) 
C5 0.0303(14) 0.0289(14) 0.0365(15) -0.0059(12) -0.0019(11) -0.0038(11) 
C6 0.0297(14) 0.0237(13) 0.0364(15) -0.0068(11) -0.0079(11) 0.0008(11) 
C7 0.0309(14) 0.0181(12) 0.0272(13) 0.0006(10) -0.0063(10) 0.000(1) 
C8 0.0248(13) 0.0181(12) 0.0338(14) -0.0019(10) -0.0059(10) -0.0002(10) 
C9 0.0294(14) 0.0213(13) 0.0330(14) 0.0003(11) -0.0053(11) -0.0016(11) 
C10 0.0325(14) 0.0265(14) 0.0354(15) -0.0090(11) -0.0065(11) -0.0015(11) 
C11 0.0338(15) 0.0169(12) 0.0443(16) -0.0057(11) -0.0075(12) -0.0008(11) 
C12 0.0326(14) 0.0162(12) 0.0421(16) 0.0019(11) -0.0093(12) -0.0018(11) 
C13 0.0293(14) 0.0228(13) 0.0325(14) -0.0025(11) -0.0076(11) -0.0034(11) 
C14 0.0291(14) 0.0211(12) 0.0298(14) -0.0046(10) -0.0065(11) 0.0000(11) 
C15 0.0314(14) 0.0171(12) 0.0311(14) -0.0065(10) -0.0058(11) 0.0002(10) 
C16 0.0306(14) 0.0293(14) 0.0355(15) -0.0026(12) -0.0038(12) 0.0009(12) 
C17 0.0327(15) 0.0317(15) 0.0355(15) -0.0052(12) -0.0071(12) 0.0071(12) 
C18 0.0427(16) 0.0199(13) 0.0302(14) -0.0049(11) -0.0113(12) 0.0050(11) 
C19 0.0400(16) 0.0219(13) 0.0338(15) -0.0047(11) -0.0054(12) -0.0042(12) 
C20 0.0300(14) 0.0230(13) 0.0335(14) -0.0063(11) -0.0096(11) 0.0007(11) 
C21 0.0284(13) 0.0200(12) 0.0321(14) -0.0061(10) -0.0089(11) -0.0023(10) 
C22 0.0325(14) 0.0228(13) 0.0371(15) -0.0045(11) -0.0068(12) 0.0016(11) 
C23 0.0278(13) 0.0221(13) 0.0304(14) -0.0069(10) -0.0047(11) 0.0024(10) 
C24 0.0291(14) 0.0321(15) 0.0355(15) -0.0029(12) -0.0084(11) -0.0017(12) 
C25 0.0382(16) 0.0309(15) 0.0388(16) -0.0018(12) -0.0014(13) -0.0079(12) 
C26 0.0377(15) 0.0263(14) 0.0305(14) -0.0032(11) -0.0006(12) 0.0018(12) 
C27 0.0327(14) 0.0290(14) 0.0321(15) -0.0053(11) -0.0099(11) 0.0045(12) 
C28 0.0297(14) 0.0233(13) 0.0342(15) -0.0046(11) -0.0044(11) -0.0013(11) 
C29 0.0490(18) 0.0317(15) 0.0380(16) 0.0024(13) -0.0074(14) 0.0010(13) 
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Table E2.5 Bond Distances in Compound 2.26, Å 
O1-C7 1.464(3)   O1-C14 1.353(3)   O2-C14 1.195(3) 
O3-N1 1.224(3)   O4-N1 1.217(3)   N1-C18 1.483(3) 
C1-C2 1.563(3)   C1-C6 1.533(4)   C1-C7 1.534(3) 
C2-C3 1.532(3)   C2-C21 1.513(4)   C3-C4 1.524(4) 
C4-C5 1.537(4)   C5-C6 1.535(4)   C7-C8 1.512(3) 
C8-C9 1.392(4)   C8-C13 1.398(4)   C9-C10 1.395(4) 
C10-C11 1.378(4)   C11-C12 1.387(4)   C12-C13 1.388(4) 
C14-C15 1.506(3)   C15-C16 1.390(4)   C15-C20 1.387(4) 
C16-C17 1.392(4)   C17-C18 1.379(4)   C18-C19 1.385(4) 
C19-C20 1.387(4)   C21-C22 1.328(4)   C21-C23 1.495(4) 
C23-C24 1.395(4)   C23-C28 1.398(4)   C24-C25 1.385(4) 
C25-C26 1.386(4)   C26-C27 1.386(4)   C26-C29 1.512(4) 
C27-C28 1.386(4)           	
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Table E2.6 Bond Angles in Compound 2.26, ° 
C14-O1-C7 115.7(2)   O3-N1-C18 117.3(3)   O4-N1-O3 124.7(2) 
O4-N1-C18 118.0(2)   C6-C1-C2 110.3(2)   C6-C1-C7 115.8(2) 
C7-C1-C2 114.1(2)   C3-C2-C1 111.9(2)   C21-C2-C1 110.4(2) 
C21-C2-C3 115.8(2)   C4-C3-C2 111.4(2)   C3-C4-C5 111.4(2) 
C6-C5-C4 110.9(2)   C1-C6-C5 114.2(2)   O1-C7-C1 109.7(2) 
O1-C7-C8 110.8(2)   C8-C7-C1 111.8(2)   C9-C8-C7 123.2(2) 
C9-C8-C13 119.1(2)   C13-C8-C7 117.7(2)   C8-C9-C10 120.1(2) 
C11-C10-C9 120.2(3)   C10-C11-C12 120.3(2)   C11-C12-C13 119.8(2) 
C12-C13-C8 120.5(3)   O1-C14-C15 111.6(2)   O2-C14-O1 125.0(2) 
O2-C14-C15 123.4(2)   C16-C15-C14 116.8(2)   C20-C15-C14 123.3(2) 
C20-C15-C16 119.9(2)   C15-C16-C17 120.3(3)   C18-C17-C16 118.3(3) 
C17-C18-N1 118.7(2)   C17-C18-C19 122.7(2)   C19-C18-N1 118.5(3) 
C18-C19-C20 118.1(3)   C19-C20-C15 120.7(3)   C22-C21-C2 123.5(2) 
C22-C21-C23 120.4(2)   C23-C21-C2 116.0(2)   C24-C23-C21 121.3(2) 
C24-C23-C28 117.7(2)   C28-C23-C21 121.0(2)   C25-C24-C23 121.2(3) 
C24-C25-C26 121.1(3)   C25-C26-C27 117.9(3)   C25-C26-C29 121.3(3) 
C27-C26-C29 120.8(3)   C28-C27-C26 121.8(2)   C27-C28-C23 120.4(3) 
 
This report has been created with Olex2 [6], compiled on 2015.09.30 svn.r3233 for OlexSys.  
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E2.3.2 X-ray Structure Determination of Compound 2.27 
       
Compound 2.27, C25H31NO4Si, crystallizes in the monoclinic space group P21/c (systematic 
absences 0k0: k=odd and h0l: l=odd) with a=7.3090(5)Å, b=15.1112(11)Å, c=21.9523(16)Å, 
β=90.131(3)°, V=2424.6(3)Å3, Z=4, and dcalc=1.199 g/cm3 . X-ray intensity data were collected on 
a Bruker APEXII [1] CCD area detector employing graphite-monochromated Mo-Kα radiation 
(λ=0.71073Å) at a temperature of 100K. Preliminary indexing was performed from a series of thirty-
six 0.5° rotation frames with exposures of 10 seconds. A total of 3872 frames were collected with 
a crystal to detector distance of 37.5 mm, rotation widths of 0.5° and exposures of 10 seconds: 
 
scan type 2θ ω φ χ Frames 
f -23.00 315.83 12.48 28.88 727 
f -23.00 334.21 38.95 73.66 739 
f -15.50 258.48 8.28 19.46 739 
f 19.50 59.55 348.71 -26.26 739 
f -23.00 123.37 310.10 -94.51 708 
f -18.00 124.02 293.36 -95.28 220 
 
Rotation frames were integrated using SAINT [2], producing a listing of unaveraged F2 and σ(F2) 
values. A total of 72039 reflections were measured over the ranges 3.272 ≤ 2θ ≤ 50.74°, -8 ≤ h ≤ 
8, -18 ≤ k ≤ 18, -26 ≤ l ≤ 24 yielding 4450 unique reflections (Rint = 0.0187). The intensity data were 
corrected for Lorentz and polarization effects and for absorption using SADABS [3] (minimum and 
maximum transmission 0.7262, 0.7452). The structure was solved by direct methods - SHELXS-
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reflections were used during refinement. The weighting scheme used was w=1/[σ2(Fo2 )+ 
(0.0385P)2 + 1.1817P] where P = (Fo2 + 2Fc2)/3. Non-hydrogen atoms were refined anisotropically 
and hydrogen atoms were refined using a riding model. Refinement converged to R1=0.0301 and 
wR2=0.0797 for 4221 observed reflections for which F > 4σ(F) and R1=0.0316 and wR2=0.0810 
and GOF =1.030 for all 4450 unique, non-zero reflections and 283 variables. The maximum Δ/σ in 
the final cycle of least squares was 0.001 and the two most prominent peaks in the final difference 
Fourier were +0.30 and -0.27 e/Å3.  
 Table E2.7. lists cell information, data collection parameters, and refinement data. Final 
positional and equivalent isotropic thermal parameters are given in Tables E2.8 and E2.9. 
Anisotropic thermal parameters are in Table E2.10, Tables E2.11, and E2.12 list bond distances 
and bond angles. Figure E2.2. is an ORTEP representation of the molecule with 50% probability 
thermal ellipsoids displayed.  
 
Figure E2.2 ORTEP Drawing of Compound 2.27 with 50% Thermal Ellipsoids 
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Table E2.7 Summary of Structure Determination of Compound 2.27 
Empirical formula  C25H31NO4Si  
Formula weight  437.60  
Temperature/K  100  
Crystal system  monoclinic  
Space group  P21/c  
a  7.3090(5)Å  
b  15.1112(11)Å  
c  21.9523(16)Å  
β  90.131(3)°  
Volume  2424.6(3)Å3  
Z  4  
dcalc  1.199 g/cm3  
μ  0.126 mm-1  
F(000)  936.0  
Crystal size, mm  0.38 × 0.25 × 0.2  
2θ range for data collection      3.272 - 50.74°  
Index ranges  -8 ≤ h ≤ 8, -18 ≤ k ≤ 18, -26 ≤ l ≤ 24  
Reflections collected  72039  
Independent reflections  4450[R(int) = 0.0187]  
Data/restraints/parameters  4450/0/283  
Goodness-of-fit on F2  1.030  
Final R indexes [I>=2σ (I)]  R1 = 0.0301, wR2 = 0.0797  
Final R indexes [all data]  R1 = 0.0316, wR2 = 0.0810  
Largest diff. peak/hole  0.30/-0.27 eÅ-3  
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Table E2.8 Refined Positional Parameters for Compound 2.27 
Atom x y z U(eq) 
C1 0.91840(15) 0.77229(7) 0.22710(5) 15.4(2) 
C2 0.82918(15) 0.73327(7) 0.28495(5) 16.4(2) 
C3 0.73501(16) 0.80711(8) 0.32198(5) 20.0(2) 
C4 0.59398(16) 0.85745(8) 0.28419(5) 22.0(3) 
C5 0.68415(16) 0.89776(8) 0.22821(5) 21.4(3) 
C6 0.77882(16) 0.82663(8) 0.19045(5) 18.7(2) 
C7 1.00622(15) 0.70016(7) 0.18727(5) 15.6(2) 
C8 1.10465(15) 0.73676(7) 0.13195(5) 16.0(2) 
C9 1.28151(15) 0.76973(8) 0.13817(5) 18.9(2) 
C10 1.37153(16) 0.80738(8) 0.08885(6) 22.9(3) 
C11 1.28604(17) 0.81177(8) 0.03243(5) 22.9(3) 
C12 1.11118(17) 0.77782(8) 0.02561(5) 23.3(3) 
C13 1.02085(16) 0.74081(8) 0.07499(5) 20.7(2) 
C14 0.90051(15) 0.56221(7) 0.14790(5) 16.2(2) 
C15 0.74098(15) 0.51688(7) 0.11863(5) 15.8(2) 
C16 0.57030(15) 0.55746(8) 0.11347(5) 17.5(2) 
C17 0.42723(16) 0.51424(8) 0.08433(5) 18.6(2) 
C18 0.45999(16) 0.43052(8) 0.06126(5) 17.7(2) 
C19 0.62764(16) 0.38863(8) 0.06567(5) 20.1(2) 
C20 0.76940(16) 0.43274(8) 0.09457(5) 18.7(2) 
C21 0.95841(16) 0.68110(8) 0.32640(5) 18.1(2) 
C22 1.12565(17) 0.71073(8) 0.33980(5) 23.7(3) 
C23 0.6601(2) 0.59547(10) 0.40570(8) 40.6(4) 
C24 1.0490(2) 0.52162(9) 0.40854(6) 32.7(3) 
C25 0.80887(18) 0.49900(8) 0.29534(6) 25.4(3) 
N1 0.30911(14) 0.38349(7) 0.03034(4) 21.8(2) 
O1 0.85599(10) 0.64361(5) 0.16728(3) 16.44(17) 
O2 1.05062(11) 0.52973(5) 0.15300(4) 20.91(19) 
O3 0.16568(12) 0.42341(7) 0.02162(4) 29.8(2) 
O4 0.33585(13) 0.30634(6) 0.01486(4) 31.3(2) 
Si1 0.87069(5) 0.57438(2) 0.35964(2) 21.94(10) 
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Table E2.9 Positional Parameters for Hydrogens in Compound 2.27 
Atom x y z U(eq) 
H1 1.0159 0.8126 0.2402 20 
H2 0.7332 0.6924 0.2715 22 
H3a 0.6752 0.7812 0.3571 27 
H3b 0.827 0.8482 0.3367 27 
H4a 0.4972 0.8175 0.2716 29 
H4b 0.5398 0.904 0.3087 29 
H5a 0.7732 0.9417 0.2409 28 
H5b 0.5922 0.9272 0.2035 28 
H6a 0.8408 0.8546 0.1565 25 
H6b 0.6869 0.787 0.1739 25 
H7 1.0921 0.6654 0.2119 21 
H9 1.3401 0.7665 0.1758 25 
H10 1.4893 0.8297 0.0937 30 
H11 1.3457 0.8373 -0.0006 30 
H12 1.054 0.7798 -0.0122 31 
H13 0.9032 0.7185 0.07 28 
H16 0.5523 0.6137 0.1296 23 
H17 0.3129 0.5407 0.0804 25 
H19 0.6448 0.3323 0.0496 27 
H20 0.8837 0.4061 0.0979 25 
H22a 1.166 0.7643 0.3238 32 
H22b 1.2019 0.6779 0.3651 32 
H23a 0.5671 0.6208 0.3801 61 
H23b 0.6884 0.6358 0.4382 61 
H23c 0.6166 0.5407 0.4225 61 
H24a 1.0063 0.4649 0.4222 49 
H24b 1.0732 0.5587 0.4432 49 
H24c 1.1593 0.5141 0.3855 49 
H25a 0.9139 0.49 0.2699 38 
H25b 0.7122 0.5251 0.2717 38 
H25c 0.7687 0.4432 0.3113 38 
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Table E2.10 Refined Thermal Parameters (U's) for Compound 2.27 
Atom U11 U22 U33 U23 U13 U12 
C1 0.0154(5) 0.0144(5) 0.0164(5) -0.0025(4) 0.0009(4) -0.0018(4) 
C2 0.0168(5) 0.0152(5) 0.0170(5) -0.0027(4) 0.0023(4) -0.0018(4) 
C3 0.0220(6) 0.0202(6) 0.0177(5) -0.0038(4) 0.0029(4) 0.0019(5) 
C4 0.0205(6) 0.0243(6) 0.0214(6) -0.0064(5) 0.0023(5) 0.0048(5) 
C5 0.0205(6) 0.0196(6) 0.0239(6) -0.0017(5) -0.0004(5) 0.0042(5) 
C6 0.0193(6) 0.0187(6) 0.0181(5) -0.0002(4) 0.0012(4) 0.0018(5) 
C7 0.0139(5) 0.0158(5) 0.0172(5) -0.0026(4) -0.0007(4) -0.0021(4) 
C8 0.0166(5) 0.0139(5) 0.0174(5) -0.0034(4) 0.0019(4) 0.0015(4) 
C9 0.0172(6) 0.0213(6) 0.0184(6) -0.0022(4) -0.0008(4) 0.0004(4) 
C10 0.0174(6) 0.0250(6) 0.0262(6) -0.0006(5) 0.0033(5) -0.0026(5) 
C11 0.0263(6) 0.0225(6) 0.0198(6) 0.0006(5) 0.0070(5) 0.0006(5) 
C12 0.0280(6) 0.0259(6) 0.0161(6) -0.0018(5) -0.0012(5) -0.0003(5) 
C13 0.0194(6) 0.0230(6) 0.0197(6) -0.0031(5) -0.0007(5) -0.0028(5) 
C14 0.0184(6) 0.0157(5) 0.0145(5) -0.0008(4) 0.0048(4) -0.0007(4) 
C15 0.0168(5) 0.0166(5) 0.0139(5) 0.0008(4) 0.0035(4) -0.0021(4) 
C16 0.0196(6) 0.0160(5) 0.0170(5) -0.0011(4) 0.0046(4) 0.0000(4) 
C17 0.0161(5) 0.0232(6) 0.0164(5) 0.0013(4) 0.0030(4) 0.0000(5) 
C18 0.0193(6) 0.0217(6) 0.0122(5) 0.0012(4) 0.0010(4) -0.0065(4) 
C19 0.0259(6) 0.0160(6) 0.0186(6) -0.0026(4) 0.0019(5) -0.0019(5) 
C20 0.0181(6) 0.0178(6) 0.0203(6) -0.0007(4) 0.0021(4) 0.0016(4) 
C21 0.0226(6) 0.0166(5) 0.0152(5) -0.0024(4) 0.0041(4) 0.0015(4) 
C22 0.0263(6) 0.0236(6) 0.0212(6) 0.0022(5) -0.0021(5) -0.0003(5) 
C23 0.0469(9) 0.0283(7) 0.0468(9) 0.0015(6) 0.0270(7) -0.0020(6) 
C24 0.0521(9) 0.0218(6) 0.0240(6) 0.0020(5) -0.0022(6) 0.0035(6) 
C25 0.0274(6) 0.0188(6) 0.0300(7) 0.0008(5) 0.0028(5) -0.0026(5) 
N1 0.0234(5) 0.0280(6) 0.0139(5) 0.0005(4) 0.0008(4) -0.0073(4) 
O1 0.0146(4) 0.0143(4) 0.0205(4) -0.0044(3) 0.0012(3) -0.0017(3) 
O2 0.0164(4) 0.0206(4) 0.0257(4) -0.0051(3) 0.0010(3) 0.0018(3) 
O3 0.0202(5) 0.0420(6) 0.0270(5) -0.0059(4) -0.0028(4) -0.0024(4) 
O4 0.0378(5) 0.0239(5) 0.0322(5) -0.0050(4) -0.0092(4) -0.0076(4) 
Si1 0.02778(19) 0.01685(17) 0.02122(18) 0.00114(12) 0.00727(13) 0.00048(13) 
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Table E2.11 Bond Distances in Compound 2.27, Å 
C1-C2 1.5457(15)   C1-C6 1.5358(15)   C1-C7 1.5386(15) 
C2-C3 1.5435(15)   C2-C21 1.5289(16)   C3-C4 1.5250(16) 
C4-C5 1.5228(17)   C5-C6 1.5245(16)   C7-C8 1.5172(15) 
C7-O1 1.4581(13)   C8-C9 1.3918(16)   C8-C13 1.3924(16) 
C9-C10 1.3901(17)   C10-C11 1.3875(18)   C11-C12 1.3850(18) 
C12-C13 1.3882(17)   C14-C15 1.4962(15)   C14-O1 1.3418(14) 
C14-O2 1.2069(14)   C15-C16 1.3944(16)   C15-C20 1.3925(16) 
C16-C17 1.3877(16)   C17-C18 1.3839(17)   C18-C19 1.3824(17) 
C18-N1 1.4759(14)   C19-C20 1.3847(17)   C21-C22 1.3340(17) 
C21-Si1 1.8833(12)   C23-Si1 1.8712(14)   C24-Si1 1.8655(14) 
C25-Si1 1.8684(13)   N1-O3 1.2242(14)   N1-O4 1.2301(14) 
 
Table E2.12 Bond Angles in Compound 2.27, ° 
C6-C1-C2 110.69(9)   C6-C1-C7 111.01(9)   C7-C1-C2 111.96(9) 
C3-C2-C1 110.27(9)   C21-C2-C1 115.11(9)   C21-C2-C3 109.57(9) 
C4-C3-C2 112.07(9)   C5-C4-C3 110.20(10)   C4-C5-C6 110.76(10) 
C5-C6-C1 113.20(9)   C8-C7-C1 113.32(9)   O1-C7-C1 105.75(8) 
O1-C7-C8 109.33(8)   C9-C8-C7 119.60(10)   C9-C8-C13 118.62(10) 
C13-C8-C7 121.76(10)   C10-C9-C8 120.75(11)   C11-C10-C9 120.12(11) 
C12-C11-C10 119.50(11)   C11-C12-C13 120.35(11)   C12-C13-C8 120.66(11) 
O1-C14-C15 111.50(9)   O2-C14-C15 124.12(10)   O2-C14-O1 124.37(10) 
C16-C15-C14 121.99(10)   C20-C15-C14 117.65(10)   C20-C15-C16 120.33(10) 
C17-C16-C15 120.23(11)   C18-C17-C16 117.91(11)   C17-C18-N1 118.61(10) 
C19-C18-C17 123.17(11)   C19-C18-N1 118.23(10)   C18-C19-C20 118.29(11) 
C19-C20-C15 120.08(11)   C2-C21-Si1 117.50(8)   C22-C21-C2 121.51(11) 
C22-C21-Si1 120.97(9)   O3-N1-C18 118.25(10)   O3-N1-O4 124.08(10) 
O4-N1-C18 117.67(10)   C14-O1-C7 116.72(8)   C23-Si1-C21 110.17(6) 
C24-Si1-C21 110.54(6)   C24-Si1-C23 109.65(7)   C24-Si1-C25 109.97(6) 
C25-Si1-C21 108.14(5)   C25-Si1-C23 108.32(7)       
 
This report has been created with Olex2 [6], compiled on 2015.09.30 svn.r3233 for OlexSys.  
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E2.4 Computational Details 
E2.4.1 Computational Methods 
All DFT calculations were performed with the Gaussian 091.Geometry optimizations were 
carried out at the M06 level of theory2.The SDD basis set3 was used for Cu, Br, and I, and 
the 6-31G(d) basis set4 for the other atoms(keyword 5D was used in the calculations).The 
vibrational frequencies were computed at the same level to evaluate its zero-point 
vibrational energy (ZPVE) and thermal corrections at 298 K. A quasiharmonic correction 
was applied duringthe entropy calculation by setting all positive frequencies that are 
lessthan 100 cm−1 to 100 cm−1.5 The single-point energies and solvent effects in 
tetrahydrofuran (THF) were computed at the M06/6-311+G(d,p)[SDD, for Cu, Br, and I] 
level using the gas-phase optimized structures. Solvation energies were evaluated by a self-
consistent reaction field (SCRF) using the CPCM model6,where UFF radii were used.The 
frontier molecular orbitals (FMOs) and their energies werecomputed at the HF/6-
311+G(d,p)[SDD, for Cu, Br, and I] level using the M06-2X/6-31G(d)[SDD, for Cu, Br, 
and I]geometries. 
E2.4.2 Coordinates and Energies of Stationary Points
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A 
Gsol = -687.041269 Hartree 
------------------------------------ 
C     -2.806075     -0.177045     1.447783 
H     -2.205635     -0.120988     2.367920 
H     -3.442391     -1.070632     1.492946 
H     -3.462933     0.704943     1.407373 
C     -1.928133     -0.227798     0.199638 
C     -1.089753     1.023370     0.118851 
H     -1.700010     1.941475     0.103082 
C     0.244782     1.123992     0.022508 
C     0.891544     2.481219     -0.081530 
H     1.611283     2.657035     0.732904 
H     1.462112     2.595821     -1.016214 
H     0.146691     3.289523     -0.044350 
O     -2.676808     -0.363156   -0.937817 
Li     -3.357154     -0.177037   -2.393773 
Si     1.365283     -0.394953     -0.007814 
C     3.147489     0.162397     -0.299293 
H     3.504392     0.839459     0.488492 
H     3.814958     -0.710611    -0.309268 
H     3.267394     0.677751     -1.261977 
C     0.891601     -1.548731     -1.427356 
H     -0.194778     -1.698043    -1.480182 
H     1.217869     -1.118546     -2.384668 
H     1.374222     -2.530364     -1.322589 
C     1.344461     -1.316460     1.640241 
H     0.344327     -1.684269     1.903046 
H     2.025721     -2.178683     1.611237 
H     1.678919     -0.656151     2.451962 
H     -1.245664     -1.097691     0.328496 
------------------------------------ 
Ac 
Gsol = -895.938339 Hartree 
------------------------------------ 
C     -1.802346     3.574908     -0.082579 
H     -2.846727     3.617529     0.257898 
H     -1.708419     4.175194     -0.995599 
H     -1.162409     4.027376     0.688326 
C     -1.351072     2.149718     -0.353153 
H     -2.038434     1.715691     -1.113468 
C     -1.449116     1.304363     0.910308 
H     -1.307924     1.863186     1.848629 
C     -1.672098     -0.049917     0.987656 
C     -1.782984     -0.692041     2.352692 
H     -2.822762     -1.001900     2.546366 
H     -1.166424     -1.596421     2.435646 
H     -1.487467     -0.001532     3.154983 
C     -4.031265     -0.984642     -0.703952 
H     -4.411164     -1.696022     -1.449802 
H     -4.568756     -1.168843     0.236272 
H     -4.287597     0.027978     -1.042501 
C     -1.268544     -0.855960     -2.090337 
H     -1.254572     0.199941     -2.385272 
H     -0.227654     -1.204574     -2.032192 
H     -1.763539     -1.428723     -2.888246 
C     -1.770951     -2.944308     0.054048 
H     -2.343333     -3.266054     0.933781 
H     -1.995928     -3.642165     -0.763794 
H     -0.700615     -3.044788     0.286747 
Si     -2.171878     -1.183586     -0.471602 
O      -0.038236     2.096633     -0.783209 
Li      1.552281     1.822229     -1.317157 
Cu      0.366704     0.326761     0.490023 
I        2.684621     -0.410079     -0.067113 
------------------------------------ 
Ap 
Gsol = -895.948494 Hartree 
------------------------------------ 
C    -2.916897     2.083311     0.861396 
H    -2.770738     2.969099     1.491816 
H    -3.520353     1.364198     1.430588 
H    -3.485231     2.385412     -0.029337 
C    -1.572478     1.520934     0.454816 
C    -0.708893     2.563080     -0.201264 
H    -1.269075     3.386721     -0.675020 
C     0.641560     2.561693     -0.208971 
C     1.348954     3.707658     -0.875872 
H     1.984158     4.237398     -0.151773 
H     2.031717     3.357561     -1.664083 
H     0.658309     4.444679     -1.320550 
O    -1.747799     0.406303     -0.478245 
H    -1.043891     1.113738     1.333895 
C    -2.243400     -1.582363     1.605131 
H    -2.633820     -0.895695     2.367320 
H    -2.694064     -2.566989     1.788422 
H    -1.159103     -1.680492     1.756474 
C    -4.444964     -0.768818     -0.443726 
H    -4.942090     -0.196955     0.348970 
H    -4.610620     -0.242672     -1.393079 
H    -4.948613     -1.742706     -0.514644 
C    -1.921866     -2.213263     -1.407940 
H    -0.852830     -2.413172     -1.238234 
H    -2.437379     -3.181346     -1.355461 
H    -2.053886     -1.835442     -2.431957 
Si    -2.612897     -1.019146     -0.139434 
Cu     1.644631     1.025876     0.353714 
I       2.030780     -1.420169     0.016636 
Li    -0.035760     0.266471     -1.268726 
------------------------------------ 
B 
Gsol = -687.041467 Hartree 
------------------------------------ 
C        0.756613   -0.368551   -3.430179 
H        1.462968    0.415657   -3.745146 
H       -0.240034    0.086774   -3.343749 
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H        0.727133   -1.134682   -4.216039 
C        1.241813   -0.983499   -2.121319 
H        0.477348   -1.735805   -1.805209 
C        1.305364    0.086426   -1.014335 
H        2.035330    0.849893   -1.339885 
H        1.740356   -0.409458   -0.129492 
C       -0.004066    0.730679   -0.650446 
C       -0.201661    2.039563   -0.851809 
H        0.572070    2.676674   -1.292201 
H       -1.133252    2.544961   -0.590093 
C       -2.422958   -1.174645   -1.198384 
H       -1.830459   -1.884437   -1.790028 
H       -3.247814   -1.729390   -0.729343 
H       -2.861763   -0.445870   -1.893407 
C       -0.632704   -1.595245    1.266185 
H       -1.420900   -2.179287    1.760633 
H        0.008255   -2.297667    0.716624 
H       -0.022406   -1.127025    2.050141 
C       -2.539518    0.807771    1.107223 
H       -1.993961    1.391735    1.859637 
H       -3.082235    1.512841    0.463460 
H       -3.290473    0.200580    1.631254 
Si       -1.384532   -0.304762    0.114981 
O        2.461643   -1.573274   -2.276642 
Li        3.955204   -2.143185   -2.485389 
------------------------------------ 
Bc 
Gsol = -895.949807 Hartree 
------------------------------------ 
C       2.02082  -0.10361  -0.7414  
 C      1.56364  -0.03945  -2.03749  
 C       2.22834  -1.4445   -0.07088  
 H       1.53317  -1.55162   0.7794  
 H        2.00276  -2.25877  -0.78237  
 C        3.67609  -1.61465   0.41517  
 H        3.82023  -0.91125   1.26784  
 C        3.90941  -3.0221    0.93725  
 H        3.76247  -3.74844   0.12499  
 H        4.93841  -3.12696   1.30508  
 H         3.22463  -3.27521   1.75865  
 O         4.55586  -1.30895  -0.61127  
 Li        6.00313  -1.19683  -1.54079  
 Si         2.22305   1.50455   0.27062  
 C         1.41454   1.23052   1.94857  
 H         1.94514   0.4663    2.53243  
 H         1.42757  2.16017   2.53335  
 H         0.36818   0.91293   1.84938  
 C         4.02963   1.98341   0.50241  
 H         4.51443   2.18946  -0.46302  
 H         4.08459   2.90428   1.10115  
 H         4.61657   1.2103    1.01322  
 C          1.38023   2.90703  -0.65544  
 H          1.42824   3.82771  -0.05821  
 H       1.88888     3.1124      -1.60789  
 H        0.32353     2.70005    -0.8679  
 H        1.2967      -0.94653    -2.58958  
 H         1.27067    0.89924     -2.50957  
I           5.52077    0.469          -3.6553  
 Cu       3.67431    -0.06406    -1.99286  
------------------------------------ 
Bp 
Gsol = -895.949383 Hartree 
------------------------------------ 
C          1.8729    1.33804  -0.4178  
 C          2.30493   1.75934  -1.62575  
 C         0.84776   2.18992   0.29273  
 H         1.30048   2.63788   1.19236  
 H          0.49899   3.02946  -0.34097  
 C          -0.36171   1.39386   0.76457  
 H         -0.02522   0.67105   1.52953  
 C          -1.45045   2.28608   1.31927  
 H         -1.85155   2.93154   0.52593  
 H        -2.28121   1.71114   1.74975  
 H          -1.04784   2.92707   2.11377  
 H         1.99658   2.72167  -2.06058  
 H         3.05264   1.20702  -2.20152  
 O          -0.86247   0.6266   -0.35551  
 Si         -2.02648  -0.60789  -0.21963  
 Cu           2.27702  -0.41626   0.26003  
 C          -1.49198  -1.74818  -1.61987  
 H       -1.4331   -1.22494  -2.58869  
 H         -0.53045  -2.24433  -1.40234  
 H         -2.218    -2.55853  -1.76505  
 C         -1.89898  -1.45892   1.43518  
 H         -2.16766  -0.80732   2.27638  
 H         -2.5782   -2.32173   1.46006  
 H          -0.87964  -1.83821   1.60082  
 C         -3.73022   0.08029  -0.57144  
 H          -4.46424  -0.73355  -0.64518  
 H          -4.07619   0.76695   0.21077  
 H           -3.7412    0.62526  -1.5243  
Li             0.53075  -0.01192  -1.51778  
 I            2.10755  -2.84421   0.60508  
------------------------------------ 
BrCuBr- 
Gsol = -224.401805 Hartree 
------------------------------------ 
Cu         -0.31317   0.22678   0.  
 Br           1.97897   0.22678   0.  
 Br          -2.60532   0.22678   0.  
------------------------------------ 
Cc 
Gsol = -924.311820 Hartree 
------------------------------------ 
C             2.04327  -0.10947  -0.73345  
  180 
 C            1.57966  -0.033    -2.02425  
 C            2.22899  -1.45629  -0.06874  
 H         1.47928  -1.58143   0.73257  
H             2.05837  -2.26205  -0.8053  
 C            3.6463   -1.61533   0.49671  
 H           3.73064  -0.91915   1.36737  
 C           3.86164  -3.02378   1.02993  
 H           3.76048  -3.7494    0.20962  
 H            4.87338  -3.12093   1.4441  
 H            3.1397   -3.28463   1.81714  
 O           4.56529  -1.29108  -0.47382  
 Li            5.81388  -0.99476  -1.58282  
 Si           2.23033   1.48254   0.29917  
 C            1.36263   1.20955   1.94863  
 H          1.87409   0.45619   2.56189  
 H              1.3372    2.14432   2.52527  
 H            0.32544   0.87863   1.80449  
 C              4.0355    1.9431    0.58321  
 H           4.49221   2.31616  -0.34488  
 H            4.10557   2.742     1.3352  
 H            4.63184   1.0876    0.92389  
 C            1.40575   2.90285  -0.62097  
 H            1.47854   3.82347  -0.02581  
 H           1.89806   3.09871  -1.58384  
 H           0.34162   2.71274  -0.81284  
 H            1.31879  -0.93552  -2.58651  
 H             1.27801   0.90911  -2.48462  
 Cu            3.68654   0.03064  -2.01728  
 C            5.25358   0.3777   -3.18761  
 H           6.09566   0.92715  -2.71837  
 H            5.69073  -0.48458  -3.7318  
 H            4.91386   1.04563  -3.98891  
------------------------------------ 
Cp 
Gsol = -924.315879 Hartree 
------------------------------------ 
C            -1.74314  -1.46399  -0.49243  
 C            -2.28654  -1.7937   -1.68524  
 C         -0.62301  -2.34996   0.00869  
 H             -0.97884  -2.94297   0.86762  
 H           -0.2815   -3.07685  -0.75659  
 C             0.57271  -1.55046   0.50562  
 H            0.25424  -0.98269   1.39654  
 C           1.76719  -2.41894   0.82984  
 H          2.1425   -2.90352  -0.08162  
 H            2.58836  -1.84127   1.276  
 H          1.48514  -3.20203   1.54526  
 H           -2.00583  -2.70056  -2.24384  
 H          -3.10625  -1.21689  -2.12525  
 O            0.93096  -0.58155  -0.51327  
 Si           1.86144   0.79976  -0.1863  
 Cu          -2.13834   0.21741   0.43669  
 C            1.14734   2.02203  -1.43029  
 H           1.16177   1.62736  -2.45919  
 H              0.12055   2.32064  -1.16227  
 H             1.73488   2.94881  -1.4567  
 C             1.5717    1.38731   1.56052  
 H            1.96374   0.69429   2.31623  
 H           2.06129   2.3577    1.71799  
 H            0.49414   1.52034   1.73902  
 C            3.66365   0.4747   -0.57018  
 H            4.24627   1.4031   -0.49842  
 H            4.11225  -0.25004   0.12047  
 H             3.78297   0.08369  -1.58882  
 C           -2.36211   1.94633   1.23578  
 H           -3.41426   2.26713   1.17469  
 H         -2.09766   1.91664   2.30659  
H           -1.76101   2.75463   0.78495  
 Li           -0.60909  -0.00156  -1.52331  
------------------------------------ 
CuBr 
Gsol = -210.807207 Hartree 
------------------------------------ 
Br            -2.44012   0.36649  -0.12536  
 Cu        -4.6539    0.36649  -0.12536  
------------------------------------ 
CuI 
Gsol = -208.851716 Hartree 
------------------------------------ 
I            -1.26615   0.55789  -0.11077  
 Cu           -3.64474   0.55789  -0.11077  
------------------------------------ 
D 
Gsol = -726.303854 Hartree 
------------------------------------ 
C     -2.855047     -0.400613     0.310183 
H     -2.814603     -0.641995     1.401423 
C     -1.398866     -0.274084     -0.154002 
H     -1.399756     -0.045417     -1.234794 
H     -0.891313     -1.247523     -0.032701 
C     -0.635970     0.812030     0.596175 
H     -1.243734     1.731304     0.583394 
H     -0.555388     0.506268     1.655738 
C     0.737783     1.092888     0.045969 
C     1.048196     2.306977     -0.423805 
H     0.322056     3.126450     -0.426637 
H     2.033223     2.551908     -0.824994 
C     -3.520038     -1.582587     -0.389220 
H     -4.561833     -1.679473     -0.056427 
H     -3.527505     -1.409913     -1.476114 
H     -3.002425     -2.533097     -0.192497 
C     1.803933     -1.420081     -1.462244 
H     2.623869     -2.149690     -1.518258 
H     0.859902     -1.976830     -1.412285 
H     1.802350     -0.846367     -2.398813 
C     3.758851     0.491722     -0.124387 
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H     3.906787     0.988379     -1.092821 
H     3.941879     1.232552     0.664676 
H     4.527034     -0.288892     -0.037472 
C     1.935658     -1.263386     1.615830 
H     2.715621     -2.036187     1.646924 
H     2.072664     -0.616279     2.492578 
H     0.965601     -1.767052     1.721772 
Si     2.041018     -0.272209     0.015697 
O     -3.552784     0.752333     0.091097 
Li     -4.391136     2.105637     -0.166072 
------------------------------------ 
Dc 
Gsol = -963.573633 Hartree 
------------------------------------ 
C     2.174047     -1.303475     -0.164627 
H     2.785680     -1.074109     -1.070470 
C     0.920481     -2.019843     -0.670596 
H     0.315473     -2.324368     0.201155 
H     1.233273     -2.951844     -1.167905 
C     0.068765     -1.213903     -1.649884 
H     0.712579     -0.836094     -2.464951 
H     -0.647468     -1.904036     -2.129206 
C     -0.732388     -0.072897     -1.060308 
C     -0.840502     1.127134     -1.741129 
H     -0.317778     1.284227     -2.691099 
H     -1.598876     1.873472     -1.502579 
C     2.985864     -2.245607     0.714775 
H     3.904874     -1.751747     1.058767 
H     2.397986     -2.519178     1.604044 
H     3.269449     -3.167678     0.187838 
C     -3.247802     0.913562     0.439261 
H     -3.939010     0.711108     1.269011 
H     -2.812003     1.907509     0.612808 
H     -3.838072     0.954841     -0.485398 
C     -2.727755     -2.096154     0.097629 
H     -3.232890     -2.131072     -0.877057 
H     -2.001975     -2.919408     0.129321 
H     -3.483177     -2.290796     0.871361 
C     -1.058278     -0.408703     2.068538 
H     -1.748704     -0.772914     2.843097 
H     -0.149715     -1.022303     2.080401 
H     -0.761165     0.615302     2.339878 
Si     -1.917504     -0.418521     0.390471 
O     1.888752     -0.141627     0.531920 
Li     2.473323     1.337841     1.195408 
Cu     0.574104     1.277491     -0.248625 
C     1.332179     2.991755     0.500157 
H     2.360598     3.284493     0.201772 
H     1.264720     3.142725     1.598536 
H     0.704578     3.792203     0.089733 
------------------------------------ 
Dp 
Gsol = -963.574806 Hartree 
------------------------------------ 
C     -1.675123     -2.093258     -1.940738 
H     -1.623251     -3.185050     -2.035100 
H     -1.150441     -1.654908     -2.801673 
H     -2.729066     -1.792535     -1.993504 
C     -1.026519     -1.637628     -0.651642 
H     -1.548844     -2.092675     0.210962 
C     0.447687     -1.991617     -0.580782 
H     0.968501     -1.428590     -1.377754 
H     0.550637     -3.049979     -0.863805 
C     1.126039     -1.727931     0.776416 
H     1.313745     -2.696043     1.278833 
H     0.406708     -1.194221     1.421392 
C     2.393693     -0.903273     0.674005 
C     3.527146     -1.437388     1.151070 
H     4.482616     -0.909382     1.119428 
H     3.565062     -2.439515     1.604750 
O     -1.179641     -0.198194     -0.551536 
C     -2.004141     2.347746     0.137694 
H     -2.727393     2.973119     0.676763 
H     -1.007293     2.673851     0.473706 
H     -2.114930     2.591181     -0.929741 
C     -4.036609     -0.005554     0.055779 
H     -4.280253     0.234526     -0.987065 
H     -4.181124     -1.085003     0.197870 
H     -4.766975     0.505899     0.696862 
C     -1.887301     0.139838     2.276431 
H     -0.865415     0.465638     2.515109 
H     -2.575792     0.667016     2.950927 
H     -1.959105     -0.931432     2.503614 
Si     -2.299005     0.529209     0.497246 
Cu     2.222044     0.814141     -0.158342 
Li     0.138350     1.083149     -1.096899 
C     1.753956     2.480514     -1.123507 
H     1.137826     3.236273     -0.601504 
H     2.753995     2.934242     -1.195655 
H     1.406717     2.465977     -2.179301 
------------------------------------ 
E 
Gsol = -878.615574 Hartree 
------------------------------------ 
C            -2.37049   1.14951   1.23644  
 C           -1.6492    1.03659   0.04619  
 C          -0.94678   2.14926  -0.4607  
 C           -1.01165   3.34384   0.25581  
 C          -1.73443   3.45172   1.44259  
 C           -2.4187    2.35029   1.93823  
 H            -2.90896   0.27485   1.6081  
 H         -0.48706   4.22076  -0.12158  
 H           -1.76222   4.40127   1.97606  
 H            -2.99083   2.42203   2.86232  
 C          -0.12016   1.97833  -1.73539  
 H          -0.83626   1.60388  -2.5059  
  182 
 C             0.43398   3.29062  -2.27651  
 H            0.97391   3.08313  -3.20829  
 H           -0.35113   4.03075  -2.48828  
 H            1.15259   3.7277   -1.56821  
 C          -1.61008  -0.29079  -0.62042  
 C           -2.50862  -0.63568  -1.54895  
 H           -2.51093  -1.62208  -2.0212  
 H           -3.28158   0.05617  -1.89215  
 C             0.87306  -0.76994   1.19351  
 H            1.09693   0.28999   1.00037  
 H          0.39375  -0.78933   2.1816  
 H           1.80706  -1.34662   1.29735  
 C            -1.13541  -3.01165   0.75687  
 H           -0.39685  -3.7517    1.09425  
 H            -1.71253  -2.6884    1.63409  
 H           -1.82974  -3.51664   0.07184  
 C            0.657    -2.17597  -1.57909  
 H          1.66103  -2.55798  -1.32644  
 H            0.12392  -3.02475  -2.02816  
 H          0.72854  -1.40464  -2.36011  
Si           -0.31536  -1.53547  -0.07429  
 O           0.88141   1.06977  -1.52955  
 Li           1.95245  -0.05666  -1.00485  
------------------------------------ 
Ec 
Gsol = -1115.897317 Hartree 
------------------------------------ 
C               3.44583   1.3611   -1.94785  
 C              2.46586   0.37935  -1.85613  
 C            1.64739   0.26123  -0.72784  
 C             1.82456   1.16209   0.3488  
 C            2.81258   2.13925   0.23553  
 C            3.61931   2.24674  -0.89438  
 H              4.07174   1.42466  -2.8368  
 H             2.33199  -0.33277  -2.67111  
 H            2.96328   2.84587   1.04966  
 H            4.38138   3.02308  -0.94451  
 C            0.62827  -0.82838  -0.71599  
 C           -0.21555  -0.98108  -1.81351  
 H          -0.16125  -0.30446  -2.67194  
 H           -0.7826   -1.8984   -1.98061  
 Si           0.7765   -2.30077   0.49362  
 C             0.52281  -3.88802  -0.49371  
 H           1.18492  -3.93249  -1.36821  
 H             0.74224  -4.75924   0.13935  
 H          -0.51181  -3.99541  -0.84633  
 C             2.51429  -2.34378   1.21542  
 H           2.65479  -3.26254   1.80128  
 H             3.26361  -2.33993   0.41201  
 H            2.73026  -1.49042   1.86974  
 C            -0.54568  -2.27119   1.8364  
 H          -1.54278  -2.38472   1.38559  
 H            -0.39957  -3.11149   2.53003  
 H             -0.55043  -1.33847   2.41343  
 C             0.92927   1.0632    1.58123  
 H              1.13177   0.06484   2.03159  
 C             1.25488   2.08104   2.66434  
 H             2.28712   1.99923   3.03031  
 H             1.09107   3.10422   2.29678  
 H             0.57931   1.91371   3.51225  
 O           -0.41619   1.15118   1.25353  
 Li           -2.01179   1.77044   1.11239  
 Cu          -1.12657   0.09165  -0.3395  
 C             -3.03235   0.72886  -0.45334  
 H           -3.20196   1.78695  -0.74229  
 H           -3.49297   0.16015  -1.26993  
 H            -3.68997   0.52296   0.41706  
------------------------------------ 
Ep 
Gsol = -1115.906710 Hartree 
------------------------------------ 
C             -0.21965   3.51813  -1.60045  
 C            0.72593   2.72397  -0.96359  
 C             0.36481   1.78621   0.01498  
 C            -1.00772   1.65774   0.34044  
 C            -1.94365   2.46526  -0.30466  
 C            -1.56313   3.39251  -1.26967  
 H           0.09632   4.24154  -2.35098  
 H            1.78336   2.83558  -1.20138  
 H            -3.00052   2.37223  -0.05776  
 H          -2.31442   4.01367  -1.75417  
 C             1.42241   0.9944    0.67591  
 C            2.28552   0.32019  -0.11911  
 H             2.22458   0.32447  -1.21823  
 H             3.14376  -0.22354   0.29202  
 C           -1.43046   0.63654   1.36985  
 H          -0.85829   0.83532   2.29411  
 C             -2.90153   0.59988   1.71732  
 H           -3.22322   1.55414   2.15108  
 H           -3.52955   0.39798   0.83765  
 H            -3.08447  -0.19149   2.45377  
 O            -0.99369  -0.69821   0.98698  
 Cu           1.64922   1.00792   2.63094  
 Si            -1.5028   -1.60032  -0.35589  
 C           -3.10915  -2.48471   0.02437  
 H            -3.3261   -3.23315  -0.75  
 H           -3.0512   -3.00824   0.98765  
 H           -3.96287  -1.79693   0.06796  
 C           -0.09207  -2.84066  -0.47115  
 H          0.03851  -3.40187   0.46707  
 H            -0.27946  -3.58671  -1.25418  
 H              0.85759  -2.34823  -0.73408  
 C            -1.62575  -0.58397  -1.91764  
 H           -2.44977   0.13898  -1.87736  
 H            -0.70393  -0.01605  -2.10311  
 H           -1.80051  -1.249    -2.77508  
  183 
 Li              0.83843  -0.96364   1.40449  
 C           1.89366   0.91226   4.52397  
 H             1.81602  -0.09852   4.95326  
 H           2.89492   1.29416   4.78029  
 H               1.15656   1.54297   5.04575  
------------------------------------ 
F 
Gsol = -882.173283 Hartree 
------------------------------------ 
C             3.01361  -0.73517  -1.79826  
 C             1.62335  -0.11159  -1.8273  
 C              0.65819  -0.84514  -0.89417  
 C              1.19724  -0.94402   0.55507  
 C             2.61022  -1.53643   0.53567  
 C              3.57003  -0.78765  -0.38135  
 H             1.69167   0.94041  -1.51767  
 H            1.22222  -0.12844  -2.85303  
 H           2.95694  -1.76317  -2.19873  
 H            3.69305  -0.18318  -2.46576  
 H            0.55981  -1.68312   1.07888  
 H           3.01358  -1.59022   1.55733  
 H            2.54004  -2.5818    0.18371  
 H             3.70095   0.23479   0.00268  
 H             4.55776  -1.27308  -0.37585  
 H            0.62978  -1.89399  -1.25849  
 C              1.0302    0.35652   1.37884  
 H           -0.07101   0.53428   1.38552  
 O             1.67838   1.4513    0.87269  
 Li            2.21481   2.94266   0.53708  
 C              1.43368   0.13213   2.83648  
 H             2.5265    0.04044   2.91802  
 H             1.13242   1.0014    3.43653  
 H             0.9755   -0.76596   3.27929  
 C            -0.77183  -0.34815  -0.94117  
 C             -1.1194    0.79898  -1.53814  
 H            -0.39195   1.4648   -2.00831  
 H               -2.15597   1.13643  -1.58842  
 Si            -2.13818  -1.42105  -0.19376  
 C           -2.33596  -1.16685   1.66517  
 H          -3.19869  -1.73942   2.0348  
 H            -1.4514   -1.4851    2.23181  
 H            -2.51203  -0.10736   1.89586  
 C             -1.75908  -3.23745  -0.53442  
 H           -1.64825  -3.4292   -1.61018  
 H          -0.83527  -3.56658  -0.03971  
 H             -2.57541  -3.87335  -0.16517  
 C            -3.79285  -0.99607  -0.99283  
 H            -4.56436  -1.69584  -0.64251  
 H          -4.13079   0.01608  -0.73298  
 H           -3.74829  -1.06535  -2.08736  
------------------------------------ 
Fc 
Gsol = -1119.435776 Hartree 
------------------------------------ 
C            -4.6203   -0.74252  -0.07782  
 C         -3.40594  -1.46864   0.48071  
 C              -2.10605  -0.64712   0.44248  
 C          -2.27971   0.80605   0.97784  
 C            -3.55375   1.43057   0.39437  
 C             -4.80608   0.59835   0.61159  
 H            -3.62155  -1.75419   1.52352  
 H           -3.25882  -2.40441  -0.07803  
 H          -4.48758  -0.57103  -1.16057  
 H            -5.51089  -1.37859   0.02978  
 H            -1.45828   1.39524   0.53788  
 H            -3.68138   2.45179   0.77692  
 H            -3.40798   1.53963  -0.6954  
 H             -4.97607   0.44381   1.69019  
 H          -5.68946   1.12187   0.21769  
 H           -1.85891  -0.51554  -0.6324  
 C             -2.07239   0.96948   2.51208  
 H           -0.96882   1.04401   2.63945  
 O           -2.53665  -0.08099   3.28315  
 Li            -2.95279  -0.97196   4.68729  
 C            -2.61941   2.28982   3.03982  
 H            -3.71823   2.30332   3.0137  
 H            -2.30851   2.4148    4.08571  
 H           -2.24736   3.15407   2.46992  
 C            -0.92759  -1.40269   1.06398  
 C             -0.94956  -2.78099   1.2475  
 H            -1.78438  -3.41722   0.94592  
 H           -0.0365   -3.33224   1.48289  
 Si            0.82961  -0.66778   1.24674  
 C               1.34475  -0.64651   3.06159  
 H            2.36356  -0.24551   3.16297  
 H             0.67602  -0.03476   3.68283  
 H          1.3449   -1.66399   3.47853  
 C             1.06189   1.04551   0.49153  
 H            0.64881   1.10842  -0.52445  
 H            0.62033   1.85139   1.09089  
 H              2.1411    1.24328   0.41702  
 C            2.03254  -1.79995   0.33101  
 H             3.0456   -1.37523   0.37001  
 H             2.08189  -2.80509   0.76927  
 H            1.75637  -1.90996  -0.72617  
 C             -2.08758  -2.92958   4.62111  
 H            -1.60213  -3.90626   4.50334  
 H            -1.6971   -2.55448   5.59036  
 H            -3.15523  -3.18539   4.78378  
 Cu            -1.60745  -1.89544   2.95529  
------------------------------------ 
Fp 
Gsol = -1119.451284 Hartree 
------------------------------------ 
C             2.7034    2.84887  -0.10119  
 C              2.57056   1.34313   0.08924  
  184 
 C             1.36528   0.98003   0.96299  
 C             0.03578   1.58105   0.42859  
 C             0.22162   3.08618   0.17128  
 C              1.42989   3.44404  -0.68846  
 H             2.49796   0.84293  -0.88947  
 H             3.47608   0.93515   0.5628  
 H             2.89741   3.32044   0.87789  
 H            3.56886   3.08356  -0.7366  
 H           -0.68175   1.49924   1.26524  
 H           -0.70146   3.51193  -0.25642  
 H            0.35294   3.5717    1.15242  
 H             1.29472   3.08157  -1.71987  
 H            1.51372   4.53789  -0.76322  
 H              1.51272   1.52251   1.92216  
 C          -0.7098    0.89152  -0.73047  
 H           -1.48983   1.61159  -1.04777  
 O            -1.40471  -0.28096  -0.23048  
 Li         -0.39376  -1.61582   0.64405  
 C               0.04355   0.45657  -1.96938  
 H              0.77336  -0.33263  -1.73508  
 H            -0.67008   0.0518   -2.70006  
 H            0.57258   1.29404  -2.43777  
 C             1.30678  -0.50604   1.26384  
 C             0.92653  -0.85551   2.51329  
 H           0.71083  -0.12274   3.30728  
 H            0.88391  -1.90234   2.84031  
 Si          -3.07648  -0.28868   0.00703  
 C            -3.31635  -1.96818   0.80992  
 H          -4.37342  -2.1765    1.01787  
 H           -2.95402  -2.78189   0.16445  
 H          -2.79484  -2.02538   1.77896  
 C            -3.93408  -0.14764  -1.6489  
 H           -3.66261   0.78522  -2.16121  
 H            -3.65709  -0.98152  -2.3066  
 H            -5.02617  -0.15294  -1.53783  
 C              -3.56261   1.09543   1.16856  
 H           -4.64269   1.08304   1.36587  
 H           -3.04376   0.9929    2.1315  
 H            -3.31503   2.08442   0.75944  
 C            2.39965  -3.25262  -1.25537  
 H              3.49425  -3.2194   -1.38693  
 H             2.14923  -4.26547  -0.90398  
 H               1.95092  -3.13191  -2.25409  
 Cu              1.89808  -1.8747   -0.02622  
------------------------------------ 
G 
Gsol = -882.181018 Hartree 
------------------------------------ 
C              2.99348  -0.84582   0.20381  
 C            3.82154   0.23778  -0.4768  
 C             3.13165   0.74965  -1.73404  
 C            1.7259    1.23769  -1.41183  
 C            0.88891   0.14108  -0.7421  
 C              1.57879  -0.37361   0.53558  
 H              3.7201    1.55108  -2.20451  
 H            3.95809   1.0809    0.22323  
 H             4.8293   -0.13584  -0.71221  
 H            2.92439  -1.72885  -0.4547  
 H              3.50268  -1.18076   1.11943  
 H             1.79988   2.11148  -0.73846  
 H             1.21302   1.59029  -2.32052  
 H          0.85792  -0.71743  -1.44088  
 H              1.66991   0.47489   1.23982  
 H             3.06826  -0.068    -2.47308  
 C           0.72824  -1.45489   1.23738  
 O             0.53043  -2.55016   0.44792  
 Li           0.29319  -3.85046  -0.47526  
 C            1.32092  -1.85045   2.58868  
 H            0.62235  -2.51391   3.11541  
 H            2.26124  -2.40404   2.45492  
 H           1.51789  -0.97718   3.23  
 H           -0.2466   -0.95727   1.46362  
 C             -0.53418   0.59974  -0.52343  
 C            -1.53381  -0.03974  -1.14383  
 H          -1.34477  -0.90317  -1.79039  
 H           -2.5821    0.24717  -1.04109  
 Si           -1.00593   2.11606   0.50859  
 C            -2.74348   1.85984   1.19646  
 H          -2.9976    2.67301   1.89031  
 H            -3.51102   1.84699   0.4116  
 H           -2.81093   0.91226   1.74803  
 C             -1.02158   3.65017  -0.5917  
 H          -1.66591   3.49036  -1.46695  
 H              -1.41018   4.51875  -0.0416  
 H            -0.01933   3.90712  -0.95907  
 C            0.12695   2.44976   1.98023  
 H             1.16054   2.67621   1.68744  
 H            -0.25809   3.32205   2.52853  
 H             0.15077   1.60384   2.68056  
------------------------------------ 
Gc 
Gsol = -1119.446083 Hartree 
------------------------------------ 
C            -3.78067  -0.63495   2.82791  
 C            -2.60559  -1.05957   3.70673  
 C             -1.29994  -0.38755   3.29959  
 C            -1.45604   1.12597   3.20028  
 C            -2.61586   1.48054   2.26096  
 C           -3.92947   0.88778   2.80937  
 H           -0.49782  -0.64945   4.0047  
 H           -2.83753  -0.78632   4.75088  
 H           -2.49176  -2.15336   3.69342  
 H            -3.64165  -0.99981   1.79475  
 H          -4.69624  -1.1103    3.2063  
 H            -1.64339   1.55503   4.20144  
 H           -0.52634   1.58542   2.83067  
  185 
 H           -2.40792   0.94191   1.31445  
 H          -4.02722   1.20144   3.86678  
 H           -0.98573  -0.77152   2.31398  
 C            -5.19254   1.42826   2.09585  
 O            -5.04646   1.54286   0.72556  
 Li          -5.39008   1.69495  -0.94079  
 C          -6.43898   0.6221    2.43288  
 H            -7.32628   1.13723   2.04193  
 H           -6.3969   -0.37285   1.96798  
 H           -6.56875   0.49335   3.51815  
 H           -5.36496   2.44017   2.52713  
 C           -2.63341   2.96127   1.91417  
 C           -1.80663   3.39627   0.88664  
 H           -1.13189   2.708     0.3643  
 H         -1.59901   4.45474   0.71463  
 Si          -3.33518   4.34615   3.02082  
 C             -4.64396   5.30273   2.06071  
 H           -5.04456   6.13203   2.66034  
 H           -4.21746   5.72888   1.14123  
 H           -5.48426   4.65789   1.76697  
 C            -1.90844   5.5076    3.44222  
 H            -1.48963   5.99965   2.5547  
 H           -2.24152   6.29503   4.13258  
 H          -1.09377   4.95492   3.93134  
 C            -4.03441   3.76506   4.67322  
 H            -3.29867   3.18062   5.24207  
 H           -4.27744   4.65354   5.27422  
 H            -4.9485    3.16549   4.58276  
 C            -4.07337   3.13027  -1.8478  
 H            -3.91639   2.2572   -2.51419  
 H            -3.36989   3.88021  -2.22986  
 H          -5.07026   3.5504   -2.09704  
 Cu             -3.62491   2.91329   0.10339  
------------------------------------ 
Gp 
Gsol = -1119.456000 Hartree 
------------------------------------ 
C              -0.44943   2.86949   0.9046  
 C          0.11122   4.01789   0.07856  
 C              1.573     3.76775  -0.2616  
 C             1.72048   2.44248  -0.9923  
 C             1.18261   1.25672  -0.17895  
 C             -0.29246   1.50805   0.2144  
 H             1.97641   4.59056  -0.86876  
 H          -0.46759   4.11038  -0.85663  
 H             -0.01327   4.96677   0.61945  
 H             0.07209   2.84817   1.87769  
 H            -1.51468   3.04624   1.12929  
 H             1.18189   2.50263  -1.95276  
 H           2.77214   2.24304  -1.24428  
 H             1.7558    1.24679   0.76801  
 H            -0.88196   1.5411   -0.7218  
 H             2.16557   3.74469   0.66913  
 C           -0.94783   0.43882   1.10238  
 O           -1.29422  -0.74521   0.34795  
 Li           0.08432  -1.68721  -0.53857  
 C           -0.13941  -0.00805   2.30125  
 H           -0.73681  -0.68428   2.92621  
 H            0.76814  -0.54519   1.98661  
 H            0.1655    0.84685   2.91722  
 H           -1.89777   0.87484   1.46894  
 C             1.42579  -0.06649  -0.9019  
 C           0.97438  -0.19939  -2.16946  
 H           0.45699   0.5872   -2.7401  
 H            1.16183  -1.11292  -2.74888  
 Si           -2.86001  -1.02174  -0.22295  
 C             -2.57482  -2.48678  -1.36176  
 H            -3.51325  -2.8544   -1.79574  
 H            -1.92824  -2.21039  -2.20948  
 H           -2.12184  -3.33763  -0.83051  
 C           -3.48251   0.46497  -1.1712  
 H             -4.4897    0.27926  -1.56745  
 H           -3.53864   1.36362  -0.54187  
 H           -2.82335   0.69078  -2.02069  
 C           -3.964    -1.44143   1.22707  
 H            -3.95701  -0.63861   1.97683  
 H           -5.006    -1.58988   0.91542  
 H          -3.62549  -2.36027   1.72274  
 C               3.33281  -2.91329   0.90965  
 H             3.90773  -3.5267    0.19825  
 H               2.67922  -3.59635   1.47428  
 H             4.04994  -2.48851   1.6315  
 Cu            2.42737  -1.48786   0.01172  
------------------------------------ 
ICuI- 
Gsol = -220.485482 Hartree 
------------------------------------ 
Cu          -1.3747   -0.49474  -0.10819  
 I             1.08895  -0.49474  -0.10819  
 I            -3.83834  -0.49474  -0.10819  
------------------------------------ 
Li+ 
Gsol = -7.472842 Hartree 
------------------------------------ 
Li                   -1.82105   1.21053   0.  
------------------------------------ 
MeCu 
Gsol = -237.237824 Hartree 
------------------------------------ 
Cu            -1.61676   1.11231  -0.57562  
 C            -3.49513   1.11231  -0.57562  
 H            -3.83989   1.60063   0.34278  
 H            -3.83989   1.66351  -1.45771  
H            -3.83989   0.0728   -0.61192  
------------------------------------ 
MeLi 
  186 
Gsol = -47.405685 Hartree 
------------------------------------ 
C          -0.94383   0.45864   0.  
H            -0.60862   1.03461   0.87993  
 H           -0.60862   1.03461  -0.87993  
 H         -2.04553   0.5266    0.  
 Li           -0.28906  -1.39341   0.  
------------------------------------ 
TSA 
Gsol = -895.912962 Hartree 
------------------------------------ 
C     -1.433869     -0.855938     1.204344 
C     -1.907576     -0.918539     2.632511 
C     -1.929891     -1.712399     0.296185 
C     -1.638591     -1.518470     -1.164382 
H     -0.844253     -2.225075     -1.477704 
C     -2.866917     -1.777276     -2.020170 
H     -3.705404     -1.143681     -1.704218 
H     -2.653091     -1.566490     -3.074987 
H     -3.180462     -2.826370     -1.933058 
O     -1.147324     -0.206557     -1.364123 
Si     -1.536387     1.104227     -0.118865 
C     -3.398609     1.334638     -0.318814 
H     -3.978997     0.702840     0.366679 
H     -3.648837     2.381586     -0.094507 
H     -3.726456     1.119687     -1.344075 
C     -1.119822     2.107543     1.470129 
H     -0.036352     2.118097     1.670087 
H     -1.434595     3.153599     1.323294 
H     -1.618484     1.725249     2.368948 
C     -0.674758     2.365307     -1.320022 
H     -1.169938     3.332044     -1.153015 
H     0.387430     2.558374     -1.088606 
H     -0.789965     2.157727     -2.397282 
H     -2.386117     -1.883360     2.863182 
H     -1.098887     -0.757831     3.357515 
Cu     0.428117     -0.394703     0.814687 
I     2.672814     -0.070251     -0.209730 
Li     0.535248     0.339620     -1.891064 
H     -2.654835     -0.133567     2.826181 
H     -2.632808     -2.517950     0.552959 
------------------------------------ 
TSB 
Gsol = -895.902193 Hartree 
------------------------------------ 
C               1.55799   0.75851  -1.19572  
 C           1.86101   0.67134  -2.50346  
 C            2.16672   1.83703  -0.34189  
 H           3.26427   1.74492  -0.36648  
 H            1.93254   2.8411   -0.72988  
 C            1.67438   1.72273   1.1156  
 H            2.51619   1.93868   1.79564  
 C            0.54966   2.69807   1.41057  
 H            -0.27503   2.57577   0.69037  
 H             0.15083   2.5493    2.4263  
 H           0.90037   3.73647   1.34633  
 O            1.23204   0.40474   1.39561  
 Li            -0.46927  -0.10448   1.92256  
 Si          1.65975  -1.03286   0.33372  
 C             3.53843  -1.07216   0.49364  
 H              3.91777  -0.39077   1.26555  
 H             3.84194  -2.09405   0.76405  
 H              4.02479  -0.83022  -0.46035  
 C              0.84658  -2.14797   1.70242  
 H          -0.20477  -2.40792   1.48537  
 H              1.37339  -3.11187   1.67784  
 H            0.93435  -1.78428   2.73914  
 C              1.31254  -2.28334  -1.08744  
 H              1.67398  -3.27361  -0.76538  
 H            0.24262  -2.39653  -1.32279  
 H            1.84157  -2.01209  -2.00901  
 H             2.53353   1.38025  -3.00434  
 H             1.4579   -0.11272  -3.14607  
Cu             -0.29922   0.22647  -0.8751  
 I             -2.55772  -0.15656   0.10358  
------------------------------------ 
TSC 
Gsol = -924.270640 Hartree 
------------------------------------ 
C             -0.1733    0.81252  -1.33325  
 C            0.18187   0.88192  -2.62738  
 C           -0.5376    2.08018  -0.6023  
 H              0.2287    2.85313  -0.77763  
 H           -1.48269   2.49694  -0.98677  
 C             -0.6812    1.8384    0.91646  
 H           -0.22808   2.68615   1.45844  
 C           -2.13515   1.71873   1.33763  
 H             -2.64209   0.93086   0.75644  
 H           -2.2169    1.48346   2.41018  
 H           -2.67849   2.65696   1.16512  
 O           0.00071   0.66301   1.32853  
 Li            -0.90701  -0.9259    1.76533  
 Si          1.33641  -0.11145   0.36574  
 C            2.61446   1.27442   0.33449  
 H             2.44406   2.02971   1.112  
 H            3.611     0.83689   0.49227  
 H             2.63049   1.7739   -0.64289  
 C             1.61826  -1.29989   1.86572  
 H            1.11239  -2.27362   1.73977  
 H              2.68796  -1.55165   1.89211  
 H             1.37041  -0.8797    2.85195  
 C             1.99894  -1.33255  -0.96173  
 H            2.96326  -1.72842  -0.6014  
 H             1.33947  -2.19466  -1.14075  
 H            2.16904  -0.82556  -1.91887  
 H            0.19861   1.82377  -3.19339  
  187 
 H             0.47105  -0.00213  -3.1988  
 Cu            -0.95468  -0.86532  -0.66683  
 C             -1.86065  -2.29966   0.31942  
 H            -2.69074  -2.01811   1.0009  
 H             -2.35955  -2.88617  -0.46504  
 H             -1.23359  -3.03801   0.85527  
------------------------------------ 
TSD 
Gsol = -963.526726 Hartree 
------------------------------------ 
C     -0.998884     -1.649310     2.126683 
H     -0.667569     -2.399732     2.857779 
H     -1.992564     -1.239208     2.306124 
C     -0.232034     -1.282626     1.084900 
C     1.105240     -1.975889     0.931839 
H     1.001830     -2.767749     0.167334 
H     1.381297     -2.495249     1.867519 
C     2.250798     -1.075126     0.492897 
H     3.160560     -1.683757     0.372882 
H     2.484486     -0.322106     1.260704 
C     1.987395     -0.375373     -0.828143 
H     1.629500     -1.149884     -1.542105 
C     3.249614     0.255779     -1.387442 
H     4.023925     -0.500805     -1.571216 
H     3.046216     0.775793     -2.332967 
H     3.646412     0.994739     -0.677267 
C     -0.586024     2.675875     -0.616873 
H     0.176870     2.968739     -1.355329 
H     -1.564676     2.557910     -1.115645 
H     -0.719029     3.548816     0.037541 
C     -1.837962     1.303398     1.490639 
H     -2.684904     0.837182     0.965964 
H     -1.772394     0.866940     2.493891 
H     -2.072632     2.374055     1.600658 
C     1.052020     1.736447     1.903835 
H     0.638030     2.639293     2.377486 
H     1.153616     0.977247     2.690267 
H     2.049410     1.977912     1.515512 
Si     -0.150606     1.182023     0.559984 
O     0.996247     0.644457     -0.761448 
Li     -0.281490     0.816154     -2.116196 
Cu     -1.219738     -0.861050     -0.562309 
C     -1.981162     -0.537381     -2.339820 
H     -1.347653     -0.768957     -3.221128 
H     -2.800383     -1.266288     -2.410493 
H     -2.468974     0.438379     -2.531255 
------------------------------------ 
TSE 
Gsol = -1115.860260 Hartree 
------------------------------------ 
C               -3.81773  -0.84213  -0.69325  
 C            -2.52736  -1.00628  -1.1709  
 C            -1.38983  -0.57648  -0.45575  
 C             -1.62412   0.09484   0.76939  
 C           -2.92802   0.24636   1.24338  
 C             -4.02641  -0.22389   0.5361  
 H            -4.66426  -1.18862  -1.28499  
 H            -2.37414  -1.45689  -2.15111  
 H           -3.08556   0.77321   2.18796  
 H             -5.03269  -0.08089   0.92591  
 C            -0.0664   -0.63981  -1.09362  
 C           0.21369  -1.72299  -1.89494  
 H           -0.46757  -2.57533  -2.06071  
 H            1.07432  -1.71149  -2.58085  
 Si            0.81861   1.88289  -0.51951  
 C             2.3817    1.32398  -1.41331  
 H             2.12428   0.84242  -2.36442  
 H            3.04826   2.17637  -1.60953  
 H             2.96216   0.57557  -0.84972  
 C            -0.69146   2.29523  -1.56261  
 H          -1.62157   2.22581  -0.9826  
 H           -0.59978   3.33333  -1.91276  
 H           -0.7946    1.62814  -2.42516  
 C              1.27313   3.56815   0.23678  
 H            1.47692   4.31954  -0.54009  
 H            0.45073   3.9556    0.85696  
 H             2.16426   3.5087    0.87881  
 C             -0.54821   0.71002   1.64351  
 H           -0.95649   1.65708   2.04555  
 C            -0.21016  -0.19838   2.81744  
 H           -1.0915   -0.38109   3.44287  
 H             0.13225  -1.18173   2.45558  
 H             0.56305   0.25667   3.4576  
 O             0.67397   1.02535   0.98937  
 Cu             1.43571  -1.81691  -0.23813  
 C             2.82842  -2.11848   1.10633  
 H            3.75131  -1.50448   1.06623  
 H              2.53077  -2.19407   2.16994  
 H             3.17741  -3.12874   0.85134  
 Li            2.05889  -0.15315   1.34584  
------------------------------------ 
TSF 
Gsol = -1119.395002 Hartree 
------------------------------------ 
C              3.62041  -0.09582  -0.67828  
 C             2.29425   0.64113  -0.54223  
 C            1.11115  -0.23561  -0.9855  
 C              1.06444  -1.59309  -0.24008  
 C            2.44034  -2.2777   -0.2518  
 C              3.61725  -1.38311   0.13407  
 H              2.16118   0.97686   0.50119  
 H            2.30404   1.55524  -1.15464  
 H            3.78576  -0.33587  -1.74263  
 H              4.45332   0.55169  -0.36913  
 H             0.41383  -2.23849  -0.85523  
 H             2.41401  -3.17871   0.38269  
  188 
 H             2.62184  -2.63867  -1.2776  
 H         3.58605  -1.12598   1.20344  
 H             4.55597  -1.93546  -0.01647  
 H           1.34978  -0.5099   -2.03628  
 C             0.39567  -1.64936   1.14928  
 H             0.23908  -2.72747   1.353  
 O           -0.88185  -1.01909   1.16387  
 Li          -0.86238   0.84309   1.41112  
 C              1.15913  -1.0866    2.33581  
 H            1.43064  -0.02802   2.1974  
 H            0.53074  -1.17021   3.23253  
 H             2.08483  -1.64012   2.52934  
 C          -0.22876   0.50001  -1.00191  
 C           -0.36565   1.46693  -1.97223  
 H              0.38981   1.6658   -2.75088  
 H            -1.34548   1.92008  -2.18681  
 Si           -2.02145  -1.02915  -0.16448  
 C           -3.18015   0.44475   0.11067  
 H             -4.17541   0.1596   -0.2608  
 H         -3.32752   0.63021   1.18949  
 H          -2.89434   1.38792  -0.37139  
 C            -3.08255  -2.45204   0.55027  
 H            -2.49044  -3.37609   0.64228  
 H            -3.45922  -2.21243   1.55502  
 H          -3.94832  -2.68578  -0.08757  
 C            -1.86556  -1.71077  -1.93246  
 H            -2.87517  -1.60302  -2.36148  
 H           -1.15873  -1.22526  -2.60971  
 H           -1.66056  -2.7904   -1.90009  
 C            -0.35701   3.07841   1.69044  
 H            -0.22694   4.16881   1.63794  
 H            -1.33189   2.94621   2.19975  
 H           0.42775   2.7296    2.38636  
 Cu           -0.20955   2.42785  -0.13962  
------------------------------------ 
TSG 
Gsol = -1119.398782 Hartree 
------------------------------------ 
C             3.05274   0.19015   1.20123  
 C               4.09307  -0.10954   0.13386  
 C              3.65039  -1.31004  -0.68894  
 C            2.27848  -1.07825  -1.30771  
 C             1.19348  -0.70587  -0.28569  
 C             1.67812   0.47399   0.59112  
 H            4.38493  -1.539    -1.47437  
 H               4.20987   0.76713  -0.52555  
 H             5.07442  -0.29068   0.59467  
 H               2.9845   -0.68426   1.87129  
 H            3.36287   1.04137   1.82869  
 H            2.34644  -0.26819  -2.0563  
 H            1.97245  -1.97759  -1.85891  
 H             1.09155  -1.57565   0.39744  
 H            1.81367   1.34512  -0.0784  
 H             3.60851  -2.19728  -0.03354  
 C            0.7115    0.93141   1.69222  
 O            -0.58455   1.26546   1.21069  
 Li             -1.71848  -0.23113   1.07137  
 C             0.51385  -0.07372   2.8165  
 H           -0.23986   0.30723   3.51863  
 H            0.17722  -1.05398   2.43883  
 H             1.43586  -0.24612   3.38335  
 H            1.15072   1.84759   2.13265  
 C            -0.19151  -0.445    -0.89589  
 C           -0.55392  -1.12091  -2.04013  
 H             0.09883  -1.77106  -2.63863  
 H            -1.48084  -0.84558  -2.567  
 Si           -0.97347   1.89817  -0.37211  
 C            -2.78695   1.40756  -0.64043  
 H           -3.2573    2.19033  -1.25255  
 H             -2.96082   0.44561  -1.14134  
 H           -3.34816   1.42113   0.31056  
 C             0.02654   2.15829  -1.9716  
 H              -0.60676   1.81287  -2.80167  
 H            0.23351   3.22835  -2.11305  
H             0.96865   1.60823  -2.0575  
 C               -1.1353    3.70819   0.2077  
 H           -0.15524   4.10345   0.51887  
 H            -1.5052    4.36383  -0.59484  
 H               -1.81041   3.80686   1.06914  
 C            -2.641    -2.38378   1.12681  
 H             -3.15753  -3.32967   0.90949  
 H           -3.46083  -1.67804   1.36821  
 H             -2.08049  -2.56508   2.06052  
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E 3 EXPERIMENTAL SECTION CORRESPONDING TO 
CHAPTER 3 
E3.1 Materials and Methods  
E3.1.1 Reaction equipment, solvents, reagents, and conditions 
All reactions that require anhydrous conditions were performed in an oven- or 
flame-dried glassware under N2 atmosphere. All reactions were stirred magnetically unless 
otherwise mentioned. All chemicals were purchased from commercial vendors, unless 
otherwise referenced. Anhydrous tetrahydrofuran (THF), diethyl ether (Et2O), 
dichloromethane (CH2Cl2), and toluene were acquired from a Pure Solve PS-400 solvent 
purification system. Hexamethylphosphoramide (HMPA), trimethylsilyl chloride 
(TMSCl), and triethylamine (Et3N), diisopropylamine, diisopropylethylamine (DIPEA) 
were distilled from calcium hydride. Commercial n-butyllithium (n-BuLi) solutions were 
titrated by using diphenylacetic acid.1 Ice/water bath was used to create 0 °C reaction 
temperature; dry ice/acetonitrile bath was used for – 41 °C reaction temperature; dry 
ice/acetone bath was used to generate −78 °C reaction temperature.  
E3.1.2 Reaction monitoring and purification 
Reactions were monitored by using thin layer chromatography (TLC) with 250 mm 
pre-coated silica gel plates purchased from Silicycle Technology. Liquid chromatography–
mass spectrometry (LC-MS) analyses for reaction monitoring were conducted with a 
Waters Acquity Ultra Performance LC system equipped with an Acquity UPLC®HSS C18 
column (1.8 µm, 2.1 ´ 50 mm), a TUV detector (253 and 215 nm) and a SQ detector. Silica 
gel flash chromatography was conducted by using ACS grade solvents and silica gel which 
was purchased from Silicycle Technology. Silica gel flash chromatography was conducted 
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under positive pressure by applying pressurized air. High-performance liquid 
chromatography (HPLC) was conducted by using Gilson 333/334 Pumps equipped with an 
UV-Vis dual wavelength detector and a C18 column [VYDACTM 5 µm C18 monomeric, 
250 × 10 mm or phenomenex® Luna® 3 µm C18(2) 100 Å, 250 x 4.6 mm].  
E3.1.3 Analyses and compound characterizations 
Supercritical fluid chromatography (SFC) analyses were performed with a JASCO 
system equipped with a Chiralcel® OJ-H column (5 µm, 4.6 mm × 250 mm), a PU-280-
CO2 plus CO2 Delivery System, a CO-2060 plus Intelligent Column Thermostat, an HC-
2068-01 Heater Controller, a BP-2080 plus Automatic Back Pressure Regulator, an MD-
2018 plus Photodiode Array Detector (200-648 nm), and PU-2080 plus Intelligent HPLC 
Pumps. All melting points were acquired on a Thomas-Hoover apparatus and are 
uncorrected. All optical rotations were measured on a Jasco P-2000 polarimeter. All 
infrared spectra were recorded on a Jasco Model FT/IR-480 Plus spectrometer. Circular 
dichroism (CD) spectra was recorded on a Lakewood Model 62A DS spectrometer r in a 1 
mm quartz cell at 25 oC. 1H NMR and 13C NMR spectra were recorded on Bruker Avance 
III 500 MHz spectrometer equipped with either an Oxford cryomagnet or a 
Spectrospin/Bruker cryomagnet (500MHz/52mm) with a 5 mm dual cryo probe by using 
either 5 mm or 3 mm NMR tubes. All chemical shifts (δ, in ppm) reported were referred to 
chloroform (δ 7.26), methanol-d4 (δ 3.31), benzene-d6 (δ 7.16), dimethyl sulfoxide-d6 (δ 
2.49) for 1H NMR and chloroform (δ 77.16), methanol-d4 (δ 49.00), benzene-d6 (δ 128.06), 
dimethyl sulfoxide-d6 (δ 39.50) for 13C NMR.2 The following abbreviations were used to 
explain the multiplicities: s=singlet, d=doublet, t=triplet, q=quartet, qn=quintet, sxt=sextet, 
dd=doublet of doublets, ddd=doublet of doublet of doublets, dt=doublet of triplets, 
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td=triplet of doublets, m=multiplet, br=broad, app=apparent. High-resolution mass spectra 
(HRMS) were acquired either on a Waters LC-TOF mass spectrometer (model LCT-XE 
Premier) or on a waters GCT Premier spectrometer at the University of Pennsylvania. 
Single crystal X-ray structures were determined at the University of Pennsylvania. X-ray 
intensity data were collected on a Bruker APEXII CCD area detector employing graphite-
monochromated Cu-Kα radiation (λ= 1.54178 Å) or on a Bruker D8QUEST CMOS area 
detector employing graphite-monochromated Mo-Kα radiation (λ=0.71073Å) at a 
temperature of 100K.  
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E3.2 Detailed Experimental Procedures 
 
To a solution of 2-bromopropene (110 uL, 1.24 mmol) in Et2O (4.4 mL) was added 
dropwise t-BuLi (1.6 mL, 1.55 M in pentane, 1.24 mmol) at –78 ºC. After 30 min, the 
linchpin (+)-3.453 (280 mg, 1.13 mmol) solution in Et2O (2.2 mL) was added. After another 
30 minutes, the reaction mixture was warmed to –20 ºC, followed by the addition of a 
mixture of epoxide (235 mg, 1.13 mmol) and HMPA (710 uL, 2.91 mmol) in Et2O (0.7 
mL). After 1 h, the reaction mixture was warmed to –10 ºC, followed by the addition of 
MOMCl (120 uL, 1.58 mmol) The reaction mixture was warmed to room temperature and 
stirred for another hour before quenching with a saturated aqueous solution of NaHCO3. 
Layers were separated and the aqueous layer was extracted with Et2O. The combined 
organic layers were washed with brine, dried over MgSO4, and concentrated in vacuo. The 
crude mixture was purified via flash chromatography on SiO2 (1:10 EtOAc/hexanes, 
buffered with 0.5% Et3N) to provide (–)-3.42 (503 mg, 0.95 mmol, 84%) as a pale-yellow 
oil: [a]20D   -15.2 (c 2.5, CHCl3); IR (neat) 2950, 1613, 1513, 1442, 1368, 1249, 1152, 1105, 
1038, 875, 840, 754 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.29 (d, J = 8.3 Hz, 2H), 6.87 (d, 
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– 4.37 (m, 2H), 4.23 – 4.08 (m, 1H), 3.80 (s, 3H), 3.60 (t, J = 7.0 Hz, 2H), 3.36 (s, 3H), 
2.91 – 2.74 (m, 2H), 2.68 – 2.58 (m, 2H), 2.24 (q, J = 7.0 Hz, 1H), 2.13 – 2.01 (m, 3H), 
2.01 – 1.80 (m, 3H), 1.73 (s, 3H), 1.06 (d, J = 6.9 Hz, 3H), 0.10 (s, 9H); 13C NMR (125 
MHz, CDCl3) δ 159.2, 148.0, 130.9, 129.5, 113.8, 111.4, 96.5, 75.0, 74.0, 72.7, 67.1, 58.5, 
56.1, 55.4, 41.4, 41.2, 37.5, 26.1, 24.9, 20.2, 8.3, 1.0; HRMS (ESI) m/z 565.2448 
[(M+Na)+; calcd for C27H46O5SiS2Na 565.2454]. 
 
To a solution of (–)-3.42 (188 mg, 0.35 mmol) in MeCN (6 mL) and H2O (1 mL) 
was added PhI(O2CCF3)2 (155 mg, 0.36 mmol) at 0 ºC. After 5 min, the reaction mixture 
was quenched with a saturated aqueous solution of NaHCO3 and extracted with EtOAc. 
The combined organic layers were washed with brine, dried over MgSO4, and concentrated 
in vacuo. The crude mixture was purified via flash chromatography on SiO2 (1:2 
EtOAc/hexanes) to provide (+)-3.49 (107 mg, 0.28 mmol, 79 %) as a pale-yellow oil.: [a]20D   
+ 25.0 (c 2.0, CHCl3); IR (neat) 3461, 2936, 1708, 1612, 1513, 1453, 1248, 1098, 1035, 
907, 821cm-1; 1H NMR (500 MHz, CDCl3) δ 7.26 (d, J = 1.5 Hz, 2H), 6.87 (d, J = 8.4 Hz, 
2H), 5.08 (s, 1H), 4.98 – 4.88 (m, 1H), 4.62 (dd, J = 11.9, 6.5 Hz, 2H), 4.45 (s, 1H), 4.42 
(s, 2H), 4.27 – 4.18 (m, 1H), 3.80 (s, 3H), 3.60 – 3.50 (m, 2H), 3.32 (s, 3H), 2.89 (dd, J = 
16.7, 7.6 Hz, 1H), 2.84 (d, J = 3.0 Hz, 1H), 2.71 – 2.55 (m, 2H), 1.95 – 1.77 (m, 2H), 1.55 
(s, 3H), 1.02 (d, J = 7.2 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 213.2, 159.3, 143.8, 130.5, 
129.5, 113.9, 111.7, 96.7, 73.3, 72.8, 72.5, 66.3, 55.8, 55.4, 49.0, 47.2, 35.1, 19.7, 8.8; 
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To a solution of (+)-3.49 (160 mg, 0.42 mmol) in THF (4.6 mL) and H2O (1.1 mL) 
at –78 ºC was added Et2BOMe (1.26 mL, 1.0 M in THF, 1.26 mL.). After 30 min, NaBH4 
(64 mg, 0.44 mol) was added. After 1 h, the reaction mixture was warmed to 0 ºC and 
stirred for another 1h at the same temperature before quenching with an aquous solution of 
NaOH (4 mL, 1N) and H2O2 (0.4 mL, 50 wt. % in H2O). The reaction mixture was then 
warmed to room temperature and stirred for 30 min. Layers were separated and the aqueous 
layer was extracted with EtOAc. The combined organic layers were washed with brine, 
dried over MgSO4, and concentrated in vacuo. The crude mixture was purified via flash 
chromatography on SiO2 (1:1 EtOAc/hexanes) to provide (+)-3.50 (135 mg, 0.35 mmol, 
84 %) as a pale-yellow oil:  [a]20D   +18.6 (c 1.7, CHCl3); IR (neat) 3435, 2941, 1612, 1513, 
1460, 1302, 1248, 1096, 1035, 902, 821 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.25 (d, J = 
8.8 Hz, 2H), 6.87 (d, J = 8.7 Hz, 2H), 5.07 (s, 1H), 4.91 (s, 1H), 4.65 (dd, J = 11.2, 6.3 Hz, 
2H), 4.42 (s, 2H), 4.27 (s, 1H), 4.15 (d, J = 8.0 Hz, 1H), 4.05 – 3.91 (m, 1H), 3.80 (s, 3H), 
3.70 (s, 1H), 3.52 (d, J = 6.5 Hz, 2H), 3.43 (s, 1H), 3.40 (s, 3H), 1.97 – 1.75 (m, 3H), 1.66 
(s, 3H), 1.63 – 1.56 (m, 1H), 1.47 (ddd, J = 14.3, 8.5, 2.4 Hz, 1H), 0.84 (d, J = 7.0 Hz, 3H); 
13C NMR (125 MHz, CDCl3) δ 159.3, 145.4, 130.4, 129.5, 113.9, 110.5, 97.0, 79.4, 74.0, 
72.8, 72.2, 66.3, 56.0, 55.4, 40.2, 39.3, 35.3, 19.8, 5.0; HRMS (ESI) m/z 405.2240 





Et2BOMe (3 eq.) 
NaBH4 (4 eq.)
THF/MeOH (3:1)
–78 ºC to rt, 2 h
PMBO
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To a solution of (+)-3.50 (167 mg, 0.44 mmol) in CH2Cl2 (6 mL) and 1,1-
dimethoxyl propane (3 mL) was added PPTS (11 mg, 0.044 mol). The resulting mixture 
was stirred at room temperature for 3 h before quenching with a saturated solution of 
NaHCO3. Layers were separated and the aqueous layer was extracted with EtOAc. The 
combined organic layers were washed with brine, dried over MgSO4, and concentrated in 
vacuo. The crude mixture was purified via flash chromatography on SiO2 (1:10 
EtOAc/hexanes) to provide (+)-3.51 (160 mg, 0.38 mmol, 86 %) as a pale-yellow oil: [a]20D   
+7.5 (c 1.7, CHCl3); IR (neat) 2937, 1612, 1513, 1444, 1379, 1247, 1200, 1095, 1037, 917, 
822, 770 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.27 (d, J = 8.7 Hz, 2H), 6.87 (d, J = 8.3 
Hz, 2H), 5.03 (s, 1H), 4.89 (s, 1H), 4.66 (dd, J = 12.6, 6.4 Hz, 2H), 4.52 – 4.39 (m, 2H), 
4.28 (s, 1H), 4.13 (dt, J = 9.6, 2.5 Hz, 1H), 3.90 – 3.84 (m, 1H), 3.80 (s, 3H), 3.55 (t, J = 
6.7 Hz, 2H), 3.37 (s, 3H), 1.96 – 1.80 (m, 2H), 1.72 – 1.65 (m, 1H), 1.64 (s, 3H), 1.53 – 
1.46 (m, 2H), 1.43 (d, J = 7.3 Hz, 6H), 0.73 (d, J = 6.9 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) δ 159.2, 142.8, 130.7, 129.4, 113.9, 110.2, 99.0, 96.9, 75.4, 73.4, 72.8, 69.4, 66.6, 
55.8, 55.4, 39.7, 35.8, 34.0, 30.1, 19.7, 19.4, 5.3; HRMS (ESI) m/z 445.2576 [(M+Na)+; 
calcd for C24H38O6Na 445.2566]. 
 
To a solution of (+)-3.51 (55 mg, 0.13 mmol) in toluene (1.5 mL) was added 
Wilkinson’s catalyst (30 mg, 0.03 mol). The flask was purged with three cycles of H2 
gas/vacuum. A H2 balloon was then attached and the resulting solution was stirred 
vigorously overnight). The reaction mixture was then concentrated directly in vacuo and 
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to provide (+)-3.52 (45 mg, 0.11 mmol, 82 %) as a pale-yellow oil: [a]20D   +1.0 (c 2.0, 
CHCl3); IR (neat) 2937, 1612, 1513, 1444, 1379, 1247, 1200, 1095, 1037, 917, 822, 770 
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.26 (d, J = 8.5 Hz, 3H), 6.87 (d, J = 9.7 Hz, 2H), 
4.65 (dd, J = 13.7, 6.3 Hz, 2H), 4.48 – 4.32 (m, 2H), 4.01 (dt, J = 9.6, 2.6 Hz, 1H), 3.88 – 
3.81 (m, 1H), 3.80 (s, 3H), 3.54 (t, J = 6.7 Hz, 2H), 3.37 (s, 3H), 3.31 (dd, J = 9.7, 2.1 Hz, 
1H), 1.90 – 1.78 (m, 2H), 1.72 – 1.60 (m, 2H), 1.51 – 1.40 (m, 2H), 1.40 – 1.37 (m, 6H), 
0.93 (d, J = 6.4 Hz, 3H), 0.82 (d, J = 6.8 Hz, 3H), 0.78 (d, J = 6.7 Hz, 3H); 13C NMR (125 
MHz, CDCl3) δ 159.2, 130.8, 129.4, 113.9, 98.9, 96.9, 79.6, 73.4, 72.7, 69.9, 66.6, 55.8, 
55.4, 39.6, 35.8, 33.7, 30.2, 29.3, 20.0, 19.8, 17.5, 5.0; HRMS (ESI) m/z 447.2728 
[(M+Na)+; calcd for C24H40O6Na 447.2723]. 
 
To a mixture of (+)-3.52 (37 mg, 0.087 mmol) in CH2Cl2 (1.5 mL) and pH 7 buffer 
(0.3 mL) was added DDQ (23 mg, 0.1 mmol) at 0 ºC. The reaction mixture was stirred at 
the same temperature for 2 h before quenching with a saturated aqueous solution of 
NaHCO3. Layers were separated and the organic layer was extracted with Et2O. The 
combined organic layers were washed with brine, dried over MgSO4, and concentrated in 
vacuo. The crude mixture was purified via flash chromatography on SiO2 (1:2 
EtOAc/hexanes) to provide (–)-3.53 (20 mg, 0.067 mmol, 77 %) as a pale-yellow oil: [a]20D   
-22.7 (c 1.5, CHCl3); IR (neat) 3445(br), 2955, 1463, 1385, 1262, 1201, 1164, 1107, 1037, 
1012, 918 cm-1; 1H NMR (500 MHz, CDCl3) δ 4.69 (t, J = 8.0, 6.8 Hz, 2H), 3.99 (dt, J = 
10.0, 2.3 Hz, 1H), 3.95 – 3.88 (m, 1H), 3.87 – 3.78 (m, 1H), 3.78 – 3.68 (m, 1H), 3.43 (s, 
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(m, 1H), 1.42 (dt, J = 6.8, 2.2 Hz, 1H), 1.40 (s, 3H), 1.38 (s, 3H), 0.94 (d, J = 6.4 Hz, 3H), 
0.84 (d, J = 6.8 Hz, 3H), 0.80 (d, J = 6.7 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 99.0, 
97.3, 79.6, 74.6, 70.0, 59.5, 56.1, 39.6, 38.0, 33.8, 30.2, 29.3, 19.9, 19.8, 17.5, 5.0; HRMS 
(ESI) m/z 327.2140 [(M+Na)+; calcd for C16H32O5Na 327.2147]. 
 
To a solution of (–)-3.53 (26 mg, 0.085 mmol) in CH2Cl2 (2.5 mL) was added Dess-
Martin periodinane (47 mg, 0.11 mmol) and NaHCO3 (36 mg, 0.43 mmol). The resulting 
suspension was stirred at room temperature for 1 h before it was diluted with hexanes. The 
reaction mixture was then filtered through celite and concentrated in vacuo. The crude 
mixture was purified via flash chromatography on SiO2 (1:5 EtOAc/hexanes) to provide (–
)-3.41 (21 mg, 0.069 mmol, 81 %) as a pale-yellow oil: [a]20D   -5.6 (c 2.0, CHCl3); IR (neat) 
2957,1726, 1461, 1385, 1262, 1201, 1164, 1109, 1038, 1011, 980, 915, 744 cm-1; 1H NMR 
(500 MHz, CDCl3) δ 9.80 (t, J = 2.4 Hz, 1H), 4.70 (d, J = 6.9 Hz, 1H), 4.67 (d, J = 6.9 Hz, 
1H), 4.37 – 4.16 (m, 1H), 4.02 (dt, J = 10.1, 2.3 Hz, 1H), 3.46 – 3.19 (m, 4H), 2.77 – 2.52 
(m, 2H), 1.86 – 1.53 (m, 3H), 1.46 – 1.40 (m, 1H), 1.38 (s, 3H), 1.38 (s, 3H), 0.93 (d, J = 
6.4 Hz, 3H), 0.83 (d, J = 6.8 Hz, 3H), 0.79 (d, J = 6.7 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) δ 201.6, 99.0, 97.1, 79.6, 71.9, 69.8, 55.8, 50.1, 39.8, 33.7, 30.1, 29.3, 19.9, 19.8, 
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PPh3 (16 mg, 0.06 mmol) was added into a solution of CBr4 (10 mg, 0.03 mmol) in 
CH2Cl2 (0.5 mL) at 0 ºC, followed by the addition of (–)-3.41 (6 mg, 0.02 mmol) in CH2Cl2 
(0.5 mL). After 1 h, the reaction mixture was diluted with hexanes, filtered through celite 
and concentrated in vacuo. The crude mixture was purified via flash chromatography on 
SiO2 (1:20 EtOAc/hexanes) to provide (+)-3.54 (6.5 mg, 0.014 mmol, 72 %) as a pale-
yellow oil: [a]20D   +10.8 (c 0.6, CHCl3); IR (neat) 2956, 1460, 1380, 1261, 1201, 1153, 1100, 
1037, 917, 745 cm-1; 1H NMR (500 MHz, CDCl3) δ 6.53 (dd, J = 7.6, 6.6 Hz, 1H), 4.67 
(s, 2H), 4.00 (dt, J = 10.0, 2.3 Hz, 1H), 3.93 – 3.69 (m, 1H), 3.40 (s, 3H), 3.31 (dd, J = 9.7, 
2.1 Hz, 1H), 2.50 – 2.39 (m, 1H), 2.36 – 2.25 (m, 1H), 1.74 – 1.58 (m, 2H), 1.51 – 1.41 
(m, 2H), 1.39 (s, 3H), 1.38 (s, 3H), 0.93 (d, J = 6.4 Hz, 3H), 0.84 (d, J = 6.8 Hz, 3H), 0.79 
(d, J = 6.8 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 135.2, 99.0, 96.8, 90.2, 79.7, 73.8, 
69.8, 55.9, 39.2, 39.2, 33.7, 30.2, 29.3, 19.9, 19.8, 17.5, 5.1; HRMS (ESI) m/z 479.0410 
[(M+Na)+; calcd for C17H30O4NaBr2 479.0409]. 
 
To a solution of (+)-3.54 (6 mg, 0.013 mmol) in THF (0.5 mL) was added n-BuLi 
(20 uL, 2.5 M in hexanes, 0.05 mmol) at –78 ºC. After 30 min, MeI (20 uL ,0.32 mmol) 
was added. The reaction mixture was then warmed to room temperature and stirred for 30 
min before quenching with MeOH. The reaction mixture was directly concentrated in 
vacuo. The crude mixture was purified via flash chromatography on SiO2 (1:20 
EtOAc/hexanes) to provide (+)-3.23-a (3.4 mg, 0.0011 mmol, 83%) as a pale-yellow oil: 
[a]20D    + 23.2 (c 1.4, CHCl3); IR (film, cm-1) 2957, 1463, 1385, 1261, 1200, 1153, 1105, 
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  200 
= 6.8 Hz, 1H), 4.10 – 4.04 (m, 1H), 3.83 – 3.76 (m, 1H), 3.42 (s, 3H), 3.31 (dd, J = 9.6, 1.7 
Hz, 1H), 2.58 – 2.51 (m, 1H), 2.36 – 2.30 (m, 1H), 1.80 (t, J = 2.5 Hz, 3H), 1.75 – 1.58 (m, 
3H), 1.49 – 1.43 (m, 1H), 1.39 (s, 3H), 1.38 (s, 3H), 0.94 (d, J = 6.4 Hz, 3H), 0.85 (d, J = 
6.8 Hz, 3H), 0.79 (d, J = 6.8 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 99.0, 96.8, 79.7, 
77.6, 75.4, 73.5, 69.7, 55.8, 38.8, 33.7, 30.2, 29.3, 26.0, 20.0, 19.8, 17.5, 5.1, 3.8; HRMS 
(ESI) m/z 335.2212 [(M+Na)+; calcd for C18H32O4Na: 335.2198]. 
 
Linchpin (+)-3.45 (5 g, 20.1 mmol) was dissolved in Et2O (100 mL) and the resulting 
solution was cooled down to –78 ºC. Before precipitates formed, isopropyl lithium (3.57) 
(34.5 mL, 0.7 M in pentane, 24.1 mmol) was added dropwise. After 30 min, a premixed 
solution of (R)-epichlorohydrin [(–)-3.58] (2.77 g, 30.2 mmol) and HMPA (7.2 g, 41.3 
mmol) in Et2O (40 mL) was added dropwise at –50 ºC. During this addition, the reaction 
mixture was gradually turned from yellow to pink. After the addition was completed, the 
reaction mixture was warmed to room temperature over 2 h and then stirred at room 
temperature for another hour. During the warming up process, the color of reaction mixture 
was changed from pink to yellow and finally to brown at room temperature. The reaction 
mixture was then quenched with a saturated solution of NaHCO3 and extracted with Et2O. 
The combined organic layers were washed with brine, dried over Na2SO4 and concentrated 
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hexanes/EtOAc to 5:1 hexanes/EtOAc) to afford the adduct (+)-3.56 (5.3 g, 76%) as a pale-
yellow oil: [a]20D   + 3.0 (c 1.6, CHCl3); IR (film, cm
-1) 2955, 1422 1249, 1096, 1060, 869, 
839, 751;1H NMR (500 MHz, CDCl3) δ 4.27 (dd, J = 4.3, 1.5 Hz, 1H), 3.29 (s, 1H), 2.87 
– 2.71 (m, 5H), 2.54 (dd, J = 5.1, 2.8 Hz, 1H), 2.29 – 2.16 (m, 2H), 2.08 (dd, J = 15.3, 5.9 
Hz, 1H), 2.05 – 1.95 (m, 1H), 1.95 – 1.85 (m, 1H), 1.77 – 1.68 (m, 1H), 1.07 (d, J = 7.1 
Hz, 3H), 0.93 (d, J = 6.9 Hz, 3H), 0.91 (d, J = 6.8 Hz, 3H), 0.15 (s, 9H);13C NMR (125 
MHz, CDCl3) δ 75.6, 58.4, 49.6, 47.3, 41.8, 39.1, 36.2, 26.3, 26.0, 25.2, 19.1, 18.1, 10.4, 
1.3; HRMS (ESI) m/z 371.1513 [(M+Na)+; calcd for C16H32O2NaSiS2: 371.1511]. 
 
To a solution of (+)-3.56 (5.3 g, 15.2 mmol) in THF (200 mL) and H2O (50 mL) was 
added mercury perchlorate hydrate (15.2 g, 38.0 mmol) and CaCO3 (7.6 g, 75.9 mmol). 
The resulting suspension was stirred vigorously at room temperature for 40 min, then 
filtrated through a tri-layer pad (Na2SO4, celite and Na2SO4) and rinsed with Et2O. The 
filtrate was then diluted with Et2O, washed with NaHCO3 and extracted with Et2O. The 
combined organic layers were washed with brine, dried over Na2SO4 and concentrated in 
vacuo to furnish a crude mixture (2.5 g). Compound (+)-3.62 was not stable. Flash 
chromatograph was quickly performed with a short SiO2 column (3:1 hexanes/EtOAc) to 
afford (+)-3.62 (2.26 g, 80%) as a pale-yellow oil. To avoid decomposition, the crude 
material could be submitted into next step without purification. [a]20D   + 23.6 (c 2.2, CH2Cl2); 
IR (film, cm-1) 3483(br), 2963, 1707, 1458, 1387, 1261, 981, 851; 1H NMR (500 MHz, 
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– 1.93 (m, 1H), 1.62 – 1.49 (m, 1H), 0.99 (d, J = 6.6 Hz, 3H), 0.92 (d, J = 7.1 Hz, 3H), 
0.62 (d, J = 6.7 Hz, 3H); 13C NMR (125 MHz, C6D6) δ 211.7, 76.1, 48.8, 47.8, 46.3, 44.5, 
31.1, 19.1, 19.1, 9.3; HRMS (ESI) m/z 209.1166 [(M+Na)+ ; calcd for C10H18O3Na: 
209.1154]. 
 
To a solution of (+)-3.62 (0.5 g, 2.69 mmol) in THF (10 mL) and MeOH (2.5 mL) was 
added Et2BOMe (2.96 mL, 2.96 mmol, 1 M in THF) at –78 ºC. After 1 hour, NaBH4 (204 
mg, 5.38 mmol) was added and the reaction mixture was stirred at the same temperature 
for 2 h before quenching with a saturated solution of NaHCO3. The reaction mixture was 
warmed to room temperature, diluted with EtOAc, and the layers were separated. The 
aqueous layer was extracted with EtOAc, and the combined organic layers were washed 
with brine, dried over MgSO4, and concentrated in vacuo. The crude mixture was 
repeatedly concentrated in vacuo with MeOH to remove boron residues. Flash column 
chromatography on SiO2 (3:1 to 1:1 hexanes/EtOAc) then provided the diol (+)-3.63 (92:8 
mixture of isomers suggested by 1H NMR), as a pale-yellow oil (379 mg, 75% yield): [a]20D   
+ 27.3 (c 1.0, CHCl3); IR (film, cm-1) 3401 (br), 2965, 1649, 1464, 1257, 1158, 1088, 972, 
924, 849, 748; 1H NMR (500 MHz, methanol-d4) δ 4.06 – 3.88 (m, 1H),3.33 – 3.29(m, 1H) 
(Signal is overlapped with methanol-d4), 3.15 – 3.03 (m, 1H), 2.79 (t, J = 4.6 Hz, 1H), 2.61 
– 2.48 (m, 1H), 1.94 – 1.62 (m, 3H), 1.59 – 1.46 (m, 1H), 0.97 (d, J = 6.7 Hz, 3H), 0.93 (d, 
J = 7.1 Hz, 3H), 0.87 (d, J = 6.8 Hz, 3H); 13C NMR (125 MHz, methanol-d4) δ 81.1, 73.9, 
51.3, 48.1, 41.0, 39.3, 32.2, 19.7, 19.2, 7.1; HRMS (ESI) m/z 211.1315 [(M+Na)+ ; calcd 
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To a solution of (+)-3.63 (0.9 g, 4.78 mmol) in CH2Cl2 (48 mL) was added 2-
methoxylpropene (0.92 mL, 9.57 mmol) and PPTS (120 mg, 0.48 mmol) at 0 ºC. The 
reaction mixture was stirred for 2 h before quenching with a saturate solution of NaHCO3, 
and the layers were separated. The aqueous layer was extracted with CH2Cl2, and the 
combined organic layers were washed with brine, dried over MgSO4, and concentrated in 
vacuo. Flash column chromatography on SiO2 (20:1 hexanes/EtOAc) provided the acetal 
(+)-3.55 (890 mg, 82% yield) as a pale-yellow oil: [a]20D   + 26.4 (c 3.7, CHCl3); IR (film, 
cm-1) 2989, 1462, 1381, 1267, 1201, 1111, 1069, 1011, 983, 913, 939 cm-1; 1H NMR (500 
MHz, CDCl3) δ 4.10 (ddd, J = 9.4, 3.6, 2.3 Hz, 1H), 3.34 (dd, J = 9.7, 2.1 Hz, 1H), 3.09 – 
3.00 (m, 1H), 2.78 (dd, J = 5.0, 4.0 Hz, 1H), 2.49 (dd, J = 5.1, 2.8 Hz, 1H), 1.94 (ddd, J = 
14.1, 9.3, 3.4 Hz, 1H), 1.73 – 1.64 (m, 1H), 1.52 – 1.45 (m, 1H), 1.42 (s, 3H), 1.39 (s, 3H), 
1.24 (ddd, J = 14.2, 8.1, 3.6 Hz, 1H), 0.93 (d, J = 6.4 Hz, 3H), 0.83 (d, J = 6.8 Hz, 3H), 
0.79 (d, J = 6.7 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 99.1, 79.5, 71.5, 50.1, 47.4, 37.0, 
33.6, 30.1, 29.3, 19.9, 19.8, 17.5, 4.9; HRMS (ESI) m/z 251.1637 [(M+Na)+ ; calcd for 
C13H24O3Na: 251.1623]. 
 
To a round bottom flask was condensed excess amount of propyne at –78 ºC, followed 
by the slow addition of THF (35 mL) and dropwise addition of n-BuLi (3.2 mL, 2.5 M in 
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and the reaction mixture was stirred for 30 min. During this process, a white solid was first 
precipitated, but slowly dissolved. A solution of (+)-3.55 (1.26 g, 5.53 mmol) in THF (3 
mL) was then added and the reaction mixture was stirred at –78 ºC for another 1 h before 
quenching with a saturated solution of NaHCO3. The reaction mixture was then warmed to 
room temperature and extracted with EtOAc. The combined organic layers were washed 
with brine, dried over MgSO4, and concentrated in vacuo. Flash column chromatography 
on SiO2 (10:1 hexanes/EtOAc) provided the alcohol (+)-3.64 (1.36 g, 92% yield) as a pale-
yellow oil: [a]20D   + 16.9 (c 1.8, CHCl3); IR (film, cm
-1) 3445 (br), 2959, 1384, 1261, 1200, 
1166, 1098, 1069, 1011, 980, 920; 1H NMR (500 MHz, CDCl3) δ 4.19 (dt, J = 10.2, 2.3 
Hz, 1H), 3.93 – 3.87 (m, 1H), 3.35 (dd, J = 9.7, 2.1 Hz, 1H), 2.45 (d, J = 5.8 Hz, 1H), 2.42 
– 2.36 (m, 1H), 2.34 – 2.26 (m, 1H), 1.81 (t, J = 2.5 Hz, 3H), 1.79 – 1.73 (m, 1H), 1.70 – 
1.62 (m, 1H), 1.52 – 1.43 (m, 2H), 1.42 (s, 3H), 1.38 (s, 3H), 0.94 (d, J = 6.4 Hz, 3H), 0.85 
(d, J = 6.8 Hz, 3H), 0.80 (d, J = 6.7 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 99.0, 79.7, 
78.4, 75.6, 70.3, 67.7, 39.1, 33.8, 30.2, 29.3, 27.9, 19.9, 19.8, 17.5, 5.1, 3.7; HRMS (ESI) 
m/z 291.1944 [(M+Na)+; calcd for C16H28O3Na: 291.1936]. 
 
To a solution of alcohol (+)-3.64 (0.5 g, 1.87 mmol) in CH2Cl2 (25 mL) was added 
TBAI (60 mg, 0.19 mmol), DIPEA (0.6 mL, 5.55 mmol) and MOMCl (0.67 mL, 5.5 mol). 
The resulting mixture was stirred at room temperature overnight and then quenched with a 
saturated solution of NaHCO4 (25 mL). The layers were separated. The aqueous layer was 
extracted with CH2Cl2, and the combined organic layers were washed with brine, dried 
over MgSO4, and concentrated in vacuo. Flash column chromatography on SiO2 (20:1 
MOMCl (3 eq.)
 DIPEA (3 eq.) Me
MeMe
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hexanes/EtOAc) provided the alkyne fragment (+)-3.23-a (0.5 g, 86% yield) as a pale-
yellow oil: [a]20D   + 23.2 (c 1.4, CHCl3); IR (film, cm-1) 2957, 1463, 1385, 1261, 1200, 1153, 
1105, 1042, 1011, 977, 919; 1H NMR (500 MHz, CDCl3) δ 4.75 (d, J = 6.8 Hz, 1H), 4.69 
(d, J = 6.8 Hz, 1H), 4.10 – 4.04 (m, 1H), 3.83 – 3.76 (m, 1H), 3.42 (s, 3H), 3.31 (dd, J = 
9.6, 1.7 Hz, 1H), 2.58 – 2.51 (m, 1H), 2.36 – 2.30 (m, 1H), 1.80 (t, J = 2.5 Hz, 3H), 1.75 – 
1.58 (m, 3H), 1.49 – 1.43 (m, 1H), 1.39 (s, 3H), 1.38 (s, 3H), 0.94 (d, J = 6.4 Hz, 3H), 0.85 
(d, J = 6.8 Hz, 3H), 0.79 (d, J = 6.8 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 99.0, 96.8, 
79.7, 77.6, 75.4, 73.5, 69.7, 55.8, 38.8, 33.7, 30.2, 29.3, 26.0, 20.0, 19.8, 17.5, 5.1, 3.8; 
HRMS (ESI) m/z 335.2212 [(M+Na)+; calcd for C18H32O4Na: 335.2198]. 
 
Diene 3.68 was prepared referring to literature protocol4,5: To a suspension of NaH 
(1.4 g, 55 mmol, 1.16 eq., 95% dispersion in mineral oil) in toluene (45 mL) and MeOH 
(50 uL) at 0 °C was added a mixture of 3-pentanone (5.3 mL, 52 mmol, 1.1 eq.) and methyl 
formate (4.00 mL, 65 mmol, 1.38 eq.) via syringe pump over 1 h. The reaction mixture was 
warmed to room temperature, stirred for another 3 h, and then diluted with Et2O. The 
resulting suspension was filtered and the filtrate was concentrated in vacuo. The resulting 
crude sodium salt of 1-hydroxy-2-methyl-1-penten-3-one was then dissolved in DMSO (50 
mL), followed by the addition of Me2SO4 (4.58 mL, 47 mmol, 1 eq.) at room temperature. 
After stirring for 30 min, the reaction mixture was treated with a 2M aqueous solution of 
NH4OH and diluted with Et2O. The organic layer was separated, washed with H2O and 
brine, dried over MgSO4, and concentrated in vacuo to afford crude 1-methoxy-2-methyl-
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mmol) was dissolved in Et2O (33.5 mL), followed by the addition of Et3N (11.5 mL, 82.6 
mmol, 2.48 eq.) and TMSOTf (7.6 mL, 33.2 mol, 1 eq.) at 0 °C. The reaction mixture was 
warmed to room temperature, stirred for 3 h, and then poured onto a saturated solution of 
NaHCO3. The organic layer was separated, washed with brine, dried over MgSO4, and 
concentrated in vacuo to afford butadiene 3.62 (6.4 g, 26.4 mmol, 56% for three steps). 1H 
NMR (500 MHz, CDCl3) δ 4.71 (q, J = 6.9 Hz, 1H), 3.63 (s, 3H), 1.67 (d, J = 1.2 Hz, 3H), 
1.61 (d, J = 6.9 Hz, 3H), 1.00 (s, 9H), 0.11 (s, 6H). The spectral data is in agreement with  
the published data.5 
 
Diene 3.68 (700 mg, 2.88 mol) and acrolein (0.96 mL, 14.4 mmol) were dissolved 
in CH2Cl2 (2.1 mL). The resulting mixture was stirred overnight at room temperature and 
concentrated in vacuo to furnish a crude product 3.71 (800 mg). Without further 
purification, the labile crude 3.71 was dissolved in Et2O (10 mL), followed by a dropwise 
addition of LiAlH4 (200 mg, 5.3 mmol) suspension in Et2O (10 mL) at 0 ºC. After 30 
minutes, the reaction mixture was quenched with H2O. Layers were separated, and the 
aqueous layer was extracted Et2O. The combined organic layers were washed with brine, 
dried over MgSO4, and concentrated in vacuo. The resulting crude material was then 
dissolved in MeCN (10 mL), followed by the addition of an aqueous solution of HF (0.5 
mL, 48 wt. % in H2O). After 30 min, the reaction mixture was quenched by dropwise 
addition of a saturated solution of NaHCO3 and layers were separated. The aqueous layer 
was extracted Et2O. The combined organic layers were washed with brine, dried over 















1) LiAlH (1.83 eq.)






3.68 cis:trans = 4.2 :1
(5 eq.)
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then provided a mixture (cis:trans = 4.2:1) of alcohols 3.72 (213 mg, 1.38 mmol, 66%) as 
a pale-yellow oil. Major isomer: IR(film, cm-1) 3424 (br), 2925, 1667, 1376, 1061; 1H 
NMR (500 MHz, CDCl3) δ 6.65 (s, 1H), 3.66 (dd, J = 10.3, 6.2 Hz, 1H), 3.61 (dd, J = 10.4, 
6.5 Hz, 1H), 2.74 – 2.63 (m, 1H), 2.44 – 2.34 (m, 1H), 2.11 – 2.04 (m, 1H), 1.79 (dd, J = 
2.5, 1.4 Hz, 3H), 1.64 (d, J = 13.2 Hz, 1H), 1.48 (q, 1H), 1.16 (d, J = 6.7 Hz, 3H); 13C 
NMR (126 MHz, CDCl3) δ 202.3, 145.3, 136.3, 66.4, 41.2, 39.9, 34.9, 16.4, 15.4; HRMS 
(ESI) m/z 177.0880 [(M+Na)+; calcd for C25H32O2NaSi: 177.0891]. 
 
Alcohol 3.72 (86 mg, 0.56 mmol) was dissolved in CH2Cl2 (1.5 mL), followed by 
the addition of TBDPSCl (160 mg, 0.58 mmol) and imidazole (40 mg, 0.58 mmol). The 
reaction mixture was stirred overnight, then quenched with a saturated solution of 
NaHCO3. Layers were separated, and the aqueous layer was extracted Et2O. The combined 
organic layers were washed with brine, dried over MgSO4, and concentrated in vacuo. The 
crude mixture was purified via flash chromatography on SiO2 (1:25 EtOAc/hexanes) to 
provide (±)-3.66 (180 mg, 0.46 mmol, 82%) as a pale-yellow oil. IR(film, cm-1): 2931, 
2859, 1676, 1428, 1208, 1381, 1109, 822, 741, 704; 1H NMR (500 MHz, CDCl3) δ 7.66 
(d, J = 7.2 Hz, 4H), 7.47 – 7.34 (m, 6H), 6.64 – 6.59 (m, 1H), 3.60 (d, J = 6.6 Hz, 2H), 
2.78 – 2.64 (m, 1H), 2.45 – 2.26 (m, 1H), 2.11 – 1.97 (m, 1H), 1.77 (s, 3H), 1.42 (d, J = 
13.1 Hz, 1H), 1.14 (d, J = 6.7 Hz, 3H), 1.07 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 202.5, 
146.1, 135.7, 135.7, 135.7, 134.9, 133.6, 133.6, 129.9, 129.9, 127.9, 67.3, 41.2, 40.1, 35.0, 
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To a solution of 3.72 (14 mg, 0.09 mmol) in CH2Cl2 (0.5 mL) was added pyridine 
(10 uL, 0.12 mmol) and p-nitrobenzoyl chloride (20 mg, 0.11 mmol). The reaction mixture 
was stirred overnight, diluted with Et2O, filtered through celite, and then concentrated in 
vacuo. The crude mixture was purified via flash chromatography on SiO2 (1:5 
EtOAc/hexanes) to provide (±)-3.73 (25 mg, 1.55 mmol, 91%) as a pale-yellow oil. This 
oil was then dissolved in EtOAc and hexanes, followed by slow evaporation to afford a 
pale-yellow crystal: m.p. 107 – 109 ºC; IR (neat) 2927, 1726, 1676, 1605, 1528, 1454, 
1349, 1276, 1106, 874, 720; 1H NMR (500 MHz, CDCl3) δ 8.31 (d, J = 8.8 Hz, 2H), 8.21 
(d, J = 8.8 Hz, 2H), 6.66 – 6.56 (m, 1H), 4.45 – 4.29 (m, 2H), 3.10 – 2.92 (m, 1H), 2.57 – 
2.38 (m, 1H), 2.26 – 2.13 (m, 1H), 1.82 (s, 3H), 1.69 – 1.53 (m, 1H), 1.18 (d, J = 6.7 Hz, 
3H); 13C NMR (126 MHz, CDCl3) δ 201.5, 164.7, 150.8, 143.3, 136.9, 135.3, 130.9, 123.8, 
68.5, 41.2, 36.9, 35.2, 16.4, 15.4; HRMS (ESI) m/z 326.1029 [(M+Na)+; calcd for 
C16H17NO5Na: 326.1004]. 
 
To a solution of propargyl alcohol (3.92 g, 70 mmol) in THF (200 mL) at –78 ºC was 
added n-BuLi (56 mL, 2.5 M in hexanes, 140 mmol) dropwise. After 1 hour, acetaldehyde 
(3.08 g, 70 mmol) was added dropwise at –78 ºC. The resulting mixture was warmed up to 




























THF, –78 ºC to r.t.
overnight
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ºC and chloromethyl methyl ether (12.40 g, 154 mmol) was added dropwise. The resulting 
mixture was then warmed up and stirred at room temperature. After 2 h, the reaction 
mixture was quenched with a saturated solution of NaHCO3 solution and extracted with 
Et2O for three times. The combined organic layers were washed with brine, dried over 
anhydrous Na2SO4, filtered and concentrated. Flash chromatography (10:1 hexanes/Et2O) 
afforded compound 3.76 (9.34 g, ca. 71% yield) as a yellow oil with minor co-eluted 
impurities.6 Further purification by flash chromatography (10:1 hexanes/Et2O) was 
conducted for characterization purpose. IR (film, cm-1) 2938, 2891, 1448, 1215, 1151, 
1102, 1034, 992, 920; 1H NMR (500 MHz, CDCl3) 4.90 (d, J = 6.8 Hz, 1H), 4.69 (s, 2H), 
4.59 (d, J = 6.8 Hz, 1H), 4.48 (q, J = 6.8 Hz, 1H), 4.24 (d, J = 1.4 Hz, 2H), 3.37 (s, 3H), 
3.37 (s, 3H), 1.45 (d, J = 6.8 Hz, 3H); 13C NMR (125 MHz, CDCl3) 94.7, 94.1, 85.8, 80.4, 
61.4, 55.51, 55.49, 54.3, 22.0; HRMS (EI) m/z 173.0843 [(M-CH3)+ calcd for C8H13O4 
173.0814]. 
 
To a 250 mL flask was added Lindlar catalyst (600 mg, 10% w/w), alkyne 3.76 (6.02 
g, 32 mmol) and methanol (90 mL). The flask was purged with three cycles of H2 
gas/vacuum. A H2 balloon was then attached and the resulting solution was stirred 
vigorously. The reaction process was monitored via 1H NMR anlaysis every 2 h until the 
alkyne 3.76 was fully converted. The reaction mixture was filtered through Celite and 
concentrated. Flash chromatography (10:1 hexanes/Et2O) afforded compound 3.77 (5.65 
g, 93% yield) as a colorless oil with minor co-eluted impurities. Further purification by 
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(film, cm-1) 2933, 1454, 1400, 1372, 1213, 1154, 1100,  1035, 919, 836, 748; 1H NMR 
(500 MHz, CDCl3) 5.72-5.66 (m, 1H), 5.52-5.46 (m, 1H), 4.67-4.61 (m, 3H), 4.53 (d, J = 
6.7 Hz, 2H), 4.19-4.10 (m, 2H), 3.37 (s, 3H), 3.35 (s, 3H), 1.25 (d, J = 6.5 Hz, 3H); 13C 
NMR (125 MHz, CDCl3) 134.6, 128.2, 95.8, 93.7, 67.1, 62.9, 55.3, 55.2, 21.5; HRMS 
(ESI) m/z 213.1111 [(M+Na)+ calcd for C9H18NaO4 213.1103]. 
 
To a solution of diisopropylamine (3.84 g, 38 mmol) in THF (150 mL) at –78 ºC was 
added n-BuLi (15.2 mL, 2.5 M in hexanes, 38 mmol) dropwise. The resulting mixture was 
warmed up to 0 ºC and stirred for 15 min. The reaction mixture was then cooled down to 
–78 ºC and alkene 3.77 (3.61 g, 19 mmol) was added dropwise. The resulting mixture was 
then warmed up to 0 ºC and stirred for 2 h. The reaction mixture was quenched with a 
saturated solution of NaHCO3 solution and extracted with Et2O for three times. The 
combined organic layers were washed with brine, dried over anhydrous Na2SO4, filtered 
and concentrated.7 Flash chromatography (10:1 hexanes/Et2O) afforded compound 3.67 
(1.21 g, 50% yield) as a pale-yellow oil: IR (film, cm-1) 2932, 1666, 1454, 1377, 1216, 
1153, 1102, 1038, 988, 921; 1H NMR (500 MHz, CDCl3) 6.43 (d, J = 12.3 Hz, 1H), 5.95-
5.85 (m, 1H), 5.80-5.68 (m, 1H), 5.51 (dq, J = 13.7, 6.7 Hz, 1H), 4.82 (s, 2H), 3.40 (s, 3H), 
1.72 (dd, J = 6.7 Hz, 1.7 Hz, 3H); 13C NMR (125 MHz, CDCl3) 145.5, 126.9, 125.1, 110.7, 





n-BuLi (2.0 eq.), 
HN(i-Pr)2 (2.0 eq.)




















  211 
Quinone 3.81 was prepared via modified literature protocols.8,9 Ortho-vanillin (2.28 
g, 15 mmol) was dissolved in MeOH (110 mL), followed by the addition of 10% Pd/C 
(0.46 g, 20 wt. %) and concentrated HCl (38 uL, 12M). The flask was purged with three 
cycles of H2 gas/vacuum. A H2 balloon was then attached and the resulting solution was 
stirred vigorously overnight. The reaction suspension was then filtered through celite, 
concentrated in vacuo to remove half of the solvent and diluted with H2O.The reaction 
mixture was then extracted with CH2Cl2, washed with brine, dried over Na2SO4 and 
concentrated in vacuo to provide 3.82 (1.86 g, 13.5 mol). The crude material was dissolved 
in DMF (35 mL), followed by the addition of N,N′-
Bis(salicylidene)ethylenediaminocobalt(II) (salcomine) (220 mg, 0.68 mol, 5 mol%). The 
flask was purged with three cycles of O2 gas/vacuum. A O2 balloon was then attached and 
the resulting solution was stirred vigorously overnight. The reaction mixture was then 
diluted with EtOAc, washed with water, and concentrated in vacuo. The crude mixture was 
dissolved in hot CH2Cl2, followed by the addition of hexanes. The resulting mixture was 
stored in –20 ºC overnight and yellow precipitates formed. The precipitates were collected 
via filtration, and the filtrate was concentrated and purified via SiO2 column 
chromatography (15:1 hexanes/EtOAc) to furnish 3.80 (1.67 g 81%). 1H NMR (500 MHz, 
CDCl3) δ 6.54 (s, 1H), 5.88 (s, 1H), 3.81 (s, 3H), 2.07 (d, J = 1.7 Hz, 3H). The spectral 
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Thermal conditions: Quinone 3.80 (450 mg, 2.96 mmol) and diene 3.67 (472 mg, 3.69 
mmol) were dissolved in CH2Cl2 (3 mL) and toluene (3 mL). The reaction flask was purged 
with 3 cycles of N2 gas/vacuum, then sealed and heated at 120 ºC for 17 h. The reaction 
mixture was then concentrated in vacuo and purified via flash chromatography (3:1 
hexanes/EtOAc) to afford the racemic material (±)-3.79 (610 mg, 74%) as a while solid.  
Lewis acid-catalyzed conditions: To a 250 mL flask was added catalyst (–)- 
C311 (1.72 g, 2.2 mmol), 11 g 4Å molecular sieves and quinone 3.80 (1.67 g, 11 mmol). 
The flask was purged with 3 cycles of N2 gas/vacuum and 110 mL toluene was added at –
78 ºC. The resulting mixture was stirred at –78 ºC for 30 min and then diene 3.67 (1.69 g, 
13.2 mmol) was added. The resulting solution was stirred at –78 ºC for 6 h and then warmed 
up to –40 ºC for 36 h. Sodium bicarbonate (4.9 g) and 2-propanol (17 mL) were added to 
the mixture at –40 ºC. The mixture was then warmed up to room temperature, filtered 
through Celite and concentrated. Flash chromatography (3:1 hexanes/EtOAc) afforded 
compound 3.79 (2.93 g, 95% yield, 86% ee) as an off-white solid. Enantiomeric excess 
(ee) was determined by supercritical fluid chromatography (SFC). Recrystallization from 
EtOAc/hexanes provided (–)-3.79 as white needle crystals (1.84 g, 98% ee):m.p. 91-92 ºC; 
[a]20D   –246.2 (c 1.1, CHCl3); IR (film, cm
-1) 2938, 1684, 1613, 1459, 1360, 1250, 1190, 
1149, 1070, 1030, 919, 833, 751; 1H NMR (500 MHz, CDCl3) δ 5.95 (s, 1H), 5.84 (d, J = 
10.3 Hz, 1H), 5.75 (ddd, J = 10.3, 4.2, 2.9 Hz, 1H), 4.50 (d, J = 6.9 Hz, 1H), 4.31 (d, J = 
6.9 Hz, 1H), 3.81 (d, J = 4.2 Hz, 1H), 3.73 (s, 2H), 3.17 (s, 3H), 2.88 (d, J = 4.9 Hz, 1H), 
2.51 – 2.45 (m, 1H), 1.47 (d, J = 7.6 Hz, 3H), 1.38 (s, 3H).; 13C NMR (125 MHz, CDCl3) 
δ 197.2, 196.4, 161.4, 134.9, 122.8, 114.7, 95.0, (75.18, 75.12), (56.17, 56.12), (55.71, 
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Table E3.1 Determination of Enantiomeric Excess of Compound 3.79 by Chiral SFC 
55.69), (53.01, 52.97), 52.3, 29.0, (20.08, 20.06), 17.6; HRMS (EI) m/z 280.1311 [(M)+; 
calcd for C15H20O5: 280.1311]. 
 
 
Sample tR 1 (min) Area 1 (%) tR 2 (min) Area 2 (%) 
(±)-3.79a 3.03 50.18 3.47 49.83 
3.79b 3.05 7.07 3.50 92.93 
(–)-3.79c   3.49 100 
aMaterial prepared under thermal conditions; bMaterial provided under Lewis acid-
catalyzed conditions; cMaterial obtained after crystallization. SFC conditions: column: 
Chiralcel® OJ-H column (5 µm, 4.6 mm × 250 mm); eluent: 99:1 supercritical CO2/MeOH; 
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Column: Chiralcel® OJ-H column (5 µm, 4.6 mm × 250 mm); eluent: 97:3 supercritical 
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To a solution of compound (–)-3.79 (1.79 g, 6.4 mmol) in Et2O (200 mL) at 0 ºC was 
added LiAlH4 (243 mg, 6.4 mmol). The reaction mixture turned into greenish yellow. After 
5 min, another portion of LiAlH4 (243 mg, 6.4 mmol) was added. After another 5 min, the 
third portion of LiAlH4 (24 mg, 0.64 mmol) was added. The resulting mixture then turned 
to grey and was stirred at 0 ºC for 5 h before pouring into 200 mL 1N HCl containing ca. 
100 g ice to keep the solution cold at 0 ºC. The resulting mixture was stirred vigorously 
and then extracted with Et2O for three times. The combined organic layers were dried over 
anhydrous Na2SO4, filtered and concentrated. Flash chromatography (8:1 to 4:1 
hexanes/EtOAc) afforded compound (–)-3.83 (989 mg, 61% yield) as an off-white solid: 
[a]20D   – 148.0 (c 1.5, CHCl3); IR (film, cm
-1) 3463(br), 2965, 1686, 1466, 1372, 1150, 1094, 
1037, 914, 780; 1H NMR (500 MHz, CDCl3) δ 6.81 (dd, J = 10.4, 2.1 Hz, 1H), 6.16 (dd, J 
= 10.7, 3.4 Hz, 1H), 5.82 – 5.73 (m, 1H), 5.55 (d, J = 0.9 Hz, 1H), 4.59 (d, J = 6.7 Hz, 1H), 
4.30 (d, J = 6.7 Hz, 1H), 3.97 (s, 1H), 3.75 (d, J = 2.1 Hz, 1H), 3.66 (d, J = 4.4 Hz, 1H), 
3.27 (d, J = 0.6 Hz, 3H), 2.75 – 2.63 (m, 1H), 2.55 (m, 1H), 1.30 (s, 3H), 1.25 (d, J = 7.4 
Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 198.5, 146.7, 132.1, 129.4, 127.7, 98.0, (80.05, 
80.00), (76.28, 76.24), 55.7, 48.2, 44.0, 28.5, (22.56, 22.53), 17.6; HRMS (EI) m/z 
252.1373 [(M)+; calcd for C14H20O4: 252.1362]. 
 
LiAlH4 (2.1 eq.)







































DCM, 0 ºC to r.t.
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To a solution of compound (–)-3.83 (989 mg, 3.92 mmol) in CH2Cl2 (70 mL) at 0 ºC 
was added 2,6-lutidine (1.39 g, 12.9 mmol) and TBSOTf (1.14 g, 4.3 mmol) under N2 
atmosphere. The resulting mixture was stirred at 0 ºC for 2 h and then warmed up to room 
temperature for another 30 min. The resulting mixture was quenched with a saturated 
solution of NaHCO3 and then extracted with CH2Cl2 for three times. The combined organic 
layers were dried over anhydrous Na2SO4, filtered and concentrated. Flash chromatography 
(20:1 hexanes/EtOAc) afforded compound (–)-3.78 (1.18 g, 82% yield) as white crystals: 
m.p. 118-119 ºC; [a]20D   – 39.8 (c 1.2, CHCl3); IR (film, cm
-1) 2953, 1697, 1469, 1252, 1148, 
1096, 1037, 904, 837, 780; 1H NMR (500 MHz, CDCl3) δ 6.67 (dd, J = 10.4, 2.1 Hz, 1H), 
6.05 (dd, J = 10.4, 3.4 Hz, 1H), 5.74 (dd, J = 8.8, 5.0 Hz, 1H), 5.51 (d, J = 10.2 Hz, 1H), 
4.74 (d, J = 7.0 Hz, 1H), 4.23 (d, J = 6.9 Hz, 1H), 4.01 (s, 1H), 3.63 (d, J = 4.3 Hz, 1H), 
3.28 (s, 3H), 2.67 – 2.63 (m, 1H), 2.56 – 2.50 (m, 1H), 1.27 – 1.17 (m, 6H), 0.96 (s, 9H), 
0.25 (s, 3H), 0.08 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 196.9, 143.6, (131.59, 131.57, 
131.55), 131.1, 128.3, (98.87, 98.83), (82.05, 82.00), (76.52, 76.48), 55.6, 48.7, 44.2, 28.9, 
26.2, (22.98, 22.97), 19.0, 17.7, -3.7, -5.6; HRMS (ESI) m/z 389.2119 [(M+Na)+; calcd for 
C20H34O4Si: 389.2124]. 
 
To a 250 mL flask was added Lindlar catalyst (710 mg, 60% w/w), compound (–)-3.78 
(1.18 g, 3.23 mmol) and methanol (50 mL). The flask was purged with 3 cycles of H2 
gas/vacuum. A H2 balloon was attached and the resulting solution was stirred vigorously 
overnight. The reaction process was carefully monitored hourly via TLC and 1H NMR 
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concentrated. Flash chromatography (20:1 hexanes/EtOAc) afforded compound (+)-3.84 
(1.05 g, 89% yield) as a while solid. Purity of starting material and quality of Lindlar 
catalyst were important: (1) 2,6-Luditine residue from the previous step was found to 
decrease the reactivity of catalyst; (2) The activity of Lindlar catalyst could vary from batch 
to batch, even purchased from the same vendor. With less active Lindlar catalyst, 5% w/w 
Pd on carbon (palladium content 5%) was mixed with 55% w/w Lindlar catalyst to achieve 
a similar result; (3) The reaction time appeared to increase on a larger scale. [a]20D   + 17.3 (c 
2.0, CHCl3); IR (film, cm-1) 2952, 1727, 1469, 1251, 1149, 1114, 1038, 936, 892, 836, 779 
; 1H NMR (500 MHz, CDCl3) δ 5.73 – 5.66 (m, 1H), 5.45 (d, J = 10.0 Hz, 1H), 4.64 (d, J 
= 7.0, 1.3 Hz, 1H), 4.22 (d, J = 6.9, 1.3 Hz, 1H), 3.70 (s, 1H), 3.57 (d, J = 4.8 Hz, 1H), 3.27 
(s, 3H), 2.61 – 2.57 (m, 1H), 2.42 (dd, J = 15.9, 4.9 Hz, 1H), 2.24 – 2.13 (m, 1H), 2.00 (dd, 
J = 12.9, 5.0 Hz, 1H), 1.72 (dd, J = 34.1, 12.6 Hz, 1H), 1.13 (d, J = 1.3 Hz, 3H), 1.05 (d, J 
= 7.5 Hz, 3H), 0.93 (s, 9H), 0.17 (d, J = 1.3 Hz, 3H), 0.00 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δ 206.9, 132.0, 125.5, 98.7, 82.6, 76.6, 55.2, 48.3, 42.6, 38.6, 30.6, 26.2, 22.1, 22.1, 
18.9, 18.0, -3.8, -5.6; HRMS (ESI) m/z 391.2260 [(M+Na)+; calcd for C20H36O4NaSi: 
391.2281]. 
 
To a solution of compound (–)-3.84 (1.05 g, 2.85 mmol) in THF (36 mL) was added 
N-methylmorpholine-N-oxide (NMO, 500 mg, 4.27 mmol) and MeSO2NH2 (388 mg, 4.27 
mmol). Then OsO4 was added (7 mL, 0.14 mmol, 0.5% w/w water solution) via syringe 
followed by 9 mL H2O. The reaction mixture was stirred at room temperature overnight 

















THF : H2O = 4:1, r.t.
92%
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extracted with EtOAc for three times and the combined organic layers were dried over 
anhydrous Na2SO4, filtered and concentrated. Flash chromatography (3:1hexanes/EtOAc) 
afforded compound (+)-3.85 (1.15 g, 92% yield) as a white foam: [a]20D   + 27.2 (c 1.0, 
CHCl3); IR (film, cm-1) 3421(br), 2930, 1725, 1470, 1252, 1119, 1032, 913, 869, 839, 780, 
743; 1H NMR (500 MHz, CDCl3) δ 4.62 (d, J = 7.2 Hz, 1H), 4.22 (d, J = 7.1 Hz, 1H), 4.07 
(t, J = 3.3, 2.3 Hz, 1H), 3.83 – 3.75 (m, 1H), 3.73 (dd, J = 3.0, 1.7 Hz, 1H), 3.68 (d, J = 1.4 
Hz, 1H), 3.26 (s, 3H), 2.43 (d, J = 3.2 Hz, 1H), 2.39 – 2.31 (m, 1H), 2.31 – 2.17 (m, 1H), 
2.08 (d, J = 7.8 Hz, 1H), 2.01 (q, J = 3.1 Hz, 1H), 1.94 – 1.84 (m, 1H), 1.85 – 1.76 (m, 
1H), 1.40 (s, 3H), 1.11 (d, J = 6.8 Hz, 3H), 0.94 (t, J = 4.3 Hz, 2H), 0.93 (s, 7H), 0.13 (s, 
3H), -0.01 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 207.2, 99.64(m), (83.78, 83.73), (83.38, 
83.33), (72.98, 72.92), (70.37, 70.32), 55.8, 49.3, 46.3, 38.4, 31.2, 26.2, 24.4, 23.9, 18.8, 
16.1, (-3.94, -3.96), (-5.52, -5.53); HRMS (ESI) m/z 425.2352 [(M+Na)+; calcd for 
C20H38O6NaSi: 425.2335]. 
 
To a solution of compound (+)-3.85 (1.02 g, 2.54 mmol) in 2,2-dimethoxypropane (10 
mL) and dichloromethane (10 mL) was added pyridinium p-toluenesulfonate (PPTS, 51 
mg, 0.20 mmol). The reaction mixture was stirred at room temperature and monitored via 
TLC until the substrate (+)-3.86 was fully converted. Then NaHCO3 (180 mg) was added 
followed by 30 mL hexanes. The resulting suspension was filtered through Celite and then 
concentrated. Flash chromatography (10:1 hexanes/EtOAc) afforded compound (+)-3.85 
(1.05 g, 94% yield) as a while foam: [a]20D   + 5.7 (c 0.85, CHCl3); IR (film, cm
-1) 2936, 1730, 
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4.32 – 4.26 (m, 2H), 3.94 (dd, J = 10.3, 5.2 Hz, 1H), 3.87 (s, 1H), 3.68 (s, 1H), 3.29 (s, 
3H), 2.39 (dt, J = 14.8, 3.5 Hz, 1H), 2.23 – 2.14 (m, 1H), 2.14 – 2.02 (m, 1H), 1.91 – 1.82 
(m, 2H), 1.74 – 1.66 (m, 1H), 1.38 (s, 3H), 1.34 (s, 3H), 1.11 (d, J = 6.8 Hz, 3H), 0.94 (s, 
9H), 0.15 (s, 3H), -0.00 (s, 3H); 13C NMR (125 MHz, CDCl3) 206.6, 108.2, 100.0, (83.09, 
83.04), (79.85, 79.79), (78.23, 78.17), (77.69, 77.64), 55.9, 49.1, 46.1, 38.7, 32.6, 28.6, 
26.3, (26.21, 26.19), 23.2, 22.9, 18.8, 16.4, -3.9, -5.5; HRMS (EI) m/z 427.2530 [(M-Me)+; 
calcd for C22H39O6Si 427.2516]. 
 
To a solution of compound (+)-3.86 (960 mg, 2.17 mmol) in THF (26 mL) was added 
LiHMDS (2.61 mL, 1.0 M in THF, 2.61 mmol) at 0 ºC. The resulting mixture was stirred 
at 0 oC for 5 min and then trimethylsilyl chloride (283 mg, 2.61 mmol) was added. The 
reaction mixture was stirred for 30 min and then quenched with water and extracted with 
hexanes for three times. The combined organic layers were washed with brine and 
concentrated in vacuo. The crude product was directly dissolved in DMSO (24 mL). 
Pd(OAc)2 (98 mg, 0.44 mmol) was added and the flask was purged with 3 cycles of O2 
gas/vacuum. An O2 balloon was attached and the resulting solution was stirred overnight. 
The reaction mixture was then quenched with water and extracted with Et2O for three 
times. The combined organic layers were dried over anhydrous Na2SO4, filtered and 
concentrated. Flash chromatography (10:1 hexanes/EtOAc) afforded compound (–)-3.87 
(810 mg, 85% yield) as white crystals: m.p. 118-119 ºC; [a]20D   – 77.0 (c 0.70, CHCl3); IR 
(film, cm-1) 2932, 1699, 1380, 1245, 1218, 1154, 1125, 1040, 907, 838, 780; 1H NMR (500 
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= 6.8 Hz, 1H), 4.25 (d, J = 7.0 Hz, 1H), 4.22 (dd, J = 4.8, 1.7 Hz, 1H), 3.94 (s, 1H), 3.89 
(s, 1H), 3.77 (dd, J = 10.8, 4.8 Hz, 1H), 3.26 (s, 3H), 2.52 – 2.43 (m, 1H), 2.27 – 2.11 (m, 
1H), 1.49 (s, 3H), 1.42 (s, 3H), 1.34 (s, 3H), 1.23 (d, J = 6.9 Hz, 3H), 0.95 (s, 9H), 0.23 (s, 
3H), 0.06 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 196.4, (142.48, 142.46), 130.0, 108.4, 
100.0, (81.92, 81.87), (80.08, 80.02), (78.22, 78.16), (77.65, 77.59), 56.0, 48.1, (47.50, 
47.46), 31.6, (28.78, 28.75), (26.32, 26.29), (26.22, 26.20), (23.73, 23.70), 18.9, (15.30, 
15.27), (-3.62, -3.63), (-5.46, -5.47); HRMS (EI) m/z 425.2365 [(M-Me)+; calcd for 
C22H37O6Si: 425.2359]. 
 
To a flame-dried flask was added CuBr2•DMS (756 mg, 3.68 mmol) and the flask was 
purged with 3 cycles of N2 gas/vacuum. Then 9 mL Et2O and 9 mL DMS was added at –
78 ºC, followed by the dropwise addition of vinylmagnesium bromide (11.0 mL, 1.0 M in 
THF, 11.0 mmol). After 30 min, HMPA (1.1 mL) was added into the flask and the reaction 
mixture was stirred at –78 ºC for 5 min. To the resulting green mixture, a solution of 
compound (–)-3.87 (810 mg, 1.84 mmol) in Et2O (8 mL) was added via cannula. The 
resulting mixture was allowed to warm up gradually to –20 ºC over 1.5 hour. The reaction 
mixture was then quenched with a saturated solution of NH4Cl solution, filtered through 
Celite and extracted with EtOAc for three times. The combined organic layers were dried 
over anhydrous Na2SO4, filtered and concentrated. Flash chromatography (10:1 
hexanes/EtOAc) afforded compound (+)-3.88 (530 mg, 62% yield) as a while foam: [a]20D   
+ 10.3 (c 0.55, CHCl3); IR (film, cm-1) 2930, 1730, 1380, 1249, 1219, 1164, 1120, 1058, 
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(d, J = 16.8 Hz, 1H), 4.91 (dd, J = 10.0, 1.4 Hz, 1H), 4.63 (d, J = 7.1 Hz, 1H), 4.32 (dd, J 
= 9.2, 6.1 Hz, 2H), 4.09 (dd, J = 11.1, 5.1 Hz, 1H), 3.86 (s, 1H), 3.67 (d, J = 1.3 Hz, 1H), 
3.33 (s, 3H), 3.03 (dt, J = 16.8, 6.1 Hz, 1H), 2.31 – 2.24 (m, 1H), 2.20 (dd, J = 15.1, 4.9 
Hz, 1H), 2.08 (dd, J = 15.8, 13.3 Hz, 1H), 1.72 (d, J = 11.9 Hz, 1H), 1.47 (s, 3H), 1.41 (s, 
3H), 1.34 (s, 3H), 1.19 (d, J = 7.2 Hz, 3H), 0.94 (s, 9H), 0.15 (s, 3H), 0.00 (s, 3H).; 13C 
NMR (125 MHz, CDCl3) ) δ 204.8, 144.3, 113.7, 107.9, 99.9, (82.46, 82.41), (79.90, 
79.83), (78.17, 78.12), (78.03, 77.99), 56.0, 51.1, 50.0, 47.2, 42.3, 33.2, (28.62, 28.60), 
(26.29, 26.26), (26.21, 26.20), (23.65, 23.62), (18.83, 18.25), 18.24, (-3.87, -3.88), (-5.49, 
-5.50); HRMS (EI) m/z 453.2682 [(M-Me)+; calcd for C24H41O6Si: 453.2672]. 
 
To a solution of compound (+)-3.88 (530 mg, 1.13 mmol) in Et2O (30 mL) was added 
LiHMDS (1.70 mL, 1.0 M in THF, 1.70 mmol) at 0 oC. The resulting mixture was warmed 
up to room temperature and stirred for 3.5 h. The reaction mixture was then cooled down 
to 0 oC and Tf2O (479 mg, 1.70 mmol) was added dropwise. The resulting mixture was 
then warmed up and stirred at room temperature. After 1 hour, the reaction mixture was 
quenched with 1N NaOH solution and extracted with Et2O for three times. The combined 
organic layers were washed with 1N NaOH solution and brine, dried over anhydrous 
Na2SO4, filtered and concentrated. Flash chromatography (50:1 hexanes/EtOAc) afforded 
compound (+)-3.89 (610 mg, 90% yield) as a colorless oil: [a]20D   + 97.6 (c 2.0, CH2Cl2); IR 
(film, cm-1) 2933, 2859, 1420, 1246, 1214, 1144, 1064, 1037, 834, 779; 1H NMR (500 
MHz, C6D6) δ 5.70 (d, J = 3.6 Hz, 1H), 5.60 – 5.48 (m, 1H), 5.06 (d, J = 6.3 Hz, 1H), 4.90 
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Hz, 1H), 4.22 (s, 1H), 4.08 (t, J = 5.5 Hz, 1H), 3.89 (d, J = 6.0 Hz, 1H), 3.19 (s, 3H), 2.86 
(s, 1H), 2.21 – 2.03 (m, 1H), 1.88 – 1.74 (m, 1H), 1.48 (s, 3H), 1.31 (s, 3H), 1.22 (s, 3H), 
1.13 (d, J = 7.5 Hz, 3H), 0.99 (s, 9H), 0.34 (s, 3H), 0.26 (s, 3H); 13C NMR (125 MHz, 
C6D6) δ 149.3, 142.2, 123.1, 115.1, 108.0, 98.0, 81.8, 79.4, 78.1, 73.2, 56.0, 46.3, 44.2, 
41.7, 35.0, 28.7, 27.7, 26.6, 26.3, 19.1, 16.9, -3.3, -4.7; HRMS (EI) m/z 585.2191 [(M-
Me)+; calcd for C25H40O8SiSF3: 585.2165]. Byproduct (+)-3.90: [a]20D   + 42.5 (c 0.5, 
CH2Cl2); IR (film, cm-1) 2959, 1666, 1462, 1368, 1254, 1215, 1062, 911, 848;1H NMR 
(500 MHz, Benzene-d6) δ 5.81 (ddd, J = 17.6, 10.2, 7.8 Hz, 1H), 5.22 (d, J = 6.2 Hz, 1H), 
4.99 (d, J = 16.7 Hz, 1H), 4.89 (d, J = 10.1 Hz, 1H), 4.85 (t, J = 6.2 Hz, 1H), 4.82 (d, J = 
6.2 Hz, 1H), 4.74 (d, J = 3.2 Hz, 1H), 4.26 (t, J = 6.7 Hz, 1H), 4.06 (s, 1H), 3.94 (d, J = 6.4 
Hz, 1H), 3.27 (s, 3H), 3.12 (s, 1H), 2.25 – 2.16 (m, 1H), 1.83 (t, J = 6.0 Hz, 1H), 1.53 (s, 
3H), 1.38 (s, 3H), 1.29 (d, J = 7.4 Hz, 3H), 1.25 (s, 3H), 1.07 (s, 9H), 0.31 (d, J = 8.8 Hz, 
6H); 13C NMR (126 MHz, Benzene-d6) δ 152.1, 146.4, 113.1, 107.8, 107.5, 97.7, 82.7, 
79.5, 79.1, 74.9, 69.7, 56.0, 46.3, 45.8, 41.1, 35.2, 29.0, 28.7, 26.7, 26.4, 19.1, 17.3, 0.3, -
3.8, -3.8. 
 
To a solution of compound (+)-3.89 (610 mg, 1.02 mmol) in THF (34 mL) and NMP 
(1.7 mL) was added Fe(acac)3 (36 mg, 0.1 mmol) and Pd(dppf)Cl2•CH2Cl2 (41 mg, 0.05 
mmol) at room temperature under N2 protection. Then MeMgBr (1.35 mL, 3.0 M in diethyl 
ether, 4.06 mmol) was added dropwise. The reaction mixture was stirred at room 
temperature for 2 h, then quenched with a saturated solution of NH4Cl and extracted with 
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filtered and concentrated.12 Flash chromatography (40:1 hexanes/EtOAc) afforded 
compound (+)-3.91 (450 mg, 95% yield) as a colorless oil: [a]20D   + 67.5 (c 0.65, CHCl3); IR 
(film, cm-1) 2930, 1463, 1378, 1252, 1213, 1152, 1058, 1034, 911, 833, 774; 1H NMR (500 
MHz, CDCl3) δ 5.76 (ddd, J = 17.4, 10.1, 8.8 Hz, 1H), 5.17 (s, 1H), 4.99 (d, J = 17.5 Hz, 
1H), 4.93 (d, J = 10.1 Hz, 1H), 4.80 (d, J = 6.4 Hz, 1H), 4.76 (d, J = 6.2 Hz, 1H), 4.45 (t, 
J = 5.8 Hz, 1H), 4.06 – 4.01 (m, 1H), 4.01 (s, 1H), 3.78 (d, J = 5.3 Hz, 1H), 3.39 (s, 3H), 
2.99 (d, J = 9.7 Hz, 1H), 2.15 – 1.94 (m, 1H), 1.75 (s, 3H), 1.62 – 1.54 (m, 1H), 1.44 (s, 
3H), 1.32 (s, 3H), 1.11 (s, 3H), 1.06 (d, J = 7.0 Hz, 3H), 0.92 (d, J = 0.9 Hz, 9H), 0.13 (s, 
3H), 0.11 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 204.8, 144.3, 113.7, 107.9, 99.9, (82.46, 
82.41), (79.90, 79.83), (78.17, 78.12), (78.03, 77.99), 77.4, 56.0, 51.1, 50.0, 47.2, 42.3, 
33.6, (28.62, 28.60), (26.29, 26.26), (26.21, 26.20), (23.65, 23.62), (18.83, 18.25), 18.24, 
(-3.87, -3.88), (-5.49, -5.50); HRMS (EI) m/z 451.2891 [(M-Me)+; calcd for C25H43O5Si: 
451.2880]. 
 
To a solution of compound (+)-3.91 (450 mg, 0.97 mmol) in THF (37 mL) was added 
TBAF (1.93 mL, 1.0 M in THF, 1.93 mmol) dropwise. The reaction mixture was stirred at 
60 ºC for 3 h , then quenched with a saturated solution of NH4Cl and extracted with Et2O 
for three times. The combined organic layers were dried over anhydrous Na2SO4, filtered 
and concentrated. Flash chromatography (5:1 hexanes/EtOAc) afforded compound (+)-
3.22-b (303 mg, 89% yield) as white crystals: m.p. 68-70 ºC; [a]20D   + 77.9 (c 0.58, CHCl3); 
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MHz, CDCl3) δ 5.73 (ddd, J = 17.4, 10.0, 7.6 Hz, 1H), 5.35 – 5.31 (m, 1H), 4.98 (d, J = 
17.9 Hz, 1H), 4.93 – 4.87 (m, 2H), 4.69 (d, J = 6.2 Hz, 1H), 4.31 (t, J = 6.6 Hz, 1H), 3.99 
(dd, J = 8.1, 6.4 Hz, 1H), 3.85 (d, J = 9.3 Hz, 1H), 3.70 (d, J = 6.8 Hz, 1H), 3.49 (d, J = 
9.3 Hz, 1H), 3.44 (s, 3H), 2.83 – 2.78 (m, 1H), 2.13 – 2.04 (m, 1H), 1.83 (q, J = 1.4 Hz, 
3H), 1.71 (t, J = 4.5 Hz, 1H), 1.47 (s, 3H), 1.33 (s, 3H), 1.27 (s, 3H), 1.13 (d, J = 7.1 Hz, 
3H); 13C NMR (125 MHz, CDCl3) δ (143.82, 143.80), 137.8, (125.62, 125.57), 113.1, 
108.2, 98.0, (84.68, 84.64), (79.09, 79.03), (78.60, 78.56), (75.97, 75.92), (56.62, 56.60), 
48.6, 43.9, (40.62, 40.58), 34.1, (28.20, 28.17), (27.59, 27.57), (25.86, 25.82), 19.8, 17.6.; 
HRMS (EI) m/z 337.2036[(M-Me)+; calcd for C19H29O5: 337.2015]. 
 
To a flame-dried flask was added a solution of alkyne (+)-3.23-a (318 mg, 1.02 mmol) 
in toluene (5.1 mL) under N2 atmosphere. Then TiCl(Oi-Pr)3 (1.12 mL, 1.0 M in hexanes, 
1.12 mmol) and c-C5H6MgCl (2.24 mL, 2.0 M in diethyl ether, 2.24 mmol) was added into 
the flask at –41 ºC. The resulting mixture was stirred at –41 ºC for 1.5 h. To another flame-
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mL), followed by the dropwise addition of n-BuLi (0.24 mL, 2.5 M in hexanes,0.61 mmol) 
at –78 ºC. After 10 min, the reaction mixture was warmed to 0 ºC and stirred for another 
10 min. The resulting lithium alkoxide was then cannulated into the first reaction flask 
containing the alkyne-complex at –41 ºC and stirred overnight. The reaction mixture was 
then warmed to 0 ºC and stirred for 6 h. After warming up to room temperature, the reaction 
mixture was quenched with a saturated solution of NH4Cl and stirred for 20 min until white 
precipitates formed. The mixture was then filtered through Celite and extracted with diethyl 
ether for three times. The combined organic layers were dried over anhydrous Na2SO4, 
filtered and concentrated. Flash chromatography (10:1 hexanes/EtOAc) afforded 
compound (–)-3.94 (202 mg, 61% yield) as a white foam, in conjunction with the recovery 
of decalin (+)-3.22-b (53 mg, 30%). [a]20D   – 19.9 (c 0.16, CHCl3); IR (film, cm
-1) 2938, 
1460, 1379, 1245, 1201, 1150, 1102, 1038, 919, 873, 757; 1H NMR (500 MHz, CDCl3) δ 
5.56 – 5.47 (m, 1H), 5.39 (s, 1H), 5.17 (t, J = 7.9, 6.5 Hz, 1H), 4.92 – 4.85 (m, 2H), 4.82 
(d, J = 17.1 Hz, 1H), 4.71 (d, J = 6.4 Hz, 1H), 4.64 (d, J = 6.6 Hz, 2H), 4.27 – 4.14 (m, 
2H), 4.02 (d, J = 10.0 Hz, 1H), 3.76 – 3.68 (m, 1H), 3.52 (d, J = 6.9 Hz, 1H), 3.42 (s, 3H), 
3.40 (s, 3H), 3.31 (d, J = 9.4 Hz, 1H), 2.42 – 2.19 (m, 4H), 2.18 – 2.10 (m, 1H), 1.70 – 1.58 
(m, 2H), 1.57 – 1.51 (m, 4H), 1.46 (s, 3H), 1.46 – 1.43 (m, 1H), 1.42 – 1.30 (m, 12H), 1.29 
– 1.24 (m, 1H), 1.22 (d, J = 6.9 Hz, 3H), 1.18 (s, 3H), 0.93 (d, J = 6.3 Hz, 3H), 0.80 (d, J 
= 4.9 Hz, 3H), 0.79 (d, J = 4.3 Hz, 3H).; 13C NMR (125 MHz, CDCl3) δ 143.8, 136.5, 
133.4, 129.5, 124.5, 114.3, 108.2, 98.9, 97.5, 96.5, 82.4, 79.7, 78.2, 78.1, 75.0, 69.8, 56.6, 
56.1, 55.7, 50.6, 44.4, 40.5, 39.0, 33.8, 33.7, 33.6, 30.2, 29.7, 29.3, 28.2, 25.8, 22.7, 19.9, 
19.8, 18.7, 17.5, 12.9, 5.0.; HRMS (ESI) m/z 649.4692 [(M+H)+; calcd for C38H65O8: 
649.4679].  
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To a heavy wall tube was added (+)-3.22-b (28 mg, 0.08 mmol), Hoveyda-Grubbs II 
catalyst (10 mg, 0.016 mmol) and methyl methacrylate (1 mL). The resulting suspension 
was degassed via three three freeze-pump-thaw cycles and then the tube was filled with 
N2, sealed and heated at 100 ºC overnight. The resulting solution was then cooled, 
concentrated in vacuo. Column chromatography with SiO2 (1:5 EtOAc/hexanes) provided 
(+)-3.94 (22 mg, 67%) as a white foam: [a]20D   + 91.0 (c 1.8, CHCl3); IR (film, cm
-1) 3486 
(br), 2936, 1712, 1437, 1380, 1270, 1218, 1155, 1038, 754; HRMS (ESI) m/z 447.2361 
[(M+Na)+; calcd for C23H36O7Na: 447.2359]. 
 
To a heavy-wall reaction tube was added Hoveyda-Grubbs II catalyst (10 mg, 0.016 
mmol), compound (–)-3.22-b (28 mg, 0.08 mmol) and methyl methacrylate (1 mL). The 
reaction mixture was degassed via three freeze-pump-thaw cycles and then the tube was 
filled with N2, sealed and heated at 100 ºC for 3 h. The reaction mixture was then 
concentrated in vacuo. Flash chromatography (5:1 hexanes/ EtOAc) afforded compound 
(–)-3.95 (22 mg, 0.054 mmol, 67% yield) as a white foam: a]20D    + 91.0 (c 1.8, CHCl3);IR 
(film, cm-1) 3487 (br), 2936, 1712, 1436, 1380, 1270, 1218, 1155, 1038, 754; 1H NMR 
(500 MHz, CDCl3) δ 6.59 (d, J = 10.0 Hz, 1H), 4.99 (s, 1H), 4.76 (d, J = 5.9 Hz, 1H), 4.66 
(d, J = 5.9 Hz, 1H), 4.21 (t, J = 6.6, 4.9 Hz, 1H), 3.96 (dd, J = 9.4, 5.9 Hz, 1H), 3.85 (d, J 
= 4.1 Hz, 1H), 3.81 (d, J = 10.2 Hz, 1H), 3.72 (s, 3H), 3.41 (s, 3H), 3.38 (d, J = 10.3 Hz, 
1H), 3.17 – 3.09 (m, 1H), 2.16 – 2.06 (m, 1H), 1.90 – 1.84 (m, 3H), 1.77 (s, 3H), 1.69 (dd, 
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NMR (125 MHz, CDCl3) δ 168.9, 148.0, 138.1, 125.1, 123.7, 108.2, 97.6, 81.6, 78.7, 77.9, 
76.8, 56.3, 51.9, 49.0, 42.8, 36.1, 33.5, 28.4, 26.1, 26.1, 20.1, 17.3, 12.8; HRMS (ESI) m/z 
447.2361 [(M+Na)+; calcd for C23H36O7Na: 447.2359]. 
 
To a solution of (–)-3.94 (8 mg, 0.012 mmol) in 1,4-dioxane (0.6 mL) and H2O (0.2 
mL) was added 2,6-lutidine (28 uL, 0.024 mmol, 10 vol% in dioxane), OsO4 (80 uL, 
0.00016 mmol, 0.5 wt% in H2O) and NaIO4 (10 mg, 0.047 mmol) at room temerature. After 
addition of all reagents, the resulting mixture was stirred at 50 ºC overnight, filtered 
through Celite, and wash with brine. The organic layer was concentrated in vacuo. Flash 
chromatography (10:1 to 5:1 hexanes/ EtOAc) afforded compound (–)-3.97 (2.0 mg, 0.003 
mol, 25% yield) as a white foam, in conjunction with the recovery of staring material (–)- 
3.94 (1.9 mg, 0.003 mmol, 25%).[a]20D   – 2.5 (c 0.22, CHCl3);IR (film, cm
-1) 2926, 1723, 
1458, 1379, 1246, 1204, 1152, 1101, 1036, 919; 1H NMR (500 MHz, CDCl3) δ 9.46 (d, J 
= 5.4 Hz, 1H), 5.45 (d, J = 2.5 Hz, 1H), 5.28 (t, J = 7.2 Hz, 1H), 4.85 (d, J = 6.9 Hz, 1H), 
4.68 (d, J = 6.7 Hz, 1H), 4.64 (t, J = 8.2, 7.0 Hz, 2H), 4.13 (t, J = 6.5 Hz, 1H), 4.06 (dd, J 
= 10.4, 6.3 Hz, 1H), 4.01 (d, J = 9.9 Hz, 1H), 3.80 – 3.71 (m, 1H), 3.55 (d, J = 6.6 Hz, 1H), 
3.41 (s, 3H), 3.39 (s, 3H), 3.31 (d, J = 9.9 Hz, 1H), 2.86 (d, J = 9.9 Hz, 1H), 2.65 – 2.54 
(m, 1H), 2.32 – 2.20 (m, 2H), 2.19 – 2.10 (m, 1H), 1.93 (dd, J = 12.0, 3.4 Hz, 1H), 1.71 – 
1.61 (m, 1H), 1.58 (t, J = 1.3 Hz, 3H), 1.46 (s, 3H), 1.44 (s, 3H), 1.38 (s, 3H), 1.37 (s, 3H), 
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0.81 (d, J = 6.9 Hz, 3H), 0.79 (d, J = 6.9 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 204.7, 
135.2, 132.3, 129.8, 125.9, 108.6, 98.9, 97.4, 96.5, 81.3, 79.7, 78.2, 77.5, 74.9, 69.9, 56.2, 
55.8, 51.6, 46.5, 39.7, 39.1, 33.9, 33.8, 32.9, 30.2, 29.9, 29.3, 29.1, 28.2, 25.8, 21.9, 20.0, 
19.8, 18.1, 17.6, 13.1, 5.0; HRMS (ESI) m/z 673.4295 [(M+Na)+; calcd for C37H62O9Na: 
673.4292]. 
 
To a heavy-wall reaction tube was added Hoveyda-Grubbs II catalyst (32 mg, 0.05 
mmol) and methyl methacrylate (2 mL). To a second heavy-wall tube was added compound 
(–)-3.94 (64 mg, 0.099 mmol) and methyl methacrylate (1 mL). Both catalyst and (–)-3.94 
solutions in methyl methacrylate were degassed via three freeze-pump-thaw cycles and 
then the tubes were filled with N2. To the tube contacting (–)-3.94 was added a quarter 
volume of the catalyst solution and the tube was sealed and heated at 137 ºC for 20 min. 
The tube was cooled down, loaded with another quarter volume of catalyst solution and 
heated at 137 ºC for another 20 min. The remaining catalyst solution was added in a similar 
manner. After all catalyst solution was added, the resulting reaction mixture was stirred at 
137 ºC for another 2.5 h. The reaction mixture was then cooled down, dissolved with 50 
mL EtOAc, and then treated with 100 mL hexanes. The precipitates were filtered through 
Celite, rinsed with EtOAc/hexanes (1:1) and the filtrate was concentrated. Flash 
chromatography (20:10:1 toluene/hexanes/ EtOAc to 10:1 hexanes/EtOAc) afforded 
compound (–)-3.96 (20 mg, 29% yield) as a white foam, in conjunction with the recovery 
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1712, 1437, 1379, 1217, 1151, 1102, 1038, 919, 873, 756; 1H NMR (500 MHz, CDCl3) δ 
6.54 (d, J = 11.0 Hz, 1H), 5.35 (s, 1H), 5.14 (t, J = 7.0 Hz, 1H), 4.82 (d, J = 6.9 Hz, 1H), 
4.66 (d, J = 6.7 Hz, 1H), 4.60 (dd, J = 6.9, 3.0 Hz, 2H), 4.21 (t, J = 5.6 Hz, 1H), 4.00 (d, J 
= 11.0 Hz, 1H), 3.88 (dd, J = 10.9, 5.9 Hz, 1H), 3.71 (s, 4H), 3.61 (d, J = 5.2 Hz, 1H), 3.41 
(s, 3H), 3.36 (s, 3H), 3.30 (d, J = 9.5 Hz, 1H), 2.83 (d, J = 10.1 Hz, 1H), 2.38 (d, J = 9.4 
Hz, 1H), 2.32 – 2.21 (m, 1H), 2.21 – 2.07 (m, 2H), 1.72 (s, 3H), 1.68 – 1.62 (m, 1H), 1.59 
– 1.56 (m, 1H), 1.56 – 1.49 (m, 4H), 1.45 (s, 3H), 1.43 (s, 3H), 1.37 (s, 3H), 1.36 (s, 3H), 
1.32 (s, 3H), 1.31 – 1.25 (m, 2H), 1.22 (s, 3H), 1.05 (d, J = 7.0 Hz, 3H), 0.92 (d, J = 6.4 
Hz, 3H), 0.79 (d, J = 2.7 Hz, 3H), 0.77 (d, J = 2.9 Hz, 3H).; 13C NMR (125 MHz, CDCl3) 
δ 168.5, 148.3, 135.5, 133.2, 130.5, 125.5, 125.2, 108.2, 98.9, 97.2, 96.5, 80.7, 79.7, 78.4, 
77.9, 74.8, 69.8, 56.2, 56.1, 55.7, 51.9, 50.5, 40.4, 39.0, 38.0, 34.2, 33.7, 33.0, 30.2, 29.4, 
29.3, 28.3, 25.9, 22.1, 20.0, 19.8, 18.0, 17.5, 13.4, 13.1, 5.0; HRMS (ESI) m/z 743.4708 
[(M+Na)+; calcd for C41H68O10Na: 743.4710]. 
 
To a heavy-wall reaction flask was added compound (–)-3.96 (16 mg, 0.022 mmol), 
LiBF4 (3 mL, 1.0 M in acetonitrile), CH3CN (3 mL) and H2O (3 mL). The reaction flask 
was then sealed and stirred at 75 ºC for one day, 85 ºC for one day and 90 ºC for one day. 
The reaction process was monitored by LC-MS. The reaction mixture was then extracted 
with EtOAc for three times. The combined organic layers were dried over anhydrous 
Na2SO4, filtered and concentrated. Flash chromatography (20:1 EtOAc/methanol) afforded 
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(film, cm-1) 3394, 2958, 1695, 1437, 1386, 1283, 1229, 1057, 971, 754; 1H NMR (500 
MHz, methanol-d4) δ 6.57 (d, J = 11.1 Hz, 1H), 5.22 (s, 1H), 5.12 (s, 1H), 4.00 – 3.95 (m, 
2H), 3.79 – 3.73 (m, 2H), 3.72 (s, 3H), 3.59 – 3.56 (m, 1H), 3.52 – 3.45 (m, 1H), 2.58 – 
2.51 (m, 1H), 2.38 (d, J = 9.4 Hz, 1H), 2.21 – 2.15 (m, 1H), 2.13 – 2.08 (m, 1H), 1.79 – 
1.70 (m, 4H), 1.68 – 1.59 (m, 3H), 1.58 (s, 3H), 1.49 (s, 3H), 1.42 – 1.33 (m, 2H), 1.25 (s, 
3H), 0.97 (d, J = 6.4 Hz, 3H), 0.96 (d, J = 6.4 Hz, 3H), 0.91(d, J = 7.2 Hz, 3H),  0.87 (d, J 
= 6.6 Hz, 3H); 13C NMR (125 MHz, methanol-d4) δ 170.6, 151.5, 137.0, 135.2, 133.3, 
126.8, 126.0, 81.7, 77.8, 75.7, 72.8, 70.8, 69.4, 58.4, 52.3, 52.3, 42.6, 42.1, 41.2, 38.2, 37.9, 
32.3, 32.1, 28.1, 22.3, 19.8, 19.2, 18.3, 13.7, 12.7, 7.0; HRMS (ESI) m/z 575.3568 
[(M+Na)+; calcd for C31H52O8Na: 575.3560]. 
 
To a solution of (–)-3.98 (3.7 mg) in MeOH(0.2 mL) and H2O (0.1 mL) was added 
LiOH (0.1 mL, 1M aqueous solution). The reaction mixture was stirred at room 
temperature for 14 h and the reaction process was monitored by LC-MS. The reaction 
mixture was acidified with TFA to pH=1. The resulting solution was concentrated in vacuo 
to remove MeOH and then lyophilized to remove H2O. The crude mixture was then purified 
by high-performance liquid chromatography (HPLC) (detected at λ=227 nm) with a 
phenomenex® reversed-phase C18 column [Luna® 3 µm C18(2) 100 Å, 250 x 4.6 mm] 
that eluted with a linear gradient elution of 5% MeCN in H2O to 95% MeCN over 30 min, 
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provide the nahuoic acid Ci(Bii) [(–)-3] (2.9 mg, 80%) as a white foam; [a]20D   – 6.1 (c 0.17, 
MeOH); IR (film, cm-1) 3384 (br), 2958, 2924, 2861, 1679, 1442, 1387, 1270, 1198, 1139, 
1054, 971, 801; HRMS (ESI) m/z 561.3408 [(M+Na)+; calcd for C30H50O8Na: 561.3403]. 
For 1H and 13C NMR data and their comparisons to the reported data, see Table 3.6.13 
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E3.3  Data for Single Crystal X-ray Structures  
E3.3.1 X-ray Structure Determination of Compound (–)-3.79 
 
Compound (–)-3.79, C15H20O5, crystallizes in the orthorhombic space group P212121 
(systematic absences h00:  h=odd, 0k0:  k=odd and 00l:  l=odd) with a=6.7894(2)Å, b=9.3371(3)Å, 
c=22.2331(8)Å, V=1409.43(8)Å3, Z=4, and dcalc=1.321 g/cm3 . X-ray intensity data were collected 
on a Bruker APEXII [1] CCD area detector employing graphite-monochromated Cu-Kα radiation 
(λ=1.54178Å) at a temperature of 100K. Preliminary indexing was performed from a series of thirty-
six 0.5° rotation frames with exposures of 10 seconds. A total of 5559 frames were collected with 
a crystal to detector distance of 37.4 mm, rotation widths of 0.5° and exposures of 30 seconds: 
 
scan type 2θ ω φ χ Frames 
f 92.00 132.53 350.39 -22.49 739 
f 67.00 65.21 334.01 -58.65 722 
f 82.00 30.51 37.31 52.47 569 
f -33.00 301.93 12.22 23.24 734 
f 87.00 172.05 333.95 -55.24 739 
f 92.00 88.66 356.08 -26.26 715 
f 87.00 76.65 105.78 62.65 514 
w 87.00 352.54 26.63 27.01 141 
w 22.00 17.71 115.96 -51.77 93 
w 92.00 352.59 317.53 90.29 135 
w 92.00 159.77 266.47 -93.68 133 
w 87.00 347.72 275.82 92.25 152 
w -33.00 336.24 356.26 -87.70 103 
w 22.00 340.68 190.04 98.03 70 
 
Rotation frames were integrated using SAINT [2], producing a listing of unaveraged F2 and 
σ(F2) values. A total of 16504 reflections were measured over the ranges 7.952 ≤ 2θ ≤ 129.994°, -
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data were corrected for Lorentz and polarization effects and for absorption using SADABS [3] 
(minimum and maximum transmission 0.6421, 0.7526). The structure was solved by direct methods 
- SHELXS-97 [4]. Refinement was by full-matrix least squares based on F2 using SHELXL-2014 
[5]. All reflections were used during refinement. The weighting scheme used was w=1/[σ2(Fo2 )+ 
(0.0440P)2] where P = (Fo2 + 2Fc2)/3. Non-hydrogen atoms were refined anisotropically and 
hydrogen atoms were refined using a riding model. Refinement converged to R1=0.0255 and 
wR2=0.0632 for 2223 observed reflections for which F > 4σ(F) and R1=0.0279 and wR2=0.0640 
and GOF =1.026 for all 2358 unique, non-zero reflections and 185 variables. The maximum Δ/σ in 
the final cycle of least squares was 0.000 and the two most prominent peaks in the final difference 
Fourier were +0.14 and -0.17 e/Å3.  The Flack absolute structure parameter was calculated as -
0.03(6) and the Hooft absolute structure parameter was calculated as -0.01(8) by PLATON [6].  
These values serve to corroborate the assigned absolute structure. 
Table E3.2. lists cell information, data collection parameters, and refinement data. Final 
positional and equivalent isotropic thermal parameters are given in Tables E3.3 and E3.4 
Anisotropic thermal parameters are in Table E3.5. Tables E3.6 and E3.7 list bond distances and 
bond angles. Figure E3.1. is an ORTEP representation of the molecule with 50% probability thermal 
ellipsoids displayed. 
 






















  234 
 
Table E3.2  Summary of Structure Determination of Compound (–)-3.79 
Empirical formula  C15H20O5  
Formula weight  280.31  
Temperature/K  100  
Crystal system  orthorhombic  
Space group  P212121  
a  6.7894(2)Å  
b  9.3371(3)Å  
c  22.2331(8)Å  
Volume  1409.43(8)Å3  
Z  4  
dcalc  1.321 g/cm3  
μ  0.818 mm-1  
F(000)  600.0  
Crystal size, mm  0.32 × 0.22 × 0.04  
2θ range for data collection      7.952 - 129.994°  
Index ranges  -7 ≤ h ≤ 6, -10 ≤ k ≤ 10, -26 ≤ l ≤ 25  
Reflections collected  16504  
Independent reflections  2358[R(int) = 0.0483]  
Data/restraints/parameters  2358/0/185  
Goodness-of-fit on F2  1.026  
Final R indexes [I>=2σ (I)]  R1 = 0.0255, wR2 = 0.0632  
Final R indexes [all data]  R1 = 0.0279, wR2 = 0.0640  
Largest diff. peak/hole  0.14/-0.17 eÅ-3  
Flack parameter -0.03(6) 
Hooft parameter -0.01(8) 
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Table E3.3 Refined Positional Parameters for Compound (–)-3.79 
Atom x y z U(eq) 
C1 0.2124(3) 0.32244(18) 0.15948(8) 0.0172(4) 
C2 0.2477(3) 0.20935(19) 0.20658(8) 0.0202(4) 
C3 0.3641(3) 0.0962(2) 0.19968(8) 0.0217(4) 
C4 0.4723(3) 0.06460(19) 0.14213(8) 0.0202(4) 
C5 0.5022(3) 0.20388(18) 0.10700(8) 0.0167(4) 
C6 0.6465(3) 0.30834(19) 0.13545(7) 0.0164(4) 
C7 0.6736(3) 0.44273(19) 0.10238(7) 0.0178(4) 
C8 0.5318(3) 0.49156(17) 0.06565(7) 0.0158(4) 
C9 0.3351(3) 0.41960(18) 0.06103(7) 0.0161(4) 
C10 0.3032(3) 0.28203(19) 0.09758(7) 0.0159(4) 
C11 0.1486(3) 0.5497(2) 0.20492(8) 0.0211(4) 
C12 0.1651(3) 0.7477(2) 0.13980(9) 0.0275(5) 
C13 0.6610(3) -0.0235(2) 0.14884(9) 0.0275(5) 
C14 0.7280(3) 0.6829(2) 0.03074(9) 0.0241(4) 
C15 0.1540(3) 0.1874(2) 0.06439(8) 0.0222(4) 
O1 0.29269(18) 0.45695(13) 0.18089(5) 0.0189(3) 
O2 0.05045(19) 0.62913(13) 0.16020(6) 0.0230(3) 
O3 0.73987(18) 0.28391(13) 0.18136(5) 0.0214(3) 
O4 0.54111(19) 0.61008(13) 0.03124(6) 0.0202(3) 
O5 0.20683(18) 0.47004(14) 0.02931(6) 0.0231(3) 
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Table E3.4 Positional Parameters for Hydrogens in Compound (–)-3.79 
Atom x y z U(eq) 
H1 0.067 0.3342 0.1542 0.023 
H2 0.1817 0.2197 0.244 0.027 
H3 0.3796 0.0322 0.2326 0.029 
H4 0.3808 0.0049 0.1173 0.027 
H5 0.5546 0.1779 0.0664 0.022 
H7 0.7923 0.4956 0.107 0.024 
H11a 0.0509 0.4925 0.2276 0.028 
H11b 0.2124 0.6166 0.2335 0.028 
H12a 0.1951 0.8107 0.1739 0.041 
H12b 0.0907 0.8013 0.1094 0.041 
H12c 0.2882 0.7127 0.1221 0.041 
H13a 0.7576 0.0309 0.1723 0.041 
H13b 0.7153 -0.0443 0.1089 0.041 
H13c 0.631 -0.1135 0.1696 0.041 
H14a 0.761 0.7139 0.0716 0.036 
H14b 0.7201 0.7667 0.0043 0.036 
H14c 0.8302 0.6177 0.0159 0.036 
H15a 0.0413 0.2457 0.0518 0.033 
H15b 0.1086 0.111 0.0913 0.033 
H15c 0.2167 0.1449 0.0289 0.033 
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Table E3.5 Refined Thermal Parameters (U's) for Compound (–)-3.79 
Atom U11 U22 U33 U23 U13 U12 
C1 0.0129(9) 0.0186(9) 0.0202(9) -0.0022(7) 0.0011(7) -0.0033(7) 
C2 0.0199(10) 0.0229(10) 0.0178(9) -0.0002(7) 0.0023(7) -0.0078(8) 
C3 0.0241(10) 0.0213(10) 0.0196(9) 0.0048(7) -0.0018(8) -0.0056(8) 
C4 0.0252(10) 0.0148(9) 0.0208(9) 0.0002(7) -0.0031(8) -0.0020(8) 
C5 0.0188(10) 0.0162(9) 0.0150(8) 0.0003(7) 0.0016(7) 0.0024(7) 
C6 0.0122(9) 0.0197(9) 0.0174(9) 0.0010(7) 0.0041(8) 0.0019(8) 
C7 0.0149(10) 0.0194(9) 0.0191(9) -0.0002(7) 0.0027(8) -0.0026(8) 
C8 0.0191(9) 0.0133(9) 0.0152(8) -0.0004(7) 0.0035(8) 0.0011(7) 
C9 0.0183(10) 0.0153(9) 0.0149(8) -0.0017(7) 0.0007(8) 0.0013(7) 
C10 0.0147(9) 0.0165(9) 0.0166(9) 0.0006(7) -0.0013(7) -0.0015(7) 
C11 0.0205(10) 0.0226(10) 0.0202(9) -0.0037(8) 0.0032(8) 0.0013(9) 
C12 0.0293(12) 0.0204(10) 0.0329(11) 0.0013(8) 0.0012(9) -0.0024(8) 
C13 0.0362(12) 0.0193(9) 0.027(1) 0.0014(8) -0.0011(9) 0.0065(9) 
C14 0.0229(10) 0.0197(9) 0.0295(10) 0.0047(8) 0.0028(9) -0.0044(8) 
C15 0.0229(10) 0.0216(9) 0.0219(9) -0.0002(8) -0.0053(8) -0.0028(8) 
O1 0.0154(6) 0.0184(6) 0.0230(6) -0.0047(5) 0.0027(5) -0.0031(5) 
O2 0.0195(7) 0.0194(6) 0.0299(7) 0.0006(5) -0.0001(6) -0.0009(6) 
O3 0.0163(7) 0.0267(7) 0.0211(7) 0.0055(5) -0.0031(5) -0.0017(6) 
O4 0.0195(7) 0.0163(6) 0.0247(6) 0.0055(5) 0.0010(5) -0.0017(6) 
O5 0.0194(7) 0.0238(7) 0.0262(7) 0.0050(6) -0.0068(6) 0.0006(6) 
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Table E3.6 Bond Distances in Compound (–)-3.79, Å 
C1-C2 1.506(3)  C1-C10 1.554(2)  C1-O1 1.450(2) 
C2-C3 1.328(3)  C3-C4 1.505(3)  C4-C5 1.530(2) 
C4-C13 1.530(3)  C5-C6 1.520(3)  C5-C10 1.550(2) 
C6-C7 1.466(2)  C6-O3 1.223(2)  C7-C8 1.343(3) 
C8-C9 1.498(3)  C8-O4 1.347(2)  C9-C10 1.535(2) 
C9-O5 1.215(2)  C10-C15 1.534(3)  C11-O1 1.411(2) 






Table E3.7 Bond Angles in Compound (–)-3.79, ° 
C2-C1-C10 112.48(15)  O1-C1-C2 108.62(14)  O1-C1-C10 110.61(14) 
C3-C2-C1 124.88(16)  C2-C3-C4 123.00(16)  C3-C4-C5 109.40(15) 
C3-C4-C13 115.56(15)  C13-C4-C5 113.32(16)  C4-C5-C10 110.71(14) 
C6-C5-C4 114.73(14)  C6-C5-C10 108.41(14)  C7-C6-C5 114.94(15) 
O3-C6-C5 124.17(16)  O3-C6-C7 120.86(17)  C8-C7-C6 120.35(17) 
C7-C8-C9 121.93(15)  C7-C8-O4 126.20(16)  O4-C8-C9 111.81(14) 
C8-C9-C10 117.67(14)  O5-C9-C8 120.29(15)  O5-C9-C10 122.04(16) 
C5-C10-C1 109.90(13)  C9-C10-C1 108.75(14)  C9-C10-C5 110.04(14) 
C15-C10-C1 107.69(15)  C15-C10-C5 111.69(15)  C15-C10-C9 108.69(14) 
O2-C11-O1 112.58(14)  C11-O1-C1 113.28(14)  C11-O2-C12 112.02(15) 
C8-O4-C14 115.71(14)       
This report has been created with Olex2 [7], compiled on 2016.08.25 svn.r3337 for OlexSys. 
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E3.3.2 X-ray Structure Determination of Compound (–)-3.87 
        
Compound (–)-3.87, C23H40O6Si, crystallizes in the monoclinic space group P21 (systematic 
absences 0k0: k=odd) with a=7.8409(3)Å, b=13.6190(5)Å, c=11.7206(4)Å, β=96.6630(10)°, 
V=1243.13(8)Å3, Z=2, and dcalc=1.177 g/cm3 . X-ray intensity data were collected on a Bruker 
D8QUEST [1] CMOS area detector employing graphite-monochromated Mo-Kα radiation 
(λ=0.71073Å) at a temperature of 100K. Preliminary indexing was performed from a series of thirty-
six 0.5° rotation frames with exposures of 10 seconds. A total of 1195 frames were collected with 
a crystal to detector distance of 34.0 mm, rotation widths of 0.5° and exposures of 10 seconds: 
 
scan type 2θ ω φ χ Frames 
w 0.00 195.50 270.00 54.72 298 
w -45.24 149.51 113.55 54.72 301 
w 0.00 195.50 0.00 54.72 298 
w 0.00 195.50 180.00 54.72 298 
 
Rotation frames were integrated using SAINT [2], producing a listing of unaveraged F2 and 
σ(F2) values. A total of 23444 reflections were measured over the ranges 5.946 ≤ 2θ ≤ 50.782°, -9 
≤ h ≤ 9, -16 ≤ k ≤ 16, -14 ≤ l ≤ 14 yielding 4565 unique reflections (Rint = 0.0260). The intensity 
data were corrected for Lorentz and polarization effects and for absorption using SADABS [3] 
(minimum and maximum transmission 0.7099, 0.7452). The structure was solved by direct 
methods - SHELXT [4]. Refinement was by full-matrix least squares based on F2 using SHELXL-
2014 [5]. All reflections were used during refinement. The weighting scheme used was 
w=1/[σ2(Fo2 )+ (0.0348P)2 + 0.2747P] where P = (Fo2 + 2Fc2)/3. Non-hydrogen atoms were refined 
anisotropically and hydrogen atoms were refined using a riding model. Refinement converged to 
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wR2=0.0641 and GOF =1.090 for all 4565 unique, non-zero reflections and 283 variables. The 
maximum Δ/σ in the final cycle of least squares was 0.000 and the two most prominent peaks in 
the final difference Fourier were +0.20 and -0.23 e/Å3. 
Table E3.8. lists cell information, data collection parameters, and refinement data. Final 
positional and equivalent isotropic thermal parameters are given in Tables E3.9. and E3.10. 
Anisotropic thermal parameters are in Table E3.11. Tables E3.12. and E3.13. list bond distances 
and bond angles. Figure E3.2. is an ORTEP representation of the molecule with 50% probability 
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Table E3.8 Summary of Structure Determination of Compound (–)-3.87 
Empirical formula C23H40O6Si 
Formula weight 440.64 
Temperature/K 100 
Crystal system monoclinic 







dcalc 1.177 g/cm3 
μ 0.128 mm-1 
F(000) 480.0 
Crystal size, mm 0.35 × 0.18 × 0.15 
2θ range for data collection 5.946 - 50.782° 
Index ranges -9 ≤ h ≤ 9, -16 ≤ k ≤ 16, -14 ≤ l ≤ 14 
Reflections collected 23444 
Independent reflections 4565[R(int) = 0.0260] 
Data/restraints/parameters 4565/1/283 
Goodness-of-fit on F2 1.090 
Final R indexes [I>=2σ (I)] R1 = 0.0247, wR2 = 0.0637 
Final R indexes [all data] R1 = 0.0251, wR2 = 0.0641 
Largest diff. peak/hole 0.20/-0.23 eÅ-3 
Flack parameter 0.00(11) 
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Table E3.9 Refined Positional Parameters for Compound (–)-3.87 
Atom x y z U(eq) 
Si1 0.87239(6) 0.62599(4) 0.60731(4) 0.01416(14) 
O1 0.65379(16) 0.64548(9) 0.21987(11) 0.0140(3) 
O2 0.92967(16) 0.67789(11) 0.16874(12) 0.0197(3) 
O3 0.67952(16) 0.3982(1) 0.11453(11) 0.0148(3) 
O4 0.41288(17) 0.39807(10) 0.01137(11) 0.0171(3) 
O5 0.60098(19) 0.75592(11) 0.45228(12) 0.0213(3) 
O6 0.78150(16) 0.58507(10) 0.48146(11) 0.0139(3) 
C1 0.6712(2) 0.54141(13) 0.23940(15) 0.0123(4) 
C2 0.6085(2) 0.49397(14) 0.12395(16) 0.0137(4) 
C3 0.4164(2) 0.47385(14) 0.09713(16) 0.0142(4) 
C4 0.3311(2) 0.43706(14) 0.19969(16) 0.0145(4) 
C5 0.3762(2) 0.50219(14) 0.30626(15) 0.0134(4) 
C6 0.2905(2) 0.60130(14) 0.29825(16) 0.0171(4) 
C7 0.3566(2) 0.68180(16) 0.34956(17) 0.0183(4) 
C8 0.5283(2) 0.68171(15) 0.41532(16) 0.0161(4) 
C9 0.6048(2) 0.57984(14) 0.44191(16) 0.0133(4) 
C10 0.5735(2) 0.50751(14) 0.34026(15) 0.0117(4) 
C11 0.8075(3) 0.69964(15) 0.24314(17) 0.0186(4) 
C12 0.8895(3) 0.71561(19) 0.05600(19) 0.0269(5) 
C13 0.5816(2) 0.35419(14) 0.01749(17) 0.0153(4) 
C14 0.6565(3) 0.37744(18) -0.09300(17) 0.0234(4) 
C15 0.5737(3) 0.24521(16) 0.03928(18) 0.0201(4) 
C16 0.1371(2) 0.42437(17) 0.16818(19) 0.0218(4) 
C17 0.9961(3) 0.73906(17) 0.5847(2) 0.0261(5) 
C18 0.7072(3) 0.64980(16) 0.70605(17) 0.0228(5) 
C19 1.0227(3) 0.52492(16) 0.66609(17) 0.0193(4) 
C20 1.1565(3) 0.5054(2) 0.5830(2) 0.0336(5) 
C21 1.1146(4) 0.5533(2) 0.7841(2) 0.0461(8) 
C22 0.9208(3) 0.43032(16) 0.67767(19) 0.0232(5) 
C23 0.6432(2) 0.40660(14) 0.38045(16) 0.0149(4) 
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Table E3.10 Positional Parameters for Hydrogens in Compound (–)-3.87 
Atom x y z U(eq) 
H1 0.7933 0.5261 0.2585 0.016 
H2 0.645 0.5351 0.0626 0.018 
H3 0.3572 0.5326 0.0646 0.019 
H4 0.3783 0.3717 0.219 0.019 
H5 0.3301 0.4681 0.3696 0.018 
H6 0.1841 0.6064 0.2544 0.023 
H7 0.2931 0.7396 0.3438 0.024 
H9 0.5473 0.5526 0.5047 0.018 
H11a 0.7806 0.7691 0.2376 0.025 
H11b 0.8568 0.6864 0.3214 0.025 
H12a 0.9904 0.7146 0.0169 0.04 
H12b 0.849 0.7819 0.0601 0.04 
H12c 0.8018 0.6759 0.0148 0.04 
H14a 0.5832 0.3512 -0.157 0.035 
H14b 0.7686 0.3486 -0.0906 0.035 
H14c 0.6653 0.4473 -0.1013 0.035 
H15a 0.511 0.2136 -0.0258 0.03 
H15b 0.5171 0.2335 0.1064 0.03 
H15c 0.6881 0.2191 0.0511 0.03 
H16a 0.0876 0.4858 0.1411 0.033 
H16b 0.086 0.4037 0.2348 0.033 
H16c 0.1162 0.3757 0.1089 0.033 
H17a 1.0763 0.7259 0.5306 0.039 
H17b 1.0573 0.7596 0.6564 0.039 
H17c 0.9188 0.7901 0.5553 0.039 
H18a 0.6292 0.6994 0.6736 0.034 
H18b 0.7623 0.6718 0.779 0.034 
H18c 0.6449 0.5904 0.7165 0.034 
H20a 1.0991 0.4893 0.5085 0.05 
H20b 1.2288 0.4517 0.6111 0.05 
H20c 1.2254 0.5631 0.5774 0.05 
H21a 1.1904 0.5012 0.8124 0.069 
H21b 1.0312 0.5643 0.8365 0.069 
H21c 1.1798 0.6123 0.7771 0.069 
H22a 0.8681 0.4102 0.6033 0.035 
H22b 0.8334 0.4418 0.7272 0.035 
H22c 0.9967 0.3796 0.7098 0.035 
H23a 0.6311 0.3617 0.3169 0.022 
H23b 0.5798 0.3825 0.4399 0.022 
H23c 0.7623 0.4124 0.4097 0.022 
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Table E3.11 Refined Thermal Parameters (U's) for Compound (–)-3.87 
Atom U11 U22 U33 U23 U13 U12 
Si1 0.0166(2) 0.0137(3) 0.0121(2) -0.0019(2) 0.00173(18) -0.0009(2) 
O1 0.0137(6) 0.0104(7) 0.0182(6) 0.0012(5) 0.0030(5) -0.0006(5) 
O2 0.0123(6) 0.0243(8) 0.0223(7) 0.0086(6) 0.0012(5) 0.0006(6) 
O3 0.0131(6) 0.0157(7) 0.0160(6) -0.0044(5) 0.0023(5) 0.0008(5) 
O4 0.0143(6) 0.0203(7) 0.0161(7) -0.0054(6) -0.0003(5) 0.0024(5) 
O5 0.0245(7) 0.0145(7) 0.0247(7) -0.0056(6) 0.0026(6) 0.0014(6) 
O6 0.0126(6) 0.0158(7) 0.0131(6) -0.0022(5) 0.0005(5) 0.0009(5) 
C1 0.0098(8) 0.0120(9) 0.0151(9) 0.0005(7) 0.0020(7) 0.0012(7) 
C2 0.0142(9) 0.0130(9) 0.0145(9) 0.0002(7) 0.0044(7) 0.0010(7) 
C3 0.0155(9) 0.0139(10) 0.0127(9) -0.0013(7) 0.0002(7) 0.0015(7) 
C4 0.0119(9) 0.0153(10) 0.0164(9) -0.0005(7) 0.0024(7) -0.0002(7) 
C5 0.0113(8) 0.0161(10) 0.0135(9) 0.0007(7) 0.0038(7) -0.0001(7) 
C6 0.0131(8) 0.0219(11) 0.0167(9) 0.0007(8) 0.0030(7) 0.0051(8) 
C7 0.0178(9) 0.0173(10) 0.0206(9) 0.0009(8) 0.0056(7) 0.0075(8) 
C8 0.0187(9) 0.0166(10) 0.0141(9) -0.0019(8) 0.0067(7) 0.0037(8) 
C9 0.0124(8) 0.0150(9) 0.0131(9) 0.0004(7) 0.0035(7) 0.0014(7) 
C10 0.0115(8) 0.0112(9) 0.0127(8) -0.0004(7) 0.0026(7) 0.0011(7) 
C11 0.0204(10) 0.0166(10) 0.0188(10) 0.0009(8) 0.0019(7) -0.0057(8) 
C12 0.0184(10) 0.0394(13) 0.0237(11) 0.0118(9) 0.0059(8) -0.0001(9) 
C13 0.0141(9) 0.0169(10) 0.0151(9) -0.0036(7) 0.0028(7) 0.0004(7) 
C14 0.0273(10) 0.0269(12) 0.0174(9) -0.0024(9) 0.0084(8) -0.0005(9) 
C15 0.0192(9) 0.0184(10) 0.0224(10) -0.0035(8) 0.0008(8) 0.0003(8) 
C16 0.0135(9) 0.0272(12) 0.0249(10) -0.0070(9) 0.0031(8) -0.0027(8) 
C17 0.0299(11) 0.0203(11) 0.0277(11) -0.0030(9) 0.0010(9) -0.0081(9) 
C18 0.0264(10) 0.0258(12) 0.0168(9) -0.0028(8) 0.0054(8) 0.0047(8) 
C19 0.0184(9) 0.0219(11) 0.0171(9) -0.0010(8) -0.0006(8) 0.0021(8) 
C20 0.0197(10) 0.0340(13) 0.0494(15) 0.0055(12) 0.014(1) 0.0048(10) 
C21 0.0554(18) 0.0400(16) 0.0355(14) -0.0059(13) -0.0266(13) 0.0124(13) 
C22 0.0257(10) 0.0216(11) 0.0231(10) 0.0080(8) 0.0059(8) 0.0070(9) 
C23 0.0157(9) 0.0129(9) 0.0159(9) -0.0011(7) 0.0006(7) 0.0010(7) 
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Table E3.12 Bond Distances in Compound (–)-3.87 , Å 
Si1-O6 1.6584(13)  Si1-C17 1.856(2)  Si1-C18 1.863(2) 
Si1-C19 1.890(2)  O1-C1 1.440(2)  O1-C11 1.412(2) 
O2-C11 1.400(2)  O2-C12 1.419(2)  O3-C2 1.428(2) 
O3-C13 1.428(2)  O4-C3 1.439(2)  O4-C13 1.446(2) 
O5-C8 1.215(3)  O6-C9 1.411(2)  C1-C2 1.528(3) 
C1-C10 1.552(2)  C2-C3 1.528(3)  C3-C4 1.526(3) 
C4-C5 1.539(3)  C4-C16 1.533(3)  C5-C6 1.506(3) 
C5-C10 1.554(2)  C6-C7 1.327(3)  C7-C8 1.471(3) 
C8-C9 1.529(3)  C9-C10 1.543(3)  C10-C23 1.533(3) 
C13-C14 1.516(3)  C13-C15 1.509(3)  C19-C20 1.535(3) 
C19-C21 1.533(3)  C19-C22 1.531(3)    
 
 
Table E3.13 Bond Angles in Compound (–)-3.87 , ° 
O6-Si1-C17 109.24(9)  O6-Si1-C18 110.67(9)  O6-Si1-C19 105.37(8) 
C17-Si1-C18 110.93(10)  C17-Si1-C19 110.01(10)  C18-Si1-C19 110.47(9) 
C11-O1-C1 114.86(14)  C11-O2-C12 114.16(15)  C2-O3-C13 105.45(13) 
C3-O4-C13 108.59(13)  C9-O6-Si1 127.84(12)  O1-C1-C2 105.10(14) 
O1-C1-C10 111.59(14)  C2-C1-C10 114.34(15)  O3-C2-C1 111.49(15) 
O3-C2-C3 101.80(14)  C3-C2-C1 117.79(15)  O4-C3-C2 102.16(14) 
O4-C3-C4 109.89(15)  C4-C3-C2 114.11(15)  C3-C4-C5 111.69(15) 
C3-C4-C16 111.13(16)  C16-C4-C5 112.87(15)  C4-C5-C10 111.29(14) 
C6-C5-C4 114.02(15)  C6-C5-C10 113.45(16)  C7-C6-C5 124.36(17) 
C6-C7-C8 121.50(18)  O5-C8-C7 123.29(18)  O5-C8-C9 121.67(16) 
C7-C8-C9 114.90(17)  O6-C9-C8 111.62(15)  O6-C9-C10 110.37(14) 
C8-C9-C10 113.46(15)  C1-C10-C5 112.55(14)  C9-C10-C1 110.47(14) 
C9-C10-C5 106.99(14)  C23-C10-C1 108.12(14)  C23-C10-C5 110.23(15) 
C23-C10-C9 108.41(14)  O2-C11-O1 113.55(16)  O3-C13-O4 105.69(14) 
O3-C13-C14 111.51(16)  O3-C13-C15 107.87(16)  O4-C13-C14 108.32(16) 
O4-C13-C15 111.10(15)  C15-C13-C14 112.18(17)  C20-C19-Si1 109.76(15) 
C21-C19-Si1 110.68(16)  C21-C19-C20 109.4(2)  C22-C19-Si1 109.58(13) 
C22-C19-C20 108.25(18)  C22-C19-C21 109.2(2)    
This report has been created with Olex2 [6], compiled on 2016.09.09 svn.r3337 for OlexSys. 
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E3.3.3 X-ray Structure Determination of Compound (+)-3.22-b 
 
 
Compound (+)-3.22-b, C20H32O5, crystallizes in the orthorhombic space group P21212 
(systematic absences h00:  h=odd and 0k0:  k=odd) with a=14.316(2)Å, b=17.322(3)Å, 
c=8.0019(13)Å, V=1984.3(5)Å3, Z=4, and dcalc=1.180 g/cm3 . X-ray intensity data were collected on 
a Bruker APEXII [1] CCD area detector employing graphite-monochromated Cu-Kα radiation 
(λ=1.54178Å) at a temperature of 100K. Preliminary indexing was performed from a series of ninety 
0.5° rotation frames with exposures of 10 seconds. A total of 3171 frames were collected with a 
crystal to detector distance of 37.6 mm, rotation widths of 0.5° and exposures of 15 seconds: 
 
scan type 2θ ω φ χ Frames 
f 92.00 132.53 -219.50 -22.49 438 
f 17.00 53.92 -16.51 -37.41 739 
f 92.00 88.66 -11.29 -26.26 739 
f 87.00 172.05 -26.05 -55.24 739 
w 92.00 -12.19 -42.47 90.29 153 
f 92.00 209.22 13.81 -95.28 277 
w 82.00 -9.88 -18.70 85.83 86 
 
Rotation frames were integrated using SAINT [2], producing a listing of unaveraged F2 and 
σ(F2) values. A total of 12841 reflections were measured over the ranges 8.012 ≤ 2θ ≤ 129.608°, -
16 ≤ h ≤ 16, -20 ≤ k ≤ 19, -9 ≤ l ≤ 9 yielding 3317 unique reflections (Rint = 0.0265). The intensity 
data were corrected for Lorentz and polarization effects and for absorption using SADABS [3] 
(minimum and maximum transmission 0.6646, 0.7526). The structure was solved by direct 
methods - SHELXS-97 [4]. Refinement was by full-matrix least squares based on F2 using 
SHELXL-2014 [5]. All reflections were used during refinement. The weighting scheme used was 
w=1/[σ2(Fo2 )+ (0.0351P)2 + 0.2847P] where P = (Fo2 + 2Fc2)/3. Non-hydrogen atoms were refined 
anisotropically and hydrogen atoms were refined using a riding model, except the hydroxyl 
hydrogen atom which was refined isotropically. Refinement converged to R1=0.0256 and 
wR2=0.0644 for 3206 observed reflections for which F > 4σ(F) and R1=0.0267 and wR2=0.0651 
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the final cycle of least squares was 0.000 and the two most prominent peaks in the final difference 
Fourier were +0.14 and -0.14 e/Å3. 
Table E3.3. lists cell information, data collection parameters, and refinement data. Final 
positional and equivalent isotropic thermal parameters are given in Tables E3.14. and E3.15. 
Anisotropic thermal parameters are in Table E3.16. Tables E3.17. and E3.18. list bond distances 
and bond angles. Figure 1E3.3. is an ORTEP representation of the molecule with 50% probability 
thermal ellipsoids displayed. 
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Table E3.14 Summary of Structure Determination of Compound (+)-3.22-b 
Empirical formula  C20H32O5  
Formula weight  352.45  
Temperature/K  100  
Crystal system  orthorhombic  
Space group  P21212  
a  14.316(2)Å  
b  17.322(3)Å  
c  8.0019(13)Å  
Volume  1984.3(5)Å3  
Z  4  
dcalc  1.180 g/cm3  
μ  0.673 mm-1  
F(000)  768.0  
Crystal size, mm  0.48 × 0.1 × 0.1  
2θ range for data collection      8.012 - 129.608°  
Index ranges  -16 ≤ h ≤ 16, -20 ≤ k ≤ 19, -9 ≤ l ≤ 9  
Reflections collected  12841  
Independent reflections  3317[R(int) = 0.0265]  
Data/restraints/parameters  3317/0/235  
Goodness-of-fit on F2  1.043  
Final R indexes [I>=2σ (I)]  R1 = 0.0256, wR2 = 0.0644  
Final R indexes [all data]  R1 = 0.0267, wR2 = 0.0651  
Largest diff. peak/hole  0.14/-0.14 eÅ-3  
Flack parameter -0.01(5) 
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Table E3.15 Refined Positional Parameters for Compound (+)-3.22-b 
Atom x y z U(eq) 
O1 0.89226(8) 0.28478(7) 0.88130(14) 0.0232(3) 
O2 0.96947(8) 0.32126(6) 0.64255(14) 0.0226(3) 
O3 0.96872(8) 0.12438(6) 0.47909(14) 0.0206(3) 
O4 1.12591(8) 0.11916(7) 0.56430(18) 0.0333(3) 
O5 0.93483(9) 0.17481(8) 0.12816(15) 0.0286(3) 
C1 0.95143(12) 0.34483(10) 0.8106(2) 0.0237(4) 
C2 0.95891(11) 0.23881(9) 0.6409(2) 0.0194(3) 
C3 0.95019(11) 0.20567(9) 0.46460(19) 0.0190(3) 
C4 0.85359(11) 0.2179(1) 0.3817(2) 0.0210(4) 
C5 0.84803(12) 0.17028(11) 0.2182(2) 0.0256(4) 
C6 0.82219(12) 0.08603(11) 0.2395(2) 0.0267(4) 
C7 0.78209(12) 0.06076(10) 0.3784(2) 0.0266(4) 
C8 0.75947(12) 0.10844(10) 0.5311(2) 0.0240(4) 
C9 0.77175(11) 0.19635(10) 0.5020(2) 0.0214(4) 
C10 0.78048(11) 0.2438(1) 0.6650(2) 0.0217(4) 
C11 0.87387(11) 0.22810(9) 0.75200(19) 0.0194(3) 
C12 0.89877(15) 0.42065(11) 0.8059(3) 0.0344(4) 
C13 1.04113(13) 0.34833(11) 0.9109(2) 0.0312(4) 
C14 1.06010(12) 0.10188(10) 0.4388(2) 0.0272(4) 
C15 1.11137(15) 0.07469(12) 0.7115(3) 0.0427(5) 
C16 0.84605(13) 0.3037(1) 0.3292(2) 0.0262(4) 
C17 0.84160(15) 0.03435(12) 0.0922(2) 0.0373(5) 
C18 0.66083(13) 0.08710(12) 0.5828(3) 0.0335(5) 
C19 0.63957(16) 0.03428(15) 0.6954(3) 0.0520(6) 
C20 0.70098(12) 0.23330(11) 0.7911(2) 0.0281(4) 
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Table E3.16 Positional Parameters for Hydrogens in Compound (+)-3.22-b 
Atom x y z U(eq) 
H5 0.9307(16) 0.2182(14) 0.069(3) 0.043 
H2 1.0143 0.215 0.6969 0.023 
H3 0.9992 0.2295 0.3922 0.023 
H5a 0.7989 0.1945 0.1465 0.031 
H7 0.7661 0.0076 0.3823 0.032 
H8 0.8028 0.0925 0.6228 0.029 
H9 0.7132 0.2144 0.4461 0.026 
H10 0.7806 0.2995 0.632 0.026 
H11 0.8739 0.175 0.8011 0.023 
H12a 0.9361 0.4593 0.7465 0.052 
H12b 0.887 0.4383 0.9204 0.052 
H12c 0.8391 0.4133 0.748 0.052 
H13a 1.0737 0.2987 0.903 0.047 
H13b 1.0265 0.3593 1.0281 0.047 
H13c 1.0813 0.3893 0.8663 0.047 
H14a 1.079 0.128 0.3341 0.033 
H14b 1.0608 0.0456 0.4178 0.033 
H15a 1.052 0.0896 0.7632 0.064 
H15b 1.1625 0.0841 0.7903 0.064 
H15c 1.1096 0.0197 0.6825 0.064 
H16a 0.861 0.3367 0.4249 0.039 
H16b 0.7823 0.3146 0.2912 0.039 
H16c 0.8901 0.3141 0.2382 0.039 
H17a 0.8168 -0.0174 0.1146 0.056 
H17b 0.9092 0.0312 0.0738 0.056 
H17c 0.8115 0.0556 -0.0076 0.056 
H18 0.6107 0.1137 0.5303 0.04 
H19a 0.6878 0.0065 0.7505 0.062 
H19b 0.576 0.024 0.7214 0.062 
H20a 0.7045 0.1815 0.84 0.042 
H20b 0.6409 0.2396 0.7342 0.042 
H20c 0.7067 0.2721 0.8797 0.042 
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Table E3.17 Refined Thermal Parameters (U's) for Compound (+)-3.22-b 
Atom U11 U22 U33 U23 U13 U12 
O1 0.0265(6) 0.0264(6) 0.0166(6) -0.0004(5) -0.0007(5) -0.0015(5) 
O2 0.0260(6) 0.0221(6) 0.0197(6) 0.0014(5) 0.0009(5) -0.0015(5) 
O3 0.0166(6) 0.0213(6) 0.0240(6) 0.0019(5) -0.0014(5) 0.0008(4) 
O4 0.0203(6) 0.0285(7) 0.0512(8) 0.0042(6) -0.0095(6) -0.0002(5) 
O5 0.0345(7) 0.0343(7) 0.0169(6) 0.0026(5) 0.0039(5) 0.0051(6) 
C1 0.0271(9) 0.0241(9) 0.0199(8) -0.0005(7) 0.0001(7) -0.0008(7) 
C2 0.0183(8) 0.0207(8) 0.0193(8) 0.0035(7) -0.0015(7) 0.0013(6) 
C3 0.0187(8) 0.0197(8) 0.0186(8) 0.0026(7) 0.0015(7) 0.0014(6) 
C4 0.0200(8) 0.0265(9) 0.0164(8) 0.0027(7) -0.0012(7) 0.0034(7) 
C5 0.0246(9) 0.036(1) 0.0161(8) 0.0019(8) -0.0026(7) 0.0060(7) 
C6 0.0224(8) 0.0348(10) 0.0228(9) -0.0023(8) -0.0080(7) 0.0023(8) 
C7 0.0208(8) 0.0294(9) 0.0296(9) -0.0012(8) -0.0072(8) -0.0013(7) 
C8 0.0179(8) 0.0331(10) 0.0210(8) 0.0026(7) -0.0045(7) -0.0032(7) 
C9 0.0150(8) 0.0317(9) 0.0176(8) 0.0028(7) -0.0026(7) 0.0038(7) 
C10 0.0184(8) 0.0282(9) 0.0186(8) 0.0024(7) 0.0005(7) 0.0026(7) 
C11 0.0210(8) 0.0224(8) 0.0147(8) 0.0007(7) -0.0012(7) 0.0000(7) 
C12 0.0385(11) 0.0267(9) 0.0381(10) -0.0021(8) 0.0006(8) 0.0035(8) 
C13 0.0298(10) 0.0347(10) 0.0292(10) -0.0027(8) -0.0039(8) -0.0026(8) 
C14 0.0202(9) 0.0251(9) 0.0361(10) -0.0020(8) -0.0015(8) 0.0028(7) 
C15 0.0395(12) 0.0346(11) 0.0541(13) 0.0109(10) -0.020(1) 0.0016(9) 
C16 0.0300(9) 0.0313(10) 0.0172(8) 0.0045(7) 0.0005(7) 0.0071(7) 
C17 0.0449(12) 0.0395(11) 0.0274(10) -0.0066(9) -0.0047(9) -0.0003(9) 
C18 0.0208(9) 0.0420(11) 0.0377(10) -0.0066(9) -0.0013(8) -0.0060(8) 
C19 0.0318(11) 0.0641(15) 0.0600(15) 0.0065(12) 0.0083(11) -0.0191(11) 
C20 0.0210(9) 0.0388(10) 0.0245(9) 0.0021(8) 0.0024(7) 0.0026(7) 
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Table E3.18 Bond Distances in Compound (+)-3.22-b, Å 
O1-C1 1.456(2)   O1-C11 1.450(2)   O2-C1 1.429(2) 
O2-C2 1.436(2)   O3-C3 1.4375(19)   O3-C14 1.403(2) 
O4-C14 1.409(2)   O4-C15 1.423(3)   O5-C5 1.439(2) 
C1-C12 1.515(3)   C1-C13 1.515(3)   C2-C3 1.528(2) 
C2-C11 1.519(2)   C3-C4 1.548(2)   C4-C5 1.549(2) 
C4-C9 1.562(2)   C4-C16 1.548(2)   C5-C6 1.515(3) 
C6-C7 1.326(3)   C6-C17 1.506(3)   C7-C8 1.510(3) 
C8-C9 1.550(2)   C8-C18 1.517(2)   C9-C10 1.547(2) 
C10-C11 1.532(2)   C10-C20 1.532(2)   C18-C19 1.320(3) 
 
 
Table E3.19 Bond Angles in Compound (+)-3.22-b, ° 
C11-O1-C1 108.18(12)   C1-O2-C2 105.87(12)   C14-O3-C3 115.20(12) 
C14-O4-C15 112.17(14)   O1-C1-C12 109.85(15)   O1-C1-C13 108.42(14) 
O2-C1-O1 105.47(13)   O2-C1-C12 108.33(14)   O2-C1-C13 110.89(14) 
C12-C1-C13 113.58(15)   O2-C2-C3 112.98(13)   O2-C2-C11 101.58(13) 
C11-C2-C3 115.40(13)   O3-C3-C2 106.17(12)   O3-C3-C4 109.48(13) 
C2-C3-C4 114.64(13)   C3-C4-C5 109.57(13)   C3-C4-C9 111.92(13) 
C3-C4-C16 108.06(14)   C5-C4-C9 110.78(14)   C16-C4-C5 106.16(13) 
C16-C4-C9 110.15(13)   O5-C5-C4 110.46(14)   O5-C5-C6 108.65(15) 
C6-C5-C4 115.51(14)   C7-C6-C5 121.20(16)   C7-C6-C17 122.68(18) 
C17-C6-C5 116.09(16)   C6-C7-C8 126.22(17)   C7-C8-C9 113.05(14) 
C7-C8-C18 106.68(14)   C18-C8-C9 112.69(15)   C8-C9-C4 114.36(14) 
C10-C9-C4 109.40(13)   C10-C9-C8 113.86(13)   C11-C10-C9 111.06(13) 
C11-C10-C20 109.16(14)   C20-C10-C9 115.61(14)   O1-C11-C2 100.91(12) 
O1-C11-C10 111.25(13)   C2-C11-C10 114.34(13)   O3-C14-O4 113.62(15) 
C19-C18-C8 124.73(19)            
 
 
This report has been created with Olex2 [6], compiled on 2017.03.21 svn.r3399 for OlexSys. 
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